Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
Physical measures,X4270.Volume level set by participant (left),GAST,Gastrin,35301,0.0735716896133105,0.0174031989319514,0.0394614197066858,0.107681959519935,2.39464091827562e-05
Physical measures,X4270.Volume level set by participant (left),SPOCK1,Testican-1,36179,-0.306258472566942,0.0730418897948727,-0.449420576564892,-0.163096368568991,2.78527149611739e-05
Physical measures,X4270.Volume level set by participant (left),ANXA10,Annexin A10,36064,0.0898642298430233,0.0242801538530802,0.0422751282909861,0.13745333139506,0.00021617947282816
Physical measures,X4270.Volume level set by participant (left),SMPD1,Sphingomyelin phosphodiesterase,36299,0.128812654047173,0.0363546899419806,0.0575574617608907,0.200067846333455,0.000397616200800685
Physical measures,X4270.Volume level set by participant (left),TFF2,Trefoil factor 2,36268,0.114824352561879,0.0325299673300009,0.051065616595077,0.178583088528681,0.000418310491331943
Physical measures,X4270.Volume level set by participant (left),NCAN,Neurocan core protein,36325,-0.171574674056554,0.0491629699491486,-0.267934095156885,-0.0752152529562227,0.000485867988875117
Physical measures,X4270.Volume level set by participant (left),MZB1,Marginal zone B- and B1-cell-specific protein,36258,0.125320744838017,0.036134929719774,0.0544962825872597,0.196145207088774,0.000526970549858285
Physical measures,X4270.Volume level set by participant (left),SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,36271,0.0951399670085946,0.0281918518053797,0.0398839374700505,0.150395996547139,0.000742538937095435
Physical measures,X4270.Volume level set by participant (left),TFF1,Trefoil factor 1,36216,0.0789324817716818,0.0239335986273042,0.0320226284621656,0.125842335081198,0.000978304727470908
Physical measures,X4270.Volume level set by participant (left),WFDC2,WAP four-disulfide core domain protein 2,35869,0.160002044114976,0.0485761209313121,0.0647928470896046,0.255211241140348,0.00099301012608233
Physical measures,X4270.Volume level set by participant (left),IL1A,Interleukin-1 alpha,36103,0.109557025811511,0.0336882264208628,0.0435281020266198,0.175585949596402,0.00115067615452757
Physical measures,X4270.Volume level set by participant (left),BMP6,Bone morphogenetic protein 6,36090,-0.149980227115422,0.0464474471182958,-0.241017223467282,-0.0589432307635621,0.0012474640074684
Physical measures,X4270.Volume level set by participant (left),LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,36232,0.149985771802874,0.0470273325262946,0.0578122000513369,0.242159343554412,0.00143178755538995
Physical measures,X4270.Volume level set by participant (left),COL3A1,Collagen alpha-1(III) chain,35320,-0.292282701980352,0.0918046189207712,-0.472219755065063,-0.11234564889564,0.00146045478770044
Physical measures,X4270.Volume level set by participant (left),DDX53,Probable ATP-dependent RNA helicase DDX53,35133,0.189029099522213,0.0609084668105877,0.0696485045734613,0.308409694470965,0.00192067123013971
Physical measures,X4270.Volume level set by participant (left),IGFL4,Insulin growth factor-like family member 4,35093,-0.0988580007692233,0.0322938159628079,-0.162153880056327,-0.0355621214821197,0.00221349347126425
Physical measures,X4270.Volume level set by participant (left),MANSC1,MANSC domain-containing protein 1,36289,0.208602313617475,0.0682313830198803,0.0748688028985092,0.34233582433644,0.00224124424222834
Physical measures,X4270.Volume level set by participant (left),VTCN1,V-set domain-containing T-cell activation inhibitor 1,36060,0.186212452560885,0.061143446357558,0.0663712977000715,0.306053607421699,0.00233103856125606
Physical measures,X4270.Volume level set by participant (left),HEG1,Protein HEG homolog 1,35165,0.244852421259631,0.0814954564706846,0.0851213265770888,0.404583515942172,0.00267029737935912
Physical measures,X4270.Volume level set by participant (left),STAB2,Stabilin-2,35320,0.237133260765741,0.0794940316116848,0.0813249588068385,0.392941562724643,0.00286433707817996
Physical measures,X4270.Volume level set by participant (left),DRAXIN,Draxin,36179,-0.12998630668506,0.0440855498099407,-0.216393984312544,-0.0435786290575764,0.00320293805232303
Physical measures,X4270.Volume level set by participant (left),IL13RA1,Interleukin-13 receptor subunit alpha-1,36183,0.23450297398507,0.0800909559062706,0.0775247004087793,0.39148124756136,0.00342211097687235
Physical measures,X4270.Volume level set by participant (left),PRSS8,Prostasin,36216,0.131183361848638,0.0455541009137109,0.0418973240577649,0.220469399639512,0.00399130100150726
Physical measures,X4270.Volume level set by participant (left),RANBP1,Ran-specific GTPase-activating protein,35151,-0.125965369374917,0.0439870815511818,-0.212180049215234,-0.0397506895346008,0.00420068236400331
Physical measures,X4270.Volume level set by participant (left),GZMB,Granzyme B,36242,-0.0802374005059175,0.0280621253497073,-0.135239166191344,-0.0252356348204912,0.00425757425060532
Physical measures,X4270.Volume level set by participant (left),BST2,Bone marrow stromal antigen 2,36325,0.102644482816981,0.0359079666388282,0.0322648682048777,0.173024097429084,0.00426730133642102
Physical measures,X4270.Volume level set by participant (left),TCL1A,T-cell leukemia/lymphoma protein 1A,36170,-0.0518272364639038,0.0183932514829191,-0.0878780093704251,-0.0157764635573824,0.00484897223016118
Physical measures,X4270.Volume level set by participant (left),MAG,Myelin-associated glycoprotein,35133,0.130234197887262,0.0463158423259021,0.0394551469284942,0.221013248846031,0.00494010949541539
Physical measures,X4270.Volume level set by participant (left),IL10RB,Interleukin-10 receptor subunit beta,36278,0.175158512585917,0.0637001593615655,0.0503062002372487,0.300010824934586,0.00597832425281086
Physical measures,X4270.Volume level set by participant (left),SMOC1,SPARC-related modular calcium-binding protein 1,36327,-0.15735209477444,0.0576236452006679,-0.270294439367749,-0.0444097501811307,0.0063346010189738
Physical measures,X4270.Volume level set by participant (left),SPON1,Spondin-1,36248,0.155216215533166,0.0568430930626933,0.0438037531302871,0.266628677936045,0.00633624792227617
Physical measures,X4270.Volume level set by participant (left),GMPR,GMP reductase 1,36342,-0.112563924059657,0.0413551183160011,-0.193619955959019,-0.031507892160295,0.00650557914303599
Physical measures,X4270.Volume level set by participant (left),CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,36060,0.113075359754249,0.0416063926920567,0.0315268300778181,0.19462388943068,0.00658813146157267
Physical measures,X4270.Volume level set by participant (left),EIF4B,Eukaryotic translation initiation factor 4B,36179,-0.101517079557899,0.037386329979889,-0.174794286318481,-0.0282398727973165,0.00663552596244367
Physical measures,X4270.Volume level set by participant (left),TGFA,Protransforming growth factor alpha,36242,0.11757987229409,0.0434765814505546,0.0323657726510028,0.202793971937177,0.0068570921821724
Physical measures,X4270.Volume level set by participant (left),BCAN,Brevican core protein,36179,-0.150985638975698,0.0560200994731734,-0.260785033943118,-0.0411862440082785,0.00705006461316846
Physical measures,X4270.Volume level set by participant (left),MMP10,Stromelysin-2,36219,0.0886343178912028,0.0330456473899703,0.023864849006861,0.153403786775545,0.00733022909489196
Physical measures,X4270.Volume level set by participant (left),APLP1,Amyloid-like protein 1,36258,-0.102037312126455,0.0380479615023333,-0.176611316671028,-0.0274633075818819,0.0073382677752976
Physical measures,X4270.Volume level set by participant (left),KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,36216,-0.112770275304785,0.0420947923416602,-0.195276068294439,-0.0302644823151309,0.00740098887784624
Physical measures,X4270.Volume level set by participant (left),IL4R,Interleukin-4 receptor subunit alpha,36242,0.130374802499166,0.04868994335205,0.0349425135291478,0.225807091469184,0.00742983766120606
Physical measures,X4270.Volume level set by participant (left),SPINK1,Serine protease inhibitor Kazal-type 1,36256,0.122047138315883,0.0456338585755106,0.0326047755078824,0.211489501123884,0.00750028566019526
Physical measures,X4270.Volume level set by participant (left),DPP6,Dipeptidyl aminopeptidase-like protein 6,36216,-0.150329501683518,0.0563939964865014,-0.26086173479706,-0.0397972685699748,0.00769903344350404
Physical measures,X4270.Volume level set by participant (left),CRELD1,Protein disulfide isomerase CRELD1,35165,0.160524422708255,0.0602570192592671,0.0424206649600914,0.278628180456418,0.0077407354843507
Physical measures,X4270.Volume level set by participant (left),GPC5,Glypican-5,36179,-0.0906896402908615,0.0341238003245525,-0.157572288926984,-0.0238069916547387,0.0078849147242015
Physical measures,X4270.Volume level set by participant (left),PI3,Elafin,36144,0.0916559909085462,0.0345088395065124,0.0240186654757819,0.159293316341311,0.00792364945500107
Physical measures,X4270.Volume level set by participant (left),CSF2RB,Cytokine receptor common subunit beta,35093,-0.136935965604202,0.0518933537093379,-0.238646938874505,-0.0352249923339001,0.00833998203178075
Physical measures,X4270.Volume level set by participant (left),YOD1,Ubiquitin thioesterase OTU1,35079,-0.0963569355274127,0.0368261425537816,-0.168536174932825,-0.0241776961220008,0.00890332558517218
Physical measures,X4270.Volume level set by participant (left),AFM,Afamin,35325,-0.281553130892889,0.10801945478053,-0.493271262262728,-0.0698349995230507,0.00916736750102155
Physical measures,X4270.Volume level set by participant (left),TLR1,Toll-like receptor 1,35093,-0.223717001065063,0.0859201911460664,-0.392120575711353,-0.0553134264187727,0.00924127802302919
Physical measures,X4270.Volume level set by participant (left),CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,35320,0.141221639968898,0.0543359118950455,0.0347232526546085,0.247720027283187,0.00936871067972471
Physical measures,X4270.Volume level set by participant (left),ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,36179,-0.135177977264859,0.0523176486495018,-0.237720568617882,-0.0326353859118351,0.00979059026656834
Physical measures,X4270.Volume level set by participant (left),TLR3,Toll-like receptor 3,36342,0.0779937330118078,0.0302801699041043,0.0186445999997633,0.137342866023852,0.0100210716046861
Physical measures,X4270.Volume level set by participant (left),BPIFB1,BPI fold-containing family B member 1,36257,0.0750001045227499,0.0291359576618434,0.0178936275055368,0.132106581539963,0.0100675208651995
Physical measures,X4270.Volume level set by participant (left),HEPACAM2,HEPACAM family member 2,35301,0.125250613189515,0.049346752612367,0.0285309780692756,0.221970248309754,0.0111657365570186
Physical measures,X4270.Volume level set by participant (left),DNAJC9,DnaJ homolog subfamily C member 9,35285,-0.0735590302428815,0.0290743164914983,-0.130544690566218,-0.0165733699195449,0.011427905794312
Physical measures,X4270.Volume level set by participant (left),ALPP,"Alkaline phosphatase, placental type",36216,0.0455256254573035,0.0181014026809809,0.010046876202581,0.081004374712026,0.0119225551434256
Physical measures,X4270.Volume level set by participant (left),PQBP1,Polyglutamine-binding protein 1,36060,0.0850094296654821,0.0338600100141175,0.0186438100378118,0.151375049293152,0.0120731165499359
Physical measures,X4270.Volume level set by participant (left),KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,36060,0.0380147887168553,0.0151806290682497,0.00826075574308585,0.0677688216906247,0.0122952877982807
Physical measures,X4270.Volume level set by participant (left),FGFR2,Fibroblast growth factor receptor 2,36289,0.208971386629813,0.0836409602335988,0.0450351045719595,0.372907668687667,0.0124950701259005
Physical measures,X4270.Volume level set by participant (left),REG4,Regenerating islet-derived protein 4,36248,0.0925568782159458,0.0371172000372402,0.019807166142955,0.165306590288937,0.0126650968708885
Physical measures,X4270.Volume level set by participant (left),LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,35305,-0.211424948636055,0.0854149910962183,-0.378838331184643,-0.0440115660874674,0.0133381842575066
Physical measures,X4270.Volume level set by participant (left),ACVRL1,Serine/threonine-protein kinase receptor R3,36163,0.186014633775581,0.0754836928081149,0.0380665958716762,0.333962671679487,0.0137501136351483
Physical measures,X4270.Volume level set by participant (left),BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,36325,0.0966549786527703,0.039238214622474,0.0197480779927213,0.173561879312819,0.0137886226384255
Physical measures,X4270.Volume level set by participant (left),GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,34997,0.109952621906145,0.0446468025345899,0.0224448889383489,0.197460354873941,0.0138148825217531
Physical measures,X4270.Volume level set by participant (left),MEGF11,Multiple epidermal growth factor-like domains protein 11,35079,-0.183953427445858,0.0753118772215738,-0.331564706800142,-0.0363421480915732,0.0146102417046101
Physical measures,X4270.Volume level set by participant (left),CTSF,Cathepsin F,36289,0.114407321410039,0.0468565155993276,0.0225685508353567,0.206246091984721,0.0146426123564626
Physical measures,X4270.Volume level set by participant (left),ANXA2,Annexin A2,35048,-0.0760933265352703,0.0312123463709491,-0.137269525422331,-0.01491712764821,0.0147987218997693
Physical measures,X4270.Volume level set by participant (left),CCS,Copper chaperone for superoxide dismutase,36179,-0.101111845286378,0.0415764391908331,-0.182601666100411,-0.0196220244723453,0.0150407694305498
Physical measures,X4270.Volume level set by participant (left),APOF,Apolipoprotein F,35317,-0.191583579186261,0.0788903111114769,-0.346208588964756,-0.036958569407766,0.0151883293261172
Physical measures,X4270.Volume level set by participant (left),SOX2,Transcription factor SOX-2,35281,0.212820826119972,0.0877451027849035,0.0408404246615609,0.384801227578382,0.0153160102569914
Physical measures,X4270.Volume level set by participant (left),CREG1,Protein CREG1,36162,0.114752420548183,0.0473476146869513,0.0219510957617581,0.207553745334607,0.0153901772084524
Physical measures,X4270.Volume level set by participant (left),MMP7,Matrilysin,36102,0.0932882388678264,0.0386291812012145,0.017575043713446,0.169001434022207,0.0157603599049917
Physical measures,X4270.Volume level set by participant (left),TK1,"Thymidine kinase, cytosolic",35195,0.122276847289955,0.0506569051206233,0.0229893132535335,0.221564381326377,0.0158131728519764
Physical measures,X4270.Volume level set by participant (left),LGALS4,Galectin-4,36232,0.0810245190454528,0.0336552620330275,0.0150602054607189,0.146988832630187,0.0160864390970242
Physical measures,X4270.Volume level set by participant (left),ATP6V1D,V-type proton ATPase subunit D,36216,-0.176431900817476,0.073370478088378,-0.320238037870696,-0.0326257637642549,0.0162107336409542
Physical measures,X4270.Volume level set by participant (left),PRTN3,Myeloblastin,36084,0.0892495275965595,0.0371499527131209,0.0164356202788425,0.162063434914276,0.0163115254479627
Physical measures,X4270.Volume level set by participant (left),F2,Prothrombin,35325,-0.346772840444103,0.144430281902645,-0.629856192973288,-0.0636894879149175,0.0163786560567052
Physical measures,X4270.Volume level set by participant (left),SELE,E-selectin,36364,0.0877294441687034,0.0366474712281878,0.0159004005614553,0.159558487775951,0.0166950511592262
Physical measures,X4270.Volume level set by participant (left),ITGB1BP1,Integrin beta-1-binding protein 1,36060,0.112162249218221,0.0470096700079187,0.0200232960027005,0.204301202433742,0.0170603373307707
Physical measures,X4270.Volume level set by participant (left),DKK3,Dickkopf-related protein 3,36364,-0.149174609356675,0.0625348780623447,-0.271742970358871,-0.0266062483544794,0.0170815060776508
Physical measures,X4270.Volume level set by participant (left),MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",35151,-0.208883437054855,0.0875858017928513,-0.380551608568843,-0.037215265540866,0.0171120190236125
Physical measures,X4270.Volume level set by participant (left),FGF21,Fibroblast growth factor 21,36321,0.0371952117754474,0.0157263150502564,0.00637163427694494,0.0680187892739499,0.0180469956452374
Physical measures,X4270.Volume level set by participant (left),OMD,Osteomodulin,36278,-0.106115679850951,0.0451931609286459,-0.194694275271097,-0.0175370844308047,0.0188973706911794
Physical measures,X4270.Volume level set by participant (left),TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,36179,0.135287070756082,0.0576995905029756,0.0221958733702498,0.248378268141914,0.0190691003789541
Physical measures,X4270.Volume level set by participant (left),IL6,Interleukin-6,36216,0.0592174878462751,0.0252577036274873,0.00971238873640004,0.10872258695615,0.019076548519293
Physical measures,X4270.Volume level set by participant (left),COMMD9,COMM domain-containing protein 9,35279,-0.128773955809795,0.054934402577731,-0.236445384862148,-0.0211025267574423,0.0191001492460184
Physical measures,X4270.Volume level set by participant (left),KLK8,Kallikrein-8,36026,0.126082843310111,0.0539169799492332,0.0204055626096137,0.231760124010608,0.0193896657346628
Physical measures,X4270.Volume level set by participant (left),PIGR,Polymeric immunoglobulin receptor,36143,0.117140683744458,0.0501786302666688,0.0187905684217872,0.215490799067129,0.0195970584412303
Physical measures,X4270.Volume level set by participant (left),NMRK2,Nicotinamide riboside kinase 2,35095,-0.137738077751995,0.0590662301946959,-0.253507888933599,-0.0219682665703911,0.0197350105665077
Physical measures,X4270.Volume level set by participant (left),GHRL,Appetite-regulating hormone,36258,-0.0539650291554776,0.023144540430054,-0.0993283283983834,-0.00860172991257178,0.0197447821849132
Physical measures,X4270.Volume level set by participant (left),GABARAP,Gamma-aminobutyric acid receptor-associated protein,35279,-0.10846712162422,0.0465513991283718,-0.199707863915829,-0.0172263793326111,0.0198331225045846
Physical measures,X4270.Volume level set by participant (left),SPINK6,Serine protease inhibitor Kazal-type 6,36327,0.0801298176705092,0.0345509738543105,0.0124099089160606,0.147849726424958,0.0204114067912843
Physical measures,X4270.Volume level set by participant (left),CRHBP,Corticotropin-releasing factor-binding protein,36232,0.160177511489026,0.0692327698822684,0.0244812825197799,0.295873740458272,0.0207156666736372
Physical measures,X4270.Volume level set by participant (left),SELL,L-selectin,35325,-0.217325408204839,0.0939852058129036,-0.40153641159813,-0.0331144048115475,0.0207892173501795
Physical measures,X4270.Volume level set by participant (left),FSTL3,Follistatin-related protein 3,36228,0.136373862840568,0.0590821484801937,0.0205728518193881,0.252174873861747,0.0210142214939939
Physical measures,X4270.Volume level set by participant (left),LCN15,Lipocalin-15,35305,0.082808090462289,0.0359087679434164,0.0124269052931929,0.153189275631385,0.0211371564085705
Physical measures,X4270.Volume level set by participant (left),HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,35305,-0.104975686796281,0.0455388004651692,-0.194231735708013,-0.0157196378845495,0.0211862126779205
Physical measures,X4270.Volume level set by participant (left),RGS8,Regulator of G-protein signaling 8,36103,0.0695860269132384,0.0302644497283819,0.0102677054456099,0.128904348380867,0.0215171752780519
Physical measures,X4270.Volume level set by participant (left),PRCP,Lysosomal Pro-X carboxypeptidase,36299,0.134993022281101,0.0587864759181145,0.0197715294815961,0.250214515080605,0.0216838829659407
Physical measures,X4270.Volume level set by participant (left),CST6,Cystatin-M,36061,0.0881266072639819,0.0384485189929416,0.0127675100378164,0.163485704490147,0.0219294653548576
Physical measures,X4270.Volume level set by participant (left),AGR3,Anterior gradient protein 3,36054,0.0739756221506368,0.0322767450362659,0.0107132018795556,0.137238042421718,0.0219381877644667
Physical measures,X4270.Volume level set by participant (left),DTYMK,Thymidylate kinase,35313,-0.0763920555467278,0.0333898660947922,-0.14183619309252,-0.0109479180009351,0.0221753881622247
Physical measures,X4270.Volume level set by participant (left),CCER2,Coiled-coil domain-containing glutamate-rich protein 2,35151,-0.0788612756122677,0.0344741440015463,-0.146430597855299,-0.0112919533692369,0.0221955700840229
Physical measures,X4270.Volume level set by participant (left),SELENOP,Selenoprotein P,35325,-0.219159809645515,0.0964094392633386,-0.408122310601658,-0.030197308689371,0.0230443733272889
Physical measures,X4270.Volume level set by participant (left),TNR,Tenascin-R,36179,-0.10120736986903,0.0445718772851468,-0.188568249347918,-0.0138464903901428,0.0231958017736452
Physical measures,X4270.Volume level set by participant (left),ZFYVE19,Abscission/NoCut checkpoint regulator,35285,-0.0580293896929249,0.0255802439513563,-0.108166667837583,-0.00789211154826645,0.0233290694322676
Physical measures,X4270.Volume level set by participant (left),CRADD,Death domain-containing protein CRADD,36168,-0.0613868763305764,0.027091440938376,-0.114486100569793,-0.00828765209135939,0.0234847818823995
Physical measures,X4270.Volume level set by participant (left),SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",35151,-0.162487576245404,0.0717743505574929,-0.30316530333809,-0.0218098491527182,0.0236148802960171
Physical measures,X4270.Volume level set by participant (left),AFP,Alpha-fetoprotein,36155,-0.065142471357216,0.0287889050892574,-0.121568725332161,-0.00871621738227144,0.0236785780864145
Physical measures,X4270.Volume level set by participant (left),GGT1,Glutathione hydrolase 1 proenzyme,36238,0.081816429835763,0.0361732667687892,0.0109168269689361,0.15271603270259,0.0237382171686312
Physical measures,X4270.Volume level set by participant (left),NECTIN4,Nectin-4,36289,0.130011656090569,0.0576436512537507,0.0170300996332181,0.242993212547921,0.02413388386621
Physical measures,X4270.Volume level set by participant (left),EDAR,Tumor necrosis factor receptor superfamily member EDAR,36242,-0.0458676202777753,0.0204453141292683,-0.0859404359711411,-0.00579480458440948,0.0248976735739657
Physical measures,X4270.Volume level set by participant (left),BMPER,BMP-binding endothelial regulator protein,35165,0.21559328929857,0.096138247951399,0.027162323313828,0.404024255283312,0.0249601375834233
Physical measures,X4270.Volume level set by participant (left),NT5C3A,Cytosolic 5'-nucleotidase 3A,36225,-0.0523817094977606,0.0233960104133941,-0.098237889908013,-0.00652552908750811,0.0251901014894052
Physical measures,X4270.Volume level set by participant (left),TRIM26,Tripartite motif-containing protein 26,35095,-0.090403487296877,0.0404129876855196,-0.169612943160495,-0.0111940314332586,0.0253207436122605
Physical measures,X4270.Volume level set by participant (left),CTSZ,Cathepsin Z,36262,0.131897256275592,0.058964597551667,0.0163266450743243,0.247467867476859,0.0253222612328952
Physical measures,X4270.Volume level set by participant (left),COL1A1,Collagen alpha-1(I) chain,36364,-0.174321017018112,0.0780220823015089,-0.327244298329069,-0.0213977357071541,0.0254948397087765
Physical measures,X4270.Volume level set by participant (left),CSNK2A1,Casein kinase II subunit alpha,35305,-0.111313597593388,0.049992131972271,-0.209298176259039,-0.0133290189277364,0.0260056307755854
Physical measures,X4270.Volume level set by participant (left),AARSD1,Alanyl-tRNA editing protein Aarsd1,36216,-0.0778812202301303,0.0349883704090053,-0.146458426231781,-0.0093040142284798,0.0260488837474865
Physical measures,X4270.Volume level set by participant (left),CD27,CD27 antigen,36289,0.100650620236778,0.045319343524026,0.0118247069296868,0.189476533543868,0.0263854406274308
Physical measures,X4270.Volume level set by participant (left),AHNAK,Neuroblast differentiation-associated protein AHNAK,35151,-0.156845428154824,0.0706339701615615,-0.295288009671484,-0.0184028466381634,0.0264163528951142
Physical measures,X4270.Volume level set by participant (left),DNAJA1,DnaJ homolog subfamily A member 1,35095,-0.105766816328474,0.047691629864528,-0.199242410862948,-0.0122912217939987,0.0266082261447478
Physical measures,X4270.Volume level set by participant (left),DUSP13,Dual specificity protein phosphatase 13 isoform A,35279,-0.111931835478385,0.0506239410378422,-0.211154759912556,-0.0127089110442143,0.0270664546753537
Physical measures,X4270.Volume level set by participant (left),CCL16,C-C motif chemokine 16,36364,0.0787500186450056,0.0357416010460413,0.00869648059476469,0.148803556695246,0.0276017997077656
Physical measures,X4270.Volume level set by participant (left),LAMP3,Lysosome-associated membrane glycoprotein 3,36328,0.0783090956238945,0.0356919901738309,0.00835279488318581,0.148265396364603,0.0282633377008998
Physical measures,X4270.Volume level set by participant (left),CHI3L1,Chitinase-3-like protein 1,36094,0.0510485187472256,0.0234254695760141,0.0051345983782379,0.0969624391162132,0.0293487032824639
Physical measures,X4270.Volume level set by participant (left),LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,36247,0.12477587062152,0.0572934567584283,0.0124806953750004,0.237071045868039,0.0294485640331661
Physical measures,X4270.Volume level set by participant (left),PTN,Pleiotrophin,36109,-0.0856050300089607,0.0393127842440068,-0.162658087127214,-0.00855197289070747,0.0294715854085997
Physical measures,X4270.Volume level set by participant (left),SFTPD,Pulmonary surfactant-associated protein D,36258,-0.0605245508292094,0.0278165833500959,-0.115045054195397,-0.00600404746302144,0.0295973973881332
Physical measures,X4270.Volume level set by participant (left),TSNAX,Translin-associated protein X,35079,-0.122119013674336,0.0565097117174083,-0.232878048640457,-0.0113599787082161,0.0307297948997514
Physical measures,X4270.Volume level set by participant (left),SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,35083,-0.0806336436707784,0.0373662901032112,-0.153871572273072,-0.00739571506848452,0.0309703054911195
Physical measures,X4270.Volume level set by participant (left),ACTN2,Alpha-actinin-2,35079,-0.0737005725715756,0.0342326863207307,-0.140796637760208,-0.00660450738294335,0.0313610097494612
Physical measures,X4270.Volume level set by participant (left),MFAP3L,Microfibrillar-associated protein 3-like,35133,-0.0792023412287294,0.0368410782887823,-0.151410854674743,-0.00699382778271605,0.0316046683167069
Physical measures,X4270.Volume level set by participant (left),COL2A1,Collagen alpha-1(II) chain,35151,-0.061560594716573,0.0286646036157386,-0.117743217803421,-0.00537797162972541,0.0317807727152761
Physical measures,X4270.Volume level set by participant (left),LXN,Latexin,36138,-0.056771141561188,0.0265039108635922,-0.108718806853829,-0.00482347626854727,0.0322261589196534
Physical measures,X4270.Volume level set by participant (left),LTA4H,Leukotriene A-4 hydrolase,36327,-0.0721835002124901,0.033733415041708,-0.138300993694238,-0.00606600673074233,0.0324004038392706
Physical measures,X4270.Volume level set by participant (left),OPTC,Opticin,36216,0.0893370097916795,0.0418517890610273,0.00730750323206589,0.171366516351293,0.0328251901542756
Physical measures,X4270.Volume level set by participant (left),ASS1,Argininosuccinate synthase,35079,0.0623549912727592,0.0293112744263917,0.00490489339703148,0.119805089148487,0.0334296814786147
Physical measures,X4270.Volume level set by participant (left),CDH15,Cadherin-15,36314,-0.057517268141887,0.027039018769601,-0.110513744930305,-0.0045207913534691,0.033435526094127
Physical measures,X4270.Volume level set by participant (left),DMP1,Dentin matrix acidic phosphoprotein 1,35151,-0.0804788650276275,0.0379300211003804,-0.154821706384373,-0.00613602367088191,0.0338943212409602
Physical measures,X4270.Volume level set by participant (left),TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,36179,0.110399118928232,0.0520523210387562,0.00837656969227028,0.212421668164194,0.0339604260931838
Physical measures,X4270.Volume level set by participant (left),TREML1,Trem-like transcript 1 protein,35317,-0.0870950061796931,0.0411004673827039,-0.167651922249793,-0.00653809010959343,0.0341206717236714
Physical measures,X4270.Volume level set by participant (left),GDF15,Growth/differentiation factor 15,36364,0.0854155414064885,0.0403593338556826,0.00631124704935065,0.164519835763626,0.0343445543866995
Physical measures,X4270.Volume level set by participant (left),MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,35285,-0.0749957903917827,0.0354436326502098,-0.144465310386194,-0.00552627039737151,0.0343887419139777
Physical measures,X4270.Volume level set by participant (left),CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,35982,0.0642506710602075,0.0303846548152893,0.00469674762224043,0.123804594498175,0.0344995172008854
Physical measures,X4270.Volume level set by participant (left),TREM2,Triggering receptor expressed on myeloid cells 2,36232,0.0745778819493876,0.0354099956896766,0.00517429039762157,0.143981473501154,0.0352260667001921
Physical measures,X4270.Volume level set by participant (left),CLUL1,Clusterin-like protein 1,36252,-0.0872643929414047,0.041497794169901,-0.168600069514411,-0.00592871636839869,0.0355098776825844
Physical measures,X4270.Volume level set by participant (left),LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,36364,0.140450579214477,0.0668098359191265,0.00950330081298914,0.271397857615965,0.0355640386714958
Physical measures,X4270.Volume level set by participant (left),LY96,Lymphocyte antigen 96,36179,0.108485867091901,0.0516114399764068,0.00732744473814395,0.209644289445659,0.0355885446843943
Physical measures,X4270.Volume level set by participant (left),ICAM2,Intercellular adhesion molecule 2,36364,0.120777479063261,0.0575160052771015,0.00804610872014208,0.23350884940638,0.0357704195616283
Physical measures,X4270.Volume level set by participant (left),ACP5,Tartrate-resistant acid phosphatase type 5,36288,0.118619821425001,0.056597453599349,0.00768881237027656,0.229550830479725,0.0361280520205436
Physical measures,X4270.Volume level set by participant (left),PSMD1,26S proteasome non-ATPase regulatory subunit 1,35305,-0.092807880290838,0.0442925962306663,-0.179621368902944,-0.00599439167873213,0.0361785474430967
Physical measures,X4270.Volume level set by participant (left),CD40LG,CD40 ligand,36342,-0.0490539434686708,0.0234142170255714,-0.0949458088387907,-0.00316207809855085,0.0361990157684571
Physical measures,X4270.Volume level set by participant (left),CGA,Glycoprotein hormones alpha chain,36256,0.0633574474472966,0.0303077858500829,0.00395418718113409,0.122760707713459,0.0366087196041072
Physical measures,X4270.Volume level set by participant (left),RNF43,E3 ubiquitin-protein ligase RNF43,35195,-0.0808331905419632,0.0387448159963712,-0.156773029894851,-0.00489335118907561,0.036990078241896
Physical measures,X4270.Volume level set by participant (left),NHLRC3,NHL repeat-containing protein 3,35012,0.142950593746802,0.0686665305744906,0.00836419382080081,0.277536993672804,0.0373995138571726
Physical measures,X4270.Volume level set by participant (left),NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],36216,-0.0696402576252698,0.0334593222249504,-0.135220529186173,-0.00405998606436705,0.0374360454439336
Physical measures,X4270.Volume level set by participant (left),IL19,Interleukin-19,36067,0.0555957089129872,0.0268127429089255,0.00304273281149328,0.108148685014481,0.0381617717673138
Physical measures,X4270.Volume level set by participant (left),RTBDN,Retbindin,36216,-0.130654357422175,0.0630249472373067,-0.254183254007296,-0.00712546083705433,0.0382004640372485
Physical measures,X4270.Volume level set by participant (left),PNLIPRP1,Inactive pancreatic lipase-related protein 1,35301,0.0538374085948089,0.026108012696322,0.00266570371001788,0.1050091134796,0.0392364233301143
Physical measures,X4270.Volume level set by participant (left),SLC12A2,Solute carrier family 12 member 2,35079,-0.168036977364904,0.0816074528502414,-0.327987584951377,-0.00808636977843072,0.0395256467031588
Physical measures,X4270.Volume level set by participant (left),KLK14,Kallikrein-14,36327,0.0827032843331611,0.040236634835519,0.00383948005554381,0.161567088610778,0.0398717609772867
Physical measures,X4270.Volume level set by participant (left),ABHD14B,Protein ABHD14B,36160,-0.0704316072054046,0.0343306446876156,-0.137719670793131,-0.00314354361767813,0.0402461826745876
Physical measures,X4270.Volume level set by participant (left),TPP1,Tripeptidyl-peptidase 1,36177,0.0816835888364238,0.0398557380662392,0.00356634222659501,0.159800835446253,0.0404494461852724
Physical measures,X4270.Volume level set by participant (left),CD48,CD48 antigen,36268,0.128505476923134,0.0628264367872751,0.00536566082007479,0.251645293026193,0.0408490628515931
Physical measures,X4270.Volume level set by participant (left),GOT1,"Aspartate aminotransferase, cytoplasmic",35320,-0.105337037345741,0.0515117124650048,-0.20629999377715,-0.00437408091433139,0.040902199004127
Physical measures,X4270.Volume level set by participant (left),FGF7,Fibroblast growth factor 7,35095,-0.0599293692689353,0.0293358186424349,-0.117427573808108,-0.0024311647297629,0.0411052547285635
Physical measures,X4270.Volume level set by participant (left),SPINK2,Serine protease inhibitor Kazal-type 2,35165,0.121158252404281,0.0594323997606573,0.00467074887339244,0.237645755935169,0.0415310389968096
Physical measures,X4270.Volume level set by participant (left),TGOLN2,Trans-Golgi network integral membrane protein 2,35317,0.166237733289409,0.0818178833190928,0.00587468198398675,0.326600784594831,0.0422130079276313
Physical measures,X4270.Volume level set by participant (left),TSHB,Thyrotropin subunit beta,36258,-0.0564938986833882,0.0278362648234684,-0.111052977737386,-0.00193481962939011,0.0424411851078357
Physical measures,X4270.Volume level set by participant (left),GPRC5C,G-protein coupled receptor family C group 5 member C,35279,0.0805411132816169,0.0398353270380019,0.00246387228713323,0.1586183542761,0.0432315136573545
Physical measures,X4270.Volume level set by participant (left),FABP9,Fatty acid-binding protein 9,36242,0.0681385189727353,0.0337527679194195,0.00198309385067309,0.134293944094798,0.0435477158612468
Physical measures,X4270.Volume level set by participant (left),CX3CL1,Fractalkine,36179,0.114891605546969,0.0570267969368989,0.00311908355064683,0.22666412754329,0.043971876057954
Physical measures,X4270.Volume level set by participant (left),LYPD3,Ly6/PLAUR domain-containing protein 3,36245,0.112887195679748,0.0561849550418998,0.00276468379762419,0.223009707561872,0.0445503014798264
Physical measures,X4270.Volume level set by participant (left),CSF1,Macrophage colony-stimulating factor 1,36278,0.14196036441901,0.0706630508638237,0.00346078472591524,0.280459944112104,0.0445746454442128
Physical measures,X4270.Volume level set by participant (left),CHGA,Chromogranin-A,35320,0.0519368575916831,0.0259179267099626,0.00113772124015647,0.10273599394321,0.0451211694152297
Physical measures,X4270.Volume level set by participant (left),GOLM2,Protein GOLM2,36325,0.15791669730852,0.0789934048182615,0.0030896238647278,0.312743770752313,0.0456311737655125
Physical measures,X4270.Volume level set by participant (left),PTPRK,Receptor-type tyrosine-protein phosphatase kappa,35285,-0.196469221616814,0.0984438034017532,-0.389419076284251,-0.00351936694937799,0.0460016635473259
Physical measures,X4270.Volume level set by participant (left),TNFAIP8,Tumor necrosis factor alpha-induced protein 8,36103,-0.103701550943141,0.0519789233809378,-0.205580240769779,-0.00182286111650265,0.0460714491385699
Physical measures,X4270.Volume level set by participant (left),RABGAP1L,Rab GTPase-activating protein 1-like,36103,-0.0645906312579316,0.0323919582871742,-0.128078869500793,-0.00110239301507016,0.0461846026154095
Physical measures,X4270.Volume level set by participant (left),CLTA,Clathrin light chain A,36109,-0.0837227201847966,0.042037335296691,-0.166115897366311,-0.0013295430032822,0.0464481019096094
Physical measures,X4270.Volume level set by participant (left),VCPKMT,Protein-lysine methyltransferase METTL21D,35095,-0.0531996338171167,0.026713010997312,-0.105557135371848,-0.000842132262385185,0.0464650114857862
Physical measures,X4270.Volume level set by participant (left),DDA1,DET1- and DDB1-associated protein 1,35079,-0.12065143288661,0.0606235594689311,-0.239473609445715,-0.00182925632750519,0.0466137425059533
Physical measures,X4270.Volume level set by participant (left),PPY,Pancreatic prohormone,36231,0.0368683605181866,0.0186312169932419,0.000351175211432547,0.0733855458249407,0.0478689454075173
Physical measures,X4270.Volume level set by participant (left),PPME1,Protein phosphatase methylesterase 1,36216,-0.0659195738994959,0.0334362120491333,-0.131454549515797,-0.000384598283194537,0.0487025875000313
Physical measures,X4270.Volume level set by participant (left),SMAD2,Mothers against decapentaplegic homolog 2,35279,-0.0607984930311296,0.0308743237254553,-0.121312167533022,-0.000284818529237119,0.0489685389657607
Physical measures,X4270.Volume level set by participant (left),MELTF,Melanotransferrin,35313,-0.141721247765556,0.0720193231703,-0.282879121179344,-0.000563374351767676,0.0491295781265399
Physical measures,X4270.Volume level set by participant (left),GHRHR,Growth hormone-releasing hormone receptor,36064,-0.0701458231002999,0.0356676083363283,-0.140054335439503,-0.000237310761096482,0.0492601908785126
Physical measures,X4270.Volume level set by participant (left),GYS1,"Glycogen [starch] synthase, muscle",36109,-0.0411505162735693,0.020925402598057,-0.082164305365761,-0.000136727181377486,0.0492737443999853
Physical measures,X4270.Volume level set by participant (left),TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,36248,0.106561751669657,0.0542360057386235,0.000259180421955052,0.212864322917359,0.0494760115395698
Physical measures,X4270.Volume level set by participant (left),QPCT,Glutaminyl-peptide cyclotransferase,36268,0.132548289390369,0.0674740495390306,0.000299152293869287,0.264797426486869,0.0495159053769897
Physical measures,X4270.Volume level set by participant (left),HSP90B1,Endoplasmin,36023,-0.0587234972345132,0.0299831974626824,-0.117490564261371,4.3569792344357e-05,0.0502032852057831
Physical measures,X4270.Volume level set by participant (left),CTSD,Cathepsin D,35776,0.0992111266788139,0.0508699871372893,-0.000494048110273135,0.198916301467901,0.0511806968866929
Physical measures,X4270.Volume level set by participant (left),NCAM2,Neural cell adhesion molecule 2,36256,-0.13320065950247,0.0684752560113862,-0.267412161284787,0.00101084227984699,0.0517829312084375
Physical measures,X4270.Volume level set by participant (left),JPT2,Jupiter microtubule associated homolog 2,35285,-0.0512464325963005,0.0263681711921681,-0.10292804813295,0.000435182940349006,0.051998202517764
Physical measures,X4270.Volume level set by participant (left),TNFRSF17,Tumor necrosis factor receptor superfamily member 17,35165,0.104095245708137,0.0536233962250741,-0.00100661089300778,0.209197102309283,0.0522733698194834
Physical measures,X4270.Volume level set by participant (left),ATP1B4,Protein ATP1B4,35095,-0.10863368878521,0.0560308846687654,-0.218454222735991,0.0011868451655699,0.0525667844014914
Physical measures,X4270.Volume level set by participant (left),UBE2B,Ubiquitin-conjugating enzyme E2 B,35279,-0.149318678001089,0.0770566403913808,-0.300349693168195,0.00171233716601712,0.0526924050813706
Physical measures,X4270.Volume level set by participant (left),VGF,Neurosecretory protein VGF,35305,-0.141696478002924,0.0732008816422273,-0.28517020602169,0.0017772500158415,0.0529438962859375
Physical measures,X4270.Volume level set by participant (left),FKBPL,FK506-binding protein-like,35285,-0.0736421684497474,0.0380626774594574,-0.148245016270284,0.000960679370789058,0.0530618364596857
Physical measures,X4270.Volume level set by participant (left),DGKA,Diacylglycerol kinase alpha,35093,-0.0803016324623062,0.0415232495873029,-0.16168720165342,0.0010839367288074,0.0531693823885424
Physical measures,X4270.Volume level set by participant (left),TNFSF13,Tumor necrosis factor ligand superfamily member 13,36278,-0.132219861522795,0.0683995602378324,-0.266282999588947,0.00184327654335648,0.0532666126469442
Physical measures,X4270.Volume level set by participant (left),STXBP3,Syntaxin-binding protein 3,36060,-0.0827961378071943,0.042915322681175,-0.166910170262297,0.00131789464790869,0.05373266750637
Physical measures,X4270.Volume level set by participant (left),ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,36109,-0.117124930773563,0.0607982554498367,-0.236289511455243,0.00203964990811675,0.0540856531848083
Physical measures,X4270.Volume level set by participant (left),L1CAM,Neural cell adhesion molecule L1,36289,0.121385150426753,0.0631748743931679,-0.00243760338385629,0.245207904237362,0.0547163499902218
Physical measures,X4270.Volume level set by participant (left),MYBPC1,"Myosin-binding protein C, slow-type",35313,-0.0539117509336729,0.0280601358609039,-0.108909617221045,0.00108611535369871,0.0547370573072357
Physical measures,X4270.Volume level set by participant (left),BEX3,Protein BEX3,35095,-0.0938309122018092,0.0488826518308137,-0.189640909790204,0.00197908538658562,0.0549631557582456
Physical measures,X4270.Volume level set by participant (left),NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,35093,-0.093895129011255,0.0489796222230849,-0.189895188568501,0.00210493054599147,0.0552786949565937
Physical measures,X4270.Volume level set by participant (left),TLR2,Toll-like receptor 2,35195,0.181067066587324,0.0944741293375281,-0.00410222691423065,0.366236360088879,0.0553347170509337
Physical measures,X4270.Volume level set by participant (left),DNPEP,Aspartyl aminopeptidase,35301,-0.0763517429857642,0.0399068688656699,-0.154569205962477,0.00186571999094876,0.055758880222257
Physical measures,X4270.Volume level set by participant (left),IGDCC3,Immunoglobulin superfamily DCC subclass member 3,35083,-0.0876911434219364,0.0458703699070042,-0.177597068439665,0.00221478159579183,0.0559566248099811
Physical measures,X4270.Volume level set by participant (left),ATP5F1D,"ATP synthase subunit delta, mitochondrial",35079,0.0821215560051784,0.043007721588528,-0.00217357830833649,0.166416690318693,0.0562468239533921
Physical measures,X4270.Volume level set by participant (left),PLA2G15,Phospholipase A2 group XV,36289,0.131394771246023,0.0688611859966237,-0.00357315330735969,0.266362695799405,0.0564141211420422
Physical measures,X4270.Volume level set by participant (left),GFRAL,GDNF family receptor alpha-like,35100,-0.0668241288457764,0.035065776340715,-0.135553050473578,0.0019047927820251,0.0567359023205133
Physical measures,X4270.Volume level set by participant (left),PRAP1,Proline-rich acidic protein 1,35320,0.105676839387232,0.0555580608595206,-0.00321695989742836,0.214570638671892,0.0572011650197382
Physical measures,X4270.Volume level set by participant (left),CRH,Corticoliberin,36038,-0.0423247477549262,0.0222709131208879,-0.0859757374718666,0.00132624196201417,0.0574127861689171
Physical measures,X4270.Volume level set by participant (left),CD34,Hematopoietic progenitor cell antigen CD34,36301,0.149515674870519,0.0786766949052736,-0.00469064714381698,0.303721996884856,0.0574204971399344
Physical measures,X4270.Volume level set by participant (left),STAMBP,STAM-binding protein,36168,-0.0604713411454059,0.0319525948563241,-0.123098427063801,0.00215574477298933,0.0584581389987797
Physical measures,X4270.Volume level set by participant (left),TCN1,Transcobalamin-1,35155,0.128751392386111,0.068032045003434,-0.00459141582062,0.262094200592841,0.0584669713039681
Physical measures,X4270.Volume level set by participant (left),MEP1B,Meprin A subunit beta,36258,-0.0309586986245,0.0163591583529682,-0.0630226489963176,0.00110525174731772,0.0584702958639281
Physical measures,X4270.Volume level set by participant (left),SCRN1,Secernin-1,36242,-0.06404553570173,0.0338525313682372,-0.130396497183475,0.00230542578001484,0.0585423602499732
Physical measures,X4270.Volume level set by participant (left),KIAA1549,UPF0606 protein KIAA1549,35195,-0.0626908676852686,0.0331777126280971,-0.127719184436339,0.0023374490658018,0.0588623311526152
Physical measures,X4270.Volume level set by participant (left),SLURP1,Secreted Ly-6/uPAR-related protein 1,35269,0.110994590023808,0.0589118690033862,-0.00447267322282846,0.226461853270445,0.0595978290328832
Physical measures,X4270.Volume level set by participant (left),PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,35165,-0.0743289979031305,0.0394696881459257,-0.151689586669145,0.00303159086288382,0.0597185537989717
Physical measures,X4270.Volume level set by participant (left),LACRT,Extracellular glycoprotein lacritin,35262,-0.0972845143915406,0.0516892004859519,-0.198595347344006,0.00402631856092524,0.0598653013718126
Physical measures,X4270.Volume level set by participant (left),IL15,Interleukin-15,36242,0.107607640750021,0.0572525145903762,-0.00460728784711675,0.219822569347158,0.0602106178030037
Physical measures,X4270.Volume level set by participant (left),C9orf40,Uncharacterized protein C9orf40,35285,-0.0511350756946932,0.0272104438791398,-0.104467545697807,0.00219739430842068,0.0602546086685852
Physical measures,X4270.Volume level set by participant (left),PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,36179,-0.120121486610754,0.0639856059792525,-0.245533274330088,0.00529030110858139,0.0605125795551037
Physical measures,X4270.Volume level set by participant (left),CCL21,C-C motif chemokine 21,36278,0.0914539359232254,0.0487207815447293,-0.00403879590444407,0.186946667750895,0.060541849668253
Physical measures,X4270.Volume level set by participant (left),FCER2,Low affinity immunoglobulin epsilon Fc receptor,36256,-0.0683054712936208,0.0365382730700357,-0.139920486510891,0.00330954392364921,0.0616022100784825
Physical measures,X4270.Volume level set by participant (left),PSCA,Prostate stem cell antigen,35285,-0.0157561068319787,0.00844626964543854,-0.0323107953370382,0.000798581673080886,0.062161928084168
Physical measures,X4270.Volume level set by participant (left),DKKL1,Dickkopf-like protein 1,36216,-0.041895945126239,0.0224674969351592,-0.085932239119151,0.00214034886667298,0.0622569001776819
Physical measures,X4270.Volume level set by participant (left),NEB,Nebulin,35079,-0.106567118164479,0.0572027767962722,-0.218684560685172,0.00555032435621464,0.0625115765885023
Physical measures,X4270.Volume level set by participant (left),ZNRF4,E3 ubiquitin-protein ligase ZNRF4,35279,-0.0769209958101982,0.0414933609465521,-0.15824798326544,0.00440599164504386,0.0638097775268622
Physical measures,X4270.Volume level set by participant (left),CXCL8,Interleukin-8,36206,0.0532762009596095,0.0287423185030209,-0.00305874330631155,0.10961114522553,0.0638379098354542
Physical measures,X4270.Volume level set by participant (left),APRT,Adenine phosphoribosyltransferase,36168,-0.0813113704448642,0.0438760630171723,-0.167308453958522,0.00468571306879344,0.0638917908290841
Physical measures,X4270.Volume level set by participant (left),SORBS1,Sorbin and SH3 domain-containing protein 1,35305,-0.10467801672598,0.0565177466284497,-0.215452800117741,0.00609676666578172,0.0640516030230085
Physical measures,X4270.Volume level set by participant (left),CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,35285,-0.048960225941892,0.0264763014529134,-0.100853776789602,0.00293332490581816,0.0644717163561005
Physical measures,X4270.Volume level set by participant (left),GZMH,Granzyme H,36109,-0.0439378184098286,0.0238414472296957,-0.0906670549800321,0.00279141816037497,0.0653804753508449
Physical measures,X4270.Volume level set by participant (left),ENOX2,Ecto-NOX disulfide-thiol exchanger 2,35079,-0.144486797907904,0.078502639611444,-0.298351971546335,0.009378375730526,0.0657355635035673
Physical measures,X4270.Volume level set by participant (left),CPQ,Carboxypeptidase Q,35309,0.108410108370791,0.0589441231395371,-0.00712037298270204,0.223940589724283,0.0659297656799193
Physical measures,X4270.Volume level set by participant (left),MRC1,Macrophage mannose receptor 1,35317,0.138843629442045,0.0755524866446335,-0.00923924438143675,0.286926503265527,0.0661491750385182
Physical measures,X4270.Volume level set by participant (left),PAEP,Glycodelin,36179,-0.0326748519536196,0.0177883234735611,-0.0675399659617993,0.00219026205456015,0.0662681217664802
Physical measures,X4270.Volume level set by participant (left),PDGFRA,Platelet-derived growth factor receptor alpha,36258,-0.121874758086061,0.0664422727583028,-0.252101612692334,0.00835209652021299,0.0666489420526165
Physical measures,X4270.Volume level set by participant (left),GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,36327,-0.126893648291116,0.0691875411861785,-0.262501229016026,0.00871393243379373,0.0666845103709981
Physical measures,X4270.Volume level set by participant (left),TERF1,Telomeric repeat-binding factor 1,35093,-0.141117817422477,0.0769468335206578,-0.291933611122967,0.00969797627801208,0.0667049172173539
Physical measures,X4270.Volume level set by participant (left),MATN3,Matrilin-3,36163,-0.106026058712782,0.0578269013602088,-0.219366785378792,0.00731466795322679,0.0667664237423983
Physical measures,X4270.Volume level set by participant (left),ANGPTL4,Angiopoietin-related protein 4,36268,0.0750507251876215,0.041030414621443,-0.00536888747040681,0.15547033784565,0.067416180831064
Physical measures,X4270.Volume level set by participant (left),NPC2,NPC intracellular cholesterol transporter 2,35192,0.127914746839909,0.0699520079135853,-0.00919118867071822,0.265020682350536,0.0675036517455244
Physical measures,X4270.Volume level set by participant (left),CRIP2,Cysteine-rich protein 2,36179,-0.0915518252609323,0.0500877394668332,-0.189723794615925,0.0066201440940607,0.0676145206088244
Physical measures,X4270.Volume level set by participant (left),MYL3,Myosin light chain 3,35151,-0.0517975720480831,0.0283536609295149,-0.107370747469932,0.00377560337376612,0.0677694880600813
Physical measures,X4270.Volume level set by participant (left),KDR,Vascular endothelial growth factor receptor 2,36289,0.135942773499372,0.0744277803521823,-0.00993567599090572,0.281821222989649,0.0678128749532464
Physical measures,X4270.Volume level set by participant (left),CDON,Cell adhesion molecule-related/down-regulated by oncogenes,36248,0.133875027932519,0.0733760039782558,-0.00994193986486189,0.277691995729901,0.0681144796400229
Physical measures,X4270.Volume level set by participant (left),PENK,Proenkephalin-A,35165,0.130088367292107,0.0713464798813582,-0.00975073327535481,0.269927467859569,0.0682984937689091
Physical measures,X4270.Volume level set by participant (left),TBCA,Tubulin-specific chaperone A,35165,-0.0504976996858591,0.02770668814408,-0.104802808448256,0.00380740907653768,0.0684122729140404
Physical measures,X4270.Volume level set by participant (left),EFHD1,EF-hand domain-containing protein D1,35305,0.111268529275515,0.0610802714217629,-0.00844880271113992,0.230985861262171,0.0685485544118105
Physical measures,X4270.Volume level set by participant (left),IL2RG,Cytokine receptor common subunit gamma,35279,-0.114758952589393,0.0630460403627324,-0.238329191700348,0.00881128652156293,0.0687671510490701
Physical measures,X4270.Volume level set by participant (left),CLEC1A,C-type lectin domain family 1 member A,36109,0.10288884534735,0.0566388093923422,-0.00812322106164028,0.213900911756341,0.0693215403216634
Physical measures,X4270.Volume level set by participant (left),NFKBIE,NF-kappa-B inhibitor epsilon,36060,-0.0705419798467655,0.0389102434572882,-0.14680605702305,0.00572209732951931,0.0698810958280639
Physical measures,X4270.Volume level set by participant (left),BLNK,B-cell linker protein,35093,-0.100681398828975,0.0555609303413339,-0.209580822297989,0.00821802464003991,0.0700185073349024
Physical measures,X4270.Volume level set by participant (left),ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,36109,-0.12586801855061,0.06948423981582,-0.262057128589617,0.0103210914883971,0.070109411229248
Physical measures,X4270.Volume level set by participant (left),BDNF,Brain-derived neurotrophic factor,35320,-0.0469870426899309,0.0259595147123396,-0.0978676915261166,0.00389360614625476,0.0703385417023825
Physical measures,X4270.Volume level set by participant (left),SNX18,Sorting nexin-18,35285,-0.0923317270213961,0.0510562145480629,-0.192401907535599,0.00773845349280711,0.0705841206786888
Physical measures,X4270.Volume level set by participant (left),ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,35325,-0.208024817985693,0.115047805181243,-0.433518516140929,0.017468880169543,0.0706263041896254
Physical measures,X4270.Volume level set by participant (left),ATXN2L,Ataxin-2-like protein,35305,-0.0828511144534607,0.0458397490726744,-0.172697022635903,0.00699479372898124,0.0707435577367418
Physical measures,X4270.Volume level set by participant (left),INSL3,Insulin-like 3,35301,-0.0445131269537256,0.0246503429589682,-0.0928277991533031,0.00380154524585201,0.0709973928995448
Physical measures,X4270.Volume level set by participant (left),CBLN4,Cerebellin-4,36327,-0.104975729000463,0.058168731818877,-0.218986443365462,0.00903498536453576,0.0711642905694545
Physical measures,X4270.Volume level set by participant (left),MYOM2,Myomesin-2,35079,-0.0721216176915065,0.0399814278382033,-0.150485216254385,0.00624198087137201,0.0712968865541796
Physical measures,X4270.Volume level set by participant (left),SCGB1A1,Uteroglobin,36249,-0.0625713440558608,0.0347703982975107,-0.130721324718982,0.00557863660726013,0.0719698879178942
Physical measures,X4270.Volume level set by participant (left),CAMLG,Guided entry of tail-anchored proteins factor CAMLG,35133,0.0724855856962365,0.0403101971140691,-0.00652240064733889,0.151493572039812,0.0721923181427971
Physical measures,X4270.Volume level set by participant (left),CXCL16,C-X-C motif chemokine 16,36344,0.145420193086687,0.0809261491106878,-0.0131950591702613,0.304035445343635,0.0723826233990614
Physical measures,X4270.Volume level set by participant (left),CDH1,Cadherin-1,36023,0.0847499829976059,0.0472174220240393,-0.00779616416951111,0.177296130164723,0.072712234944604
Physical measures,X4270.Volume level set by participant (left),WDR46,WD repeat-containing protein 46,35279,-0.113138828972298,0.0631679877278147,-0.236948084918815,0.0106704269742191,0.0733259730341491
Physical measures,X4270.Volume level set by participant (left),TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,35195,-0.0491054486143507,0.0274341962484391,-0.102876473261291,0.00466557603259003,0.0735101230560455
Physical measures,X4270.Volume level set by participant (left),KLHL41,Kelch-like protein 41,35305,-0.0722784975986777,0.0404123444795769,-0.151486692778648,0.00692969758129298,0.0737364623952907
Physical measures,X4270.Volume level set by participant (left),SETMAR,Histone-lysine N-methyltransferase SETMAR,36155,-0.116256731040772,0.0650028211508028,-0.243662260496346,0.011148798414801,0.0737374671787713
Physical measures,X4270.Volume level set by participant (left),NOS2,"Nitric oxide synthase, inducible",35079,-0.101205013321108,0.0566006981940992,-0.212142381781543,0.0097323551393261,0.0738142940427961
Physical measures,X4270.Volume level set by participant (left),REG3A,Regenerating islet-derived protein 3-alpha,36364,0.0527811495698315,0.0295999234016655,-0.00523470029743289,0.110796999437096,0.0746007054326696
Physical measures,X4270.Volume level set by participant (left),RBKS,Ribokinase,36069,-0.0652094468563182,0.0365915383169289,-0.136928861957499,0.0065099682448624,0.0747750419118396
Physical measures,X4270.Volume level set by participant (left),KLK3,Prostate-specific antigen,35320,0.0338236745474167,0.0189824809913591,-0.00338198819564726,0.0710293372904806,0.0748210879807283
Physical measures,X4270.Volume level set by participant (left),CALB2,Calretinin,36064,-0.120796208782851,0.0679472101364837,-0.253972740650359,0.0123803230846568,0.0754782545644997
Physical measures,X4270.Volume level set by participant (left),DLL1,Delta-like protein 1,36289,0.111670860485641,0.0629338180492476,-0.0116794228908848,0.235021143862166,0.0760337135630493
Physical measures,X4270.Volume level set by participant (left),PREB,Prolactin regulatory element-binding protein,36103,0.1158168702958,0.0652859635750076,-0.0121436183112149,0.243777358902815,0.0761048013598252
Physical measures,X4270.Volume level set by participant (left),APP,Amyloid-beta precursor protein,36239,-0.0508852274296223,0.0287271374088585,-0.107190416750985,0.00541996189174038,0.0765457948599799
Physical measures,X4270.Volume level set by participant (left),CLEC14A,C-type lectin domain family 14 member A,36256,0.105443412048006,0.0596264201344857,-0.0114243714155857,0.222311195511598,0.0770337454484645
Physical measures,X4270.Volume level set by participant (left),IL2RA,Interleukin-2 receptor subunit alpha,36220,0.0820518924722438,0.0464230105778339,-0.00893720826031054,0.173040993204798,0.0771873676378376
Physical measures,X4270.Volume level set by participant (left),GLT8D2,Glycosyltransferase 8 domain-containing protein 2,36064,0.0729034398763775,0.0412785832191531,-0.00800258323316257,0.153809462985918,0.0774145403704421
Physical measures,X4270.Volume level set by participant (left),CEP43,Centrosomal protein 43,36053,-0.0494494551558212,0.0280342158647611,-0.104396518250753,0.00549760793911045,0.0777903860970554
Physical measures,X4270.Volume level set by participant (left),MSMB,Beta-microseminoprotein,36260,0.0473218584767384,0.026836635543248,-0.00527794718802762,0.0999216641415044,0.077884640010765
Physical measures,X4270.Volume level set by participant (left),IGSF21,Immunoglobulin superfamily member 21,35151,0.0994966501242116,0.0565066468372865,-0.0112563776768698,0.210249677925293,0.0783196928036326
Physical measures,X4270.Volume level set by participant (left),CLGN,Calmegin,35133,0.0885733116982883,0.0504162658833033,-0.0102425694329862,0.187389192829563,0.0789919507640188
Physical measures,X4270.Volume level set by participant (left),NPHS1,Nephrin,35093,-0.113347945794213,0.0645496766007957,-0.239865311931772,0.0131694203433469,0.079138976229337
Physical measures,X4270.Volume level set by participant (left),SSB,Lupus La protein,36064,-0.0564951523949049,0.032184197389471,-0.119576179278268,0.0065858744884583,0.0792371927938905
Physical measures,X4270.Volume level set by participant (left),AREG,Amphiregulin,36216,0.0847661566211518,0.0483043332707329,-0.00991033658948473,0.179442649831788,0.0793276798301902
Physical measures,X4270.Volume level set by participant (left),NID2,Nidogen-2,36256,-0.0450310513530444,0.0256797038824556,-0.0953632709626574,0.0053011682565685,0.0795449584659629
Physical measures,X4270.Volume level set by participant (left),CAPN3,Calpain-3,35279,-0.0976463639426198,0.0557194776779157,-0.206856540191335,0.011563812306095,0.0797400035949144
Physical measures,X4270.Volume level set by participant (left),QSOX1,Sulfhydryl oxidase 1,35176,-0.101642598408963,0.0580287891917825,-0.215379025224857,0.0120938284069308,0.0798911124696037
Physical measures,X4270.Volume level set by participant (left),TIGAR,"Fructose-2,6-bisphosphatase TIGAR",36053,-0.071990327940432,0.0411019812287264,-0.152550211148736,0.00856955526787175,0.0799000978355184
Physical measures,X4270.Volume level set by participant (left),CPM,Carboxypeptidase M,36282,0.0945382914362036,0.0540246429372596,-0.0113500087208251,0.200426591593232,0.0801736936814044
Physical measures,X4270.Volume level set by participant (left),NT5E,5'-nucleotidase,36289,0.0588354260842432,0.0336486356836438,-0.00711589985569853,0.124786752024185,0.0804133623420031
Physical measures,X4270.Volume level set by participant (left),TMEM106A,Transmembrane protein 106A,35279,-0.0532473484500878,0.0304547559139536,-0.112938670041437,0.00644397314126122,0.0804393114887609
Physical measures,X4270.Volume level set by participant (left),GGACT,Gamma-glutamylaminecyclotransferase,35313,-0.0548796113652702,0.0313943514554736,-0.116412540217998,0.00665331748745808,0.0804971590965361
Physical measures,X4270.Volume level set by participant (left),NPTXR,Neuronal pentraxin receptor,36258,-0.09542651144595,0.0546305662116121,-0.20250242122071,0.0116493983288097,0.0807190075571747
Physical measures,X4270.Volume level set by participant (left),CCL20,C-C motif chemokine 20,36342,0.038760289602262,0.0222260443740441,-0.00480275737086436,0.0823233365753884,0.0812139511514452
Physical measures,X4270.Volume level set by participant (left),OMG,Oligodendrocyte-myelin glycoprotein,36216,-0.0489756608937343,0.0280918863836825,-0.104035758205752,0.00608443641828346,0.0813024822474587
Physical measures,X4270.Volume level set by participant (left),TTN,Titin,35079,-0.0546739040157913,0.031362125103673,-0.11614366921899,0.00679586118740778,0.0813269490711688
Physical measures,X4270.Volume level set by participant (left),DHODH,Dihydroorotate dehydrogenase,35079,-0.0843721087555751,0.0484525645090494,-0.179339135193312,0.0105949176821617,0.0816724960725857
Physical measures,X4270.Volume level set by participant (left),PPIE,Peptidyl-prolyl cis-trans isomerase E,35195,0.0627831832772915,0.0360866630883471,-0.00794667637586882,0.133513042930452,0.0819427277456063
Physical measures,X4270.Volume level set by participant (left),GAMT,Guanidinoacetate N-methyltransferase,35079,-0.115069570320565,0.0661402588541305,-0.244704477674661,0.0145653370335303,0.0819449752639956
Physical measures,X4270.Volume level set by participant (left),CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",36221,0.0515405160534127,0.0297778277887152,-0.00682402641246922,0.109905058519295,0.0835216326427785
Physical measures,X4270.Volume level set by participant (left),CARHSP1,Calcium-regulated heat-stable protein 1,36064,-0.064823603640346,0.0374651091120822,-0.138255217500027,0.00860801021933508,0.0836288831487187
Physical measures,X4270.Volume level set by participant (left),SRPX,Sushi repeat-containing protein SRPX,35313,-0.0978828879346601,0.0566065550038557,-0.208831735742217,0.0130659598728971,0.0838229879935449
Physical measures,X4270.Volume level set by participant (left),RNASE6,Ribonuclease K6,35267,0.123856383691954,0.071730058832788,-0.0167345316203103,0.264447299004219,0.0842676704762868
Physical measures,X4270.Volume level set by participant (left),ANKRA2,Ankyrin repeat family A protein 2,35095,-0.0707762164121941,0.0410045963505584,-0.151145225259288,0.00959279243490034,0.0843849756768251
Physical measures,X4270.Volume level set by participant (left),CSPG4,Chondroitin sulfate proteoglycan 4,35320,-0.112374854549178,0.0652932207695488,-0.240349567257494,0.0155998581591376,0.0852823617541334
Physical measures,X4270.Volume level set by participant (left),ACP1,Low molecular weight phosphotyrosine protein phosphatase,35093,-0.0830412444600364,0.0482936101990545,-0.177696720450183,0.0116142315301105,0.0855696091360043
Physical measures,X4270.Volume level set by participant (left),RASSF2,Ras association domain-containing protein 2,36060,0.0577580685306563,0.0336343109239013,-0.00816518088019028,0.123681317941503,0.0859774790235482
Physical measures,X4270.Volume level set by participant (left),ADGRD1,Adhesion G-protein coupled receptor D1,35165,0.0934169609626447,0.0545306027887188,-0.0134630205032443,0.200296942428534,0.0867394055783817
Physical measures,X4270.Volume level set by participant (left),NME3,Nucleoside diphosphate kinase 3,36248,0.133635391674417,0.0780581490631467,-0.0193585804893507,0.286629363838185,0.086937601125135
Physical measures,X4270.Volume level set by participant (left),PARP1,Poly [ADP-ribose] polymerase 1,36242,-0.0542414024627248,0.031791480856316,-0.116552704941104,0.00806990001565466,0.0880186518345425
Physical measures,X4270.Volume level set by participant (left),MB,Myoglobin,36364,-0.0565541205639738,0.0331680432000081,-0.12156348523599,0.00845524410804217,0.0882197861492462
Physical measures,X4270.Volume level set by participant (left),CASP8,Caspase-8,36309,-0.0531802863873854,0.0311975141045547,-0.114327414032313,0.00796684125754184,0.0883033557168984
Physical measures,X4270.Volume level set by participant (left),SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,36247,0.0262459188350417,0.0154048892211439,-0.00394766403840027,0.0564395017084837,0.0884704033972338
Physical measures,X4270.Volume level set by participant (left),RALB,Ras-related protein Ral-B,35093,-0.126472739476904,0.0742454078962264,-0.271993738953507,0.0190482599997001,0.0885332760417356
Physical measures,X4270.Volume level set by participant (left),LRP2BP,LRP2-binding protein,35133,-0.0498688754389497,0.0292776896162969,-0.107253147086892,0.00751539620899216,0.0885583319221838
Physical measures,X4270.Volume level set by participant (left),ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,36289,-0.0831818296786794,0.0489156493378462,-0.179056502380858,0.0126928430234992,0.0890744203350479
Physical measures,X4270.Volume level set by participant (left),TIMP4,Metalloproteinase inhibitor 4,36256,0.0811717485480216,0.0477453451191328,-0.0124091278854786,0.174752624981522,0.0891531942006641
Physical measures,X4270.Volume level set by participant (left),CEP350,Centrosome-associated protein 350,35095,-0.106097252058498,0.0624495256102742,-0.228498322254636,0.0163038181376392,0.0893806501079814
Physical measures,X4270.Volume level set by participant (left),ADAMTSL4,ADAMTS-like protein 4,35151,-0.155614165206344,0.0917880193531132,-0.335518683138446,0.024290352725758,0.0900538061754911
Physical measures,X4270.Volume level set by participant (left),VIPR1,Vasoactive intestinal polypeptide receptor 1,35151,-0.15295212193834,0.0902688102173387,-0.329878989964324,0.0239747460876441,0.0902354853789569
Physical measures,X4270.Volume level set by participant (left),IGFBP3,Insulin-like growth factor-binding protein 3,36289,-0.0989486305530757,0.0584207158692833,-0.213453233656871,0.0155559725507195,0.0903580585712276
Physical measures,X4270.Volume level set by participant (left),CELA2A,Chymotrypsin-like elastase family member 2A,35320,0.0570526845219532,0.0337198610269079,-0.00903824309078621,0.123143612134693,0.0906998219614465
Physical measures,X4270.Volume level set by participant (left),HBQ1,Hemoglobin subunit theta-1,36327,-0.0479944813095735,0.0283922926903699,-0.103643374982698,0.00765441236355138,0.09099079610517
Physical measures,X4270.Volume level set by participant (left),MUC13,Mucin-13,36064,0.0604591220340099,0.0357983392895766,-0.00970562297356019,0.13062386704158,0.0912840925484963
Physical measures,X4270.Volume level set by participant (left),MAMDC4,Apical endosomal glycoprotein,35279,-0.0657934388526399,0.0389684847183611,-0.142171668900628,0.0105847911953479,0.0913858551321231
Physical measures,X4270.Volume level set by participant (left),MMP12,Macrophage metalloelastase,36272,0.0590655095706461,0.0350471574807108,-0.00962691909154709,0.127757938232839,0.0919684456156563
Physical measures,X4270.Volume level set by participant (left),INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",35151,-0.0676761312099564,0.0401675401923925,-0.146404509987046,0.0110522475671329,0.0920658842535295
Physical measures,X4270.Volume level set by participant (left),ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,35151,-0.0952512510003545,0.0565377076165343,-0.206065157928762,0.0155626559280527,0.0920866955957941
Physical measures,X4270.Volume level set by participant (left),SNAPIN,SNARE-associated protein Snapin,35305,-0.0611484793299132,0.0363423771409985,-0.13237953852627,0.0100825798664438,0.092505553014745
Physical measures,X4270.Volume level set by participant (left),OCLN,Occludin,35305,0.0833493851984421,0.0495790007864771,-0.0138254563430531,0.180524226739937,0.0927817560607003
Physical measures,X4270.Volume level set by participant (left),TEX33,Testis-expressed protein 33,35195,-0.101161207234927,0.0602698663680826,-0.219290145316369,0.016967730846515,0.0933026362187529
Physical measures,X4270.Volume level set by participant (left),TXNL1,Thioredoxin-like protein 1,35071,-0.0368942650003421,0.021994764877898,-0.0800040041610222,0.00621547416033794,0.0935104177185568
Physical measures,X4270.Volume level set by participant (left),PCBP2,Poly(rC)-binding protein 2,35305,-0.0523672007047569,0.0312287619630385,-0.113575574152312,0.00884117274279867,0.0936106164314156
Physical measures,X4270.Volume level set by participant (left),KLK15,Kallikrein-15,35260,0.0672325077565462,0.0401029727800573,-0.0113693188923662,0.145834334405459,0.093687865935237
Physical measures,X4270.Volume level set by participant (left),SPACA5_SPACA5B,Sperm acrosome-associated protein 5,35305,-0.12370425856858,0.0738720357603461,-0.268493448658858,0.0210849315216982,0.0940643197438729
Physical measures,X4270.Volume level set by participant (left),KITLG,Kit ligand,36258,-0.0844544815455916,0.0504350328308598,-0.183307145894077,0.0143981828028936,0.0940692555521535
Physical measures,X4270.Volume level set by participant (left),NID1,Nidogen-1,36260,-0.0857331779349703,0.0512085151412368,-0.186101867611794,0.0146355117418538,0.0941325933913807
Physical measures,X4270.Volume level set by participant (left),BOLA2_BOLA2B,BolA-like protein 2,35151,-0.0730189800086408,0.0436137792958691,-0.158501987428544,0.0124640274112626,0.0941354950974648
Physical measures,X4270.Volume level set by participant (left),USP25,Ubiquitin carboxyl-terminal hydrolase 25,35279,-0.053230712658489,0.031806108269439,-0.115570684866589,0.00910925954961148,0.0942560250273109
Physical measures,X4270.Volume level set by participant (left),YARS1,"Tyrosine--tRNA ligase, cytoplasmic",35285,-0.0269328411546378,0.0161562951516112,-0.0585991796517956,0.0047334973425201,0.0955576118819744
Physical measures,X4270.Volume level set by participant (left),DCTPP1,dCTP pyrophosphatase 1,36258,-0.0980100638600152,0.0587991071631498,-0.213256313899789,0.0172361861797584,0.0955825320296027
Physical measures,X4270.Volume level set by participant (left),SIRT2,NAD-dependent protein deacetylase sirtuin-2,36216,-0.0387018629513726,0.0232834428130579,-0.084337410864966,0.00693368496222087,0.0965127787367711
Physical measures,X4270.Volume level set by participant (left),IL31,Interleukin-31,35093,0.0695903917936965,0.0418694214687875,-0.0124736742851271,0.15165445787252,0.0965447232665802
Physical measures,X4270.Volume level set by participant (left),SH3GL3,Endophilin-A3,35146,-0.0435962334487325,0.0262318466094152,-0.0950106528031863,0.00781818590572132,0.0965690525261148
Physical measures,X4270.Volume level set by participant (left),CSRP3,Cysteine and glycine-rich protein 3,35079,-0.0377777426747723,0.0227323132413765,-0.0823330766278702,0.0067775912783256,0.0965908311517782
Physical measures,X4270.Volume level set by participant (left),FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,35313,-0.0503021985992266,0.0302740974463452,-0.109639429594063,0.00903503239560997,0.096647947400721
Physical measures,X4270.Volume level set by participant (left),HCLS1,Hematopoietic lineage cell-specific protein,36342,-0.0594169250930244,0.0357660335713856,-0.12951835089294,0.0106845007068913,0.0967003746406632
Physical measures,X4270.Volume level set by participant (left),SERPINB9,Serpin B9,36179,-0.104448146354127,0.0628853636695287,-0.227703459146403,0.018807166438149,0.0967690155024717
Physical measures,X4270.Volume level set by participant (left),ALMS1,Alstrom syndrome protein 1,35195,0.0839654421708406,0.0506108394618914,-0.0152318031744666,0.183162687516148,0.0971551640864951
Physical measures,X4270.Volume level set by participant (left),CA14,Carbonic anhydrase 14,36327,-0.0843514086321671,0.0508542207191804,-0.184025681241761,0.0153228639774265,0.0972187932206743
Physical measures,X4270.Volume level set by participant (left),KCTD5,BTB/POZ domain-containing protein KCTD5,35162,-0.0843117810620927,0.0508362209738214,-0.183950774170783,0.0153272120465973,0.0972647654156658
Physical measures,X4270.Volume level set by participant (left),HRG,Histidine-rich glycoprotein,35293,-0.111741307348229,0.0673965531422733,-0.243838551507084,0.0203559368106268,0.0973708717386783
Physical measures,X4270.Volume level set by participant (left),HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,35151,-0.114020055590751,0.0688029693821158,-0.248873875579698,0.0208337643981954,0.0975276144114634
Physical measures,X4270.Volume level set by participant (left),CORO6,Coronin-6,35083,-0.0966631468205104,0.0583469819499025,-0.211023231442319,0.0176969378012984,0.0976295896630055
Physical measures,X4270.Volume level set by participant (left),ARHGAP25,Rho GTPase-activating protein 25,36060,-0.0531956367427632,0.0321386063103629,-0.116187305111074,0.00979603162554797,0.0979271794465583
Physical measures,X4270.Volume level set by participant (left),LRRN1,Leucine-rich repeat neuronal protein 1,36103,-0.0776090916230067,0.0469184565524785,-0.169569266465865,0.0143510832198511,0.098143532592368
Physical measures,X4270.Volume level set by participant (left),PGD,"6-phosphogluconate dehydrogenase, decarboxylating",35313,-0.0700979776437202,0.0423923183966269,-0.153186921701109,0.0129909664136686,0.0982649914736804
Physical measures,X4270.Volume level set by participant (left),IMPACT,Protein IMPACT,35301,-0.068680821928579,0.0415944179063256,-0.150205881024977,0.0128442371678191,0.0987440381037204
Physical measures,X4270.Volume level set by participant (left),FLT1,Vascular endothelial growth factor receptor 1,36197,0.139794493119511,0.0849172367195585,-0.0266432908508238,0.306232277089846,0.0997549097807379
Physical measures,X4270.Volume level set by participant (left),CD101,Immunoglobulin superfamily member 2,35285,-0.0826169037907281,0.0502199311225783,-0.181047968790982,0.0158141612095253,0.0999958360374314
Physical measures,X4270.Volume level set by participant (left),HGFAC,Hepatocyte growth factor activator,35252,0.135774111959975,0.0826633907892081,-0.0262461339868725,0.297794357906823,0.100534984705314
Physical measures,X4270.Volume level set by participant (left),PALLD,Palladin,35093,-0.100595695443761,0.0612735338258898,-0.220691821742505,0.0195004308549833,0.100690711663379
Physical measures,X4270.Volume level set by participant (left),SBSN,Suprabasin,35310,0.102086638091043,0.0622037778237356,-0.0198327664434786,0.224006042625565,0.100810139653875
Physical measures,X4270.Volume level set by participant (left),PRDX1,Peroxiredoxin-1,36019,-0.0335885888521885,0.0204863217422938,-0.0737417794670844,0.0065646017627074,0.101138743043436
Physical measures,X4270.Volume level set by participant (left),LSP1,Lymphocyte-specific protein 1,36242,-0.0764278289482397,0.0466547650335558,-0.167871168414009,0.0150155105175296,0.101430135871354
Physical measures,X4270.Volume level set by participant (left),ADH1B,All-trans-retinol dehydrogenase,35165,0.0491503520027899,0.0300601915950512,-0.00976762352351045,0.10806832752909,0.102083492032829
Physical measures,X4270.Volume level set by participant (left),CCDC28A,Coiled-coil domain-containing protein 28A,35133,-0.121389930888744,0.0743940402783024,-0.267202249834216,0.0244223880567289,0.102787590269459
Physical measures,X4270.Volume level set by participant (left),KLK13,Kallikrein-13,36076,0.0704858805934073,0.0432480058669804,-0.0142802109058743,0.155251972092689,0.103184547468071
Physical measures,X4270.Volume level set by participant (left),SLA2,Src-like-adapter 2,35305,-0.0341746288955199,0.0209769271568576,-0.0752894061229608,0.00694014833192104,0.10332758012064
Physical measures,X4270.Volume level set by participant (left),ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",35313,0.0483308175108325,0.0296806848849785,-0.00984332486372531,0.10650495988539,0.103495681057512
Physical measures,X4270.Volume level set by participant (left),TNFSF11,Tumor necrosis factor ligand superfamily member 11,36242,-0.0492871649802665,0.0302740234329714,-0.10862425090889,0.0100499209483574,0.103558736629519
Physical measures,X4270.Volume level set by participant (left),YJU2,Splicing factor YJU2,35279,-0.11042934929696,0.0678542586712539,-0.243423696292618,0.0225649976986972,0.103688950291965
Physical measures,X4270.Volume level set by participant (left),TMED8,Protein TMED8,35285,-0.0356820520063769,0.0219333885557437,-0.0786714935756345,0.00730738956288073,0.103818834298779
Physical measures,X4270.Volume level set by participant (left),GIMAP7,GTPase IMAP family member 7,35165,-0.115614814685518,0.0710825667191369,-0.254936645455027,0.0237070160839897,0.103894280036189
Physical measures,X4270.Volume level set by participant (left),AMPD3,AMP deaminase 3,35301,-0.0497692534789417,0.030601125766228,-0.109747459980749,0.0102089530228652,0.10391453264759
Physical measures,X4270.Volume level set by participant (left),ATP2B4,Plasma membrane calcium-transporting ATPase 4,35079,-0.0549258082814361,0.033771633383266,-0.121118209712637,0.0112665931497652,0.103915613480259
Physical measures,X4270.Volume level set by participant (left),ASGR1,Asialoglycoprotein receptor 1,36179,0.104567205470295,0.0643349785367375,-0.0215293524617101,0.230663763402301,0.104128445927162
Physical measures,X4270.Volume level set by participant (left),TTF2,Transcription termination factor 2,35133,-0.0704010793864106,0.0433275262947157,-0.155323030924053,0.0145208721512322,0.104241071460129
Physical measures,X4270.Volume level set by participant (left),BCL7A,B-cell CLL/lymphoma 7 protein family member A,35095,-0.0586337197263094,0.0361458865117073,-0.129479657289256,0.0122122178366369,0.104821747364136
Physical measures,X4270.Volume level set by participant (left),RGMA,Repulsive guidance molecule A,36325,-0.094736546503651,0.0584335157619622,-0.209266237397097,0.0197931443897948,0.105000425302596
Physical measures,X4270.Volume level set by participant (left),SPON2,Spondin-2,36225,0.0893106449057517,0.0550878654369709,-0.0186615713507112,0.197282861162215,0.105007564152733
Physical measures,X4270.Volume level set by participant (left),ACRBP,Acrosin-binding protein,35279,-0.0905347215964842,0.0559555837026186,-0.200207665653617,0.0191382224606483,0.105715280327177
Physical measures,X4270.Volume level set by participant (left),KRT19,"Keratin, type I cytoskeletal 19",36234,0.0452723982804648,0.0279941523608915,-0.00959614034688262,0.100140936907812,0.105874482529269
Physical measures,X4270.Volume level set by participant (left),CCL14,C-C motif chemokine 14,36236,0.0729895691798963,0.0451546045061946,-0.0155134556522452,0.161492594012038,0.106041209426251
Physical measures,X4270.Volume level set by participant (left),RBP7,Retinoid-binding protein 7,35285,-0.0541835244965434,0.0335292076108799,-0.119900771413868,0.0115337224207811,0.106139425853341
Physical measures,X4270.Volume level set by participant (left),VSIG4,V-set and immunoglobulin domain-containing protein 4,36244,0.0707654570177832,0.0438162560855029,-0.0151144049098025,0.156645318945369,0.106341092536613
Physical measures,X4270.Volume level set by participant (left),CNTN4,Contactin-4,36256,-0.1270546866216,0.0786865527988669,-0.281280330107379,0.0271709568641792,0.106418251460245
Physical measures,X4270.Volume level set by participant (left),ENAH,Protein enabled homolog,36103,0.0634525268507666,0.0393279595125523,-0.0136302737938359,0.140535327495369,0.106695303856995
Physical measures,X4270.Volume level set by participant (left),DOCK9,Dedicator of cytokinesis protein 9,35083,0.0317780901700964,0.0197323401509595,-0.00689729652578428,0.070453476865977,0.107346778255329
Physical measures,X4270.Volume level set by participant (left),IL36A,Interleukin-36 alpha,35093,0.0638722246525065,0.0396639839249876,-0.0138691838404692,0.141613633145482,0.107373797183263
Physical measures,X4270.Volume level set by participant (left),IGFBP7,Insulin-like growth factor-binding protein 7,36364,0.0961198342006498,0.0597198176769956,-0.0209310084462614,0.213170676847561,0.107544844127063
Physical measures,X4270.Volume level set by participant (left),CALB1,Calbindin,36216,-0.0680346603209014,0.0422985283750004,-0.150939775935902,0.0148704552940994,0.107780233076326
Physical measures,X4270.Volume level set by participant (left),NPTX1,Neuronal pentraxin-1,36256,0.0729709904133764,0.0453738977056044,-0.0159618490896081,0.161903829916361,0.107829312323286
Physical measures,X4270.Volume level set by participant (left),MDH1,"Malate dehydrogenase, cytoplasmic",35277,-0.0902614929465388,0.0561246656942225,-0.200265837707215,0.0197428518141373,0.107831639943732
Physical measures,X4270.Volume level set by participant (left),TDGF1,Teratocarcinoma-derived growth factor 1,36064,-0.0209257148356639,0.0130154100318817,-0.046435918498152,0.00458448882682415,0.107929068174084
Physical measures,X4270.Volume level set by participant (left),REPS1,RalBP1-associated Eps domain-containing protein 1,35093,-0.0932636507151287,0.0580081243339329,-0.206959574409637,0.0204322729793798,0.107934473744377
Physical measures,X4270.Volume level set by participant (left),PRSS2,Trypsin-2,36289,0.0527078360527133,0.0328126258509063,-0.0116049106150631,0.11702058272049,0.108242964696645
Physical measures,X4270.Volume level set by participant (left),PAGR1,PAXIP1-associated glutamate-rich protein 1,35151,-0.0828498854078232,0.0515795759122167,-0.183945854195768,0.0182460833801215,0.108266394266515
Physical measures,X4270.Volume level set by participant (left),MAMDC2,MAM domain-containing protein 2,35313,-0.0973569945037571,0.0606454779627766,-0.216222131310799,0.021508142303285,0.108464670313571
Physical measures,X4270.Volume level set by participant (left),TRIM21,E3 ubiquitin-protein ligase TRIM21,36242,-0.0422438727754168,0.0263693076156807,-0.0939277157021509,0.00943997015131732,0.109194927050279
Physical measures,X4270.Volume level set by participant (left),CHIT1,Chitotriosidase-1,36307,0.0186079072123716,0.0116233564836606,-0.00417387149560316,0.0413896859203464,0.109438626095475
Physical measures,X4270.Volume level set by participant (left),ST13,Hsc70-interacting protein,35165,-0.0680396495458892,0.0425187840463282,-0.151376466276692,0.015297167184914,0.109596669564263
Physical measures,X4270.Volume level set by participant (left),EFNB2,Ephrin-B2,35133,-0.0624531370318389,0.0390370818481683,-0.138965817454249,0.0140595433905709,0.109682163691569
Physical measures,X4270.Volume level set by participant (left),IGBP1,Immunoglobulin-binding protein 1,35305,-0.0599117972322024,0.0374577233528618,-0.133328935003812,0.0135053405394066,0.109767539912878
Physical measures,X4270.Volume level set by participant (left),LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,35313,-0.0465944493866398,0.0291421995921174,-0.10371316058719,0.0105242618139103,0.109897635766872
Physical measures,X4270.Volume level set by participant (left),CLSPN,Claspin,36053,-0.0793721353455483,0.0497736549212254,-0.17692849899115,0.0181842283000535,0.110830351769572
Physical measures,X4270.Volume level set by participant (left),FDX1,"Adrenodoxin, mitochondrial",35079,-0.0561499052607157,0.0352438873283885,-0.125227924424357,0.0129281139029256,0.111168308675911
Physical measures,X4270.Volume level set by participant (left),SLIT2,Slit homolog 2 protein,36064,-0.0569442598698549,0.0357716162015267,-0.127056627624847,0.0131681078851374,0.111453157580455
Physical measures,X4270.Volume level set by participant (left),MAPK13,Mitogen-activated protein kinase 13,35095,0.0828723738137261,0.0520909620798147,-0.0192259118627108,0.184970659490163,0.111677046465444
Physical measures,X4270.Volume level set by participant (left),AMY2B,Alpha-amylase 2B,35746,0.0638809055200168,0.0401700560137762,-0.0148524042669846,0.142614215307018,0.111820059708019
Physical measures,X4270.Volume level set by participant (left),GGT5,Glutathione hydrolase 5 proenzyme,36179,0.130395807554356,0.0821090226319242,-0.030537876804215,0.291329491912928,0.112309674853064
Physical measures,X4270.Volume level set by participant (left),CYTL1,Cytokine-like protein 1,35320,0.136871905464787,0.0862361478497567,-0.0321509443207357,0.305894755250311,0.11251995939891
Physical measures,X4270.Volume level set by participant (left),TEK,Angiopoietin-1 receptor,36289,0.134799854471294,0.0849341559131715,-0.0316710911185226,0.30127080006111,0.112528851705835
Physical measures,X4270.Volume level set by participant (left),PSRC1,Proline/serine-rich coiled-coil protein 1,36060,-0.0503439317209049,0.031889055897873,-0.112846481280736,0.0121586178389262,0.114442412729164
Physical measures,X4270.Volume level set by participant (left),ZHX2,Zinc fingers and homeoboxes protein 2,35301,-0.107505044373219,0.0681779257977446,-0.241133778936799,0.02612369019036,0.114881717797837
Physical measures,X4270.Volume level set by participant (left),TPM3,Tropomyosin alpha-3 chain,35079,-0.0768859412619418,0.0487935535953116,-0.172521306308753,0.018749423784869,0.115134641814783
Physical measures,X4270.Volume level set by participant (left),CD58,Lymphocyte function-associated antigen 3,36225,0.169127422441355,0.10738709420146,-0.0413512821935064,0.379606127076217,0.115313533963125
Physical measures,X4270.Volume level set by participant (left),IFNL1,Interferon lambda-1,36064,-0.0677689666662579,0.0430675774966009,-0.152181418559596,0.0166434852270798,0.115634027890648
Physical measures,X4270.Volume level set by participant (left),PLPBP,Pyridoxal phosphate homeostasis protein,36258,-0.0461795314461059,0.0293582397649984,-0.103721681385503,0.0113626184932911,0.115767872299444
Physical measures,X4270.Volume level set by participant (left),PSMD9,26S proteasome non-ATPase regulatory subunit 9,36216,-0.0526671456923314,0.0334839914046628,-0.11829576884547,0.0129614774608077,0.115782315475194
Physical measures,X4270.Volume level set by participant (left),AAMDC,Mth938 domain-containing protein,35151,-0.0664983656129119,0.0424230151835405,-0.149647475372651,0.0166507441468275,0.117044593975216
Physical measures,X4270.Volume level set by participant (left),BOLA1,BolA-like protein 1,35083,-0.0634203173761689,0.0405462913495426,-0.142891048421272,0.0160504136689346,0.117832128052197
Physical measures,X4270.Volume level set by participant (left),SCLY,Selenocysteine lyase,36309,0.0621302753789599,0.0397226162563675,-0.0157260524835203,0.13998660324144,0.117834372120356
Physical measures,X4270.Volume level set by participant (left),HBEGF,Proheparin-binding EGF-like growth factor,36309,-0.0390490756524548,0.0249977042042006,-0.0880445758926879,0.00994642458777823,0.118303970742112
Physical measures,X4270.Volume level set by participant (left),CD226,CD226 antigen,35093,-0.082755239444013,0.0529939705903655,-0.186623421801129,0.0211129429131033,0.118431652086616
Physical measures,X4270.Volume level set by participant (left),HDDC2,5'-deoxynucleotidase HDDC2,35285,-0.0750558824326197,0.0481099011428135,-0.169351288672534,0.0192395238072947,0.118785447398662
Physical measures,X4270.Volume level set by participant (left),LYN,Tyrosine-protein kinase Lyn,36216,-0.0359283985795133,0.0230349502995268,-0.0810769011665858,0.0092201040075592,0.118864285181235
Physical measures,X4270.Volume level set by participant (left),TSC22D1,TSC22 domain family protein 1,35305,-0.0518700356480427,0.0332807146396176,-0.117100236341693,0.0133601650456077,0.119147452746471
Physical measures,X4270.Volume level set by participant (left),CD209,CD209 antigen,36292,0.0751223193387513,0.0482341510281282,-0.0194166166763799,0.169661255353883,0.119404638273366
Physical measures,X4270.Volume level set by participant (left),DXO,Decapping and exoribonuclease protein,35301,-0.0772517620296615,0.0496295597401393,-0.174525699120335,0.0200221750610116,0.119620439496406
Physical measures,X4270.Volume level set by participant (left),AMBP,Protein AMBP,36315,0.143798748060732,0.0923940778332735,-0.0372936444924845,0.324891140613948,0.119662770442931
Physical measures,X4270.Volume level set by participant (left),ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,36057,-0.051409981585455,0.033057855626296,-0.116203378612995,0.0133834154420852,0.119952389729941
Physical measures,X4270.Volume level set by participant (left),TSPYL1,Testis-specific Y-encoded-like protein 1,35093,-0.086076383795851,0.0553698014888516,-0.194601194714,0.0224484271222982,0.120096621092654
Physical measures,X4270.Volume level set by participant (left),KIF1C,Kinesin-like protein KIF1C,35079,0.0956363188358498,0.0615243468692303,-0.0249514010278417,0.216224038699541,0.120126763016266
Physical measures,X4270.Volume level set by participant (left),CDC26,Anaphase-promoting complex subunit CDC26,35261,-0.0479955356820233,0.0308770492595323,-0.108514552230707,0.01252348086666,0.120134630314168
Physical measures,X4270.Volume level set by participant (left),VEGFB,Vascular endothelial growth factor B,35093,0.1129162520664,0.0726437987533974,-0.0294655934902592,0.255298097623058,0.12014195655993
Physical measures,X4270.Volume level set by participant (left),SERPINI2,Serpin I2,35285,0.0581449832669678,0.0375680926730371,-0.0154884783721848,0.131778444906121,0.121736473818419
Physical measures,X4270.Volume level set by participant (left),TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,35079,-0.0760157403404203,0.0491923414946834,-0.17243272967,0.0204012489891591,0.122328401831947
Physical measures,X4270.Volume level set by participant (left),CPA2,Carboxypeptidase A2,36303,0.0425112022730707,0.0275123468401372,-0.0114129975335983,0.0964354020797396,0.12234668959535
Physical measures,X4270.Volume level set by participant (left),NUB1,NEDD8 ultimate buster 1,36242,-0.0353505005336579,0.0229164836095806,-0.0802668084084358,0.00956580734111997,0.122974228091479
Physical measures,X4270.Volume level set by participant (left),CAT,Catalase,35211,-0.062473217992431,0.0405191429773324,-0.141890738228002,0.0169443022431404,0.123165266243172
Physical measures,X4270.Volume level set by participant (left),RAB6A,Ras-related protein Rab-6A,36242,-0.0616437229812759,0.0400486392104325,-0.140139055833724,0.0168516098711718,0.12379167073482
Physical measures,X4270.Volume level set by participant (left),NPDC1,Neural proliferation differentiation and control protein 1,36258,0.0896773740906127,0.0583300332124659,-0.0246494910058205,0.204004239187046,0.124233439657853
Physical measures,X4270.Volume level set by participant (left),LPP,Lipoma-preferred partner,35079,-0.0530491057893804,0.0345327295099964,-0.120733255628973,0.0146350440502125,0.124538709056759
Physical measures,X4270.Volume level set by participant (left),LY6D,Lymphocyte antigen 6D,36212,0.0755280754946103,0.0492329359216245,-0.0209684789117736,0.172024629900994,0.125047486064184
Physical measures,X4270.Volume level set by participant (left),TACSTD2,Tumor-associated calcium signal transducer 2,35437,0.104463435847719,0.0681217188052294,-0.0290551330105309,0.237982004705968,0.125203405417298
Physical measures,X4270.Volume level set by participant (left),CDH4,Cadherin-4,35083,0.0739870532697848,0.0482620843544101,-0.0206066320648589,0.168580738604429,0.125318148355282
Physical measures,X4270.Volume level set by participant (left),CTSL,Cathepsin L1,36258,0.11736107191488,0.0765639317599241,-0.0327042343345717,0.267426378164331,0.125353984005981
Physical measures,X4270.Volume level set by participant (left),ULBP2,UL16-binding protein 2,36179,0.0756516467969006,0.0493761672332705,-0.0211256409803096,0.172428934574111,0.125527416844238
Physical measures,X4270.Volume level set by participant (left),UNC5D,Netrin receptor UNC5D,35093,-0.131065147030283,0.0855520374328104,-0.298747140398591,0.0366168463380254,0.125572831952894
Physical measures,X4270.Volume level set by participant (left),ITGAX,Integrin alpha-X,35195,0.0630787487831559,0.0411880492882406,-0.0176498278217957,0.143807325388107,0.125698341155697
Physical measures,X4270.Volume level set by participant (left),IL33,Interleukin-33,36103,-0.073450431452736,0.0479615507892049,-0.167455070999578,0.0205542080941056,0.125701861176186
Physical measures,X4270.Volume level set by participant (left),ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",35195,0.0479166361130158,0.0313442899605926,-0.0135181722097458,0.109351444435777,0.126381906440926
Physical measures,X4270.Volume level set by participant (left),MORN4,MORN repeat-containing protein 4,35095,0.0421764366909825,0.0275940718693681,-0.0119079441729788,0.0962608175549439,0.12644707204487
Physical measures,X4270.Volume level set by participant (left),CXADR,Coxsackievirus and adenovirus receptor,36242,0.0580455655178114,0.0380192845036149,-0.0164722321092738,0.132563363144897,0.126867057146543
Physical measures,X4270.Volume level set by participant (left),IL4,Interleukin-4,36103,-0.0330432035858215,0.0216490391111953,-0.0754753202437643,0.00938891307212124,0.126974171663598
Physical measures,X4270.Volume level set by participant (left),BLMH,Bleomycin hydrolase,36364,-0.0930754759001616,0.0610039035153273,-0.212643126790203,0.0264921749898799,0.127117908124565
Physical measures,X4270.Volume level set by participant (left),CCDC50,Coiled-coil domain-containing protein 50,35305,-0.044501082518158,0.0291942944372043,-0.101721899615078,0.0127197345787623,0.127479093194885
Physical measures,X4270.Volume level set by participant (left),FBLN2,Fibulin-2,35320,-0.104378853101282,0.0686424877162433,-0.238918129025119,0.0301604228225545,0.128403342124769
Physical measures,X4270.Volume level set by participant (left),GORASP2,Golgi reassembly-stacking protein 2,35285,-0.069987100608785,0.0460312332004223,-0.160208317681613,0.0202341164640426,0.128451167145074
Physical measures,X4270.Volume level set by participant (left),DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",36289,0.0814839776702951,0.0536419335417535,-0.0236542120715418,0.186622167412132,0.128794802796843
Physical measures,X4270.Volume level set by participant (left),ELN,Elastin,35313,-0.0966517315837998,0.0636987094745689,-0.221501202153955,0.0281977389863553,0.129231412783405
Physical measures,X4270.Volume level set by participant (left),ART3,Ecto-ADP-ribosyltransferase 3,36289,-0.0804548899096762,0.0531339086981653,-0.18459735095808,0.0236875711387278,0.130018505607602
Physical measures,X4270.Volume level set by participant (left),HSPA2,Heat shock-related 70 kDa protein 2,35279,-0.093396625925962,0.061793208373494,-0.21451131433801,0.0277180624860862,0.130724131168718
Physical measures,X4270.Volume level set by participant (left),ADGRB3,Adhesion G protein-coupled receptor B3,36163,0.0847432152601467,0.0562210694251995,-0.0254500808132442,0.194936511333538,0.13177010498547
Physical measures,X4270.Volume level set by participant (left),SAP18,Histone deacetylase complex subunit SAP18,35195,-0.0476451620697549,0.0316244291981571,-0.109629043298143,0.0143387191586331,0.131962779885339
Physical measures,X4270.Volume level set by participant (left),PRDX6,Peroxiredoxin-6,36327,-0.0429155845654481,0.0284989071314623,-0.0987734425431142,0.012942273412218,0.132142024063339
Physical measures,X4270.Volume level set by participant (left),GMFG,Glia maturation factor gamma,35313,-0.0469435723535343,0.0311981962994502,-0.108092037100457,0.0142048923933881,0.132451205121111
Physical measures,X4270.Volume level set by participant (left),FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",35305,-0.0413477498110093,0.0275812410481725,-0.0954069822654274,0.0127114826434088,0.133888101955156
Physical measures,X4270.Volume level set by participant (left),RETN,Resistin,36269,0.0641691647013384,0.0428806824650447,-0.0198769729301493,0.148215302332826,0.134575363992513
Physical measures,X4270.Volume level set by participant (left),TP53BP1,TP53-binding protein 1,35093,-0.0394415309755741,0.0263740253189812,-0.0911346206007773,0.012251558649629,0.13484076854137
Physical measures,X4270.Volume level set by participant (left),UBXN1,UBX domain-containing protein 1,35165,-0.0498104101681607,0.0333384539268371,-0.115153779864761,0.01553295952844,0.135202064062055
Physical measures,X4270.Volume level set by participant (left),DNAJC6,Putative tyrosine-protein phosphatase auxilin,35151,-0.04095797778671,0.0274204068065073,-0.0947019751274643,0.0127860195540443,0.135301123741971
Physical measures,X4270.Volume level set by participant (left),BAG6,Large proline-rich protein BAG6,36109,-0.0762536119003641,0.051060367838728,-0.176331932864271,0.0238247090635429,0.13537424488757
Physical measures,X4270.Volume level set by participant (left),CLEC11A,C-type lectin domain family 11 member A,36245,-0.0579558586591139,0.0388744059573204,-0.134149694335462,0.018237977017234,0.136042488367501
Physical measures,X4270.Volume level set by participant (left),TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,35301,-0.0378683987759729,0.0254238868521755,-0.0876992170062368,0.0119624194542911,0.136407811523733
Physical measures,X4270.Volume level set by participant (left),STIP1,Stress-induced-phosphoprotein 1,36232,-0.0453077435887896,0.0304548549406733,-0.104999259272509,0.0143837720949301,0.136870872825682
Physical measures,X4270.Volume level set by participant (left),IMPA1,Inositol monophosphatase 1,36179,-0.0469245426736879,0.0315561949381938,-0.108774684752548,0.014925599405172,0.13705240225712
Physical measures,X4270.Volume level set by participant (left),SEPTIN9,Septin-9,36216,-0.0991400268665928,0.0666887838793653,-0.229850043270149,0.0315699895369632,0.137159993979253
Physical measures,X4270.Volume level set by participant (left),USP8,Ubiquitin carboxyl-terminal hydrolase 8,36109,-0.0305022498903983,0.0205263032194881,-0.070733804200595,0.00972930441979847,0.137319015325692
Physical measures,X4270.Volume level set by participant (left),ADGRG1,Adhesion G-protein coupled receptor G1,36216,0.0352697316455418,0.0237499322304283,-0.0112801355260977,0.0818195988171814,0.137573156938773
Physical measures,X4270.Volume level set by participant (left),MPHOSPH8,M-phase phosphoprotein 8,36109,-0.0372979054036816,0.0251803865353076,-0.0866514630128844,0.0120556522055212,0.138587677408203
Physical measures,X4270.Volume level set by participant (left),DTNB,Dystrobrevin beta,35255,-0.0684404046432023,0.0462056009014174,-0.15900338240998,0.0221225731235758,0.138596795318914
Physical measures,X4270.Volume level set by participant (left),GSTA3,Glutathione S-transferase A3,36060,0.0372955926838474,0.0251794115426399,-0.0120560539397267,0.0866472393074216,0.138597141923388
Physical measures,X4270.Volume level set by participant (left),THBS4,Thrombospondin-4,36260,-0.0605269910600017,0.0408670170498521,-0.140626344477712,0.0195723623577085,0.138628558452982
Physical measures,X4270.Volume level set by participant (left),AFAP1,Actin filament-associated protein 1,35165,-0.0378066847172583,0.0255870052289137,-0.0879572149659292,0.0123438455314125,0.139569923053609
Physical measures,X4270.Volume level set by participant (left),CPA1,Carboxypeptidase A1,36364,0.0420559398407904,0.0284771962260745,-0.0137593647623157,0.0978712444438965,0.139762142842934
Physical measures,X4270.Volume level set by participant (left),ANXA4,Annexin A4,36224,-0.0394260282349336,0.026765971970211,-0.0918873332965472,0.01303527682668,0.140794837042611
Physical measures,X4270.Volume level set by participant (left),BTLA,B- and T-lymphocyte attenuator,35095,0.0381901167346678,0.0259486313973529,-0.0126692008041439,0.0890494342734795,0.141134597353615
Physical measures,X4270.Volume level set by participant (left),NAA80,N-alpha-acetyltransferase 80,35133,-0.0271338755213489,0.0184472377927062,-0.063290461595053,0.0090227105523552,0.141368788492419
Physical measures,X4270.Volume level set by participant (left),LAMP1,Lysosome-associated membrane glycoprotein 1,35141,0.127382524707397,0.0866068556585892,-0.0423669123834374,0.297131961798232,0.141389709188468
Physical measures,X4270.Volume level set by participant (left),TRAF2,TNF receptor-associated factor 2,36242,-0.0410110914475906,0.0279298710537778,-0.0957536387129952,0.0137314558178139,0.14204777125259
Physical measures,X4270.Volume level set by participant (left),PSME2,Proteasome activator complex subunit 2,36145,-0.0801870856019015,0.0546585851661942,-0.187317912527642,0.026943741323839,0.142403113824943
Physical measures,X4270.Volume level set by participant (left),APOB,Apolipoprotein B-100,35317,-0.14010305161704,0.0955520774599623,-0.327385123438567,0.0471790202044857,0.142627542447525
Physical measures,X4270.Volume level set by participant (left),TXNDC9,Thioredoxin domain-containing protein 9,35301,-0.0600824250634698,0.0409785370803411,-0.140400357740938,0.0202355076139989,0.142642786170675
Physical measures,X4270.Volume level set by participant (left),PHLDB2,Pleckstrin homology-like domain family B member 2,35095,0.0336937544763876,0.0229833936382637,-0.0113536970546093,0.0787412060073846,0.142695540587421
Physical measures,X4270.Volume level set by participant (left),CXCL17,C-X-C motif chemokine 17,36342,0.0615722736312931,0.0420038664425729,-0.0207553045961499,0.143899851858736,0.142723906063141
Physical measures,X4270.Volume level set by participant (left),PRDX5,"Peroxiredoxin-5, mitochondrial",36342,-0.0445182935283739,0.0303763015366025,-0.104055844540115,0.015019257483367,0.142808811419785
Physical measures,X4270.Volume level set by participant (left),GSTA1,Glutathione S-transferase A1,36248,0.0337332260971085,0.0230680847263988,-0.0114802199666332,0.0789466721608502,0.143691030720302
Physical measures,X4270.Volume level set by participant (left),INPP1,Inositol polyphosphate 1-phosphatase,36216,-0.0517312096032579,0.0353995584527556,-0.121114344170659,0.017651924964143,0.143960183871364
Physical measures,X4270.Volume level set by participant (left),SLC4A1,Band 3 anion transport protein,35320,-0.0616232312848909,0.0421763776320084,-0.144288931443627,0.0210424688738455,0.144039160532268
Physical measures,X4270.Volume level set by participant (left),DARS1,"Aspartate--tRNA ligase, cytoplasmic",36168,-0.0417885529704319,0.0286050297561524,-0.0978544112924905,0.0142773053516267,0.144089550609059
Physical measures,X4270.Volume level set by participant (left),GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,35313,-0.0535695089656352,0.0366716031935519,-0.125445851224997,0.0183068332937265,0.144119919425222
Physical measures,X4270.Volume level set by participant (left),EFNA4,Ephrin-A4,36163,0.0908502270246506,0.0622034776615951,-0.0310685891920757,0.212769043241377,0.144185221802318
Physical measures,X4270.Volume level set by participant (left),LEG1,Protein LEG1 homolog,34976,0.0473082445051269,0.0323968755786734,-0.0161896316290731,0.110806120639327,0.14426467657676
Physical measures,X4270.Volume level set by participant (left),MYBPC2,"Myosin-binding protein C, fast-type",35151,-0.0375256844088748,0.0257079536806306,-0.0879132736229107,0.0128619048051611,0.144422819164197
Physical measures,X4270.Volume level set by participant (left),ADM,Pro-adrenomedullin,36327,0.103325455062264,0.0708580016999473,-0.0355562282696324,0.242207138394161,0.144824849457212
Physical measures,X4270.Volume level set by participant (left),FABP6,Gastrotropin,36099,0.0497690303584821,0.0341780154980678,-0.0172198800177309,0.116757940734695,0.145387272895747
Physical measures,X4270.Volume level set by participant (left),LPO,Lactoperoxidase,36002,0.0466559048833124,0.032049707147653,-0.0161615211260875,0.109473330892712,0.145508106708632
Physical measures,X4270.Volume level set by participant (left),CCL23,C-C motif chemokine 23,36278,0.0638376281276741,0.0438676905849032,-0.0221430454187362,0.149818301674084,0.145646188691868
Physical measures,X4270.Volume level set by participant (left),OGN,Mimecan,36256,0.0647665404322197,0.0446300055004852,-0.0227082703487312,0.152241351213171,0.146768430175047
Physical measures,X4270.Volume level set by participant (left),IL10RA,Interleukin-10 receptor subunit alpha,36103,0.0479095531187979,0.0330674885980187,-0.0169027245333187,0.112721830770914,0.147423629724791
Physical measures,X4270.Volume level set by participant (left),ATXN10,Ataxin-10,36064,-0.0396725003457509,0.0273849809428604,-0.0933470629937573,0.0140020623022555,0.147464644613476
Physical measures,X4270.Volume level set by participant (left),NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,36179,-0.0380106916157477,0.0262456745850089,-0.0894522138023651,0.0134308305708697,0.147584338251715
Physical measures,X4270.Volume level set by participant (left),ITPA,Inosine triphosphate pyrophosphatase,35079,-0.0466748468322145,0.0322320495389134,-0.109849663928485,0.0164999702640558,0.147640828441882
Physical measures,X4270.Volume level set by participant (left),C1QL2,Complement C1q-like protein 2,35093,-0.0754294222470994,0.0521550360143216,-0.17765329283517,0.0267944483409709,0.148154301701188
Physical measures,X4270.Volume level set by participant (left),SCARF2,Scavenger receptor class F member 2,36325,0.0962874192067812,0.066616852971292,-0.0342816126169511,0.226856451030514,0.148388587557469
Physical measures,X4270.Volume level set by participant (left),NUP50,Nuclear pore complex protein Nup50,35079,-0.101252598406942,0.0700897573298825,-0.238628522773512,0.0361233259596277,0.148614903899375
Physical measures,X4270.Volume level set by participant (left),ARAF,Serine/threonine-protein kinase A-Raf,35195,-0.0490095143022676,0.0339678552831203,-0.115586510657183,0.0175674820526482,0.149118586018197
Physical measures,X4270.Volume level set by participant (left),ENOPH1,Enolase-phosphatase E1,35279,-0.0576712335464916,0.0399728239492066,-0.136017968486936,0.0206755013939533,0.149134708889889
Physical measures,X4270.Volume level set by participant (left),COL9A1,Collagen alpha-1(IX) chain,36242,-0.0611996648140665,0.0424581580149961,-0.144417654523459,0.0220183248953259,0.1495095361192
Physical measures,X4270.Volume level set by participant (left),ACYP1,Acylphosphatase-1,35132,-0.0495069604092237,0.0343628909398266,-0.116858226651284,0.0178443058328364,0.149714582622092
Physical measures,X4270.Volume level set by participant (left),CLEC4G,C-type lectin domain family 4 member G,36242,-0.080522477670079,0.0559035307655071,-0.190093397970473,0.029048442630315,0.149800142310158
Physical measures,X4270.Volume level set by participant (left),MRPL46,"39S ribosomal protein L46, mitochondrial",36064,-0.0980456931743198,0.0680734140066342,-0.231469584627323,0.0353781982786832,0.14982634940878
Physical measures,X4270.Volume level set by participant (left),PSMC3,26S proteasome regulatory subunit 6A,35095,-0.101635316341849,0.0706151862389842,-0.240041081370258,0.0367704486865599,0.150118252107461
Physical measures,X4270.Volume level set by participant (left),PITHD1,PITH domain-containing protein 1,35084,0.0413345546241485,0.0287268624315742,-0.0149700957417369,0.0976392049900339,0.15023235385321
Physical measures,X4270.Volume level set by participant (left),NAPRT,Nicotinate phosphoribosyltransferase,35301,-0.0913683071250877,0.0637927957858468,-0.216402186865348,0.0336655726151721,0.15211412904777
Physical measures,X4270.Volume level set by participant (left),CDSN,Corneodesmosin,36327,0.0619234212167646,0.0432646231564377,-0.0228752401698532,0.146722082603382,0.152392882369646
Physical measures,X4270.Volume level set by participant (left),PLAUR,Urokinase plasminogen activator surface receptor,36179,0.0948887566594924,0.0663666268651646,-0.0351898319962302,0.224967345315215,0.152825382451337
Physical measures,X4270.Volume level set by participant (left),CA11,Carbonic anhydrase-related protein 11,36060,0.0860769333031071,0.060308052740431,-0.0321268500681377,0.204280716674352,0.153538897034975
Physical measures,X4270.Volume level set by participant (left),DDHD2,Phospholipase DDHD2,35305,-0.0485087186727616,0.034009025354866,-0.115166408368299,0.0181489710227758,0.15381438113285
Physical measures,X4270.Volume level set by participant (left),NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",35313,-0.0425918493667965,0.0298630412736755,-0.1011234102632,0.0159397115296075,0.153845740721248
Physical measures,X4270.Volume level set by participant (left),STXBP1,Syntaxin-binding protein 1,35305,-0.0411344583256548,0.0288550942890631,-0.0976904431322186,0.0154215264809089,0.154044061217945
Physical measures,X4270.Volume level set by participant (left),GM2A,Ganglioside GM2 activator,35146,0.0834638308292161,0.0585760889907545,-0.0313453035926627,0.198272965251095,0.154239917473649
Physical measures,X4270.Volume level set by participant (left),CFHR5,Complement factor H-related protein 5,35223,0.0745256329235636,0.0523567707439451,-0.0280936377345687,0.177144903581696,0.154661794626107
Physical measures,X4270.Volume level set by participant (left),BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,35301,-0.0725497012747455,0.0510029787706345,-0.172515539665189,0.0274161371156982,0.154939299610746
Physical measures,X4270.Volume level set by participant (left),TXNDC15,Thioredoxin domain-containing protein 15,36289,0.095319287955998,0.0670652899058968,-0.0361286802595598,0.226767256171556,0.155272771372084
Physical measures,X4270.Volume level set by participant (left),CHL1,Neural cell adhesion molecule L1-like protein,36273,-0.09048587709955,0.0636791658816988,-0.21529704222768,0.0343252880285796,0.155367536312405
Physical measures,X4270.Volume level set by participant (left),PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,36064,-0.0253365148642054,0.0178325764168884,-0.0602883646413066,0.00961533491289594,0.155416858721611
Physical measures,X4270.Volume level set by participant (left),NAGK,N-acetyl-D-glucosamine kinase,35141,-0.0568530453077639,0.0400194210377771,-0.135291110541807,0.0215850199262792,0.155470184833781
Physical measures,X4270.Volume level set by participant (left),TPMT,Thiopurine S-methyltransferase,36060,-0.037321681267745,0.0263181221611898,-0.088905200703677,0.0142618381681869,0.156203887622519
Physical measures,X4270.Volume level set by participant (left),TIA1,Nucleolysin TIA-1 isoform p40,36059,-0.0226416557046549,0.0159936359482472,-0.0539891821632193,0.00870587075390959,0.156914919912791
Physical measures,X4270.Volume level set by participant (left),EPHB4,Ephrin type-B receptor 4,36364,0.104502632532647,0.0738986093345109,-0.0403386417629946,0.249343906828288,0.157362291310921
Physical measures,X4270.Volume level set by participant (left),CRYZL1,Quinone oxidoreductase-like protein 1,35151,-0.0371291495463043,0.026278397678281,-0.0886348089957352,0.0143765099031265,0.157728166083926
Physical measures,X4270.Volume level set by participant (left),PSMG4,Proteasome assembly chaperone 4,35093,-0.0541233146898286,0.0383368843503171,-0.12926360801645,0.0210169786367929,0.158062167247826
Physical measures,X4270.Volume level set by participant (left),MORC3,MORC family CW-type zinc finger protein 3,35301,-0.114214361466789,0.0809815392007908,-0.272938178300339,0.0445094553667613,0.158475335921511
Physical measures,X4270.Volume level set by participant (left),IGDCC4,Immunoglobulin superfamily DCC subclass member 4,35320,-0.115634685841121,0.0821085583861154,-0.276567460277907,0.0452980885956654,0.159084201126151
Physical measures,X4270.Volume level set by participant (left),IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,35195,0.0600006162592409,0.0426156525376493,-0.0235260627145517,0.143527295233033,0.159193669013715
Physical measures,X4270.Volume level set by participant (left),TBCB,Tubulin-folding cofactor B,36179,-0.0283722517237961,0.0201580103818477,-0.0678819520722176,0.0111374486246254,0.15932237758794
Physical measures,X4270.Volume level set by participant (left),FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,35279,-0.0910783882719188,0.0647125348766809,-0.217914956630213,0.0357581800863758,0.159346360975646
Physical measures,X4270.Volume level set by participant (left),RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,35151,-0.143754896340568,0.102148564184134,-0.343966082141471,0.0564562894603354,0.159382368582974
Physical measures,X4270.Volume level set by participant (left),IST1,IST1 homolog,35219,-0.0338616478174204,0.0240732804194452,-0.0810452774395329,0.0133219818046921,0.159590887350604
Physical measures,X4270.Volume level set by participant (left),UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,35313,-0.0510249397666323,0.0362976436908148,-0.122168321400629,0.0201184418673647,0.159848544589142
Physical measures,X4270.Volume level set by participant (left),TNFSF12,Tumor necrosis factor ligand superfamily member 12,36342,-0.0944547128663348,0.0672247117402356,-0.226215147877196,0.0373057221445269,0.160043754855198
Physical measures,X4270.Volume level set by participant (left),NRP1,Neuropilin-1,36313,-0.09642246086832,0.0686376868508962,-0.230952327096077,0.0381074053594366,0.160120012383348
Physical measures,X4270.Volume level set by participant (left),SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,35133,0.0660663848132044,0.0470519768195862,-0.0261554897531845,0.158288259379593,0.160332175539303
Physical measures,X4270.Volume level set by participant (left),GCLM,Glutamate--cysteine ligase regulatory subunit,35079,-0.0722018956986165,0.0514464282613449,-0.173036895090853,0.0286331036936195,0.160534079090037
Physical measures,X4270.Volume level set by participant (left),DNAJB2,DnaJ homolog subfamily B member 2,35165,-0.0588570543702396,0.0419644777672358,-0.141107430794022,0.0233933220535426,0.160799969714503
Physical measures,X4270.Volume level set by participant (left),TGFBR2,TGF-beta receptor type-2,36289,0.079599944712979,0.0567550114260677,-0.0316398776821136,0.190839767108072,0.160800904862239
Physical measures,X4270.Volume level set by participant (left),ACTA2,"Actin, aortic smooth muscle",36109,-0.0611838693867024,0.0437216900977659,-0.146878381978324,0.0245106432049188,0.161736198568818
Physical measures,X4270.Volume level set by participant (left),NRN1,Neuritin,35305,-0.0864026637192204,0.0617635331368283,-0.207459188667404,0.034653861228963,0.161881200836248
Physical measures,X4270.Volume level set by participant (left),MSR1,Macrophage scavenger receptor types I and II,36325,0.0552483190020028,0.0395017887890206,-0.0221751870244776,0.132671825028483,0.161964640493259
Physical measures,X4270.Volume level set by participant (left),TOP1,DNA topoisomerase 1,35285,0.0253281334577391,0.0181144028540091,-0.0101760961361186,0.0608323630515969,0.162089886454858
Physical measures,X4270.Volume level set by participant (left),APOBR,Apolipoprotein B receptor,35151,-0.0725678010819537,0.051905252926379,-0.174302096817656,0.0291664946537491,0.162135790300674
Physical measures,X4270.Volume level set by participant (left),RRM2,Ribonucleoside-diphosphate reductase subunit M2,36060,0.053946737807017,0.0385977649334015,-0.02170488146245,0.129598357076484,0.162255322611018
Physical measures,X4270.Volume level set by participant (left),PRR4,Proline-rich protein 4,35112,0.0449809020084079,0.032186051225485,-0.0181037583935428,0.108065562410359,0.162302536599425
Physical measures,X4270.Volume level set by participant (left),EDDM3B,Epididymal secretory protein E3-beta,35279,0.0505807343046987,0.0362142531570778,-0.0203992018831739,0.121560670492571,0.162547849034739
Physical measures,X4270.Volume level set by participant (left),CNTNAP2,Contactin-associated protein-like 2,36242,-0.0609982597021475,0.0438115953801674,-0.146868986647276,0.0248724672429806,0.163876413723303
Physical measures,X4270.Volume level set by participant (left),CCN1,CCN family member 1,36204,-0.0357349204658492,0.025676323639788,-0.0860605147998337,0.0145906738681352,0.164040054111063
Physical measures,X4270.Volume level set by participant (left),FADD,FAS-associated death domain protein,36258,-0.0355700690394293,0.0255659267664488,-0.085679285501669,0.0145391474228103,0.164172592016586
Physical measures,X4270.Volume level set by participant (left),AMY2A,Pancreatic alpha-amylase,35984,0.0550943162881746,0.0396795073151934,-0.0226775180496046,0.132866150625954,0.165031956331329
Physical measures,X4270.Volume level set by participant (left),FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,36284,0.0522984746636726,0.0376807478690118,-0.0215557911595904,0.126152740486936,0.165196725208989
Physical measures,X4270.Volume level set by participant (left),FHIT,Bis(5'-adenosyl)-triphosphatase,36064,-0.0395002091354809,0.0284638866906859,-0.0952894270492252,0.0162890087782634,0.165260508470575
Physical measures,X4270.Volume level set by participant (left),OSMR,Oncostatin-M-specific receptor subunit beta,36313,0.133025156796592,0.0960079096334717,-0.0551503460850125,0.321200659678197,0.165919985713314
Physical measures,X4270.Volume level set by participant (left),PDIA3,Protein disulfide-isomerase A3,35165,0.124913966885282,0.0902398925201007,-0.051956222454115,0.30178415622468,0.166331040301653
Physical measures,X4270.Volume level set by participant (left),ZNF174,Zinc finger protein 174,35093,0.0866777863040473,0.0626249289530246,-0.0360670744438808,0.209422647051975,0.166382165180396
Physical measures,X4270.Volume level set by participant (left),CDH3,Cadherin-3,36325,0.0706758119744661,0.0512690340741029,-0.0298114948107756,0.171163118759708,0.168080185431291
Physical measures,X4270.Volume level set by participant (left),MSLN,Mesothelin,36201,0.044851935230711,0.03253754969577,-0.0189216621729982,0.10862553263442,0.168099766265542
Physical measures,X4270.Volume level set by participant (left),BCL2L1,Bcl-2-like protein 1,35301,-0.0316165518901467,0.0230097079807333,-0.0767155795323839,0.0134824757520905,0.169471292687874
Physical measures,X4270.Volume level set by participant (left),CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,35165,0.105088365987781,0.0764917532650425,-0.0448354704117028,0.255012202387264,0.169534489001637
Physical measures,X4270.Volume level set by participant (left),AKR7L,Aflatoxin B1 aldehyde reductase member 4,35093,0.0452022354395131,0.0329376294929211,-0.0193555183666124,0.109759989245638,0.169999292187136
Physical measures,X4270.Volume level set by participant (left),IGFBP4,Insulin-like growth factor-binding protein 4,36160,0.06015345299359,0.0439075607617061,-0.025905366099354,0.146212272086534,0.170726928386517
Physical measures,X4270.Volume level set by participant (left),USP47,Ubiquitin carboxyl-terminal hydrolase 47,35079,0.0350098859113087,0.0255737615163263,-0.0151146866606907,0.0851344584833082,0.171054009350255
Physical measures,X4270.Volume level set by participant (left),IL1RN,Interleukin-1 receptor antagonist protein,36232,0.0483476854583453,0.0353916659066567,-0.0210199797187019,0.117715350635393,0.171955553428695
Physical measures,X4270.Volume level set by participant (left),SMAD3,Mothers against decapentaplegic homolog 3,35279,-0.0564801608237433,0.0413688434923161,-0.137563094068683,0.0246027724211962,0.172210258560085
Physical measures,X4270.Volume level set by participant (left),RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,36060,-0.0389814935079236,0.0285688932978519,-0.0949765243717133,0.0170135373558661,0.172459810466115
Physical measures,X4270.Volume level set by participant (left),VPS28,Vacuolar protein sorting-associated protein 28 homolog,35195,-0.0459955629470851,0.0337818268062053,-0.112207943487247,0.0202168175930772,0.173387255189697
Physical measures,X4270.Volume level set by participant (left),AGT,Angiotensinogen,35317,-0.118538003035574,0.0870889076611703,-0.289232262051468,0.0521562559803196,0.173523086667278
Physical measures,X4270.Volume level set by participant (left),ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,35079,-0.104861723762386,0.0770462046442831,-0.255872284865181,0.0461488373404086,0.173553503208806
Physical measures,X4270.Volume level set by participant (left),ROBO4,Roundabout homolog 4,35151,-0.166361345363266,0.122247887986625,-0.405967205817051,0.0732445150905184,0.173607137703913
Physical measures,X4270.Volume level set by participant (left),OPLAH,5-oxoprolinase,35151,-0.0446248971333122,0.0327947686929282,-0.108902643771451,0.019652849504827,0.173645173249154
Physical measures,X4270.Volume level set by participant (left),LACTB2,Endoribonuclease LACTB2,36258,-0.0403306767482554,0.0296428394414797,-0.0984306420535556,0.0177692885570448,0.17369480960192
Physical measures,X4270.Volume level set by participant (left),SUSD4,Sushi domain-containing protein 4,35279,0.0751838570405002,0.0552840630595099,-0.0331729065561392,0.18354062063714,0.173889978227749
Physical measures,X4270.Volume level set by participant (left),AKR1B10,Aldo-keto reductase family 1 member B10,35133,0.0478907750760089,0.0352304442971637,-0.021160895746432,0.11694244589845,0.174080214358109
Physical measures,X4270.Volume level set by participant (left),CETN3,Centrin-3,35285,-0.0385839570414712,0.0283913181220546,-0.0942309405606982,0.0170630264777558,0.174190717908396
Physical measures,X4270.Volume level set by participant (left),LBR,Delta(14)-sterol reductase LBR,36325,0.0372793064818279,0.027434123725452,-0.016491576020058,0.0910501889837137,0.174228644290222
Physical measures,X4270.Volume level set by participant (left),TNFSF14,Tumor necrosis factor ligand superfamily member 14,36179,-0.0445750560897711,0.0328042947184407,-0.108871473737915,0.0197213615583726,0.174244817411527
Physical measures,X4270.Volume level set by participant (left),TWF2,Twinfilin-2,35320,-0.0350740437655543,0.0258194409289935,-0.0856801479863816,0.015532060455273,0.17437117263241
Physical measures,X4270.Volume level set by participant (left),CD300LF,CMRF35-like molecule 1,36327,0.0414742755491971,0.030561648691838,-0.0184265558868053,0.1013751069852,0.174798842453651
Physical measures,X4270.Volume level set by participant (left),SEMA3G,Semaphorin-3G,35165,0.0654465862295879,0.0483649377007576,-0.0293486916638969,0.160241864123073,0.176043956075798
Physical measures,X4270.Volume level set by participant (left),MME,Neprilysin,36216,0.0329523564902088,0.0244042876465663,-0.0148800472970612,0.0807847602774787,0.176969806515038
Physical measures,X4270.Volume level set by participant (left),LGALS3,Galectin-3,36292,0.0840753795646712,0.0622738469375796,-0.0379813604329849,0.206132119562327,0.177026435486904
Physical measures,X4270.Volume level set by participant (left),UBAC1,Ubiquitin-associated domain-containing protein 1,36216,-0.0786606619043113,0.0582999822160686,-0.192928627047806,0.0356073032391831,0.177300048907951
Physical measures,X4270.Volume level set by participant (left),CTRB1,Chymotrypsinogen B,36256,0.043257832148163,0.0320616373766289,-0.0195829771100297,0.106098641406356,0.177309935155855
Physical measures,X4270.Volume level set by participant (left),RGL2,Ral guanine nucleotide dissociation stimulator-like 2,35195,-0.0462381332956169,0.0343036774388327,-0.113473341075729,0.0209970744844952,0.1777349294514
Physical measures,X4270.Volume level set by participant (left),MYOM3,Myomesin-3,35165,-0.0304583004364286,0.0226391533681655,-0.074831041038033,0.0139144401651758,0.178548521165924
Physical measures,X4270.Volume level set by participant (left),KLK10,Kallikrein-10,36275,0.0614429259111054,0.0456711707558675,-0.0280725687703948,0.150958420592606,0.178557533926367
Physical measures,X4270.Volume level set by participant (left),COL18A1,Collagen alpha-1(XVIII) chain,36308,0.107352508676178,0.0798370270926642,-0.0491280644254437,0.2638330817778,0.178779285480647
Physical measures,X4270.Volume level set by participant (left),CD36,Platelet glycoprotein 4,35093,-0.0651131392337246,0.0484551530582664,-0.160085239227927,0.0298589607604775,0.179066023715682
Physical measures,X4270.Volume level set by participant (left),ARID3A,AT-rich interactive domain-containing protein 3A,35083,-0.0762302354094114,0.0567753916063473,-0.187510002957852,0.0350495321390293,0.179428049379967
Physical measures,X4270.Volume level set by participant (left),SERPINA9,Serpin A9,36177,-0.0364636063406765,0.0271983364713165,-0.0897723458244568,0.0168451331431039,0.180072453868072
Physical measures,X4270.Volume level set by participant (left),ITGB5,Integrin beta-5,36289,0.0658490626661486,0.0491476186340979,-0.0304802698566833,0.162178395188981,0.180342818598139
Physical measures,X4270.Volume level set by participant (left),RBM19,Probable RNA-binding protein 19,35079,-0.0657951199295543,0.0491078938541071,-0.162046591883604,0.0304563520244956,0.180354977525958
Physical measures,X4270.Volume level set by participant (left),DCTN2,Dynactin subunit 2,36216,-0.0262102642893029,0.0195715500011589,-0.0645705022915744,0.0121499737129686,0.180544812946318
Physical measures,X4270.Volume level set by participant (left),CHMP1A,Charged multivesicular body protein 1a,36179,-0.0340864026286115,0.0254784395985213,-0.0840241442417133,0.0158513389844903,0.180984571184953
Physical measures,X4270.Volume level set by participant (left),TSPAN8,Tetraspanin-8,35285,0.0304510508617854,0.0227749638223767,-0.0141878782300729,0.0750899799536437,0.181254905838005
Physical measures,X4270.Volume level set by participant (left),CPB1,Carboxypeptidase B,36364,0.039497694180976,0.029586913662954,-0.0184926565984138,0.0974880449603657,0.181924746816737
Physical measures,X4270.Volume level set by participant (left),IL25,Interleukin-25,35073,-0.0889343727931114,0.0666300816312027,-0.219529332790269,0.0416605872040459,0.182005781467448
Physical measures,X4270.Volume level set by participant (left),MCFD2,Multiple coagulation factor deficiency protein 2,36227,-0.0557422690620657,0.0417829030542457,-0.137636759048387,0.0261522209242559,0.182213301252121
Physical measures,X4270.Volume level set by participant (left),GPR15L,Protein GPR15L,35285,0.0461310747854341,0.0345787596453875,-0.0216432941195253,0.113905443690394,0.182220800631543
Physical measures,X4270.Volume level set by participant (left),RILP,Rab-interacting lysosomal protein,36309,-0.0438791340934471,0.0329003929781186,-0.108363904330559,0.0206056361436653,0.182342808658387
Physical measures,X4270.Volume level set by participant (left),BPIFA2,BPI fold-containing family A member 2,34968,-0.0277249743871802,0.0208049759169409,-0.0685027271843844,0.0130527784100239,0.182706649680497
Physical measures,X4270.Volume level set by participant (left),ECM1,Extracellular matrix protein 1,35152,-0.0774990275416811,0.0581665503304356,-0.191505466189335,0.0365074111059728,0.182786908173824
Physical measures,X4270.Volume level set by participant (left),CD99L2,CD99 antigen-like protein 2,36256,0.101762735209254,0.0764732804785085,-0.0481248945286227,0.251650364947131,0.183328504154105
Physical measures,X4270.Volume level set by participant (left),EDNRB,Endothelin receptor type B,35093,0.0713673070900607,0.0536578031281101,-0.0338019870410351,0.176536601221157,0.183550095479146
Physical measures,X4270.Volume level set by participant (left),FZD10,Frizzled-10,35133,0.0501723928305822,0.0377361213412292,-0.023790404998227,0.124135190659391,0.183710118179394
Physical measures,X4270.Volume level set by participant (left),MASP1,Mannan-binding lectin serine protease 1,36168,-0.108275281584157,0.0815508036609445,-0.268114856759608,0.0515642935912943,0.184316161448415
Physical measures,X4270.Volume level set by participant (left),CCL27,C-C motif chemokine 27,36258,0.039708278101761,0.0299146152594339,-0.0189243678067294,0.0983409240102513,0.184420208786734
Physical measures,X4270.Volume level set by participant (left),HBZ,Hemoglobin subunit zeta,35313,-0.0254285143302659,0.0191624653679843,-0.0629869464515152,0.0121299177909833,0.184555168448705
Physical measures,X4270.Volume level set by participant (left),CLU,Clusterin,35325,-0.10010461971306,0.0754529478711868,-0.247992397540586,0.0477831581144666,0.184647772673951
Physical measures,X4270.Volume level set by participant (left),DRG2,Developmentally-regulated GTP-binding protein 2,36216,-0.0443144236617418,0.0334461008818565,-0.109868781390181,0.021239934066697,0.185227379211155
Physical measures,X4270.Volume level set by participant (left),GNPDA1,Glucosamine-6-phosphate isomerase 1,35151,-0.0877020921898025,0.0662817943588131,-0.217614409133076,0.0422102247534712,0.185824998982995
Physical measures,X4270.Volume level set by participant (left),MAPT,Microtubule-associated protein tau,36064,-0.048543629101113,0.0366981699581587,-0.120472042219104,0.0233847840168781,0.185948875134016
Physical measures,X4270.Volume level set by participant (left),PRND,Prion-like protein doppel,35301,0.0593241295053352,0.0448687701385302,-0.028618659966184,0.147266918976854,0.186156788009856
Physical measures,X4270.Volume level set by participant (left),ARG2,"Arginase-2, mitochondrial",35279,0.0701380056642097,0.0530951881543088,-0.0339285631182356,0.174204574446655,0.186551273845934
Physical measures,X4270.Volume level set by participant (left),ITGAL,Integrin alpha-L,35093,-0.0658012002114764,0.0498273458895691,-0.163462798155032,0.0318603977320791,0.186686646526126
Physical measures,X4270.Volume level set by participant (left),EGF,Pro-epidermal growth factor,36235,-0.0242541543411055,0.0183692281399768,-0.06025784149546,0.0117495328132491,0.186751534991837
Physical measures,X4270.Volume level set by participant (left),BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,35079,-0.114539630563876,0.0867762951518396,-0.284621169061481,0.0555419079337301,0.18690121491255
Physical measures,X4270.Volume level set by participant (left),PPCDC,Phosphopantothenoylcysteine decarboxylase,36325,-0.0535661552732264,0.0406391469745489,-0.133218883343342,0.0260865727968894,0.187511778844299
Physical measures,X4270.Volume level set by participant (left),FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",35181,-0.047793840140394,0.0362887214004466,-0.118919734085269,0.0233320538044814,0.18786977820683
Physical measures,X4270.Volume level set by participant (left),TNPO1,Transportin-1,35195,0.0788666050412545,0.0599053913908889,-0.0385479620848877,0.196281172167397,0.188045569031712
Physical measures,X4270.Volume level set by participant (left),RAP1A,Ras-related protein Rap-1A,35093,-0.0434216061946736,0.0329917574589398,-0.108085450814196,0.0212422384248483,0.18817522292963
Physical measures,X4270.Volume level set by participant (left),CASP10,Caspase-10,36064,-0.0362978435144976,0.0275903769629537,-0.0903749823618869,0.0177792953328917,0.188349444575983
Physical measures,X4270.Volume level set by participant (left),SLITRK1,SLIT and NTRK-like protein 1,35093,-0.0901988829270295,0.0685884441212366,-0.224632233404653,0.0442344675505942,0.188531479433597
Physical measures,X4270.Volume level set by participant (left),LIFR,Leukemia inhibitory factor receptor,36242,0.102681281517336,0.0781108003860658,-0.0504158872393524,0.255778450274025,0.188697511305422
Physical measures,X4270.Volume level set by participant (left),VPS4B,Vacuolar protein sorting-associated protein 4B,35279,-0.031015460731884,0.0236062882930556,-0.0772837857862731,0.015252864322505,0.188937001444545
Physical measures,X4270.Volume level set by participant (left),AIF1L,Allograft inflammatory factor 1-like,35151,0.052233727307149,0.0397587034378512,-0.0256933314310393,0.130160786045337,0.188970188357493
Physical measures,X4270.Volume level set by participant (left),RWDD1,RWD domain-containing protein 1,36325,-0.0415557317000369,0.0317092850596244,-0.103705930416901,0.0205944670168269,0.190058112229836
Physical measures,X4270.Volume level set by participant (left),AHSG,Alpha-2-HS-glycoprotein,35317,-0.10573254503914,0.0807476559106509,-0.263997950624016,0.0525328605457357,0.190437139491839
Physical measures,X4270.Volume level set by participant (left),PRUNE2,Protein prune homolog 2,35195,0.101915274012705,0.0780299262268592,-0.0510233813919386,0.25485392941735,0.191562437546019
Physical measures,X4270.Volume level set by participant (left),CD55,Complement decay-accelerating factor,36006,0.0964150569292175,0.0738978776901182,-0.0484247833434142,0.241254897201849,0.192033291607408
Physical measures,X4270.Volume level set by participant (left),ADGRE5,Adhesion G protein-coupled receptor E5,36325,-0.0791787056900107,0.0606875164190356,-0.19812623787132,0.039768826491299,0.192035569038228
Physical measures,X4270.Volume level set by participant (left),IL1RAP,Interleukin-1 receptor accessory protein,36256,-0.0548861344688767,0.0421247105372408,-0.137450567121869,0.0276782981841153,0.192633117853834
Physical measures,X4270.Volume level set by participant (left),TBCC,Tubulin-specific chaperone C,36179,-0.0318616231294412,0.0244578903879263,-0.0797990882897766,0.0160758420308943,0.192712199501713
Physical measures,X4270.Volume level set by participant (left),HYOU1,Hypoxia up-regulated protein 1,36364,0.105650436906986,0.0811728203084698,-0.0534482908976152,0.264749164711586,0.193109094059419
Physical measures,X4270.Volume level set by participant (left),EVI2B,Protein EVI2B,35095,0.0778724383132089,0.059837724918806,-0.0394095025276508,0.195154379154069,0.193169909560784
Physical measures,X4270.Volume level set by participant (left),TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,36283,0.0501066341880135,0.0385142673224181,-0.025381329763926,0.125594598139953,0.193301285803734
Physical measures,X4270.Volume level set by participant (left),REN,Renin,36258,0.0303928435263861,0.0233709799291528,-0.0154142771347534,0.0761999641875257,0.19348515962552
Physical measures,X4270.Volume level set by participant (left),ATG4A,Cysteine protease ATG4A,36060,-0.0424946033630647,0.0326884976908799,-0.106564058837189,0.0215748521110598,0.193645801157869
Physical measures,X4270.Volume level set by participant (left),HS1BP3,HCLS1-binding protein 3,35151,-0.0325863943270347,0.0250692376687662,-0.0817221001578165,0.0165493115037472,0.193696147350455
Physical measures,X4270.Volume level set by participant (left),YY1,Transcriptional repressor protein YY1,35093,-0.103273487268242,0.0795041695737374,-0.259101659632767,0.0525546850962837,0.19400056082873
Physical measures,X4270.Volume level set by participant (left),ADD1,Alpha-adducin,35165,-0.0433532463217947,0.0334048039391865,-0.1088266620426,0.0221201693990109,0.194396626757713
Physical measures,X4270.Volume level set by participant (left),CEP112,Centrosomal protein of 112 kDa,35079,0.0623150967948419,0.0480352475140091,-0.0318339883326159,0.1564641819223,0.194581570064562
Physical measures,X4270.Volume level set by participant (left),SF3B4,Splicing factor 3B subunit 4,36216,-0.0336447816361177,0.0259357687039268,-0.0844788882958141,0.0171893250235788,0.194589721220562
Physical measures,X4270.Volume level set by participant (left),UPK3A,Uroplakin-3a,35083,0.0585041074108719,0.0451010645954676,-0.0298939791962446,0.146902194017988,0.194616140293288
Physical measures,X4270.Volume level set by participant (left),EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,36270,0.0755215572442607,0.0582209217394627,-0.0385914493650862,0.189634563853608,0.194616906758158
Physical measures,X4270.Volume level set by participant (left),IDUA,Alpha-L-iduronidase,36327,0.0512319845254515,0.0395455944520127,-0.0262773806004933,0.128741349651396,0.195180702894168
Physical measures,X4270.Volume level set by participant (left),CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",35141,-0.0386669814677452,0.0298693339018664,-0.0972108759154033,0.0198769129799129,0.195525443381552
Physical measures,X4270.Volume level set by participant (left),VIM,Vimentin,36109,0.0218266290947076,0.016881115785301,-0.0112603578444823,0.0549136160338975,0.196064245154432
Physical measures,X4270.Volume level set by participant (left),CRYGD,Gamma-crystallin D,35301,-0.0290315725985541,0.0224895679147445,-0.0731111257114533,0.0150479805143451,0.196786156515844
Physical measures,X4270.Volume level set by participant (left),HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",36309,-0.0347004132389087,0.0268986069137002,-0.0874216827897611,0.0180208563119436,0.197073746520367
Physical measures,X4270.Volume level set by participant (left),NELL1,Protein kinase C-binding protein NELL1,36289,-0.058140277692283,0.0451196881825574,-0.146574866530095,0.0302943111455295,0.197583311950429
Physical measures,X4270.Volume level set by participant (left),PTH,Parathyroid hormone,35133,-0.0335536414771305,0.0260858825068577,-0.0846819711905716,0.0175746882363106,0.198392400459159
Physical measures,X4270.Volume level set by participant (left),RANBP2,E3 SUMO-protein ligase RanBP2,35083,-0.0864522006167495,0.0672302656318177,-0.218223521255112,0.0453191200216132,0.198519747153525
Physical measures,X4270.Volume level set by participant (left),GIP,Gastric inhibitory polypeptide,35151,0.0569214285908166,0.0443250522498678,-0.0299556738189243,0.143798531000558,0.199123760337819
Physical measures,X4270.Volume level set by participant (left),LTBP2,Latent-transforming growth factor beta-binding protein 2,36364,-0.0735083223468859,0.0572517201330698,-0.185721693807703,0.0387050491139309,0.199197924690593
Physical measures,X4270.Volume level set by participant (left),EXOSC10,Exosome component 10,35079,-0.0502800085594241,0.03920038100997,-0.127112755338965,0.026552738220117,0.199663850727387
Physical measures,X4270.Volume level set by participant (left),FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,36179,-0.0606690023459182,0.0473669746431122,-0.153508272646418,0.0321702679545817,0.200292886976805
Physical measures,X4270.Volume level set by participant (left),CCL8,C-C motif chemokine 8,36315,-0.0398377714141471,0.0311053925239524,-0.100804340761094,0.0211287979327997,0.200325202687508
Physical measures,X4270.Volume level set by participant (left),FST,Follistatin,36268,0.049119294434828,0.0383552577099612,-0.0260570106766959,0.124295599546352,0.20035873478406
Physical measures,X4270.Volume level set by participant (left),AK1,Adenylate kinase isoenzyme 1,36258,-0.0383452644666658,0.0299969208539254,-0.0971392293403597,0.0204487004070281,0.201180068401723
Physical measures,X4270.Volume level set by participant (left),UROD,Uroporphyrinogen decarboxylase,35165,-0.0438395022888072,0.0342982908833249,-0.111064152420124,0.0233851478425095,0.201230015999184
Physical measures,X4270.Volume level set by participant (left),DBH,Dopamine beta-hydroxylase,35301,0.0243063939098007,0.0190274537048998,-0.012987415351803,0.0616002031714043,0.201491904170077
Physical measures,X4270.Volume level set by participant (left),CNPY4,Protein canopy homolog 4,36216,-0.032403360647131,0.025367400563122,-0.0821234657508501,0.0173167444565882,0.201513328008958
Physical measures,X4270.Volume level set by participant (left),ATP6V1G1,V-type proton ATPase subunit G 1,35151,-0.0403533593881621,0.0315976798690049,-0.102284811931412,0.0215780931550876,0.201612647396837
Physical measures,X4270.Volume level set by participant (left),PLA2G1B,Phospholipase A2,36350,0.0532964925179513,0.0417623986887497,-0.0285578089119981,0.135150793947901,0.201928846809647
Physical measures,X4270.Volume level set by participant (left),TANK,TRAF family member-associated NF-kappa-B activator,36103,-0.0348200152251707,0.0272867232915197,-0.0883019928765494,0.0186619624262079,0.201967101566037
Physical measures,X4270.Volume level set by participant (left),MMP3,Stromelysin-1,36256,-0.0483688612081362,0.0379090603567371,-0.122670619507341,0.0259328970910686,0.20202314878738
Physical measures,X4270.Volume level set by participant (left),ANGPT1,Angiopoietin-1,36221,-0.0286740718932178,0.0224899849915782,-0.0727544424767111,0.0154062986902756,0.20235849619146
Physical measures,X4270.Volume level set by participant (left),PF4,Platelet factor 4,35249,-0.0290132725024746,0.022755870685286,-0.0736147790456352,0.0155882340406859,0.202361007606122
Physical measures,X4270.Volume level set by participant (left),MIF,Macrophage migration inhibitory factor,36232,-0.0384425446719742,0.0301538282599843,-0.0975440480615434,0.020658958717595,0.202390167564232
Physical measures,X4270.Volume level set by participant (left),XRCC4,DNA repair protein XRCC4,36064,-0.0643511686010294,0.0505577633310085,-0.163444384729806,0.0347420475277472,0.20311992387749
Physical measures,X4270.Volume level set by participant (left),FABP1,"Fatty acid-binding protein, liver",36232,0.0255929191180246,0.020122723658683,-0.013847619252994,0.0650334574890432,0.20346813688854
Physical measures,X4270.Volume level set by participant (left),WAS,Wiskott-Aldrich syndrome protein,36103,0.0352634123675038,0.027794700456451,-0.0192142005271401,0.0897410252621477,0.204583915622036
Physical measures,X4270.Volume level set by participant (left),UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,35285,-0.0204443967170279,0.0161156715039621,-0.0520311128647935,0.0111423194307377,0.204626720222963
Physical measures,X4270.Volume level set by participant (left),TRIM58,E3 ubiquitin-protein ligase TRIM58,35279,-0.0325877800672492,0.025694094312475,-0.0829482049197002,0.0177726447852018,0.204735614880957
Physical measures,X4270.Volume level set by participant (left),BIRC2,Baculoviral IAP repeat-containing protein 2,36060,-0.0391194502397914,0.0308497434568132,-0.0995849474151452,0.0213460469355624,0.204814672157136
Physical measures,X4270.Volume level set by participant (left),GMPR2,GMP reductase 2,35165,-0.0444908201254291,0.0351496011423603,-0.113384038364455,0.0244023981135971,0.205645373523685
Physical measures,X4270.Volume level set by participant (left),PSME1,Proteasome activator complex subunit 1,36168,-0.06785802699174,0.0536589279732045,-0.173029525819221,0.0373134718357408,0.206047383005769
Physical measures,X4270.Volume level set by participant (left),CST5,Cystatin-D,36093,-0.0429994524991531,0.0340432271615107,-0.109724177735714,0.0237252727374079,0.206598342766674
Physical measures,X4270.Volume level set by participant (left),ING1,Inhibitor of growth protein 1,36053,-0.0523397367517388,0.0414390282657405,-0.13356023215259,0.0288807586491126,0.206609246643317
Physical measures,X4270.Volume level set by participant (left),GC,Vitamin D-binding protein,35325,-0.107831827984831,0.0854108993612633,-0.275237190732907,0.0595735347632449,0.206810333248876
Physical measures,X4270.Volume level set by participant (left),C4BPB,C4b-binding protein beta chain,36289,0.0617205249329283,0.0489504033916325,-0.0342222657146714,0.157663315580528,0.207390796547675
Physical measures,X4270.Volume level set by participant (left),ATOX1,Copper transport protein ATOX1,36289,-0.0342683104065646,0.0272308538944385,-0.0876407840396641,0.019104163226535,0.208272031310182
Physical measures,X4270.Volume level set by participant (left),EPGN,Epigen,35279,0.0559501119436692,0.0444621381795883,-0.0311956788883238,0.143095902775662,0.208299615390379
Physical measures,X4270.Volume level set by participant (left),ELAC1,Zinc phosphodiesterase ELAC protein 1,35305,-0.0340084124100323,0.0270583530346773,-0.0870427843579999,0.0190259595379353,0.208850133012024
Physical measures,X4270.Volume level set by participant (left),CHP1,Calcineurin B homologous protein 1,35083,0.0381224836785001,0.030387636842415,-0.0214372845326334,0.0976822518896336,0.20969130989517
Physical measures,X4270.Volume level set by participant (left),MYOC,Myocilin,36256,-0.0530234663380912,0.0422968325898284,-0.135925258214155,0.0298783255379725,0.210024375478531
Physical measures,X4270.Volume level set by participant (left),RELT,Tumor necrosis factor receptor superfamily member 19L,36256,0.0816545011242905,0.0652317663997766,-0.0461997610192717,0.209508763267853,0.210695669552254
Physical measures,X4270.Volume level set by participant (left),TACC3,Transforming acidic coiled-coil-containing protein 3,36216,-0.020607480481371,0.0164637811546144,-0.0528764915444153,0.0116615305816733,0.210722846608359
Physical measures,X4270.Volume level set by participant (left),NECAP2,Adaptin ear-binding coat-associated protein 2,35079,-0.043034526785002,0.0343831154357614,-0.110425433039094,0.0243563794690905,0.210754292908031
Physical measures,X4270.Volume level set by participant (left),PPBP,Platelet basic protein,35254,-0.0322478869178406,0.0257719550500787,-0.0827609188159949,0.0182651449803136,0.210876986121707
Physical measures,X4270.Volume level set by participant (left),MYDGF,Myeloid-derived growth factor,35313,-0.0277002187557268,0.0221412871387344,-0.0710971415476462,0.0156967040361926,0.21095389779749
Physical measures,X4270.Volume level set by participant (left),FGF20,Fibroblast growth factor 20,35093,-0.0644923267958501,0.0515821662937139,-0.165593372731529,0.0366087191398291,0.211241114202442
Physical measures,X4270.Volume level set by participant (left),FAM172A,Cotranscriptional regulator FAM172A,35151,-0.0463776606554437,0.037128776111812,-0.119150061834595,0.0263947405237079,0.21167210335691
Physical measures,X4270.Volume level set by participant (left),ITGAM,Integrin alpha-M,36256,-0.0736710400562652,0.0590016219114388,-0.189314219002685,0.0419721388901548,0.211839590886295
Physical measures,X4270.Volume level set by participant (left),GRN,Progranulin,36213,0.0961807252474352,0.0771096349548005,-0.0549541592639738,0.247315609758844,0.212316976578518
Physical measures,X4270.Volume level set by participant (left),ICOSLG,ICOS ligand,36216,-0.12293187011643,0.0987133236059179,-0.316409984384029,0.070546244151169,0.213044308638758
Physical measures,X4270.Volume level set by participant (left),SEPTIN3,Neuronal-specific septin-3,35305,0.0341840828963856,0.0274641758959067,-0.0196457018595916,0.0880138676523628,0.213293291980146
Physical measures,X4270.Volume level set by participant (left),ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",35151,-0.0407545625164854,0.0327550290286688,-0.104954419412676,0.0234452943797054,0.213462013369414
Physical measures,X4270.Volume level set by participant (left),MAX,Protein max,36064,-0.0229059733989947,0.0184182006661366,-0.0590056467046225,0.0131936999066331,0.213663918104056
Physical measures,X4270.Volume level set by participant (left),PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,35285,-0.0870035410238674,0.0699747955433588,-0.224154140288851,0.0501470582411158,0.213780513537995
Physical measures,X4270.Volume level set by participant (left),LEFTY2,Left-right determination factor 2,36321,-0.0444042456942343,0.0357459596497118,-0.114466326607669,0.0256578352192008,0.214194180858666
Physical measures,X4270.Volume level set by participant (left),ERBB2,Receptor tyrosine-protein kinase erbB-2,36289,0.0958006778759371,0.0771372247201025,-0.0553882825754638,0.246989638327338,0.214292419445646
Physical measures,X4270.Volume level set by participant (left),IMPG1,Interphotoreceptor matrix proteoglycan 1,35083,0.0930559399547452,0.0749836670996805,-0.0539120475606285,0.240023927470119,0.214644717012123
Physical measures,X4270.Volume level set by participant (left),HAO1,Hydroxyacid oxidase 1,36327,0.0191437670193569,0.0154290144149478,-0.0110971012339408,0.0493846352726545,0.214730595275878
Physical measures,X4270.Volume level set by participant (left),MYL4,Myosin light chain 4,35151,-0.050211703980669,0.0404802812116591,-0.129553055155521,0.0291296471941829,0.214872260784323
Physical measures,X4270.Volume level set by participant (left),PVR,Poliovirus receptor,36325,0.0615218996492544,0.0496226700134002,-0.0357385335770099,0.158782332875519,0.215089189618829
Physical measures,X4270.Volume level set by participant (left),CUZD1,CUB and zona pellucida-like domain-containing protein 1,35133,0.0691512951701337,0.0558241362835355,-0.0402640119455959,0.178566602285863,0.21548828610707
Physical measures,X4270.Volume level set by participant (left),ENO2,Gamma-enolase,36325,-0.0371522516676537,0.0300346473420809,-0.0960201604581323,0.0217156571228249,0.216132203310566
Physical measures,X4270.Volume level set by participant (left),TGFBR1,TGF-beta receptor type-1,35093,0.122290001935818,0.0989801456105909,-0.0717110834609404,0.316291087332576,0.216689076527843
Physical measures,X4270.Volume level set by participant (left),FRMD7,FERM domain-containing protein 7,35133,-0.0828098615991014,0.0671430150880573,-0.214410171171694,0.0487904479734908,0.217495025453487
Physical measures,X4270.Volume level set by participant (left),EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,36179,-0.0254186001932746,0.0206226100330373,-0.0658389158580278,0.0150017154714785,0.217778288874513
Physical measures,X4270.Volume level set by participant (left),VSIG2,V-set and immunoglobulin domain-containing protein 2,35279,0.0443115497544431,0.0359595664060693,-0.0261692004014526,0.114792299910339,0.217895223005561
Physical measures,X4270.Volume level set by participant (left),COL24A1,Collagen alpha-1(XXIV) chain,35285,-0.04648262466687,0.0377600437063622,-0.12049231033134,0.0275270609975998,0.218366083623341
Physical measures,X4270.Volume level set by participant (left),PLG,Plasminogen,35130,0.128112315078547,0.104071559176826,-0.0758679409080315,0.332092571065125,0.218366408915672
Physical measures,X4270.Volume level set by participant (left),ERP44,Endoplasmic reticulum resident protein 44,36204,-0.0886504338238693,0.0722063256058352,-0.230174832011306,0.0528739643635676,0.219583438403522
Physical measures,X4270.Volume level set by participant (left),PLXNB3,Plexin-B3,36241,-0.0478201280210842,0.0389703872786323,-0.124202087087204,0.0285618310450352,0.219827015853627
Physical measures,X4270.Volume level set by participant (left),ASAH2,Neutral ceramidase,36179,-0.0440659670990985,0.0359309983579684,-0.114490723880717,0.0263587896825196,0.220084305038037
Physical measures,X4270.Volume level set by participant (left),CINP,Cyclin-dependent kinase 2-interacting protein,35195,-0.0630512331968124,0.0514245388269848,-0.163843329297703,0.0377408629040778,0.220207724637477
Physical measures,X4270.Volume level set by participant (left),LTBR,Tumor necrosis factor receptor superfamily member 3,36201,0.0792159485316362,0.0647065270441891,-0.0476088444749745,0.206040741538247,0.220901819009407
Physical measures,X4270.Volume level set by participant (left),RGS10,Regulator of G-protein signaling 10,35305,-0.0457690672633219,0.0374174810932748,-0.119107330206141,0.0275691956794967,0.221297128239013
Physical measures,X4270.Volume level set by participant (left),PSMA1,Proteasome subunit alpha type-1,36060,-0.0523413310230209,0.0427958357912616,-0.136221169173894,0.0315385071278519,0.221350484462445
Physical measures,X4270.Volume level set by participant (left),NIT1,Deaminated glutathione amidase,35151,-0.069049687501209,0.0564700729015482,-0.179731030388244,0.0416316553858255,0.221462082407769
Physical measures,X4270.Volume level set by participant (left),SPTBN2,"Spectrin beta chain, non-erythrocytic 2",35083,-0.0892916918005109,0.0730289989449186,-0.232428529732551,0.0538451461315295,0.221491970639109
Physical measures,X4270.Volume level set by participant (left),CLSTN3,Calsyntenin-3,35301,-0.0893636839291219,0.0731700760418372,-0.232777032971123,0.054049665112879,0.222009904306599
Physical measures,X4270.Volume level set by participant (left),IL22,Interleukin-22,35279,0.0388668227215785,0.03183489556183,-0.0235295725796084,0.101263218022765,0.222171774471323
Physical measures,X4270.Volume level set by participant (left),WNT9A,Protein Wnt-9a,36103,0.0821220289306956,0.0672828841244035,-0.0497524239531354,0.213996481814527,0.222295356318052
Physical measures,X4270.Volume level set by participant (left),DSG3,Desmoglein-3,36299,0.0649123001879534,0.0531885258703836,-0.0393372105179983,0.169161810893905,0.22234338073873
Physical measures,X4270.Volume level set by participant (left),ARSA,Arylsulfatase A,36256,0.0497539219302737,0.040800813510877,-0.0302156725510451,0.129723516411593,0.222716881731694
Physical measures,X4270.Volume level set by participant (left),AGRN,Agrin,36278,0.0648598763395986,0.05328615543251,-0.0395809883081211,0.169300740987318,0.223565783481619
Physical measures,X4270.Volume level set by participant (left),GET3,ATPase GET3,35313,-0.0501555322181016,0.0412092047197263,-0.130925573468765,0.0306145090325619,0.223610736401343
Physical measures,X4270.Volume level set by participant (left),PKN3,Serine/threonine-protein kinase N3,35195,-0.035417377937841,0.029102418254632,-0.0924581177169197,0.0216233618412378,0.223651248785975
Physical measures,X4270.Volume level set by participant (left),RNF41,E3 ubiquitin-protein ligase NRDP1,36060,-0.0356840510736444,0.0293403205471386,-0.093191079346036,0.0218229771987471,0.223942655040602
Physical measures,X4270.Volume level set by participant (left),GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,35285,-0.0376075558927736,0.0309372829827864,-0.0982446305390349,0.0230295187534878,0.224177881301283
Physical measures,X4270.Volume level set by participant (left),HEPH,Hephaestin,35313,-0.102046469512261,0.0839621328058315,-0.266612249811691,0.0625193107871689,0.224261353801612
Physical measures,X4270.Volume level set by participant (left),ENSA,Alpha-endosulfine,35279,-0.0521740424017207,0.0429459123597203,-0.136348030626773,0.0319999458233312,0.224455606811334
Physical measures,X4270.Volume level set by participant (left),PDCD5,Programmed cell death protein 5,36325,-0.0399306952757047,0.0329795559864125,-0.104570625009073,0.0247092344576638,0.226020176566228
Physical measures,X4270.Volume level set by participant (left),FGF12,Fibroblast growth factor 12,35093,-0.0598177933410178,0.0494161333770479,-0.156673414760032,0.0370378280779961,0.226134557392954
Physical measures,X4270.Volume level set by participant (left),DFFA,DNA fragmentation factor subunit alpha,36342,-0.0351362056462662,0.0290332085630349,-0.0920412944298146,0.0217688831372823,0.226236257274575
Physical measures,X4270.Volume level set by participant (left),NSFL1C,NSFL1 cofactor p47,36325,-0.0371364551924504,0.030710984777599,-0.0973299853565445,0.0230570749716437,0.226613879281748
Physical measures,X4270.Volume level set by participant (left),NOTCH3,Neurogenic locus notch homolog protein 3,36364,-0.0665030488564671,0.055010279563916,-0.174323196801743,0.0413170990888083,0.226730258725418
Physical measures,X4270.Volume level set by participant (left),GLO1,Lactoylglutathione lyase,36109,-0.0421642368492764,0.0348835361902331,-0.110535967782133,0.0262074940835805,0.226810614700672
Physical measures,X4270.Volume level set by participant (left),NPPC,C-type natriuretic peptide,36242,0.0441247864057987,0.0365076536041199,-0.0274302146582763,0.115679787469874,0.226836740051704
Physical measures,X4270.Volume level set by participant (left),ATF2,Cyclic AMP-dependent transcription factor ATF-2,36064,-0.0356427098063157,0.0295212382786421,-0.0935043368324542,0.0222189172198228,0.227332490204354
Physical measures,X4270.Volume level set by participant (left),IL17A,Interleukin-17A,36090,0.0533225331054874,0.0441999715257508,-0.0333094110849841,0.139954477295959,0.227704139411523
Physical measures,X4270.Volume level set by participant (left),CTBS,Di-N-acetylchitobiase,35214,0.0980238371249334,0.0812547892404804,-0.0612355497864082,0.257283224036275,0.227715669004856
Physical measures,X4270.Volume level set by participant (left),APOA1,Apolipoprotein A-I,35325,-0.0995688524235475,0.0825427821511192,-0.261352705439741,0.0622150005926461,0.227755991266043
Physical measures,X4270.Volume level set by participant (left),CASQ2,Calsequestrin-2,35079,0.0566671889223706,0.0469943200681005,-0.0354416784111064,0.148776056255848,0.227926869905944
Physical measures,X4270.Volume level set by participant (left),PNLIP,Pancreatic triacylglycerol lipase,35317,0.0386490391356305,0.0321382768852716,-0.0243419835595019,0.101640061830763,0.229179008917469
Physical measures,X4270.Volume level set by participant (left),IL18BP,Interleukin-18-binding protein,36289,0.0725950846848925,0.060534070869589,-0.046051694219502,0.191241863589287,0.230470287233734
Physical measures,X4270.Volume level set by participant (left),NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,35285,-0.0296277792695475,0.0247327438354142,-0.0781039571869593,0.0188483986478644,0.230991741479128
Physical measures,X4270.Volume level set by participant (left),GSTM4,Glutathione S-transferase Mu 4,35079,-0.0381424063697947,0.0318675662294024,-0.100602836179423,0.024318023439834,0.231387923722664
Physical measures,X4270.Volume level set by participant (left),GUK1,Guanylate kinase,35079,-0.0662755628356027,0.0554313713926511,-0.174921050765199,0.0423699250939933,0.231883684639855
Physical measures,X4270.Volume level set by participant (left),C2,Complement C2,36276,0.0995024256309937,0.0832268440705138,-0.0636221887472133,0.262627040009201,0.231906475970084
Physical measures,X4270.Volume level set by participant (left),DHPS,Deoxyhypusine synthase,35279,-0.0676953038443293,0.0567592016535855,-0.178943339085357,0.0435527313966983,0.233038909260123
Physical measures,X4270.Volume level set by participant (left),MNAT1,CDK-activating kinase assembly factor MAT1,35195,0.0556366751334118,0.0466884874382774,-0.0358727602456119,0.147146110512436,0.233438562462595
Physical measures,X4270.Volume level set by participant (left),SLC34A3,Sodium-dependent phosphate transport protein 2C,35095,-0.0553083781819523,0.0464582955409113,-0.146366637442138,0.0357498810782338,0.233895341719818
Physical measures,X4270.Volume level set by participant (left),PTK7,Inactive tyrosine-protein kinase 7,36064,0.060487338232165,0.0508484305187602,-0.039175585584605,0.160150262048935,0.234256616159516
Physical measures,X4270.Volume level set by participant (left),GP1BB,Platelet glycoprotein Ib beta chain,35079,-0.0384950680388521,0.0323743691915338,-0.101948831654258,0.0249586955765542,0.234459646705243
Physical measures,X4270.Volume level set by participant (left),CD86,T-lymphocyte activation antigen CD86,35285,-0.0874063947875662,0.0735224125576484,-0.231510323400557,0.0566975338254247,0.234544828569304
Physical measures,X4270.Volume level set by participant (left),ACY1,Aminoacylase-1,36258,0.0364713038292794,0.0306943955584306,-0.0236897114652447,0.0966323191238035,0.234788624118474
Physical measures,X4270.Volume level set by participant (left),TPSD1,Tryptase delta,35305,-0.0716462935566931,0.0603776073538182,-0.189986403970177,0.0466938168567906,0.235412957188606
Physical measures,X4270.Volume level set by participant (left),MAN2B2,Epididymis-specific alpha-mannosidase,35313,0.0436817644712609,0.0368582303066052,-0.0285603669296854,0.115923895872207,0.23600834384474
Physical measures,X4270.Volume level set by participant (left),DDR1,Epithelial discoidin domain-containing receptor 1,36325,0.0929557906901559,0.0784841399332313,-0.0608731235789774,0.246784704959289,0.236295370601874
Physical measures,X4270.Volume level set by participant (left),DSG4,Desmoglein-4,36189,0.0460466782273043,0.0389605495383953,-0.0303159988679505,0.122409355322559,0.237290528624962
Physical measures,X4270.Volume level set by participant (left),SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,36288,-0.0386738799693311,0.0327253237525072,-0.102815514524245,0.025467754585583,0.237332642041332
Physical measures,X4270.Volume level set by participant (left),CENPF,Centromere protein F,35195,-0.0463427131839691,0.0392802958325869,-0.123332093015839,0.0306466666479012,0.238124165165283
Physical measures,X4270.Volume level set by participant (left),PCARE,Photoreceptor cilium actin regulator,35083,0.0322704628107092,0.0273644481962135,-0.0213638556538691,0.0859047812752876,0.238328302644938
Physical measures,X4270.Volume level set by participant (left),TMSB10,Thymosin beta-10,36256,-0.0294932338623276,0.0250188095950157,-0.0785301006685584,0.0195436329439031,0.23849758143538
Physical measures,X4270.Volume level set by participant (left),FCAR,Immunoglobulin alpha Fc receptor,36242,0.0455337207575996,0.0386576059866081,-0.0302351869761523,0.121302628491352,0.238884238488808
Physical measures,X4270.Volume level set by participant (left),WASF3,Wiskott-Aldrich syndrome protein family member 3,36064,-0.0261003300910972,0.0221757141740272,-0.0695647298721906,0.0173640696899962,0.239241790761777
Physical measures,X4270.Volume level set by participant (left),NOP56,Nucleolar protein 56,35079,-0.0234192529093924,0.0199036624785939,-0.0624304313674365,0.0155919255486516,0.239386334138159
Physical measures,X4270.Volume level set by participant (left),TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,36342,0.0571138402553526,0.0485521896481696,-0.0380484514550597,0.152276131965765,0.239495569592659
Physical measures,X4270.Volume level set by participant (left),KLF4,Krueppel-like factor 4,35083,-0.0631367579548064,0.0536749364704587,-0.168339633436905,0.0420661175272927,0.239526187812523
Physical measures,X4270.Volume level set by participant (left),METAP2,Methionine aminopeptidase 2,36321,-0.0420992066758553,0.0358082211519799,-0.112283320133736,0.0280849067820253,0.239756836766354
Physical measures,X4270.Volume level set by participant (left),CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",36168,-0.0232878991527743,0.0198176356104318,-0.0621304649492207,0.015554666643672,0.239987747784698
Physical measures,X4270.Volume level set by participant (left),MRPL28,"39S ribosomal protein L28, mitochondrial",35305,0.066572515256997,0.0566871399673841,-0.0445342790790758,0.17767930959307,0.240282659095629
Physical measures,X4270.Volume level set by participant (left),EIF5,Eukaryotic translation initiation factor 5,35079,-0.0643578543761104,0.0548768346705623,-0.171916450330412,0.0432007415781917,0.240931560647725
Physical measures,X4270.Volume level set by participant (left),APCS,Serum amyloid P-component,35273,0.0801990241389038,0.0683943296350332,-0.0538538619457614,0.214251910223569,0.240999104520806
Physical measures,X4270.Volume level set by participant (left),SCARB1,Scavenger receptor class B member 1,36064,-0.041687620964248,0.0356153891142124,-0.111493783628104,0.0281185416996083,0.241839366768405
Physical measures,X4270.Volume level set by participant (left),BTN3A2,Butyrophilin subfamily 3 member A2,36242,0.0588544263541548,0.050298214234216,-0.0397300735449086,0.157438926253218,0.241993345500937
Physical measures,X4270.Volume level set by participant (left),RBP5,Retinol-binding protein 5,36216,0.0399762827517007,0.0341660593222707,-0.0269891935199499,0.106941759023351,0.242014118274016
Physical measures,X4270.Volume level set by participant (left),OGA,Protein O-GlcNAcase,35285,-0.0368960927001154,0.0316312875455979,-0.0988934162894874,0.0251012308892565,0.243477026113249
Physical measures,X4270.Volume level set by participant (left),PRAME,Melanoma antigen preferentially expressed in tumors,35095,-0.106169154416214,0.0910575693344757,-0.284641990311787,0.0723036814793579,0.243674912490542
Physical measures,X4270.Volume level set by participant (left),S100A16,Protein S100-A16,36053,-0.0368312336318904,0.0315899438146278,-0.0987475235085609,0.0250850562447801,0.243685570789914
Physical measures,X4270.Volume level set by participant (left),CSF2,Granulocyte-macrophage colony-stimulating factor,35079,-0.0689687489904345,0.0591851854752129,-0.184971712521852,0.0470342145409827,0.243938773292137
Physical measures,X4270.Volume level set by participant (left),RAPGEF2,Rap guanine nucleotide exchange factor 2,35195,-0.0477077560797989,0.0409689913673024,-0.128006979159712,0.0325914670001138,0.244269855454536
Physical measures,X4270.Volume level set by participant (left),LMNB2,Lamin-B2,35301,0.0868396091178492,0.0745811119505177,-0.0593393703051654,0.233018588540864,0.244317743901404
Physical measures,X4270.Volume level set by participant (left),JCHAIN,Immunoglobulin J chain,36103,0.0353557664717371,0.0303720501861585,-0.0241734518931337,0.0948849848366078,0.244425015796479
Physical measures,X4270.Volume level set by participant (left),TNFRSF14,Tumor necrosis factor receptor superfamily member 14,36248,0.0710053611794592,0.0610540559752653,-0.0486605885320608,0.190671310890979,0.244869163934808
Physical measures,X4270.Volume level set by participant (left),LTB,Lymphotoxin-beta,35279,-0.0703291398331226,0.0605271365193239,-0.188962327410997,0.0483040477447523,0.245299772943789
Physical measures,X4270.Volume level set by participant (left),PPT1,Palmitoyl-protein thioesterase 1,35133,-0.0325111064849708,0.0279945333080165,-0.0873803917686831,0.0223581787987416,0.245547049198501
Physical measures,X4270.Volume level set by participant (left),LYZL2,Lysozyme-like protein 2,35095,-0.072429921201374,0.0623965912446548,-0.194727240040897,0.0498673976381493,0.24576619796796
Physical measures,X4270.Volume level set by participant (left),GLB1,Beta-galactosidase,36179,0.0512222595630574,0.0441629193583915,-0.0353370623793898,0.137781581505505,0.246147378401421
Physical measures,X4270.Volume level set by participant (left),SHISA5,Protein shisa-5,35320,0.0992168735237444,0.0856041140899276,-0.0685671900925137,0.267000937140002,0.246489266510495
Physical measures,X4270.Volume level set by participant (left),SPINT1,Kunitz-type protease inhibitor 1,36214,0.0818126277269935,0.0707099107445818,-0.0567787973323868,0.220404052786374,0.247301385813769
Physical measures,X4270.Volume level set by participant (left),FLI1,Friend leukemia integration 1 transcription factor,36060,-0.0201815948538556,0.0174469374150933,-0.0543775921874385,0.0140144024797272,0.247415082960865
Physical measures,X4270.Volume level set by participant (left),GKN1,Gastrokine-1,35943,-0.0800638463291471,0.0693214664113011,-0.215933920495297,0.055806227837003,0.248142482287344
Physical measures,X4270.Volume level set by participant (left),AKAP12,A-kinase anchor protein 12,35165,-0.118810907898497,0.102935712547732,-0.320564904492052,0.0829430886950579,0.248450227809152
Physical measures,X4270.Volume level set by participant (left),ACAN,Aggrecan core protein,36192,-0.08067071560142,0.0699013247031088,-0.217677312019513,0.0563358808166732,0.248509608835068
Physical measures,X4270.Volume level set by participant (left),FAM20A,Pseudokinase FAM20A,35313,0.0901734947139088,0.0781822626880332,-0.0630637401546362,0.243410729582454,0.248797436060678
Physical measures,X4270.Volume level set by participant (left),THBD,Thrombomodulin,36258,0.0746792792258854,0.0647807505108093,-0.0522909917753008,0.201649550227072,0.249028290205896
Physical measures,X4270.Volume level set by participant (left),LAT,Linker for activation of T-cells family member 1,36342,-0.028696303562759,0.0249291448623898,-0.0775574274930429,0.020164820367525,0.249720639824027
Physical measures,X4270.Volume level set by participant (left),LEP,Leptin,36258,0.0310351284580857,0.0269696111269621,-0.0218253093507601,0.0838955662669315,0.249873356369368
Physical measures,X4270.Volume level set by participant (left),TMED1,Transmembrane emp24 domain-containing protein 1,35195,0.046423630211908,0.0403710746374916,-0.0327036760775755,0.125550936501392,0.250217272288018
Physical measures,X4270.Volume level set by participant (left),CAPG,Macrophage-capping protein,36223,-0.037051852148508,0.0322246239669619,-0.100212115123753,0.0261084108267374,0.250262601988426
Physical measures,X4270.Volume level set by participant (left),WFDC12,WAP four-disulfide core domain protein 12,36327,0.0336641450016828,0.0293211204393404,-0.0238052510594244,0.09113354106279,0.250954863928599
Physical measures,X4270.Volume level set by participant (left),NARS1,"Asparagine--tRNA ligase, cytoplasmic",35305,-0.056969444207574,0.0497801003611975,-0.154538440915521,0.0405995525003732,0.25248952027351
Physical measures,X4270.Volume level set by participant (left),DNAJB6,DnaJ homolog subfamily B member 6,35088,-0.0309070438330722,0.0270298904401217,-0.0838856290957107,0.0220715414295662,0.252898376542208
Physical measures,X4270.Volume level set by participant (left),ERBB3,Receptor tyrosine-protein kinase erbB-3,36217,0.108658559573277,0.0950610447294215,-0.0776610880963894,0.294978207242943,0.253057996738876
Physical measures,X4270.Volume level set by participant (left),TNFRSF8,Tumor necrosis factor receptor superfamily member 8,36325,0.0485079998024799,0.0424856147852442,-0.0347638051765988,0.131779804781559,0.253592873334234
Physical measures,X4270.Volume level set by participant (left),SERPINE2,Glia-derived nexin,35313,-0.0384631804142977,0.0336967977709812,-0.104508904045421,0.0275825432168255,0.25372380405449
Physical measures,X4270.Volume level set by participant (left),DKK1,Dickkopf-related protein 1,36325,-0.0357941735059902,0.0313781069828621,-0.0972952631923999,0.0257069161804196,0.254014683400834
Physical measures,X4270.Volume level set by participant (left),RAB6B,Ras-related protein Rab-6B,36064,-0.0472394804141192,0.041448248340359,-0.128478047161223,0.0339990863329844,0.254438726867616
Physical measures,X4270.Volume level set by participant (left),CELA3A,Chymotrypsin-like elastase family member 3A,36352,0.0351105558830632,0.030812365322884,-0.0252816801497895,0.0955027919159158,0.254531708451245
Physical measures,X4270.Volume level set by participant (left),STK11,Serine/threonine-protein kinase STK11,36109,-0.031063262062856,0.0272782949701042,-0.0845287202042602,0.0224021960785482,0.254842198577652
Physical measures,X4270.Volume level set by participant (left),RAB39B,Ras-related protein Rab-39B,35079,0.0281014361933707,0.0247153994514746,-0.0203407467315196,0.0765436191182609,0.255579897017574
Physical measures,X4270.Volume level set by participant (left),NAP1L4,Nucleosome assembly protein 1-like 4,35261,-0.0663912637240315,0.0584444332018854,-0.180942352799727,0.0481598253516639,0.256008998189164
Physical measures,X4270.Volume level set by participant (left),PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,36060,-0.0331706435545978,0.0292117275619446,-0.0904256295760091,0.0240843424668136,0.256191956326369
Physical measures,X4270.Volume level set by participant (left),SNX15,Sorting nexin-15,35165,-0.0465962795401339,0.0410469635982913,-0.127048328192785,0.0338557691125171,0.256335374679734
Physical measures,X4270.Volume level set by participant (left),LAT2,Linker for activation of T-cells family member 2,36216,-0.0172974971726285,0.0152512397243188,-0.0471899270322933,0.0125949326870362,0.256758994574562
Physical measures,X4270.Volume level set by participant (left),VMO1,Vitelline membrane outer layer protein 1 homolog,36216,0.0309441469536038,0.0272951038017013,-0.0225542564977307,0.0844425504049383,0.256960907905039
Physical measures,X4270.Volume level set by participant (left),SMNDC1,Survival of motor neuron-related-splicing factor 30,35285,-0.0417489740708511,0.0368476577971403,-0.113970383353246,0.0304724352115439,0.257248320183902
Physical measures,X4270.Volume level set by participant (left),IL34,Interleukin-34,36053,0.0604929437343552,0.0534070693119688,-0.0441849121171037,0.165170799585814,0.257386492235253
Physical measures,X4270.Volume level set by participant (left),AIF1,Allograft inflammatory factor 1,36060,0.0419737667647733,0.0370615303030681,-0.0306668326292402,0.114614366158787,0.257442743992397
Physical measures,X4270.Volume level set by participant (left),GP1BA,Platelet glycoprotein Ib alpha chain,36214,0.0625878234902561,0.0552990547570478,-0.0457983238335576,0.17097397081407,0.257751498871069
Physical measures,X4270.Volume level set by participant (left),KCNIP4,Kv channel-interacting protein 4,36064,0.04242770095445,0.0375495787464801,-0.0311694733886509,0.116024875297551,0.258549839817096
Physical measures,X4270.Volume level set by participant (left),RBPMS,RNA-binding protein with multiple splicing,35093,0.0388075185062487,0.0343596201319124,-0.0285373369522997,0.106152373964797,0.258749234940349
Physical measures,X4270.Volume level set by participant (left),CRISP3,Cysteine-rich secretory protein 3,35253,-0.0916344131087169,0.0811831067511404,-0.250753302340952,0.0674844761235183,0.259049322176219
Physical measures,X4270.Volume level set by participant (left),PDAP1,28 kDa heat- and acid-stable phosphoprotein,35313,-0.0261665521066846,0.0231921029072836,-0.0716230738049605,0.0192899695915913,0.259253562823372
Physical measures,X4270.Volume level set by participant (left),SERPINF2,Alpha-2-antiplasmin,35187,-0.180535522397257,0.160199914773214,-0.494527355352757,0.133456310558243,0.259809367133644
Physical measures,X4270.Volume level set by participant (left),TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,36232,0.0719555773760337,0.0638639805371049,-0.053217824476692,0.197128979228759,0.259904578391286
Physical measures,X4270.Volume level set by participant (left),EPHA1,Ephrin type-A receptor 1,36271,0.0659031881024829,0.0585059048688841,-0.0487683854405299,0.180574761645496,0.260016045122027
Physical measures,X4270.Volume level set by participant (left),TFF3,Trefoil factor 3,36258,0.0633824063973504,0.0563012446182591,-0.0469680330544374,0.173732845849138,0.260297018528222
Physical measures,X4270.Volume level set by participant (left),MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,35195,-0.0218698018395184,0.0194457131206662,-0.0599833995560242,0.0162437958769875,0.260774389840878
Physical measures,X4270.Volume level set by participant (left),OTUD6B,Deubiquitinase OTUD6B,35285,-0.0434911267650438,0.0386943166736283,-0.119331987445355,0.0323497339152677,0.261067493003288
Physical measures,X4270.Volume level set by participant (left),COPE,Coatomer subunit epsilon,36064,-0.0472934796224676,0.0421175215799646,-0.129843821919198,0.035256862674263,0.261518976949684
Physical measures,X4270.Volume level set by participant (left),CD164,Sialomucin core protein 24,36256,-0.0717634477416671,0.0639340598871737,-0.197074205120528,0.0535473096371934,0.26170196717163
Physical measures,X4270.Volume level set by participant (left),MITD1,MIT domain-containing protein 1,36179,-0.0227952801160455,0.0203226004879515,-0.0626275770724304,0.0170370168403395,0.262037723258196
Physical measures,X4270.Volume level set by participant (left),STK24,Serine/threonine-protein kinase 24,36064,-0.0348500298587964,0.0311534248578837,-0.0959107425802484,0.0262106828626557,0.263322057961181
Physical measures,X4270.Volume level set by participant (left),GSR,"Glutathione reductase, mitochondrial",35272,-0.107300210193366,0.0960879781504805,-0.295632647368308,0.0810322269815756,0.264168345650836
Physical measures,X4270.Volume level set by participant (left),CA3,Carbonic anhydrase 3,36363,-0.0343064437435268,0.030738218891566,-0.0945533527709962,0.0259404652839425,0.264420607022275
Physical measures,X4270.Volume level set by participant (left),CCL17,C-C motif chemokine 17,36224,0.0227136589185204,0.020392707210734,-0.0172560472145182,0.062683365051559,0.265394618599286
Physical measures,X4270.Volume level set by participant (left),PLA2G7,Platelet-activating factor acetylhydrolase,36256,-0.0645842705660245,0.0580073872933101,-0.178278749660912,0.0491102085288633,0.265580186741475
Physical measures,X4270.Volume level set by participant (left),PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,35133,0.0770331415963934,0.0692138679474303,-0.0586260395805699,0.212692322773357,0.265761147079969
Physical measures,X4270.Volume level set by participant (left),IL11,Interleukin-11,36103,0.0345606440648981,0.0310990589788933,-0.0263935115337327,0.0955147996635289,0.266471268128406
Physical measures,X4270.Volume level set by participant (left),CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",35093,0.0869235671449579,0.0782253931983477,-0.0663982035238036,0.240245337813719,0.266526129325761
Physical measures,X4270.Volume level set by participant (left),LGALS7_LGALS7B,Galectin-7,36282,0.0488354921081412,0.0439743335536437,-0.0373542016570004,0.135025185873283,0.26679886537589
Physical measures,X4270.Volume level set by participant (left),C1GALT1C1,C1GALT1-specific chaperone 1,35079,-0.0792776464405419,0.0713869282831117,-0.219196025875441,0.0606407329943569,0.266810002960121
Physical measures,X4270.Volume level set by participant (left),MYO6,Unconventional myosin-VI,35305,-0.0643964569359677,0.0580040285228689,-0.178084352840791,0.0492914389688554,0.266949827925096
Physical measures,X4270.Volume level set by participant (left),SPINT2,Kunitz-type protease inhibitor 2,36278,-0.0519973716513374,0.0469172166407685,-0.143955116267244,0.0399603729645688,0.267776018023982
Physical measures,X4270.Volume level set by participant (left),FXYD5,FXYD domain-containing ion transport regulator 5,36103,-0.0330725094631708,0.0298615284228888,-0.0916011051720328,0.0254560862456912,0.268100788298285
Physical measures,X4270.Volume level set by participant (left),SCP2,Non-specific lipid-transfer protein,36060,-0.0283845772445908,0.0256304750671898,-0.0786203083762829,0.0218511538871013,0.268133324438335
Physical measures,X4270.Volume level set by participant (left),PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,35093,0.0545129198353915,0.0492255144010557,-0.0419690883906776,0.150994928061461,0.268156929829043
Physical measures,X4270.Volume level set by participant (left),FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,36179,-0.0234179660187279,0.0211707813880431,-0.0649126975392923,0.0180767655018365,0.268698641031315
Physical measures,X4270.Volume level set by participant (left),CDC37,Hsp90 co-chaperone Cdc37,36289,-0.0254916361847535,0.0230554335821841,-0.0706802860058343,0.0196970136363273,0.268905208750977
Physical measures,X4270.Volume level set by participant (left),ARHGAP5,Rho GTPase-activating protein 5,35095,0.0324477192584298,0.0293551060014944,-0.0250882885044992,0.0899837270213589,0.269048142373696
Physical measures,X4270.Volume level set by participant (left),VSNL1,Visinin-like protein 1,35301,0.0616099565369337,0.0557434427904653,-0.0476471913323784,0.170867104406246,0.269094733544583
Physical measures,X4270.Volume level set by participant (left),CRELD2,Protein disulfide isomerase CRELD2,36268,0.0395977495116673,0.0358340570745879,-0.0306370023545251,0.10983250137786,0.269180773843306
Physical measures,X4270.Volume level set by participant (left),RLN1,Prorelaxin H1,35305,0.0564697935791859,0.0511764937829116,-0.0438361342353207,0.156775721393693,0.269879116627594
Physical measures,X4270.Volume level set by participant (left),NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",36103,0.0348557908911529,0.0315978470958232,-0.0270759894166606,0.0967875711989663,0.270016306662638
Physical measures,X4270.Volume level set by participant (left),CGREF1,Cell growth regulator with EF hand domain protein 1,36258,0.0480876435632318,0.0436890026295815,-0.0375428015907478,0.133718088717211,0.27107024278356
Physical measures,X4270.Volume level set by participant (left),EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",35301,-0.0426240433261027,0.038740999854865,-0.118556403041638,0.0333083163894326,0.271271090770101
Physical measures,X4270.Volume level set by participant (left),F3,Tissue factor,36289,0.0777184965103149,0.070648252895772,-0.0607520791653981,0.216189072186028,0.271333160327143
Physical measures,X4270.Volume level set by participant (left),EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,36258,-0.032240298155048,0.029308618988676,-0.089685191372853,0.0252045950627571,0.271354563778797
Physical measures,X4270.Volume level set by participant (left),PPM1F,Protein phosphatase 1F,35313,-0.0452603610832201,0.0412045792158071,-0.126021336346202,0.0355006141797617,0.272056020090792
Physical measures,X4270.Volume level set by participant (left),TET2,Methylcytosine dioxygenase TET2,35169,0.0238658237834606,0.0217586380577155,-0.0187811068096618,0.0665127543765829,0.272749973862185
Physical measures,X4270.Volume level set by participant (left),ZBP1,Z-DNA-binding protein 1,35093,-0.0605545504419782,0.0552084679095692,-0.168763147544734,0.0476540466607775,0.272754455746971
Physical measures,X4270.Volume level set by participant (left),HIP1R,Huntingtin-interacting protein 1-related protein,35285,0.055719728686504,0.0508014394947073,-0.0438510927231223,0.15529055009613,0.272762246077747
Physical measures,X4270.Volume level set by participant (left),CTRL,Chymotrypsin-like protease CTRL-1,35301,0.0339154926347253,0.0309295262440137,-0.0267063788035415,0.0945373640729921,0.272881527454925
Physical measures,X4270.Volume level set by participant (left),GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,36060,-0.0326182307186632,0.0297794696137994,-0.0909859911617101,0.0257495297243837,0.273409165891952
Physical measures,X4270.Volume level set by participant (left),GPI,Glucose-6-phosphate isomerase,35317,-0.0510864026171043,0.0466885727272887,-0.14259600516259,0.0404231999283815,0.273908719263373
Physical measures,X4270.Volume level set by participant (left),RRAS,Ras-related protein R-Ras,35133,-0.0187175868031155,0.0171321075812804,-0.0522965176624251,0.0148613440561941,0.274634226639229
Physical measures,X4270.Volume level set by participant (left),DUSP3,Dual specificity protein phosphatase 3,36064,-0.0254100297672558,0.0232878428879286,-0.0710542018275959,0.0202341422930843,0.275251565600397
Physical measures,X4270.Volume level set by participant (left),NMT1,Glycylpeptide N-tetradecanoyltransferase 1,35305,-0.0351178618605896,0.0321965405904389,-0.0982230814178498,0.0279873576966707,0.275429152676865
Physical measures,X4270.Volume level set by participant (left),CD84,SLAM family member 5,36242,-0.0644160877182568,0.0590816523948144,-0.180216126412093,0.0513839509755794,0.275620159724617
Physical measures,X4270.Volume level set by participant (left),DLGAP5,Disks large-associated protein 5,35305,-0.0502450404989528,0.0461973520088102,-0.140791850436221,0.0403017694383151,0.276803189898437
Physical measures,X4270.Volume level set by participant (left),INHBB,Inhibin beta B chain,35165,0.046717122741973,0.0429666007341098,-0.0374974146968823,0.130931660180828,0.276948936610181
Physical measures,X4270.Volume level set by participant (left),SOD2,"Superoxide dismutase [Mn], mitochondrial",36256,0.0540362609854992,0.0497040036734687,-0.0433835862144995,0.151456108185498,0.27699984266948
Physical measures,X4270.Volume level set by participant (left),IL24,Interleukin-24,36103,0.0436273310747786,0.0401891254726794,-0.035143354851673,0.12239801700123,0.277712735983294
Physical measures,X4270.Volume level set by participant (left),FHIP2A,FHF complex subunit HOOK interacting protein 2A,35079,-0.0505225813796726,0.0465431333406697,-0.141747122727385,0.0407019599680399,0.2777405725815
Physical measures,X4270.Volume level set by participant (left),OGFR,Opioid growth factor receptor,36216,-0.0634369066625433,0.0584674750422458,-0.178033157745345,0.0511593444202584,0.27795831283712
Physical measures,X4270.Volume level set by participant (left),SUGP1,SURP and G-patch domain-containing protein 1,35285,-0.0577814415078567,0.0533608469070385,-0.162368701445652,0.0468058184299389,0.278917005930029
Physical measures,X4270.Volume level set by participant (left),FUT8,"Alpha-(1,6)-fucosyltransferase",36179,-0.0354914482260354,0.032784298265458,-0.0997486728263331,0.0287657763742623,0.279031745882847
Physical measures,X4270.Volume level set by participant (left),RBM17,Splicing factor 45,35305,-0.0312688762625275,0.0288960856397543,-0.087905204116446,0.025367451591391,0.27924054000744
Physical measures,X4270.Volume level set by participant (left),DLL4,Delta-like protein 4,35151,0.0284861186667697,0.0263405391990417,-0.023141338163352,0.0801135754968913,0.279534410542559
Physical measures,X4270.Volume level set by participant (left),VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,36325,-0.030425358931691,0.0281362638904428,-0.0855724361569589,0.0247217182935769,0.279571904238099
Physical measures,X4270.Volume level set by participant (left),THTPA,Thiamine-triphosphatase,35259,-0.0276693394963505,0.0256287576840912,-0.0779017045571693,0.0225630255644683,0.280350201175281
Physical measures,X4270.Volume level set by participant (left),HAVCR1,Hepatitis A virus cellular receptor 1,36315,0.0310460479732175,0.0287850874336496,-0.0253727233967358,0.0874648193431707,0.280823787929519
Physical measures,X4270.Volume level set by participant (left),CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,36179,0.0340165483961119,0.0315583115576879,-0.0278377422569564,0.0958708390491802,0.281114905480476
Physical measures,X4270.Volume level set by participant (left),STX5,Syntaxin-5,35093,-0.0566238489247375,0.05253931247053,-0.159600901366976,0.0463532035175012,0.281188751565062
Physical measures,X4270.Volume level set by participant (left),CEP152,Centrosomal protein of 152 kDa,35095,-0.057585434542201,0.0534462872612824,-0.162340157574314,0.0471692884899124,0.281321547063705
Physical measures,X4270.Volume level set by participant (left),LRRC38,Leucine-rich repeat-containing protein 38,35133,0.050188539851634,0.0466145875079169,-0.0411760516638831,0.141553131367151,0.281667379930499
Physical measures,X4270.Volume level set by participant (left),CD74,HLA class II histocompatibility antigen gamma chain,36325,0.0585870759087805,0.0544224174887193,-0.0480808623691092,0.16525501418667,0.28172629757101
Physical measures,X4270.Volume level set by participant (left),CDH23,Cadherin-23,35301,-0.0896191045341413,0.0832486153181949,-0.252786390557803,0.0735481814895208,0.281731894995387
Physical measures,X4270.Volume level set by participant (left),FLT4,Vascular endothelial growth factor receptor 3,36289,0.0590014862538015,0.054811229952435,-0.0484285244529712,0.166431496960574,0.281760344905909
Physical measures,X4270.Volume level set by participant (left),SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,35285,0.0454127998627496,0.0422018794713127,-0.0373028839010232,0.128128483626522,0.28192819597868
Physical measures,X4270.Volume level set by participant (left),KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,35279,0.0262612916188038,0.024407506534957,-0.021577421189712,0.0741000044273195,0.281987859090925
Physical measures,X4270.Volume level set by participant (left),STAT5B,Signal transducer and activator of transcription 5B,36216,-0.0156335161809015,0.0145336927050986,-0.0441195538828948,0.0128525215210918,0.282107142173699
Physical measures,X4270.Volume level set by participant (left),TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,36256,0.0543778540589113,0.0505558346491531,-0.0447115818534287,0.153467289971251,0.282140109929766
Physical measures,X4270.Volume level set by participant (left),GIPR,Gastric inhibitory polypeptide receptor,35093,0.0501408221970811,0.0466237571429145,-0.0412417418030313,0.141523386197194,0.282219978222201
Physical measures,X4270.Volume level set by participant (left),MYH7B,Myosin-7B,35095,-0.0574168893054032,0.0534601166074523,-0.16219871785601,0.0473649392452032,0.2828565283449
Physical measures,X4270.Volume level set by participant (left),DBI,Acyl-CoA-binding protein,36217,-0.0265136105286976,0.0246933237432921,-0.0749125250655501,0.0218853040081548,0.282984128299477
Physical measures,X4270.Volume level set by participant (left),FAM171A2,Protein FAM171A2,35305,-0.0150516141354417,0.0140197841145637,-0.0425303909999866,0.0124271627291033,0.283041484726324
Physical measures,X4270.Volume level set by participant (left),PARK7,Parkinson disease protein 7,36256,-0.0414145441901975,0.0385947280663511,-0.117060211200246,0.0342311228198506,0.28327703916381
Physical measures,X4270.Volume level set by participant (left),ASPSCR1,Tether containing UBX domain for GLUT4,35305,-0.0360397028649627,0.0335932289009754,-0.101882431510874,0.0298030257809491,0.283387640059563
Physical measures,X4270.Volume level set by participant (left),IL17C,Interleukin-17C,36103,0.0289819747600992,0.0270148749067098,-0.023967180057052,0.0819311295772504,0.283388451374892
Physical measures,X4270.Volume level set by participant (left),ACOT13,Acyl-coenzyme A thioesterase 13,35285,-0.0210552778569959,0.0196440214603487,-0.0595575599192793,0.0174470042052874,0.283829929781786
Physical measures,X4270.Volume level set by participant (left),AGXT,Serine--pyruvate aminotransferase,36258,0.027016917917688,0.0252665730889262,-0.0225055653366074,0.0765394011719834,0.284979434433395
Physical measures,X4270.Volume level set by participant (left),AKT2,RAC-beta serine/threonine-protein kinase,35305,-0.0186118390358617,0.0174152120003052,-0.0527456545564599,0.0155219764847365,0.285238134683034
Physical measures,X4270.Volume level set by participant (left),IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,35079,-0.0510036705778043,0.0477751813629283,-0.144643026049144,0.0426356848935353,0.285751292058174
Physical measures,X4270.Volume level set by participant (left),TST,Thiosulfate sulfurtransferase,36049,-0.0276740369294247,0.0259257379370057,-0.0784884832859559,0.0231404094271065,0.285810111973013
Physical measures,X4270.Volume level set by participant (left),SPINK5,Serine protease inhibitor Kazal-type 5,36256,0.0570042920344863,0.0534417379788976,-0.0477415144041529,0.161750098473126,0.286157963532426
Physical measures,X4270.Volume level set by participant (left),PDLIM5,PDZ and LIM domain protein 5,35305,-0.0205185808932449,0.0192549009389639,-0.0582581867336142,0.0172210249471244,0.286629770811946
Physical measures,X4270.Volume level set by participant (left),PALM2,Paralemmin-2,35301,0.0608592967226654,0.0572002326554916,-0.0512531592820981,0.172971752727429,0.28738092094464
Physical measures,X4270.Volume level set by participant (left),DYNLT1,Dynein light chain Tctex-type 1,35133,0.030575161077659,0.0288504773575504,-0.0259717745431399,0.0871220966984578,0.289283860604424
Physical measures,X4270.Volume level set by participant (left),TNFRSF21,Tumor necrosis factor receptor superfamily member 21,36325,0.0717583042370573,0.0677172763072683,-0.0609675573251886,0.204484165799303,0.289325627510318
Physical measures,X4270.Volume level set by participant (left),LECT2,Leukocyte cell-derived chemotaxin-2,35313,-0.0330425635658646,0.0311871175352402,-0.0941693139349354,0.0280841868032062,0.289413001621669
Physical measures,X4270.Volume level set by participant (left),NAAA,N-acylethanolamine-hydrolyzing acid amidase,36137,0.0331406480630328,0.0313202984411459,-0.0282471368816131,0.0945284330076787,0.290034459702873
Physical measures,X4270.Volume level set by participant (left),THPO,Thrombopoietin,36109,-0.0515918081596754,0.0487747812138651,-0.147190379338851,0.0440067630195002,0.290200824220624
Physical measures,X4270.Volume level set by participant (left),VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,36248,-0.032400596893658,0.0306634242033285,-0.0925009083321819,0.0276997145448658,0.290703404691474
Physical measures,X4270.Volume level set by participant (left),LELP1,Late cornified envelope-like proline-rich protein 1,35083,0.0353037068424891,0.0334513096766502,-0.0302608601237452,0.100868273808723,0.291292775747076
Physical measures,X4270.Volume level set by participant (left),TPBGL,Trophoblast glycoprotein-like,35133,0.056737198517906,0.0537615536544754,-0.0486354466448657,0.162109843680678,0.291304810993583
Physical measures,X4270.Volume level set by participant (left),EBI3_IL27,Interleukin-27,36321,0.0648573334459375,0.0614645203559656,-0.055613126451755,0.18532779334363,0.291367105408958
Physical measures,X4270.Volume level set by participant (left),CTSE,Cathepsin E,35165,-0.0438318642734168,0.0415426544391884,-0.125255466974226,0.0375917384273925,0.291416129964042
Physical measures,X4270.Volume level set by participant (left),DNAJB8,DnaJ homolog subfamily B member 8,36109,-0.0363843296831015,0.0344864399025786,-0.103977751892156,0.0312090925259526,0.291444222662218
Physical measures,X4270.Volume level set by participant (left),S100P,Protein S100-P,36109,0.0349012708746303,0.0330839035029156,-0.0299431799910843,0.0997457217403449,0.291490347249597
Physical measures,X4270.Volume level set by participant (left),OFD1,Oral-facial-digital syndrome 1 protein,35195,0.0356391179839544,0.0337845634768088,-0.0305786264305909,0.1018568623985,0.291512674946972
Physical measures,X4270.Volume level set by participant (left),FGF9,Fibroblast growth factor 9,35084,-0.0589018239988895,0.0558613133074707,-0.168389998081532,0.0505863500837531,0.291725568664558
Physical measures,X4270.Volume level set by participant (left),KEL,Kell blood group glycoprotein,36064,0.0579520303906672,0.0549860298484339,-0.0498205881122633,0.165724648893598,0.291944066661777
Physical measures,X4270.Volume level set by participant (left),RTN4R,Reticulon-4 receptor,36327,0.0592566386535075,0.0563199086311849,-0.0511303822636149,0.16964365957063,0.29276652617589
Physical measures,X4270.Volume level set by participant (left),TMEM132A,Transmembrane protein 132A,35151,-0.0357119502323657,0.0339590434097254,-0.102271675315427,0.0308477748506961,0.293013532182994
Physical measures,X4270.Volume level set by participant (left),EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,35151,-0.0532364226543727,0.0506418224072104,-0.152494394572505,0.0460215492637597,0.293189769307098
Physical measures,X4270.Volume level set by participant (left),PCYT2,Ethanolamine-phosphate cytidylyltransferase,35285,-0.0316825987868443,0.0301624210594805,-0.0908009440634261,0.0274357464897374,0.293572358917732
Physical measures,X4270.Volume level set by participant (left),GPA33,Cell surface A33 antigen,36216,-0.0148596794904585,0.0141475293182314,-0.0425888369541921,0.0128694779732751,0.293596344768687
Physical measures,X4270.Volume level set by participant (left),C7,Complement component C7,35146,-0.0696091978755245,0.0662734018625232,-0.19950506552607,0.060286669775021,0.29360343512184
Physical measures,X4270.Volume level set by participant (left),RILPL2,RILP-like protein 2,35313,-0.0239242880345445,0.0227792504055633,-0.0685716188294486,0.0207230427603597,0.293633337001505
Physical measures,X4270.Volume level set by participant (left),EXTL1,Exostosin-like 1,35079,-0.0500575711926518,0.0476785559645251,-0.143507540883121,0.0433923984978173,0.293804664667696
Physical measures,X4270.Volume level set by participant (left),THOP1,Thimet oligopeptidase,36220,0.0600382012018566,0.0571927264363331,-0.0520595426133564,0.17213594501707,0.293865274966218
Physical measures,X4270.Volume level set by participant (left),SIGLEC5,Sialic acid-binding Ig-like lectin 5,36256,0.0163602563054262,0.0156245140454881,-0.0142637912237305,0.046984303834583,0.295091614651353
Physical measures,X4270.Volume level set by participant (left),PTPN9,Tyrosine-protein phosphatase non-receptor type 9,35079,-0.0594293977962934,0.0567749680334984,-0.17070833514195,0.0518495395493633,0.295252337500183
Physical measures,X4270.Volume level set by participant (left),HARS1,"Histidine--tRNA ligase, cytoplasmic",36256,-0.0267372254131268,0.0255469560099696,-0.0768092591926672,0.0233348083664135,0.29532110607934
Physical measures,X4270.Volume level set by participant (left),HIP1,Huntingtin-interacting protein 1,35079,-0.0677384358036033,0.0647886658663655,-0.19472422090168,0.059247349294473,0.295817519127202
Physical measures,X4270.Volume level set by participant (left),FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,36293,-0.0173572287698642,0.016617087104438,-0.0499267194945627,0.0152122619548343,0.296267993692101
Physical measures,X4270.Volume level set by participant (left),BCL2L15,Bcl-2-like protein 15,35093,0.0397235809969271,0.0380434180666665,-0.0348415184137393,0.114288680407593,0.296448246713305
Physical measures,X4270.Volume level set by participant (left),LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,35133,-0.0227475095119582,0.0217880264859077,-0.0654520414243373,0.0199570224004208,0.296506840341913
Physical measures,X4270.Volume level set by participant (left),NUDT5,ADP-sugar pyrophosphatase,36256,-0.0403923649768889,0.0386908438397273,-0.116226418902754,0.0354416889489766,0.296528839550332
Physical measures,X4270.Volume level set by participant (left),LZTFL1,Leucine zipper transcription factor-like protein 1,35165,-0.0330072001907639,0.0316280852992957,-0.0949982473773834,0.0289838469958557,0.296707028849873
Physical measures,X4270.Volume level set by participant (left),SAT2,Thialysine N-epsilon-acetyltransferase,35195,-0.0351426846294517,0.0336862768460793,-0.101167787247767,0.0308824179888637,0.296877975923973
Physical measures,X4270.Volume level set by participant (left),AIDA,"Axin interactor, dorsalization-associated protein",35133,0.0265526870017102,0.0254539596693412,-0.0233370739501986,0.0764424479536189,0.296910366879422
Physical measures,X4270.Volume level set by participant (left),WIF1,Wnt inhibitory factor 1,36327,0.0579172550834267,0.0555392682558592,-0.0509397106980574,0.166774220864911,0.297066010451787
Physical measures,X4270.Volume level set by participant (left),CSH1,Chorionic somatomammotropin hormone 1,35317,-0.0810687780145243,0.0777610926140802,-0.233480519538122,0.0713429635090729,0.29720054496975
Physical measures,X4270.Volume level set by participant (left),CIRBP,Cold-inducible RNA-binding protein,35285,-0.0245225130556104,0.0235532665921154,-0.0706869155761565,0.0216418894649356,0.297843023715804
Physical measures,X4270.Volume level set by participant (left),LAP3,Cytosol aminopeptidase,36103,0.0407456666287074,0.0391473585048255,-0.0359831560407505,0.117474489298165,0.297988935660419
Physical measures,X4270.Volume level set by participant (left),MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,36168,-0.0184178676532047,0.0177040228353066,-0.0531177524104057,0.0162820171039962,0.298224013652267
Physical measures,X4270.Volume level set by participant (left),TBL1X,F-box-like/WD repeat-containing protein TBL1X,36060,-0.0240908015271056,0.0231602944387779,-0.0694849786271103,0.0213033755728991,0.298291480296182
Physical measures,X4270.Volume level set by participant (left),DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",36242,-0.0210964800286675,0.0202899579210042,-0.0608647975538358,0.0186718374965008,0.298489056821785
Physical measures,X4270.Volume level set by participant (left),PBK,Lymphokine-activated killer T-cell-originated protein kinase,35095,-0.0731131575341125,0.0703793235487046,-0.211056631689574,0.0648303166213486,0.298915853890538
Physical measures,X4270.Volume level set by participant (left),IDO1,"Indoleamine 2,3-dioxygenase 1",35151,-0.0355604130165553,0.0342738711199423,-0.102737200411642,0.0316163743785317,0.299523924166623
Physical measures,X4270.Volume level set by participant (left),WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",36248,0.0592115066699239,0.0570706545072812,-0.0526469761643473,0.171069989504195,0.299529974750863
Physical measures,X4270.Volume level set by participant (left),SSNA1,Sjoegren syndrome nuclear autoantigen 1,35285,-0.0450530421040317,0.0434247318317442,-0.13016551649425,0.0400594322861868,0.299541694595034
Physical measures,X4270.Volume level set by participant (left),STX1B,Syntaxin-1B,35133,0.0536797838898401,0.0517930316066176,-0.0478345580591304,0.155194125838811,0.300040569382662
Physical measures,X4270.Volume level set by participant (left),HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",35151,-0.0461867964230707,0.0445780392192071,-0.133559753292717,0.0411861604465752,0.300199089452796
Physical measures,X4270.Volume level set by participant (left),RUVBL1,RuvB-like 1,36060,-0.0207736041590879,0.0200693030581863,-0.0601094381531331,0.0185622298349573,0.300658836265003
Physical measures,X4270.Volume level set by participant (left),DPY30,Protein dpy-30 homolog,36312,0.032063132191919,0.0309912995441392,-0.0286798149145938,0.0928060792984318,0.300895236859203
Physical measures,X4270.Volume level set by participant (left),MGMT,Methylated-DNA--protein-cysteine methyltransferase,36242,-0.0168807412357981,0.0163174686098491,-0.0488629797111023,0.0151014972395062,0.300926063145264
Physical measures,X4270.Volume level set by participant (left),RAB11FIP3,Rab11 family-interacting protein 3,35313,-0.0211508981882139,0.0204565500099834,-0.0612457362077814,0.0189439398313537,0.301200267489389
Physical measures,X4270.Volume level set by participant (left),BCAM,Basal cell adhesion molecule,36256,-0.0781809734678432,0.0756309628990722,-0.226417660750025,0.0700557138143383,0.301301385961334
Physical measures,X4270.Volume level set by participant (left),CD300C,CMRF35-like molecule 6,36325,0.0553756752822643,0.0536395074900522,-0.049757759398238,0.160509109962767,0.301932400461349
Physical measures,X4270.Volume level set by participant (left),COL5A1,Collagen alpha-1(V) chain,35165,-0.0577324642587494,0.0559526216026228,-0.16739960259989,0.0519346740823912,0.302199246052366
Physical measures,X4270.Volume level set by participant (left),CDKN1A,Cyclin-dependent kinase inhibitor 1,36216,-0.0184175244764946,0.0178524597076164,-0.0534083455034226,0.0165732965504335,0.302267977025344
Physical measures,X4270.Volume level set by participant (left),CD248,Endosialin,35320,-0.0554473173325186,0.0537486174075066,-0.160794607451232,0.0498999727861942,0.302294558226795
Physical measures,X4270.Volume level set by participant (left),TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,36103,-0.0465670417075261,0.0451428738747068,-0.135047074501951,0.0419129910868992,0.302317169146027
Physical measures,X4270.Volume level set by participant (left),LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,35064,0.0857093898486722,0.0831719635579983,-0.0773076587250044,0.248726438422349,0.302810082249686
Physical measures,X4270.Volume level set by participant (left),VEGFC,Vascular endothelial growth factor C,36289,-0.0346444994944562,0.0336734499585635,-0.100644461413241,0.0313554624243282,0.303588536710306
Physical measures,X4270.Volume level set by participant (left),PTGES2,Prostaglandin E synthase 2,35054,-0.042480487044912,0.0413006693843591,-0.123429799038256,0.0384688249484319,0.30372196608781
Physical measures,X4270.Volume level set by participant (left),TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,36289,0.0532229913312844,0.0518007859965855,-0.0483065492220231,0.154752531884592,0.304238463490475
Physical measures,X4270.Volume level set by participant (left),SNX5,Sorting nexin-5,35151,-0.0756344983012939,0.0738264336490845,-0.2203343082535,0.0690653116509117,0.305641383639108
Physical measures,X4270.Volume level set by participant (left),DCN,Decorin,36109,-0.0870569565553137,0.0851705085697514,-0.253991153352026,0.079877240241399,0.306743290837269
Physical measures,X4270.Volume level set by participant (left),MDM1,Nuclear protein MDM1,35133,-0.0697477891751728,0.0682426026245194,-0.203503290319231,0.0640077119688851,0.306792066213796
Physical measures,X4270.Volume level set by participant (left),CLEC4D,C-type lectin domain family 4 member D,36242,0.0303091684082743,0.0297010294155935,-0.0279048492462889,0.0885231860628376,0.307535390117726
Physical measures,X4270.Volume level set by participant (left),IL7,Interleukin-7,36242,-0.0298149477096386,0.0292249464895017,-0.087095842829062,0.0274659474097847,0.307671485359469
Physical measures,X4270.Volume level set by participant (left),BECN1,Beclin-1,35151,-0.0382600697193552,0.0375190958278824,-0.111797497542005,0.0352773581032942,0.307885073368728
Physical measures,X4270.Volume level set by participant (left),POF1B,Protein POF1B,35093,0.0500245124471505,0.0490678417391054,-0.0461484573614962,0.146197482255797,0.308005126848201
Physical measures,X4270.Volume level set by participant (left),ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",36364,0.062391696016125,0.0612203343781356,-0.0576001593650209,0.182383551397271,0.308171341077312
Physical measures,X4270.Volume level set by participant (left),TGFB2,Transforming growth factor beta-2 proprotein,35279,-0.0426716462629007,0.0418763643301935,-0.12474932035008,0.0394060278242787,0.308244074837415
Physical measures,X4270.Volume level set by participant (left),OSCAR,Osteoclast-associated immunoglobulin-like receptor,36248,0.0559945794168319,0.0549622725478759,-0.0517314747770049,0.163720633610669,0.3083386643162
Physical measures,X4270.Volume level set by participant (left),BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,36060,0.0306711009998707,0.0301083940794272,-0.0283413513958067,0.089683553395548,0.308383509001393
Physical measures,X4270.Volume level set by participant (left),FES,Tyrosine-protein kinase Fes/Fps,36060,0.0421982301330243,0.0414265226865343,-0.0389977543325828,0.123394214598631,0.308412489924452
Physical measures,X4270.Volume level set by participant (left),TALDO1,Transaldolase,35293,-0.0517335883111721,0.0507928878061259,-0.151287648411179,0.0478204717888347,0.308467580560745
Physical measures,X4270.Volume level set by participant (left),ADGRE2,Adhesion G protein-coupled receptor E2,36278,-0.0662927288488461,0.0650989932218167,-0.193886755563607,0.0613012978659147,0.308549817017661
Physical measures,X4270.Volume level set by participant (left),BTN2A1,Butyrophilin subfamily 2 member A1,36278,0.0730355524929249,0.0717260063476924,-0.0675474199485522,0.213618524934402,0.30858763945864
Physical measures,X4270.Volume level set by participant (left),APOL1,Apolipoprotein L1,35317,0.0388610631085517,0.0381844779955159,-0.0359805137626594,0.113702639979763,0.308848256718727
Physical measures,X4270.Volume level set by participant (left),VCAM1,Vascular cell adhesion protein 1,36276,-0.0695194219872051,0.0683252210471465,-0.203436855239612,0.064398011265202,0.308958084777177
Physical measures,X4270.Volume level set by participant (left),FUOM,Fucose mutarotase,35165,0.0360949880627982,0.0354764890772606,-0.0334389305286327,0.105628906654229,0.308984499665382
Physical measures,X4270.Volume level set by participant (left),ERCC1,DNA excision repair protein ERCC-1,35095,-0.068805135943426,0.0676997364655764,-0.201496619415956,0.0638863475291037,0.309511106246846
Physical measures,X4270.Volume level set by participant (left),AMOT,Angiomotin,35165,-0.0589936057025606,0.0580514506136592,-0.172774448905333,0.0547872375002115,0.309557503812448
Physical measures,X4270.Volume level set by participant (left),EPO,Erythropoietin,36242,0.0266651668150474,0.0262470414741504,-0.0247790344742875,0.0781093681043823,0.309694715910191
Physical measures,X4270.Volume level set by participant (left),DENND2B,DENN domain-containing protein 2B,35079,0.0466910305384239,0.0459708074557432,-0.0434117520748328,0.136793813151681,0.309825947246265
Physical measures,X4270.Volume level set by participant (left),LPL,Lipoprotein lipase,36258,-0.0393742032980551,0.0387735383422733,-0.115370338448911,0.0366219318528006,0.30990363297936
Physical measures,X4270.Volume level set by participant (left),EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,35079,-0.0630553862651254,0.0620950740638516,-0.184761731430275,0.0586509589000238,0.309922067147171
Physical measures,X4270.Volume level set by participant (left),NRGN,Neurogranin,35317,-0.0246624591131763,0.0243071498820701,-0.0723044728820336,0.0229795546556811,0.310324765776263
Physical measures,X4270.Volume level set by participant (left),F9,Coagulation factor IX,36276,-0.104517250941142,0.103065662081149,-0.306525948620193,0.0974914467379092,0.31057459135414
Physical measures,X4270.Volume level set by participant (left),FABP4,"Fatty acid-binding protein, adipocyte",36364,0.0375673621838734,0.0370970495702426,-0.0351428549738021,0.110277579341549,0.311245607663464
Physical measures,X4270.Volume level set by participant (left),PAXX,Protein PAXX,35165,-0.0486886040047824,0.0481126933299642,-0.142989482931512,0.0456122749219474,0.311589692237973
Physical measures,X4270.Volume level set by participant (left),PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,36258,-0.0235140534985175,0.0232431141892714,-0.0690705573094894,0.0220424503124544,0.311734173465817
Physical measures,X4270.Volume level set by participant (left),PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,36109,0.0342912816761351,0.0340249696552602,-0.0323976588481748,0.100980222200445,0.313570028780268
Physical measures,X4270.Volume level set by participant (left),PDGFA,Platelet-derived growth factor subunit A,36364,-0.0259198075568572,0.0257215022697232,-0.0763339520055146,0.0244943368918002,0.313625259010956
Physical measures,X4270.Volume level set by participant (left),IFI30,Gamma-interferon-inducible lysosomal thiol reductase,35128,-0.0573240243673693,0.0568899910424898,-0.168828406810649,0.0541803580759108,0.313669800219664
Physical measures,X4270.Volume level set by participant (left),ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,35093,0.072064902016099,0.0715419798072259,-0.0681573784060637,0.212287182438262,0.313823712900419
Physical measures,X4270.Volume level set by participant (left),HK2,Hexokinase-2,36109,0.0695477668046135,0.0690558506850164,-0.0658017005380187,0.204897234147246,0.313907916664331
Physical measures,X4270.Volume level set by participant (left),PCNA,Proliferating cell nuclear antigen,35095,-0.0337078426837717,0.0334964446239661,-0.0993608741467452,0.0319451887792018,0.314303467184198
Physical measures,X4270.Volume level set by participant (left),NFX1,Transcriptional repressor NF-X1,35079,-0.0336987625491279,0.0335164731789189,-0.099391049979809,0.0319935248815532,0.314723170476903
Physical measures,X4270.Volume level set by participant (left),KIF22,Kinesin-like protein KIF22,35079,-0.0185914183180015,0.0185005935198962,-0.0548525816169981,0.0176697449809951,0.314978075937082
Physical measures,X4270.Volume level set by participant (left),SIGLEC1,Sialoadhesin,36278,0.0451827972418394,0.0449802172761399,-0.0429784286193949,0.133344023103074,0.315167529043553
Physical measures,X4270.Volume level set by participant (left),AKR1C4,Aldo-keto reductase family 1 member C4,36109,-0.0361103165689502,0.0360482353542933,-0.106764857863365,0.0345442247254647,0.316510087099988
Physical measures,X4270.Volume level set by participant (left),ADA2,Adenosine deaminase 2,36203,-0.0439292602780637,0.0439301882467747,-0.130032429241742,0.0421739086856147,0.31735256714479
Physical measures,X4270.Volume level set by participant (left),CPXM2,Inactive carboxypeptidase-like protein X2,35313,0.0854137392113448,0.0854753691013333,-0.0821179842272685,0.252945462649958,0.317695601467535
Physical measures,X4270.Volume level set by participant (left),SIGLEC6,Sialic acid-binding Ig-like lectin 6,36327,0.0570415703995433,0.0571743215201712,-0.0550200997799923,0.169103240579079,0.318466712895096
Physical measures,X4270.Volume level set by participant (left),ATXN2,Ataxin-2,35083,-0.0215259347268956,0.0215775317475251,-0.0638178969520447,0.0207660274982536,0.31850636111796
Physical measures,X4270.Volume level set by participant (left),SERPINA4,Kallistatin,35195,-0.0959760901363633,0.0962222240682441,-0.284571649310122,0.0926194690373952,0.318586612020776
Physical measures,X4270.Volume level set by participant (left),HDGFL2,Hepatoma-derived growth factor-related protein 2,35301,-0.0351992066256506,0.0353075918023028,-0.104402086558164,0.0340036733068629,0.318834376540695
Physical measures,X4270.Volume level set by participant (left),DTD1,D-aminoacyl-tRNA deacylase 1,35165,-0.0258658757813523,0.0259526433426507,-0.0767330567329476,0.025001305170243,0.318967925285249
Physical measures,X4270.Volume level set by participant (left),GART,Trifunctional purine biosynthetic protein adenosine-3,35305,-0.08404416499604,0.0844235472288766,-0.249514317564638,0.0814259875725581,0.319526068907806
Physical measures,X4270.Volume level set by participant (left),AMBN,Ameloblastin,36103,-0.0699137049007157,0.0702761810231441,-0.207655019706078,0.0678276099046467,0.31984515203769
Physical measures,X4270.Volume level set by participant (left),CDK1,Cyclin-dependent kinase 1,35095,-0.0613480110374477,0.0616682918182364,-0.182217863001191,0.0595218409262956,0.319867512261006
Physical measures,X4270.Volume level set by participant (left),NLGN1,Neuroligin-1,35133,-0.0342673793509577,0.0344635340941486,-0.101815906175489,0.0332811474735735,0.320109619332077
Physical measures,X4270.Volume level set by participant (left),PCDH9,Protocadherin-9,35285,-0.0643468143925719,0.0647479355359619,-0.191252768043057,0.0625591392579133,0.32035385516785
Physical measures,X4270.Volume level set by participant (left),MST1,Hepatocyte growth factor-like protein,35205,-0.0328650590622967,0.0330930969349689,-0.0977275290548357,0.0319974109302423,0.32069313678558
Physical measures,X4270.Volume level set by participant (left),CD3E,T-cell surface glycoprotein CD3 epsilon chain,35195,0.056362056352056,0.0567706819533159,-0.0549084802764431,0.167632592980555,0.32084281143564
Physical measures,X4270.Volume level set by participant (left),PBLD,Phenazine biosynthesis-like domain-containing protein,36064,-0.0371510362050497,0.0374207548380749,-0.110495715687676,0.036193643277577,0.320843392670505
Physical measures,X4270.Volume level set by participant (left),HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,36060,-0.0258065419488398,0.0260354852258105,-0.0768360929914283,0.0252230090937487,0.321616922903655
Physical measures,X4270.Volume level set by participant (left),CKAP4,Cytoskeleton-associated protein 4,36304,0.0670194250579219,0.0676466935675628,-0.0655680943345012,0.199606944450345,0.321849891117316
Physical measures,X4270.Volume level set by participant (left),CIAPIN1,Anamorsin,36289,-0.0318091038667983,0.0321095047981799,-0.0947437332712309,0.0311255255376343,0.321890392456331
Physical measures,X4270.Volume level set by participant (left),LEPR,Leptin receptor,36258,0.0581612084349277,0.0587107139058322,-0.0569117908205035,0.173234207690359,0.321892486671972
Physical measures,X4270.Volume level set by participant (left),CD79B,B-cell antigen receptor complex-associated protein beta chain,36342,0.0411868827774229,0.0415838633651129,-0.0403174894181983,0.122691254973044,0.32198347502806
Physical measures,X4270.Volume level set by participant (left),EFCAB2,Dynein regulatory complex protein 8,35195,-0.0620798954418613,0.0627283272320058,-0.185027416816593,0.0608676259328701,0.32237526028417
Physical measures,X4270.Volume level set by participant (left),CD99,CD99 antigen,36256,0.0945295301523227,0.0955790937475137,-0.0928054935928042,0.28186455389745,0.322685162370105
Physical measures,X4270.Volume level set by participant (left),MAGEA3,Melanoma-associated antigen 3,35195,-0.0262903214652218,0.026591397520139,-0.0784094606046941,0.0258288176742506,0.32285714927107
Physical measures,X4270.Volume level set by participant (left),YTHDF3,YTH domain-containing family protein 3,36103,-0.0226904033790506,0.0229702514294361,-0.0677120961807454,0.0223312894226443,0.323274178065647
Physical measures,X4270.Volume level set by participant (left),YWHAQ,14-3-3 protein theta,35165,-0.0302870782557535,0.0306612088707538,-0.0903830476424309,0.0298088911309239,0.323288048424794
Physical measures,X4270.Volume level set by participant (left),LRP1,Prolow-density lipoprotein receptor-related protein 1,36216,0.0694817835572162,0.0704714188674541,-0.0686421974229939,0.207605764537426,0.324185583586732
Physical measures,X4270.Volume level set by participant (left),TCTN3,Tectonic-3,35313,0.071695159581517,0.0727241729112341,-0.0708442193245018,0.214234538487536,0.324242044293482
Physical measures,X4270.Volume level set by participant (left),COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",36216,-0.0274564598293904,0.0278733577000125,-0.0820882409214148,0.027175321262634,0.324634184368617
Physical measures,X4270.Volume level set by participant (left),TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,36256,0.0624451013391837,0.0634082959917223,-0.061835158804592,0.186725361482959,0.324748715985704
Physical measures,X4270.Volume level set by participant (left),TNFRSF4,Tumor necrosis factor receptor superfamily member 4,36328,0.0494587249581043,0.0502584082841362,-0.0490477552788026,0.147965205195011,0.325102787937293
Physical measures,X4270.Volume level set by participant (left),LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,36103,-0.0433358594337342,0.044050475599053,-0.129674791607878,0.0430030727404097,0.325256740487005
Physical measures,X4270.Volume level set by participant (left),PLXDC2,Plexin domain-containing protein 2,35301,-0.0791018626486589,0.080492759698596,-0.236867671657907,0.0786639463605893,0.325780650461314
Physical measures,X4270.Volume level set by participant (left),ARTN,Artemin,36103,0.0420969808734017,0.042931184418725,-0.0420481405872993,0.126242102334103,0.3268370451464
Physical measures,X4270.Volume level set by participant (left),NECTIN2,Nectin-2,36247,0.0609292759984862,0.0621898162026414,-0.0609627637586909,0.182821315755663,0.327250043360127
Physical measures,X4270.Volume level set by participant (left),FABP3,"Fatty acid-binding protein, heart",35313,-0.0395528069433693,0.0404005644716528,-0.118737913307809,0.0396322994210702,0.327607272602532
Physical measures,X4270.Volume level set by participant (left),LATS1,Serine/threonine-protein kinase LATS1,35093,-0.0255707768954244,0.0261867151115425,-0.0768967385140477,0.0257551847231989,0.328863554124873
Physical measures,X4270.Volume level set by participant (left),NXPE4,NXPE family member 4,35079,-0.065260073154458,0.0669012859812932,-0.196386593677793,0.0658664473688767,0.329364532193417
Physical measures,X4270.Volume level set by participant (left),PALM,Paralemmin-1,35239,-0.0690866392040645,0.0708700962211172,-0.207992027797454,0.0698187493893251,0.329677723308515
Physical measures,X4270.Volume level set by participant (left),PDRG1,p53 and DNA damage-regulated protein 1,35133,0.043232918986574,0.0443698451126514,-0.0437319774342226,0.130197815407371,0.329905898223185
Physical measures,X4270.Volume level set by participant (left),GSN,Gelsolin,35292,-0.115899362457348,0.118961113684961,-0.349063145279872,0.117264420365176,0.329961406084122
Physical measures,X4270.Volume level set by participant (left),RLN2,Prorelaxin H2,35152,0.0410056019888072,0.0421043785933616,-0.0415189800541817,0.123530184031796,0.330140422125988
Physical measures,X4270.Volume level set by participant (left),KHDC3L,KH domain-containing protein 3,35095,0.032227211997764,0.0331079225870007,-0.0326643162727573,0.0971187402682854,0.330391403441178
Physical measures,X4270.Volume level set by participant (left),AZU1,Azurocidin,36059,0.0234803549900037,0.0241756729041237,-0.0239039639020788,0.0708646738820861,0.331460811493302
Physical measures,X4270.Volume level set by participant (left),GNLY,Granulysin,36256,-0.0329554905825137,0.0339443140528956,-0.099486346126189,0.0335753649611617,0.331644077468874
Physical measures,X4270.Volume level set by participant (left),PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,34912,-0.0215079891419127,0.0221584688057833,-0.064938588001248,0.0219226097174226,0.331762699512679
Physical measures,X4270.Volume level set by participant (left),PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",36064,-0.0609343240146152,0.0628098280114056,-0.18404158691697,0.0621729388877396,0.332008181307522
Physical measures,X4270.Volume level set by participant (left),FGF16,Fibroblast growth factor 16,35093,0.0479226328592277,0.0494170289311502,-0.0489347438458266,0.144780009564282,0.332202527160495
Physical measures,X4270.Volume level set by participant (left),AP3B1,AP-3 complex subunit beta-1,35285,-0.0279055417829673,0.0287807372274599,-0.0843157867487886,0.0285047031828541,0.332285529335299
Physical measures,X4270.Volume level set by participant (left),CLIC5,Chloride intracellular channel protein 5,35133,0.0685504798856572,0.0708310232889651,-0.0702783257607145,0.207379285532029,0.3331785861844
Physical measures,X4270.Volume level set by participant (left),IFNL2,Interferon lambda-2,35083,-0.0367101247946847,0.0379338381667311,-0.111060447601478,0.0376401980121082,0.333209927778057
Physical measures,X4270.Volume level set by participant (left),SUGT1,Protein SGT1 homolog,36060,-0.02463778071835,0.0255111455606647,-0.0746396260172527,0.0253640645805527,0.334192923570113
Physical measures,X4270.Volume level set by participant (left),CSF3,Granulocyte colony-stimulating factor,36103,-0.0383370256975231,0.0397090779281459,-0.116166818436689,0.039492767041643,0.334351902799672
Physical measures,X4270.Volume level set by participant (left),ERP29,Endoplasmic reticulum resident protein 29,35165,-0.0185083628006116,0.0192136051018809,-0.0561670288002981,0.0191503031990749,0.335435178737667
Physical measures,X4270.Volume level set by participant (left),FZD8,Frizzled-8,35083,0.0495151798431161,0.0514872295381532,-0.0513997900516641,0.150430149737896,0.336237072607583
Physical measures,X4270.Volume level set by participant (left),AMN,Protein amnionless,36103,0.038436372714423,0.0400084770611582,-0.0399802423254472,0.116852987754293,0.336731125370757
Physical measures,X4270.Volume level set by participant (left),TPD52L2,Tumor protein D54,35165,-0.0203394088315745,0.021221149452085,-0.0619328617576612,0.0212540440945121,0.337871247989
Physical measures,X4270.Volume level set by participant (left),PGLYRP1,Peptidoglycan recognition protein 1,36325,0.0412950144744949,0.0431017929038196,-0.0431844996169915,0.125774528565981,0.33805184443924
Physical measures,X4270.Volume level set by participant (left),FUS,RNA-binding protein FUS,36058,-0.0469809328106674,0.0490478679274765,-0.143114753948521,0.0491528883271866,0.338165016471429
Physical measures,X4270.Volume level set by participant (left),CTLA4,Cytotoxic T-lymphocyte protein 4,35320,-0.0732762389622479,0.076518564995729,-0.223252626353877,0.0767001484293808,0.338285376860581
Physical measures,X4270.Volume level set by participant (left),DNAJA4,DnaJ homolog subfamily A member 4,35301,-0.0289597855600696,0.0302419155411477,-0.088233940020719,0.0303143689005799,0.338296939153581
Physical measures,X4270.Volume level set by participant (left),CCDC134,Coiled-coil domain-containing protein 134,35279,-0.0434380386338441,0.0453931660191803,-0.132408644031438,0.0455325667637493,0.338637724895486
Physical measures,X4270.Volume level set by participant (left),HIF1A,Hypoxia-inducible factor 1-alpha,35093,-0.0347893867083283,0.0363811615198244,-0.106096463287184,0.0365176898705275,0.338982936181318
Physical measures,X4270.Volume level set by participant (left),LRRC25,Leucine-rich repeat-containing protein 25,36216,-0.0457853466029958,0.0478875762461079,-0.139644996045367,0.0480743028393757,0.339051704874504
Physical measures,X4270.Volume level set by participant (left),DOK1,Docking protein 1,35301,-0.0162685591975503,0.0170165434700855,-0.049620984398918,0.0170838660038173,0.339084660048331
Physical measures,X4270.Volume level set by participant (left),DPP7,Dipeptidyl peptidase 2,36209,0.0290986824400469,0.0304479604169282,-0.0305793199771325,0.0887766848572262,0.339261387864924
Physical measures,X4270.Volume level set by participant (left),RARRES2,Retinoic acid receptor responder protein 2,36313,0.0360542980335817,0.0377303403752189,-0.0378971691018473,0.110005765169011,0.339315241796612
Physical measures,X4270.Volume level set by participant (left),CDCP1,CUB domain-containing protein 1,36179,0.0326270989446678,0.034149510439634,-0.0343059415170148,0.0995601394063504,0.339396217920277
Physical measures,X4270.Volume level set by participant (left),MEP1A,Meprin A subunit alpha,35285,-0.0275985201446573,0.0289082347518628,-0.0842586602583083,0.0290616199689937,0.339766967672703
Physical measures,X4270.Volume level set by participant (left),DEFA1_DEFA1B,Neutrophil defensin 1,36096,0.0332813578997829,0.034862136708303,-0.035048430048491,0.101611145848057,0.339782340221173
Physical measures,X4270.Volume level set by participant (left),SPINK4,Serine protease inhibitor Kazal-type 4,36242,0.0281072136752452,0.0294550847204614,-0.0296247523768591,0.0858391797273494,0.339992474985944
Physical measures,X4270.Volume level set by participant (left),ARF6,ADP-ribosylation factor 6,35285,-0.0197587237103189,0.0207638380427524,-0.0604558462741136,0.0209383988534758,0.341337832493108
Physical measures,X4270.Volume level set by participant (left),ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,35279,-0.0481834414390373,0.0506352958583549,-0.147428621321413,0.0510617384433382,0.341345413183325
Physical measures,X4270.Volume level set by participant (left),TMPRSS11D,Transmembrane protease serine 11D,35287,0.0539764870632866,0.0568420211285517,-0.0574338743486747,0.165386848475248,0.342356096659632
Physical measures,X4270.Volume level set by participant (left),PTPRF,Receptor-type tyrosine-protein phosphatase F,36364,0.0621002840170134,0.0654268274069193,-0.0661362977005484,0.190336865734575,0.342570688703261
Physical measures,X4270.Volume level set by participant (left),SORT1,Sortilin,36247,-0.046741183845565,0.0492502168068564,-0.143271608787004,0.0497892410958736,0.342622443232977
Physical measures,X4270.Volume level set by participant (left),SH3GLB2,Endophilin-B2,35301,-0.0316903787529494,0.033428681288744,-0.0972105940788876,0.0338298365729888,0.343163823970907
Physical measures,X4270.Volume level set by participant (left),TARS1,"Threonine--tRNA ligase 1, cytoplasmic",35279,-0.0577425630107812,0.0609549398510406,-0.177214245118821,0.0617291190972585,0.343520648048968
Physical measures,X4270.Volume level set by participant (left),SIT1,Signaling threshold-regulating transmembrane adapter 1,36103,0.0339798484069864,0.0358864594859366,-0.0363576121854493,0.104317308999422,0.343735013467478
Physical measures,X4270.Volume level set by participant (left),EDA2R,Tumor necrosis factor receptor superfamily member 27,36327,0.0425001617674319,0.0449279167164428,-0.045558554996796,0.13055887853166,0.344196880315012
Physical measures,X4270.Volume level set by participant (left),SARG,Specifically androgen-regulated gene protein,35288,-0.019351194513357,0.020482515487811,-0.0594969248694665,0.0207945358427525,0.344812241542644
Physical measures,X4270.Volume level set by participant (left),CNTN3,Contactin-3,36256,0.0613847776969717,0.0650110566748225,-0.0660368933856803,0.188806448779624,0.345086747912544
Physical measures,X4270.Volume level set by participant (left),RP2,Protein XRP2,36216,-0.0427768730001123,0.0453268553179966,-0.131617509423386,0.0460637634231609,0.345331274759492
Physical measures,X4270.Volume level set by participant (left),PSIP1,PC4 and SFRS1-interacting protein,36242,-0.0275097271716354,0.0291639925837335,-0.0846711526357531,0.0296516982924822,0.345569002471438
Physical measures,X4270.Volume level set by participant (left),CD244,Natural killer cell receptor 2B4,36342,0.0625659832224956,0.0663430744018555,-0.0674664426051411,0.192598409050132,0.345675925334415
Physical measures,X4270.Volume level set by participant (left),SCIN,Adseverin,35083,-0.0286978291558009,0.0304307475912529,-0.0883420944346566,0.0309464361230547,0.345688593014035
Physical measures,X4270.Volume level set by participant (left),KIRREL2,Kin of IRRE-like protein 2,36064,-0.0449019989094775,0.0476523774586056,-0.138300658728344,0.0484966609093894,0.346078560407823
Physical measures,X4270.Volume level set by participant (left),RPA2,Replication protein A 32 kDa subunit,35093,-0.0669506142740657,0.0710584724950641,-0.206225220364391,0.0723239918162599,0.346130211227564
Physical measures,X4270.Volume level set by participant (left),CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,35083,-0.0363758237295924,0.0386877732865324,-0.112203859371196,0.0394522119120111,0.347129094211235
Physical measures,X4270.Volume level set by participant (left),GGH,Gamma-glutamyl hydrolase,36140,0.0534737563594446,0.0568834179682888,-0.0580177428584015,0.164965255577291,0.347217538001406
Physical measures,X4270.Volume level set by participant (left),GAS6,Growth arrest-specific protein 6,36318,0.067520046040677,0.0718273908138127,-0.0732616399543959,0.20830173203575,0.347230575422701
Physical measures,X4270.Volume level set by participant (left),NOMO1,Nodal modulator 1,36256,0.0753953627351329,0.0802300991520949,-0.0818556316029731,0.232646357073239,0.347381052552587
Physical measures,X4270.Volume level set by participant (left),NCAM1,Neural cell adhesion molecule 1,36289,-0.0537609364342331,0.0572105419744189,-0.165893598704094,0.058371725835628,0.347399290122797
Physical measures,X4270.Volume level set by participant (left),KLKB1,Plasma kallikrein,35172,-0.0837948552389439,0.0891890281982152,-0.258605350507446,0.0910156400295579,0.34749849109113
Physical measures,X4270.Volume level set by participant (left),SLC28A1,Sodium/nucleoside cotransporter 1,35095,0.037782007722752,0.0402295338179608,-0.041067878560451,0.116631894005955,0.347683048085812
Physical measures,X4270.Volume level set by participant (left),NTF4,Neurotrophin-4,36060,0.0475666197661914,0.0506523706700766,-0.0517120267471588,0.146845266279542,0.347720173628623
Physical measures,X4270.Volume level set by participant (left),DCTN1,Dynactin subunit 1,36327,-0.0281332623549713,0.0299835866258383,-0.0869010921416143,0.0306345674316717,0.348125372070341
Physical measures,X4270.Volume level set by participant (left),CNTN2,Contactin-2,36327,0.039111767246167,0.041695723248658,-0.0426118503212028,0.120835384813537,0.348259210579867
Physical measures,X4270.Volume level set by participant (left),KCNC4,Potassium voltage-gated channel subfamily C member 4,35083,0.0381611894888681,0.0406904924108239,-0.0415921756363468,0.117914554614083,0.348361365545907
Physical measures,X4270.Volume level set by participant (left),OLR1,Oxidized low-density lipoprotein receptor 1,36194,-0.0288454833635554,0.0307976124528146,-0.0892088037710721,0.0315178370439612,0.348986803989094
Physical measures,X4270.Volume level set by participant (left),RNASE4,Ribonuclease 4,35099,0.0744642917917096,0.0795132254289235,-0.0813816300489804,0.2303102136324,0.349049615714536
Physical measures,X4270.Volume level set by participant (left),SUSD2,Sushi domain-containing protein 2,36256,-0.060342279944402,0.0644482459107221,-0.186660841929417,0.0659762820406133,0.349153185439072
Physical measures,X4270.Volume level set by participant (left),BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,35083,0.0277949792055971,0.0296879662228848,-0.0303934345912571,0.0859833930024513,0.349185948926625
Physical measures,X4270.Volume level set by participant (left),LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,35279,-0.0404715858198789,0.0432555675594514,-0.125252498236404,0.044309326596646,0.349493050692767
Physical measures,X4270.Volume level set by participant (left),MAPRE3,Microtubule-associated protein RP/EB family member 3,35095,-0.0140314633166369,0.015010776058345,-0.0434525843909931,0.0153896577577193,0.349947098264215
Physical measures,X4270.Volume level set by participant (left),C1RL,Complement C1r subcomponent-like protein,35309,0.10219100657818,0.109533682646101,-0.112495011408178,0.316877024564539,0.350872032385248
Physical measures,X4270.Volume level set by participant (left),PTPRM,Receptor-type tyrosine-protein phosphatase mu,36229,0.0713026450054388,0.0764371541226172,-0.0785141770748909,0.221119467085768,0.350938804620625
Physical measures,X4270.Volume level set by participant (left),RSPO1,R-spondin-1,36179,0.0517934750866122,0.0555443599227769,-0.0570734703620305,0.160660420535255,0.351123158886201
Physical measures,X4270.Volume level set by participant (left),CMIP,C-Maf-inducing protein,35279,-0.0247018490833225,0.0265007762141405,-0.0766433704630378,0.0272396722963929,0.351309282095899
Physical measures,X4270.Volume level set by participant (left),BSG,Basigin,36328,0.0882508001901234,0.0946828020945701,-0.097327491915234,0.273829092295481,0.351330566380624
Physical measures,X4270.Volume level set by participant (left),LGALS9,Galectin-9,36244,0.0569036034919025,0.0610594603982256,-0.0627729388886197,0.176580145872425,0.351398248579205
Physical measures,X4270.Volume level set by participant (left),GDNF,Glial cell line-derived neurotrophic factor,36064,-0.047594742297285,0.0510830236848359,-0.147717468719563,0.0525279841249934,0.351514759902636
Physical measures,X4270.Volume level set by participant (left),SLC27A4,Long-chain fatty acid transport protein 4,36064,-0.0219911918203956,0.0236148894604282,-0.0682763751628349,0.0242939915220436,0.351758200629351
Physical measures,X4270.Volume level set by participant (left),BABAM1,BRISC and BRCA1-A complex member 1,35093,-0.0740384294751391,0.079556838743876,-0.229969833413136,0.0818929744628579,0.352076687395199
Physical measures,X4270.Volume level set by participant (left),PLIN3,Perilipin-3,36258,-0.0410919827190108,0.0441570266132992,-0.127639754881077,0.0454557894430556,0.352096261415084
Physical measures,X4270.Volume level set by participant (left),ITGB7,Integrin beta-7,36327,0.038150657705636,0.0410033339998528,-0.0422158769340754,0.118517192345347,0.35217850818679
Physical measures,X4270.Volume level set by participant (left),EZR,Ezrin,36325,-0.0689932119696927,0.0744042787865053,-0.214825598391243,0.0768391744518577,0.35381286085675
Physical measures,X4270.Volume level set by participant (left),MCEMP1,Mast cell-expressed membrane protein 1,35093,-0.0238618055195747,0.0257372002773922,-0.0743067180632634,0.026583107024114,0.353892004628256
Physical measures,X4270.Volume level set by participant (left),IL2,Interleukin-2,36103,0.0558927886682328,0.0602878799349831,-0.0622714560043341,0.1740570333408,0.353905351257378
Physical measures,X4270.Volume level set by participant (left),PRDX2,Peroxiredoxin-2,35183,-0.032954076169691,0.0355575679847104,-0.102646909419723,0.0367387570803414,0.354074275602514
Physical measures,X4270.Volume level set by participant (left),ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,35285,-0.067867510826828,0.0732483420059558,-0.211434261158501,0.0756992395048454,0.354198939112478
Physical measures,X4270.Volume level set by participant (left),LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,36256,-0.0289281164917554,0.031235020240019,-0.0901487561621927,0.0322925231786818,0.354400522284591
Physical measures,X4270.Volume level set by participant (left),INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",35305,-0.0518684142010803,0.0560399527515156,-0.161706721594051,0.0579698931918904,0.35470731369484
Physical measures,X4270.Volume level set by participant (left),MRPL52,"39S ribosomal protein L52, mitochondrial",35071,-0.0781791429155382,0.0845063421195686,-0.243811573469893,0.0874532876388161,0.354934092141314
Physical measures,X4270.Volume level set by participant (left),CST1,Cystatin-SN,34432,0.0220205050603427,0.0238035574643866,-0.0246344675698551,0.0686754776905405,0.354955814902976
Physical measures,X4270.Volume level set by participant (left),AGR2,Anterior gradient protein 2 homolog,36015,0.0182051975302078,0.0196857808585877,-0.0203789329526242,0.0567893280130397,0.355105676063843
Physical measures,X4270.Volume level set by participant (left),DAB2,Disabled homolog 2,36327,-0.0158793223004144,0.0171720060218092,-0.0495364541031604,0.0177778095023316,0.355139707266729
Physical measures,X4270.Volume level set by participant (left),ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,35151,-0.0579627728472738,0.0627260345395185,-0.18090580054473,0.0649802548501824,0.355487855088623
Physical measures,X4270.Volume level set by participant (left),IRAK4,Interleukin-1 receptor-associated kinase 4,36242,-0.0179037982155498,0.0193777922633119,-0.0558842710516411,0.0200766746205415,0.355549940712388
Physical measures,X4270.Volume level set by participant (left),PSMG3,Proteasome assembly chaperone 3,36242,-0.034306812777054,0.0372599065071592,-0.107336229531086,0.038722603976978,0.357213490151296
Physical measures,X4270.Volume level set by participant (left),PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,35093,-0.0362384032027212,0.0393818282794208,-0.113426786630386,0.0409499802249436,0.357512473740653
Physical measures,X4270.Volume level set by participant (left),AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,34939,0.0416833382427117,0.0453508598809139,-0.0472043471238796,0.130571023609303,0.358062540449268
Physical measures,X4270.Volume level set by participant (left),STOML2,"Stomatin-like protein 2, mitochondrial",35095,-0.0219660519271497,0.0239237681201421,-0.0688566374426282,0.0249245335883288,0.358564731163485
Physical measures,X4270.Volume level set by participant (left),CD59,CD59 glycoprotein,35995,0.0774132465821101,0.0843627480621592,-0.0879377396197219,0.242764232783942,0.358845908398163
Physical measures,X4270.Volume level set by participant (left),EIF4E,Eukaryotic translation initiation factor 4E,35093,-0.0243565322631064,0.0265436701034491,-0.0763821256658666,0.0276690611396538,0.358861220431791
Physical measures,X4270.Volume level set by participant (left),SCG3,Secretogranin-3,36248,-0.0514164568445672,0.0560656450104516,-0.161305121065052,0.0584722073759179,0.359131750833227
Physical measures,X4270.Volume level set by participant (left),DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",35285,-0.0199827483802323,0.0218568707879551,-0.0628222151246242,0.0228567183641597,0.360615979155211
Physical measures,X4270.Volume level set by participant (left),HNMT,Histamine N-methyltransferase,36152,0.0372202127261667,0.0407974786564274,-0.0427428454404311,0.117183270892764,0.361631266824659
Physical measures,X4270.Volume level set by participant (left),MOG,Myelin-oligodendrocyte glycoprotein,36327,0.0513257150993314,0.056369540804386,-0.0591585848772651,0.161810015075928,0.36257562227114
Physical measures,X4270.Volume level set by participant (left),LCN2,Neutrophil gelatinase-associated lipocalin,36043,0.0441105134455878,0.0484567673905777,-0.0508647506399445,0.13908577753112,0.362690347470299
Physical measures,X4270.Volume level set by participant (left),WASL,Neural Wiskott-Aldrich syndrome protein,35093,-0.0334905575358638,0.0368362642307765,-0.105689635428186,0.0387085203564581,0.36329227872561
Physical measures,X4270.Volume level set by participant (left),CD177,CD177 antigen,36244,-0.0132460718014913,0.0145721638719987,-0.0418075129906088,0.0153153693876263,0.363379706790083
Physical measures,X4270.Volume level set by participant (left),DNAJB14,DnaJ homolog subfamily B member 14,35285,-0.0314704026464123,0.034660097222931,-0.0994041932033571,0.0364633879105325,0.363925685557398
Physical measures,X4270.Volume level set by participant (left),SH3BP1,SH3 domain-binding protein 1,35285,0.0395629541402771,0.0435904433317877,-0.0458743147900267,0.125000223070581,0.364119077641666
Physical measures,X4270.Volume level set by participant (left),DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,36242,-0.0145950661294426,0.0161038937552736,-0.0461586978897789,0.0169685656308936,0.364802147974326
Physical measures,X4270.Volume level set by participant (left),CCL25,C-C motif chemokine 25,36342,0.0341516693066206,0.0377016787253051,-0.0397436209949775,0.108046959608219,0.365049017903363
Physical measures,X4270.Volume level set by participant (left),PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,35305,-0.016459578969667,0.0181706048607566,-0.0520739644967498,0.0191548065574158,0.365055490648901
Physical measures,X4270.Volume level set by participant (left),S100A4,Protein S100-A4,36289,-0.0324499769506093,0.0359052654324546,-0.10282429719822,0.0379243432970016,0.366147540364119
Physical measures,X4270.Volume level set by participant (left),RABEPK,Rab9 effector protein with kelch motifs,36060,-0.0299544276465781,0.0331705901792363,-0.0949687843978813,0.0350599291047251,0.366532908831473
Physical measures,X4270.Volume level set by participant (left),ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,35079,0.035762533231146,0.0396492636882205,-0.0419500235977661,0.113475090060058,0.367105184952089
Physical measures,X4270.Volume level set by participant (left),MED18,Mediator of RNA polymerase II transcription subunit 18,36060,-0.0233854322370377,0.0259277671567501,-0.0742038558642679,0.0274329913901924,0.367114964066343
Physical measures,X4270.Volume level set by participant (left),PECAM1,Platelet endothelial cell adhesion molecule,36256,0.0535409808846882,0.0593720673486802,-0.062828271118725,0.169910232888101,0.367198205790312
Physical measures,X4270.Volume level set by participant (left),CORO1A,Coronin-1A,36130,0.0186633535894795,0.0207013825026942,-0.0219113561158011,0.0592380632947602,0.367324238208378
Physical measures,X4270.Volume level set by participant (left),PMVK,Phosphomevalonate kinase,36052,-0.0166819701960011,0.0185091541332869,-0.0529599122972435,0.0195959719052413,0.367467461785371
Physical measures,X4270.Volume level set by participant (left),GTPBP2,GTP-binding protein 2,35133,-0.0247525240034104,0.027514807635561,-0.07868154696911,0.0291764989622891,0.368362400943631
Physical measures,X4270.Volume level set by participant (left),FCRL3,Fc receptor-like protein 3,36103,0.0319285900953239,0.0355106871211908,-0.03767235666221,0.101529536852858,0.368614295764691
Physical measures,X4270.Volume level set by participant (left),RPE,Ribulose-phosphate 3-epimerase,35195,-0.0283334710703125,0.0315191842179954,-0.0901110721375835,0.0334441299969584,0.36872395029239
Physical measures,X4270.Volume level set by participant (left),TXLNA,Alpha-taxilin,36179,-0.0203093172157675,0.0226090911651706,-0.0646231358995019,0.0240045014679669,0.369064301539061
Physical measures,X4270.Volume level set by participant (left),RGCC,Regulator of cell cycle RGCC,35305,-0.025942765898577,0.0288954146432646,-0.0825777785993755,0.0306922468022215,0.369315898795384
Physical measures,X4270.Volume level set by participant (left),PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,35279,-0.0230646680045113,0.0256965643565835,-0.073429934143415,0.0273005981343924,0.369442998625428
Physical measures,X4270.Volume level set by participant (left),CCN4,CCN family member 4,36327,-0.0429527768719312,0.0478734090155512,-0.136784658542411,0.050879104798549,0.369631762910039
Physical measures,X4270.Volume level set by participant (left),FETUB,Fetuin-B,36276,0.0512285548512642,0.0570992804542683,-0.0606860348391016,0.16314314454163,0.369648945886241
Physical measures,X4270.Volume level set by participant (left),CLEC3B,Tetranectin,35160,-0.0929391756268625,0.103610702113794,-0.296016151769899,0.110137800516174,0.369749913482888
Physical measures,X4270.Volume level set by participant (left),CD14,Monocyte differentiation antigen CD14,36107,0.0418311561326474,0.0466455267322247,-0.0495940762625129,0.133256388527808,0.369860735205926
Physical measures,X4270.Volume level set by participant (left),ARFIP1,Arfaptin-1,35305,-0.0282752553113097,0.0315356284957951,-0.090085087163068,0.0335345765404487,0.369957648841112
Physical measures,X4270.Volume level set by participant (left),ANXA11,Annexin A11,36225,-0.0275648065821741,0.0307512181361881,-0.0878371941291027,0.0327075809647546,0.370077639462722
Physical measures,X4270.Volume level set by participant (left),MYO9B,Unconventional myosin-IXb,36103,0.0239475703985336,0.026747554277386,-0.0284776359851429,0.0763727767822101,0.370645781596112
Physical measures,X4270.Volume level set by participant (left),CDH6,Cadherin-6,36258,0.0441489225356688,0.0493174037016749,-0.052513188719614,0.140811033790952,0.370708518620839
Physical measures,X4270.Volume level set by participant (left),FXN,"Frataxin, mitochondrial",36327,-0.0239284522045278,0.0267326621825303,-0.0763244700822872,0.0284675656732315,0.370760600595735
Physical measures,X4270.Volume level set by participant (left),CD200,OX-2 membrane glycoprotein,36242,-0.0632245218010174,0.0707487526336323,-0.201892076962937,0.0754430333609019,0.371538101847457
Physical measures,X4270.Volume level set by participant (left),DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,35279,0.0412023798204718,0.0461063646592801,-0.0491660949117171,0.131570854552661,0.371548049260515
Physical measures,X4270.Volume level set by participant (left),NTRK3,NT-3 growth factor receptor,36325,-0.077981423643865,0.0872828121557973,-0.249055735469228,0.0930928881814978,0.371652695675902
Physical measures,X4270.Volume level set by participant (left),F13B,Coagulation factor XIII B chain,35293,0.0780557198731896,0.0874122664629099,-0.0932723223941139,0.249383762140493,0.37191033052612
Physical measures,X4270.Volume level set by participant (left),PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,35305,-0.0254271195839543,0.0285276307217611,-0.081341275798606,0.0304870366306974,0.372791929994298
Physical measures,X4270.Volume level set by participant (left),CD274,Programmed cell death 1 ligand 1,36179,0.0509063333393935,0.0571277220927392,-0.0610640019623754,0.162876668641162,0.372905511750297
Physical measures,X4270.Volume level set by participant (left),MESD,LRP chaperone MESD,36256,-0.0140422980685652,0.0157748303006159,-0.0449609654577724,0.016876369320642,0.373402001014155
Physical measures,X4270.Volume level set by participant (left),BRSK2,Serine/threonine-protein kinase BRSK2,35305,-0.049648249352562,0.0557873403684518,-0.158991436474727,0.0596949377696035,0.37352173486423
Physical measures,X4270.Volume level set by participant (left),ZP3,Zona pellucida sperm-binding protein 3,35151,0.00747035284155102,0.00839937217237646,-0.00899241661630684,0.0239331222994089,0.373823936880586
Physical measures,X4270.Volume level set by participant (left),KRT18,"Keratin, type I cytoskeletal 18",36216,0.0205849727679972,0.0232116372681793,-0.0249098362776342,0.0660797818136286,0.375193888942391
Physical measures,X4270.Volume level set by participant (left),CTAG1A_CTAG1B,Cancer/testis antigen 1,35184,0.038903034001489,0.0438840122398247,-0.0471096299885674,0.124915697991545,0.375382300440189
Physical measures,X4270.Volume level set by participant (left),HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,36216,-0.0441353849885797,0.0498826883813795,-0.141905454216084,0.0536346842389242,0.376301294916526
Physical measures,X4270.Volume level set by participant (left),GSAP,Gamma-secretase-activating protein,36060,0.0203884184542744,0.023044505599401,-0.0247788125205516,0.0655556494291003,0.376324874055423
Physical measures,X4270.Volume level set by participant (left),CC2D1A,Coiled-coil and C2 domain-containing protein 1A,36179,-0.0232163900439771,0.0262963430467979,-0.074757222415701,0.0283244423277469,0.377331698320666
Physical measures,X4270.Volume level set by participant (left),SEMA4C,Semaphorin-4C,36216,-0.0595718647069731,0.0674876799365827,-0.191847717382675,0.0727039879687289,0.377422332127395
Physical measures,X4270.Volume level set by participant (left),GPD1,Glycerol-3-phosphate dehydrogenase,35279,-0.0353333888700954,0.0400336784571024,-0.113799398646016,0.0431326209058253,0.377488739273059
Physical measures,X4270.Volume level set by participant (left),SEPTIN8,Septin-8,35287,-0.0575725171003152,0.0652463255663023,-0.185455315210268,0.0703102810096372,0.37759923205861
Physical measures,X4270.Volume level set by participant (left),ALCAM,CD166 antigen,36364,0.0836016335529725,0.0948062216245178,-0.102218560831082,0.269421827937027,0.37790368156467
Physical measures,X4270.Volume level set by participant (left),PROCR,Endothelial protein C receptor,35079,-0.0596152940885267,0.0676060091010979,-0.192123071926679,0.0728924837496252,0.377915176757402
Physical measures,X4270.Volume level set by participant (left),CDH22,Cadherin-22,35195,0.0723192822730033,0.0820799074071526,-0.0885573362450159,0.233195900791022,0.378304550785558
Physical measures,X4270.Volume level set by participant (left),NGFR,Tumor necrosis factor receptor superfamily member 16,35313,-0.065425405304281,0.074396049351896,-0.211241662033997,0.0803908514254352,0.37920485410855
Physical measures,X4270.Volume level set by participant (left),DPP4,Dipeptidyl peptidase 4,36100,-0.0607171857798453,0.0690797889434949,-0.196113572109095,0.0746792005494046,0.379460439453142
Physical measures,X4270.Volume level set by participant (left),KHK,Ketohexokinase,35151,0.0324013375325632,0.0368710254183369,-0.0398658722873771,0.104668547352504,0.37955549735167
Physical measures,X4270.Volume level set by participant (left),PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,35165,-0.0461652003993168,0.0525964839756509,-0.149254308991593,0.056923908192959,0.380125608802195
Physical measures,X4270.Volume level set by participant (left),HTR1A,5-hydroxytryptamine receptor 1A,35083,-0.0279380186881995,0.0318363721107525,-0.0903373080252743,0.0344612706488754,0.380220330880946
Physical measures,X4270.Volume level set by participant (left),ICAM1,Intercellular adhesion molecule 1,36214,0.0576590177005108,0.0657110369544146,-0.0711346147301418,0.186452650131164,0.380262787191759
Physical measures,X4270.Volume level set by participant (left),VSTM2B,V-set and transmembrane domain-containing protein 2B,35195,0.0457405841056462,0.0521343121414646,-0.0564426676916244,0.147923835902917,0.380322855630071
Physical measures,X4270.Volume level set by participant (left),IGLC2,Immunoglobulin lambda constant 2,35310,0.0740104863752758,0.0844481330906295,-0.0915078544823581,0.23952882723291,0.380843088529317
Physical measures,X4270.Volume level set by participant (left),REXO2,"Oligoribonuclease, mitochondrial",35079,-0.0405536731945898,0.0462762484018426,-0.131255120062201,0.0501477736730217,0.380878368273647
Physical measures,X4270.Volume level set by participant (left),RBFOX3,RNA binding protein fox-1 homolog 3,35305,-0.0481559824543403,0.0549563542331298,-0.155870436751275,0.0595584718425941,0.38092082735421
Physical measures,X4270.Volume level set by participant (left),PRELP,Prolargin,36232,-0.0713831288843862,0.0814910483058274,-0.231105583563808,0.0883393257950355,0.381077822721636
Physical measures,X4270.Volume level set by participant (left),IL1RL1,Interleukin-1 receptor-like 1,36339,0.0339361676239858,0.0388036494982261,-0.0421189853925375,0.109991320640509,0.381839837645971
Physical measures,X4270.Volume level set by participant (left),LCP1,Plastin-2,35320,0.0394128484008025,0.0450735762899281,-0.0489313611274566,0.127757057929062,0.38192552023407
Physical measures,X4270.Volume level set by participant (left),INSL5,Insulin-like peptide INSL5,35285,0.0190854625332808,0.0218269516223088,-0.0236953626464443,0.061866287713006,0.381932480699393
Physical measures,X4270.Volume level set by participant (left),CPA4,Carboxypeptidase A4,35039,0.045120534594214,0.0516143723495638,-0.056043635210931,0.146284704399359,0.38204987290089
Physical measures,X4270.Volume level set by participant (left),CCDC80,Coiled-coil domain-containing protein 80,36258,0.0471663125834789,0.053970031420926,-0.058614949001536,0.152947574168494,0.382180935157959
Physical measures,X4270.Volume level set by participant (left),VAT1,Synaptic vesicle membrane protein VAT-1 homolog,36216,-0.0836844436954485,0.0958551312784766,-0.271560501001263,0.104191613610366,0.38267404257039
Physical measures,X4270.Volume level set by participant (left),IL32,Interleukin-32,36242,0.0376874207199826,0.0432515791751064,-0.0470856744632261,0.122460515903191,0.38358847675338
Physical measures,X4270.Volume level set by participant (left),BPIFB2,BPI fold-containing family B member 2,35304,0.0313785195287333,0.0360371247233838,-0.0392542449290989,0.102011283986566,0.383934089962845
Physical measures,X4270.Volume level set by participant (left),CALY,Neuron-specific vesicular protein calcyon,35079,-0.0531809657344174,0.0610932443804312,-0.172923724720062,0.0665617932512277,0.384065774656194
Physical measures,X4270.Volume level set by participant (left),CD302,CD302 antigen,36216,0.0545745952735946,0.06277291783425,-0.0684603236815354,0.177609514228725,0.384657355102092
Physical measures,X4270.Volume level set by participant (left),C5,Complement C5,35325,-0.12391015523236,0.142527886611499,-0.403264812990897,0.155444502526177,0.384673193641806
Physical measures,X4270.Volume level set by participant (left),MEGF10,Multiple epidermal growth factor-like domains protein 10,36232,-0.0413357944185089,0.047553461023555,-0.134540578024677,0.0518689891876588,0.384738343601052
Physical measures,X4270.Volume level set by participant (left),SCGB3A2,Secretoglobin family 3A member 2,36268,-0.0210594899870098,0.0242322215616995,-0.0685546442479409,0.0264356642739213,0.384836209342426
Physical measures,X4270.Volume level set by participant (left),UPB1,Beta-ureidopropionase,35313,0.0212873286425236,0.0245129394136459,-0.0267580326082224,0.0693326898932697,0.385199932785305
Physical measures,X4270.Volume level set by participant (left),ASRGL1,Isoaspartyl peptidase/L-asparaginase,35151,-0.0197594489610967,0.022754672784689,-0.0643586076190871,0.0248397096968937,0.385224268390252
Physical measures,X4270.Volume level set by participant (left),DGCR6,Protein DGCR6,35083,-0.0474758724236867,0.0546887551985558,-0.154665832612856,0.0597140877654827,0.38536609352137
Physical measures,X4270.Volume level set by participant (left),ARNT,Aryl hydrocarbon receptor nuclear translocator,36103,-0.0435906981860112,0.0502147116115892,-0.142011532944726,0.0548301365727035,0.385374920273575
Physical measures,X4270.Volume level set by participant (left),ACSL1,Long-chain-fatty-acid--CoA ligase 1,35079,-0.0590798761630301,0.0680893209567864,-0.192534945238331,0.0743751929122712,0.385600608985332
Physical measures,X4270.Volume level set by participant (left),GSTT2B,Glutathione S-transferase theta-2B,35301,-0.00780887395184238,0.00900419190978896,-0.0254570900950287,0.00983934219134398,0.385836811985146
Physical measures,X4270.Volume level set by participant (left),PRKAB1,5'-AMP-activated protein kinase subunit beta-1,36103,-0.0302141162182873,0.0348742249201235,-0.0985675970617294,0.0381393646251549,0.386312898645613
Physical measures,X4270.Volume level set by participant (left),ITGAV,Integrin alpha-V,36327,0.098127659242641,0.113263175484962,-0.123868164707884,0.320123483193166,0.386314966033802
Physical measures,X4270.Volume level set by participant (left),SFTPA2,Pulmonary surfactant-associated protein A2,36060,0.0324136519944325,0.037420140648343,-0.0409298236763198,0.105757127665185,0.386403582749315
Physical measures,X4270.Volume level set by participant (left),CD300A,CMRF35-like molecule 8,35165,0.0630336474364624,0.0728767723603891,-0.0798048263899002,0.205872121262825,0.387106261978831
Physical measures,X4270.Volume level set by participant (left),VPS37A,Vacuolar protein sorting-associated protein 37A,36216,-0.0204987979217354,0.0237001638762906,-0.0669511191192649,0.0259535232757941,0.387108743430752
Physical measures,X4270.Volume level set by participant (left),VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,35079,0.0563167596295417,0.065153333161644,-0.0713837733672806,0.184017292626364,0.387415223580765
Physical measures,X4270.Volume level set by participant (left),ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,36278,-0.0364732880154668,0.0422617972126952,-0.119306410552349,0.0463598345214159,0.388146779653791
Physical measures,X4270.Volume level set by participant (left),PPL,Periplakin,35093,-0.0594954904329214,0.0689445380597356,-0.194626785030003,0.0756358041641604,0.388198429863523
Physical measures,X4270.Volume level set by participant (left),LTBP3,Latent-transforming growth factor beta-binding protein 3,36060,0.0307132457456813,0.0356827040922621,-0.0392248542751525,0.100651345766515,0.389413330065114
Physical measures,X4270.Volume level set by participant (left),CSPG5,Chondroitin sulfate proteoglycan 5,35083,-0.039942275798684,0.0464228797238711,-0.130931120057471,0.0510465684601034,0.389600060476987
Physical measures,X4270.Volume level set by participant (left),AMIGO1,Amphoterin-induced protein 1,35133,-0.039058969043523,0.045413046496647,-0.128068540176951,0.049950602089905,0.389775112058585
Physical measures,X4270.Volume level set by participant (left),IGHMBP2,DNA-binding protein SMUBP-2,35079,-0.0335492834178233,0.0390223223076873,-0.11003303514089,0.0429344683052437,0.389960925986123
Physical measures,X4270.Volume level set by participant (left),SYAP1,Synapse-associated protein 1,35165,-0.0327208106789385,0.0380588129320469,-0.10731608402575,0.0418744626678733,0.389961949671231
Physical measures,X4270.Volume level set by participant (left),HMCN2,Hemicentin-2,35151,0.0331575007749323,0.0385855329531983,-0.0424701438133364,0.108785145363201,0.390192868817083
Physical measures,X4270.Volume level set by participant (left),BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",35313,-0.0617840636691367,0.0719056263372387,-0.202719091290124,0.0791509639518511,0.390239785661142
Physical measures,X4270.Volume level set by participant (left),GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,36060,-0.0138100542367302,0.0160732645291797,-0.0453136527139225,0.017693544240462,0.390261049824269
Physical measures,X4270.Volume level set by participant (left),SRP14,Signal recognition particle 14 kDa protein,36216,-0.0274270656985847,0.0319423233137325,-0.0900340193935005,0.0351798879963311,0.390564308729043
Physical measures,X4270.Volume level set by participant (left),DNAJB1,DnaJ homolog subfamily B member 1,36216,-0.0200102419108809,0.0233090392600219,-0.0656959588605238,0.025675475038762,0.390656914771789
Physical measures,X4270.Volume level set by participant (left),RPGR,X-linked retinitis pigmentosa GTPase regulator,35133,-0.0473627549744302,0.0551868574742706,-0.155528995624,0.0608034856751401,0.390799591003487
Physical measures,X4270.Volume level set by participant (left),RPL14,60S ribosomal protein L14,35151,-0.0486776933079302,0.0567384235264216,-0.159885003419717,0.0625296168038562,0.390961568232092
Physical measures,X4270.Volume level set by participant (left),KYAT1,Kynurenine--oxoglutarate transaminase 1,36238,-0.0292504452257391,0.0341071032646449,-0.0961003676244432,0.0375994771729649,0.391137160802575
Physical measures,X4270.Volume level set by participant (left),PADI2,Protein-arginine deiminase type-2,36103,-0.0282707370171476,0.0329776479952702,-0.0929069270878772,0.036365453053582,0.391323264761197
Physical measures,X4270.Volume level set by participant (left),IPCEF1,Interactor protein for cytohesin exchange factors 1,36163,-0.0183453135431152,0.0214109013619639,-0.0603106802125645,0.0236200531263342,0.391570882711105
Physical measures,X4270.Volume level set by participant (left),TXN,Thioredoxin,35204,-0.0455878483838054,0.0532548248748368,-0.149967305138486,0.0587916083708748,0.392011004600763
Physical measures,X4270.Volume level set by participant (left),TP53,Cellular tumor antigen p53,36060,0.0371256876208062,0.0433765548521308,-0.0478923598893701,0.122143735130982,0.392084493546359
Physical measures,X4270.Volume level set by participant (left),ITGB6,Integrin beta-6,36103,-0.053651860891934,0.0626877458909089,-0.176519842838116,0.0692161210542475,0.392103210812322
Physical measures,X4270.Volume level set by participant (left),ENO1,Alpha-enolase,36255,-0.0216672173191302,0.025329683657477,-0.0713133972877851,0.0279789626495247,0.392352027219833
Physical measures,X4270.Volume level set by participant (left),FTCD,Formimidoyltransferase-cyclodeaminase,35277,0.0223384730164032,0.0261435915902803,-0.0289029665005462,0.0735799125333526,0.392884651181698
Physical measures,X4270.Volume level set by participant (left),CNTF,Ciliary neurotrophic factor,35083,0.0548788735459914,0.0642670926504048,-0.0710846280488019,0.180842375140785,0.393181591099306
Physical measures,X4270.Volume level set by participant (left),CSNK1D,Casein kinase I isoform delta,35093,-0.0299774894009065,0.0351507380436082,-0.0988729359663785,0.0389179571645654,0.393786863390966
Physical measures,X4270.Volume level set by participant (left),PER3,Period circadian protein homolog 3,35093,-0.0154030004512895,0.0180647362818759,-0.0508098835637663,0.0200038826611873,0.39388172599475
Physical measures,X4270.Volume level set by participant (left),LARP1,La-related protein 1,35279,-0.0301084522093184,0.0353879701240828,-0.0994688736525206,0.0392519692338839,0.394905210308442
Physical measures,X4270.Volume level set by participant (left),THSD1,Thrombospondin type-1 domain-containing protein 1,35043,-0.0578290876416473,0.0680468726833008,-0.191200958100917,0.0755427828176222,0.395444549797264
Physical measures,X4270.Volume level set by participant (left),TBC1D17,TBC1 domain family member 17,36064,-0.0358392753389684,0.0421930841315224,-0.118537720236752,0.0468591695588154,0.395679814761339
Physical measures,X4270.Volume level set by participant (left),LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,35079,-0.0277468522788623,0.0327128555591718,-0.091864049174839,0.0363703446171145,0.396361210537006
Physical measures,X4270.Volume level set by participant (left),KLB,Beta-klotho,36064,-0.0217528701510176,0.0256676946506039,-0.0720615516662013,0.028555811364166,0.396754547804459
Physical measures,X4270.Volume level set by participant (left),CCN2,CCN family member 2,36239,-0.0280584890812174,0.0331324128589433,-0.0929980182847463,0.0368810401223115,0.397100138514365
Physical measures,X4270.Volume level set by participant (left),SPRY2,Protein sprouty homolog 2,36103,-0.017615748000547,0.0208322246453762,-0.0584469083054843,0.0232154123043903,0.397802396818788
Physical measures,X4270.Volume level set by participant (left),CASP4,Caspase-4,35195,0.0111229527207713,0.0131623987391974,-0.0146753488080556,0.0369212542495982,0.398110722327379
Physical measures,X4270.Volume level set by participant (left),CLNS1A,Methylosome subunit pICln,35133,-0.051836709204297,0.0613594228794776,-0.172101178048073,0.0684277596394792,0.398251019019039
Physical measures,X4270.Volume level set by participant (left),NTRK2,BDNF/NT-3 growth factors receptor,36258,-0.063391793651117,0.0750632234165789,-0.210515711547612,0.0837321242453776,0.398409746930921
Physical measures,X4270.Volume level set by participant (left),DDX25,ATP-dependent RNA helicase DDX25,35133,-0.0522800256806123,0.0619576495945146,-0.173717018885861,0.0691569675246364,0.398810632852533
Physical measures,X4270.Volume level set by participant (left),CDC25A,M-phase inducer phosphatase 1,35095,0.0469224446141118,0.0556285157779173,-0.062109446310606,0.15595433553883,0.39898203802585
Physical measures,X4270.Volume level set by participant (left),SLAMF1,Signaling lymphocytic activation molecule,36103,0.0262362683676038,0.0311548904312067,-0.0348273168775613,0.0872998536127689,0.399745626456435
Physical measures,X4270.Volume level set by participant (left),GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,35195,0.0264610356014946,0.0314551490361032,-0.0351910565092677,0.088113127712257,0.400249244626876
Physical measures,X4270.Volume level set by participant (left),IL9,Interleukin-9,35195,0.0333641182678925,0.0397163541294111,-0.0444799358257533,0.111208172361538,0.40090524327647
Physical measures,X4270.Volume level set by participant (left),CD3G,T-cell surface glycoprotein CD3 gamma chain,35093,0.0213724306972018,0.0254662716690642,-0.0285414617741641,0.0712863231685676,0.401362982028222
Physical measures,X4270.Volume level set by participant (left),TAGLN3,Transgelin-3,35095,-0.0313208199796735,0.0373372862052389,-0.104501900941942,0.0418602609825948,0.401577799438467
Physical measures,X4270.Volume level set by participant (left),OXT,Oxytocin-neurophysin 1,36325,0.0107447009768547,0.0128748177370619,-0.0144899417877866,0.0359793437414959,0.403995985680534
Physical measures,X4270.Volume level set by participant (left),GLYR1,Putative oxidoreductase GLYR1,35279,-0.0318239742226659,0.0381767498772882,-0.106650403982151,0.043002455536819,0.404538677293786
Physical measures,X4270.Volume level set by participant (left),AGRP,Agouti-related protein,36342,-0.0297592010383117,0.0357056456255797,-0.0997422664644479,0.0402238643878244,0.40461148639075
Physical measures,X4270.Volume level set by participant (left),PKD2,Polycystin-2,35079,-0.0309119078141268,0.0371086693934106,-0.103644899825212,0.0418210841969578,0.404869579482026
Physical measures,X4270.Volume level set by participant (left),VASH1,Tubulinyl-Tyr carboxypeptidase 1,36242,-0.019299795217856,0.023173867708246,-0.0647205759260182,0.0261209854903061,0.404969010885812
Physical measures,X4270.Volume level set by participant (left),OBP2B,Odorant-binding protein 2b,36149,-0.0273848341984357,0.0328894940971978,-0.0918482426289433,0.037078574232072,0.405078845888429
Physical measures,X4270.Volume level set by participant (left),PTPRH,Receptor-type tyrosine-protein phosphatase H,35285,-0.0368192480775138,0.044227334005149,-0.123504822727606,0.0498663265725782,0.405156625871772
Physical measures,X4270.Volume level set by participant (left),EFNA1,Ephrin-A1,36238,0.0550790401713087,0.0661640658648724,-0.0746025289238413,0.184760609266459,0.40517451550108
Physical measures,X4270.Volume level set by participant (left),ALDH1A1,Retinal dehydrogenase 1,36256,-0.0291944652299703,0.0350787005919018,-0.0979487183900978,0.0395597879301572,0.405290329973413
Physical measures,X4270.Volume level set by participant (left),MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",35095,-0.0365522300271391,0.0439443147412533,-0.122683086919996,0.0495786268657174,0.405560800284405
Physical measures,X4270.Volume level set by participant (left),SESTD1,SEC14 domain and spectrin repeat-containing protein 1,36064,-0.0250690647759152,0.0301776255447279,-0.084217210843582,0.0340790812917515,0.406160135468027
Physical measures,X4270.Volume level set by participant (left),RABEP1,Rab GTPase-binding effector protein 1,35165,-0.0248813697265514,0.0299870333560548,-0.0836559551044189,0.033893215651316,0.406717328947243
Physical measures,X4270.Volume level set by participant (left),MMP8,Neutrophil collagenase,36318,-0.0211388183851785,0.0254873234849184,-0.0710939724156185,0.0288163356452615,0.406911922767702
Physical measures,X4270.Volume level set by participant (left),PFDN6,Prefoldin subunit 6,35133,-0.0291688927409663,0.0352043223261264,-0.098169364500174,0.0398315790182414,0.40738372180976
Physical measures,X4270.Volume level set by participant (left),BRD3,Bromodomain-containing protein 3,35079,0.0393517693980809,0.047564864923037,-0.0538753658510717,0.132578904647233,0.408081365616451
Physical measures,X4270.Volume level set by participant (left),NELL2,Protein kinase C-binding protein NELL2,36278,-0.0531075954262705,0.0642455239769921,-0.179028822421175,0.072813631568634,0.408469699634826
Physical measures,X4270.Volume level set by participant (left),CASP7,Caspase-7,35301,-0.0217602979539253,0.0263417222286231,-0.0733900735220264,0.0298694776141759,0.408789684540722
Physical measures,X4270.Volume level set by participant (left),TXNRD1,"Thioredoxin reductase 1, cytoplasmic",36256,-0.0342743159480867,0.0414980253517025,-0.115610445637424,0.0470618137412501,0.40887157283131
Physical measures,X4270.Volume level set by participant (left),CPB2,Carboxypeptidase B2,35317,0.0802246260580757,0.0971638027458035,-0.110216427323699,0.270665679439851,0.40902421901148
Physical measures,X4270.Volume level set by participant (left),HNRNPK,Heterogeneous nuclear ribonucleoprotein K,36085,-0.0205334142541907,0.0248862933520731,-0.069310549224254,0.0282437207158725,0.409347201051735
Physical measures,X4270.Volume level set by participant (left),DNAJA2,DnaJ homolog subfamily A member 2,36318,-0.0197474620072931,0.0239444568374696,-0.0666785974087334,0.0271836733941473,0.409556319114974
Physical measures,X4270.Volume level set by participant (left),C9,Complement component C9,35317,0.0312994165008818,0.0379611204438387,-0.0431043795690421,0.105703212570806,0.409677733748865
Physical measures,X4270.Volume level set by participant (left),GNAS,Neuroendocrine secretory protein 55,35305,0.0197125858562485,0.0239154915267478,-0.0271617775361772,0.0665869492486743,0.409821107260685
Physical measures,X4270.Volume level set by participant (left),IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,35195,-0.0471691694666186,0.0573528559640875,-0.15958076715623,0.0652424282229928,0.410857394121271
Physical measures,X4270.Volume level set by participant (left),AK2,"Adenylate kinase 2, mitochondrial",35301,-0.0170815062263946,0.0207724239931563,-0.057795457252981,0.0236324448001918,0.410926081291352
Physical measures,X4270.Volume level set by participant (left),GLP1R,Glucagon-like peptide 1 receptor,35083,0.0510082778961276,0.0620767276879384,-0.0706621083722316,0.172678664164487,0.411279442135522
Physical measures,X4270.Volume level set by participant (left),GALNT7,N-acetylgalactosaminyltransferase 7,36216,-0.0738925454608344,0.0899686432763579,-0.250231086282496,0.102445995360827,0.411492905633253
Physical measures,X4270.Volume level set by participant (left),STC2,Stanniocalcin-2,36244,-0.0630156713562224,0.07673147456721,-0.213409361507954,0.0873780187955091,0.411529890271787
Physical measures,X4270.Volume level set by participant (left),DNM1,Dynamin-1,35285,-0.0158098377675959,0.0192602748935675,-0.0535599765589881,0.0219403010237963,0.411759780890741
Physical measures,X4270.Volume level set by participant (left),RHOC,Rho-related GTP-binding protein RhoC,36147,-0.0136909264499409,0.016733020261275,-0.0464876461620399,0.019105793262158,0.413269885720381
Physical measures,X4270.Volume level set by participant (left),ARHGEF5,Rho guanine nucleotide exchange factor 5,35083,0.0261689233666577,0.0320058277230951,-0.0365624989706086,0.088900345703924,0.413598581240726
Physical measures,X4270.Volume level set by participant (left),MEGF9,Multiple epidermal growth factor-like domains protein 9,36339,0.0749853899197916,0.0918540272527426,-0.105048503495584,0.255019283335167,0.414322912977484
Physical measures,X4270.Volume level set by participant (left),FAM171B,Protein FAM171B,35279,-0.0659023268725394,0.0808576319826445,-0.224383285558523,0.0925786318134439,0.415077621312279
Physical measures,X4270.Volume level set by participant (left),RAC3,Ras-related C3 botulinum toxin substrate 3,35133,0.0269691110549427,0.0330895823889618,-0.0378864704274224,0.0918246925373078,0.415082981424686
Physical measures,X4270.Volume level set by participant (left),ECHS1,"Enoyl-CoA hydratase, mitochondrial",35151,0.0193846749788182,0.0237851110252603,-0.027234142630692,0.0660034925883284,0.415106535424153
Physical measures,X4270.Volume level set by participant (left),NEO1,Neogenin,35305,-0.0756956202338542,0.0929388937282557,-0.257855851941235,0.106464611473527,0.415406665103847
Physical measures,X4270.Volume level set by participant (left),CREBZF,CREB/ATF bZIP transcription factor,35095,-0.0696962372303689,0.0855953270426652,-0.237463078233993,0.098070603773255,0.415529991995133
Physical measures,X4270.Volume level set by participant (left),PHACTR2,Phosphatase and actin regulator 2,35305,-0.0157887326506766,0.0193929295895624,-0.0537988746462188,0.0222214093448657,0.415588570211003
Physical measures,X4270.Volume level set by participant (left),NRTN,Neurturin,36103,0.029550556746929,0.0362985839908503,-0.0415946678751376,0.100695781368996,0.415615413296237
Physical measures,X4270.Volume level set by participant (left),FH,"Fumarate hydratase, mitochondrial",35083,0.0226738734296694,0.0278524268298267,-0.031916883156791,0.0772646300161299,0.415633770424579
Physical measures,X4270.Volume level set by participant (left),LPCAT2,Lysophosphatidylcholine acyltransferase 2,36216,0.03614358220628,0.0444288212825881,-0.0509369075075927,0.123224071920153,0.415947393063733
Physical measures,X4270.Volume level set by participant (left),COMT,Catechol O-methyltransferase,36047,-0.0194464869419222,0.0239136687189661,-0.0663172776310956,0.0274243037472513,0.416132007230693
Physical measures,X4270.Volume level set by participant (left),F11R,Junctional adhesion molecule A,36256,0.026834688513623,0.0330320990912601,-0.0379082257052468,0.0915776027324929,0.41659763981233
Physical measures,X4270.Volume level set by participant (left),SLC51B,Organic solute transporter subunit beta,35079,-0.0255801141297483,0.0314999231654064,-0.0873199635339449,0.0361597352744482,0.416781833103471
Physical measures,X4270.Volume level set by participant (left),KLRD1,Natural killer cells antigen CD94,36342,-0.0317869426985316,0.0391994143758754,-0.108617794875247,0.0450439094781843,0.41744602101625
Physical measures,X4270.Volume level set by participant (left),MRPS16,"28S ribosomal protein S16, mitochondrial",35093,-0.0616116343052053,0.0759939036382402,-0.210559685436156,0.0873364168257454,0.417542179741176
Physical measures,X4270.Volume level set by participant (left),PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,35296,-0.023619105085752,0.0291539317615271,-0.080760811338345,0.0335226011668411,0.417881841655966
Physical measures,X4270.Volume level set by participant (left),S100A13,Protein S100-A13,35093,-0.0502526322114011,0.0620830002012907,-0.171935312605931,0.0714300481831286,0.418290215484485
Physical measures,X4270.Volume level set by participant (left),TYRO3,Tyrosine-protein kinase receptor TYRO3,36258,0.0540692712716068,0.0668238136952826,-0.0769054035711472,0.185043946114361,0.418464497961058
Physical measures,X4270.Volume level set by participant (left),BAX,Apoptosis regulator BAX,36053,-0.0172310501104524,0.0213300176722162,-0.0590378847479961,0.0245757845270912,0.419213652682191
Physical measures,X4270.Volume level set by participant (left),AHSP,Alpha-hemoglobin-stabilizing protein,36237,-0.0182335558171279,0.0225973999023684,-0.0625244596257699,0.0260573479915142,0.419756532520514
Physical measures,X4270.Volume level set by participant (left),PSAP,Prosaposin,35245,-0.0637223463342724,0.0790789980057816,-0.218717182425604,0.0912724897570595,0.420383453877512
Physical measures,X4270.Volume level set by participant (left),GFRA3,GDNF family receptor alpha-3,36162,-0.0552709172114506,0.0686631564371298,-0.189850703828225,0.0793088694053238,0.420869569381054
Physical measures,X4270.Volume level set by participant (left),SDC1,Syndecan-1,36258,0.0379110626142972,0.0471326864019136,-0.0544690027334536,0.130291127962048,0.421221239981736
Physical measures,X4270.Volume level set by participant (left),SLAMF7,SLAM family member 7,36242,0.0253454487926272,0.031515112010699,-0.0364241707483428,0.0871150683335971,0.421288261733337
Physical measures,X4270.Volume level set by participant (left),STX7,Syntaxin-7,35093,-0.036033161463986,0.0448070131717768,-0.123854907280669,0.0517885843526966,0.421319162987117
Physical measures,X4270.Volume level set by participant (left),NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,35285,0.0497813381164336,0.0619379089615355,-0.071616963448176,0.171179639681043,0.421581677612182
Physical measures,X4270.Volume level set by participant (left),AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,35320,-0.0685053058930208,0.0852951594773173,-0.235683818468563,0.098673206682521,0.421913081432525
Physical measures,X4270.Volume level set by participant (left),ADAMTSL5,ADAMTS-like protein 5,35313,-0.0434907434126902,0.0541563855284179,-0.149637259048389,0.0626557722230089,0.421969391670091
Physical measures,X4270.Volume level set by participant (left),KIF20B,Kinesin-like protein KIF20B,35083,0.0241315227274181,0.0300507164134418,-0.0347678814429277,0.083030926897764,0.421988849064751
Physical measures,X4270.Volume level set by participant (left),METAP1D,"Methionine aminopeptidase 1D, mitochondrial",36242,-0.0188906418161004,0.0235277152203656,-0.0650049636480171,0.0272236800158162,0.422051637489267
Physical measures,X4270.Volume level set by participant (left),SEZ6L,Seizure 6-like protein,36289,-0.0550966170425702,0.0686360033087994,-0.189623183527817,0.0794299494426767,0.422151940009269
Physical measures,X4270.Volume level set by participant (left),NFKB2,Nuclear factor NF-kappa-B p100 subunit,35195,0.0328858388881213,0.0409687870864916,-0.0474129838014023,0.113184661577645,0.422174361196399
Physical measures,X4270.Volume level set by participant (left),SIGLEC15,Sialic acid-binding Ig-like lectin 15,36064,-0.020858391459929,0.0259944176904569,-0.0718074501332245,0.0300906672133664,0.422336699758036
Physical measures,X4270.Volume level set by participant (left),NUMB,Protein numb homolog,35093,-0.0221613753901773,0.0276210306455196,-0.0762985954553957,0.0319758446750411,0.422387412225386
Physical measures,X4270.Volume level set by participant (left),CSF3R,Granulocyte colony-stimulating factor receptor,35093,0.0569078585433707,0.0709759618323314,-0.0822050266479989,0.19602074373474,0.422703456338671
Physical measures,X4270.Volume level set by participant (left),SPRR1B,Cornifin-B,35195,-0.0206463275406148,0.0257577541111766,-0.0711315255985211,0.0298388705172914,0.422837714774778
Physical measures,X4270.Volume level set by participant (left),ICAM5,Intercellular adhesion molecule 5,36258,0.0321874182328444,0.0401878677840731,-0.0465808026239389,0.110955639089628,0.423200640447375
Physical measures,X4270.Volume level set by participant (left),CYB5R2,NADH-cytochrome b5 reductase 2,35223,-0.0315154718555963,0.0393533076974943,-0.108647954942685,0.0456170112314925,0.423256418551188
Physical measures,X4270.Volume level set by participant (left),GRPEL1,"GrpE protein homolog 1, mitochondrial",36216,0.0249251636424175,0.0311592173255033,-0.0361469023155689,0.085997229600404,0.423776854779869
Physical measures,X4270.Volume level set by participant (left),FCRL2,Fc receptor-like protein 2,36303,0.0297552872369177,0.0372271827409953,-0.0432099909354331,0.102720565409268,0.424147361188804
Physical measures,X4270.Volume level set by participant (left),TRIM40,E3 ubiquitin ligase TRIM40,35133,0.0242517052393975,0.0303425255026342,-0.0352196447457655,0.0837230552245606,0.424166095872571
Physical measures,X4270.Volume level set by participant (left),ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",35305,-0.0369770729887533,0.0463304128146283,-0.127784682105425,0.0538305361279182,0.424831089490772
Physical measures,X4270.Volume level set by participant (left),SUSD5,Sushi domain-containing protein 5,35122,0.0504921966319449,0.0633094190964521,-0.0735942647971013,0.174578658060991,0.425162838993882
Physical measures,X4270.Volume level set by participant (left),MATN2,Matrilin-2,36248,0.0503643036822967,0.0631733685123772,-0.0734554986019625,0.174184105966556,0.42533671837446
Physical measures,X4270.Volume level set by participant (left),ERBIN,Erbin,36216,-0.0149921304127095,0.0188100512873118,-0.0518598309358407,0.0218755701104217,0.425459846226238
Physical measures,X4270.Volume level set by participant (left),SMARCA2,Probable global transcription activator SNF2L2,36064,-0.0217427688580424,0.0273453899686904,-0.0753397331966757,0.0318541954805908,0.426571070677972
Physical measures,X4270.Volume level set by participant (left),B4GAT1,"Beta-1,4-glucuronyltransferase 1",36256,-0.0615797294638389,0.077458176562438,-0.213397755526217,0.0902382965985395,0.426634558473598
Physical measures,X4270.Volume level set by participant (left),RCC1,Regulator of chromosome condensation,35279,-0.033383379925921,0.0419960261095119,-0.115695591100564,0.0489288312487222,0.426689699171903
Physical measures,X4270.Volume level set by participant (left),TFAP2A,Transcription factor AP-2-alpha,35083,0.0306751002631552,0.0386202692008591,-0.0450206273705287,0.106370827896839,0.427064652939157
Physical measures,X4270.Volume level set by participant (left),GLOD4,Glyoxalase domain-containing protein 4,36237,-0.0462685234994394,0.0583552072090369,-0.160644729629152,0.0681076826302729,0.427873910420975
Physical measures,X4270.Volume level set by participant (left),LMNB1,Lamin-B1,35274,-0.0293660053974576,0.0370441699800754,-0.101972578558405,0.0432405677634901,0.427963644782307
Physical measures,X4270.Volume level set by participant (left),CA5A,"Carbonic anhydrase 5A, mitochondrial",36109,0.0168677496405673,0.0213279410923954,-0.0249350149005277,0.0586705141816623,0.429041536811381
Physical measures,X4270.Volume level set by participant (left),IL1B,Interleukin-1 beta,36059,-0.0250400497240204,0.031663868019765,-0.0871012310427598,0.037021131594719,0.429081017132567
Physical measures,X4270.Volume level set by participant (left),ICAM4,Intercellular adhesion molecule 4,36242,0.0281946186452534,0.0357160795397295,-0.0418088972526164,0.0981981345431232,0.429897105244991
Physical measures,X4270.Volume level set by participant (left),NAA10,N-alpha-acetyltransferase 10,35079,-0.0350144984588578,0.0443886832995317,-0.12201631772594,0.0519873208082242,0.430248500033649
Physical measures,X4270.Volume level set by participant (left),ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,36109,0.0187084124042937,0.0237194330906831,-0.0277816764534451,0.0651985012620325,0.430290206971272
Physical measures,X4270.Volume level set by participant (left),PEBP1,Phosphatidylethanolamine-binding protein 1,36256,-0.0268408006019315,0.0340364722796963,-0.0935522862701361,0.0398706850662732,0.4303764662709
Physical measures,X4270.Volume level set by participant (left),CD200R1,Cell surface glycoprotein CD200 receptor 1,36210,0.0411848423374079,0.0522890395488641,-0.0613016751783657,0.143671359853182,0.430932933900909
Physical measures,X4270.Volume level set by participant (left),MMP15,Matrix metalloproteinase-15,35313,-0.035138918191656,0.0446249155430435,-0.122603752656021,0.0523259162727093,0.43105904001917
Physical measures,X4270.Volume level set by participant (left),RBM25,RNA-binding protein 25,35095,-0.0395831121860718,0.0502734060175028,-0.138118987980377,0.0589527636082338,0.43110172387102
Physical measures,X4270.Volume level set by participant (left),LIPF,Gastric triacylglycerol lipase,35151,-0.0288596997527385,0.0366569191311322,-0.100707261249758,0.0429878617442806,0.431139437516077
Physical measures,X4270.Volume level set by participant (left),ROBO1,Roundabout homolog 1,36248,0.0625543629661249,0.0795069703395141,-0.0932792988993227,0.218388024831573,0.431436017145602
Physical measures,X4270.Volume level set by participant (left),STEAP4,Metalloreductase STEAP4,35083,0.0244433361993967,0.0310688744452668,-0.0364516577133263,0.0853383301121197,0.431458898440764
Physical measures,X4270.Volume level set by participant (left),SMTN,Smoothelin,35278,0.017118337582923,0.0217914880790149,-0.0255929790519461,0.0598296542177921,0.432158131198093
Physical measures,X4270.Volume level set by participant (left),GNPDA2,Glucosamine-6-phosphate isomerase 2,35165,-0.0464311295031287,0.0591331323310646,-0.162332068872015,0.0694698098657578,0.432366705196152
Physical measures,X4270.Volume level set by participant (left),GIMAP8,GTPase IMAP family member 8,35095,-0.0373503719314312,0.0476219277571179,-0.130689350335382,0.0559886064725198,0.432886630311299
Physical measures,X4270.Volume level set by participant (left),ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,35079,-0.0432534151434803,0.055183711926093,-0.151413490518622,0.064906660231662,0.433181654515404
Physical measures,X4270.Volume level set by participant (left),CDH17,Cadherin-17,36258,0.0217358025029112,0.0277339494057089,-0.0326227383322784,0.0760943433381007,0.433225462618252
Physical measures,X4270.Volume level set by participant (left),GAS2,Growth arrest-specific protein 2,35195,-0.0329208659275375,0.0420512935679414,-0.115341401320703,0.0494996694656276,0.433729208368525
Physical measures,X4270.Volume level set by participant (left),PTPRN2,Receptor-type tyrosine-protein phosphatase N2,36154,-0.0439431694904834,0.0562115956169577,-0.15411789689972,0.0662315579187537,0.434388587400667
Physical measures,X4270.Volume level set by participant (left),AHCY,Adenosylhomocysteinase,36258,-0.0222193517015642,0.0284836829514228,-0.0780473702863529,0.0336086668832246,0.435372032522016
Physical measures,X4270.Volume level set by participant (left),RBP1,Retinol-binding protein 1,35133,-0.0244389774000367,0.0313427101306299,-0.0858706892560713,0.036992734455998,0.435575708479879
Physical measures,X4270.Volume level set by participant (left),MN1,Transcriptional activator MN1,35133,0.0311815503619366,0.0400267204868469,-0.0472708217922834,0.109633922516157,0.435997125786628
Physical measures,X4270.Volume level set by participant (left),RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,35095,-0.0406059842528305,0.0521490510686079,-0.142818124347302,0.0616061558416409,0.436212876747392
Physical measures,X4270.Volume level set by participant (left),MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",35305,0.0243808601650929,0.031347273912094,-0.0370597967026114,0.0858215170327972,0.436734122407701
Physical measures,X4270.Volume level set by participant (left),TGFB1,Transforming growth factor beta-1 proprotein,36328,-0.0361819743476232,0.0465293370285673,-0.127379474923615,0.0550155262283687,0.436819018432217
Physical measures,X4270.Volume level set by participant (left),NRCAM,Neuronal cell adhesion molecule,36258,-0.0506878370761486,0.065238809988455,-0.17855590465352,0.0771802305012232,0.437207361193455
Physical measures,X4270.Volume level set by participant (left),NGF,Beta-nerve growth factor,36179,0.121818708349079,0.156984949186899,-0.185871792057243,0.429509208755402,0.437779272971315
Physical measures,X4270.Volume level set by participant (left),SWAP70,Switch-associated protein 70,35285,-0.0480966045574799,0.062021792483495,-0.16965931782513,0.0734661087101704,0.438084046867837
Physical measures,X4270.Volume level set by participant (left),RAD23B,UV excision repair protein RAD23 homolog B,36060,-0.0331805853051174,0.0427912990351367,-0.117051531413985,0.0506903608037505,0.438124996590523
Physical measures,X4270.Volume level set by participant (left),IL1R1,Interleukin-1 receptor type 1,36238,0.0622102923788861,0.0804063424796631,-0.0953861388812535,0.219806723639026,0.439132871900007
Physical measures,X4270.Volume level set by participant (left),TMPRSS5,Transmembrane protease serine 5,36135,0.0390170047931654,0.0504597714339983,-0.0598841472174713,0.137918156803802,0.439410589819857
Physical measures,X4270.Volume level set by participant (left),CEBPA,CCAAT/enhancer-binding protein alpha,35093,0.0464677622632154,0.0601229294266305,-0.0713731794129804,0.164308703939411,0.439622015271252
Physical measures,X4270.Volume level set by participant (left),SUMF1,Formylglycine-generating enzyme,35093,0.0267104458674592,0.0345677929472737,-0.0410424283091973,0.0944633200441157,0.439729587829871
Physical measures,X4270.Volume level set by participant (left),CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,35317,-0.0469761801044833,0.0609390427929777,-0.16641670397872,0.072464343769753,0.440810142003233
Physical measures,X4270.Volume level set by participant (left),TDRKH,Tudor and KH domain-containing protein,36064,-0.0163713457612365,0.0212377061455443,-0.0579972498065034,0.0252545582840304,0.440812999710619
Physical measures,X4270.Volume level set by participant (left),DNLZ,DNL-type zinc finger protein,35083,0.0207030661229355,0.0268861957455054,-0.0319938775382551,0.073400009784126,0.441312620165836
Physical measures,X4270.Volume level set by participant (left),PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,35305,-0.0436511073908641,0.0567016253339905,-0.154786293045485,0.0674840782637573,0.441422693208512
Physical measures,X4270.Volume level set by participant (left),MAPK9,Mitogen-activated protein kinase 9,36242,-0.0329617458896347,0.0428393669103545,-0.116926905033929,0.05100341325466,0.441663927659545
Physical measures,X4270.Volume level set by participant (left),SRPK2,SRSF protein kinase 2,36242,-0.0169294876448641,0.0220069080993544,-0.0600630275195988,0.0262040522298705,0.44175053126456
Physical measures,X4270.Volume level set by participant (left),TP73,Tumor protein p73,35133,-0.0502418392346588,0.0653283921438973,-0.178285487836697,0.0778018093673799,0.441882000368189
Physical measures,X4270.Volume level set by participant (left),SAFB2,Scaffold attachment factor B2,35305,-0.0610824457002199,0.0794712241199494,-0.216846044975321,0.0946811535748809,0.442151440863461
Physical measures,X4270.Volume level set by participant (left),IL31RA,Interleukin-31 receptor subunit alpha,35074,0.0458418771940255,0.0596468196515345,-0.0710658893229822,0.162749643711033,0.442185418904374
Physical measures,X4270.Volume level set by participant (left),MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,36148,-0.0306172255660259,0.0398398554763041,-0.108703342299582,0.0474688911675302,0.44220982202155
Physical measures,X4270.Volume level set by participant (left),NBN,Nibrin,36103,-0.0269099421481927,0.0350226398637206,-0.0955543162810851,0.0417344319846996,0.442298435460056
Physical measures,X4270.Volume level set by participant (left),SLK,STE20-like serine/threonine-protein kinase,35195,0.0214331536335245,0.0279145588420066,-0.0332793816968084,0.0761456889638574,0.442625952096539
Physical measures,X4270.Volume level set by participant (left),CDKN2D,Cyclin-dependent kinase 4 inhibitor D,36216,-0.0162692649794694,0.0211922124506291,-0.0578060013827024,0.0252674714237636,0.442689147995843
Physical measures,X4270.Volume level set by participant (left),CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,35083,-0.0556445548019778,0.0725561662273424,-0.197854640607569,0.0865655310036133,0.443158825605201
Physical measures,X4270.Volume level set by participant (left),MAEA,E3 ubiquitin-protein transferase MAEA,36060,-0.037245585639136,0.0485662980751239,-0.132435529866379,0.0579443585881068,0.443164130023635
Physical measures,X4270.Volume level set by participant (left),PLIN1,Perilipin-1,36064,0.0432400773322476,0.0563874606517417,-0.067279345545166,0.153759500209661,0.443201789011323
Physical measures,X4270.Volume level set by participant (left),RFC4,Replication factor C subunit 4,35279,-0.0772899342837632,0.100802670040456,-0.274863167563056,0.12028329899553,0.44326030778079
Physical measures,X4270.Volume level set by participant (left),ENG,Endoglin,36364,0.0824683133771758,0.107583622870977,-0.128395587449939,0.29333221420429,0.443371945770249
Physical measures,X4270.Volume level set by participant (left),CLC,Galectin-10,36248,-0.0200542317856771,0.0261984978223782,-0.0714032875175385,0.0312948239461842,0.444013817165459
Physical measures,X4270.Volume level set by participant (left),TIMP1,Metalloproteinase inhibitor 1,36172,0.0501977605270126,0.0656169567925917,-0.0784114747864671,0.178806995840492,0.444288239526325
Physical measures,X4270.Volume level set by participant (left),UBE2Z,Ubiquitin-conjugating enzyme E2 Z,35093,-0.0299072553903827,0.0391061046605728,-0.106555220525105,0.0467407097443399,0.44443510698681
Physical measures,X4270.Volume level set by participant (left),TPPP2,Tubulin polymerization-promoting protein family member 2,35195,0.0221427461609142,0.0289669873807125,-0.0346325491052824,0.0789180414271107,0.444648434246374
Physical measures,X4270.Volume level set by participant (left),CEMIP2,Cell surface hyaluronidase,35093,0.0567108290570858,0.0741970475695938,-0.088715384179318,0.20213704229349,0.4447000081164
Physical measures,X4270.Volume level set by participant (left),NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",36060,0.0187390478389588,0.0245218066659266,-0.0293236932262573,0.0668017889041749,0.44478480334302
Physical measures,X4270.Volume level set by participant (left),RIDA,2-iminobutanoate/2-iminopropanoate deaminase,35165,0.0338638894418872,0.0443346240517481,-0.0530319736995392,0.120759752583314,0.444999062785314
Physical measures,X4270.Volume level set by participant (left),MSTN,Growth/differentiation factor 8,36109,-0.0267486508872202,0.0350315297519196,-0.0954104492009825,0.0419131474265422,0.445153900566089
Physical measures,X4270.Volume level set by participant (left),MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,36242,-0.014957734908524,0.0195936240022795,-0.0533612379529919,0.0234457681359438,0.445249600852536
Physical measures,X4270.Volume level set by participant (left),RNASE1,Ribonuclease pancreatic,35317,0.0674481080582562,0.0884798077754507,-0.105972315181627,0.24086853129814,0.445908085621354
Physical measures,X4270.Volume level set by participant (left),KRT6C,"Keratin, type II cytoskeletal 6C",35079,0.043346208683675,0.0568652317680578,-0.0681096455817184,0.154802062949068,0.445931374322748
Physical measures,X4270.Volume level set by participant (left),HTR1B,5-hydroxytryptamine receptor 1B,35083,-0.0403382454745943,0.0529195287043624,-0.144060521735145,0.063384030785956,0.445934778806255
Physical measures,X4270.Volume level set by participant (left),CADPS,Calcium-dependent secretion activator 1,35133,0.0413659225510811,0.0542925484907885,-0.0650474724908644,0.147779317593027,0.446142480992682
Physical measures,X4270.Volume level set by participant (left),NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",35285,-0.0164228052125889,0.0215621235420776,-0.058684567355061,0.0258389569298832,0.446295422291895
Physical measures,X4270.Volume level set by participant (left),BHLHE40,Class E basic helix-loop-helix protein 40,35083,-0.0244422737587516,0.0321146104416845,-0.0873869102244532,0.0385023627069501,0.446627941179907
Physical measures,X4270.Volume level set by participant (left),LYPLA2,Acyl-protein thioesterase 2,35083,-0.0153877856019356,0.020223074839068,-0.0550250122865088,0.0242494410826376,0.44674306884184
Physical measures,X4270.Volume level set by participant (left),MANSC4,MANSC domain-containing protein 4,35079,-0.0243929720866592,0.0321006370267486,-0.0873102206590864,0.038524276485768,0.447347646792867
Physical measures,X4270.Volume level set by participant (left),CLEC7A,C-type lectin domain family 7 member A,36342,-0.0231773025214871,0.0305017026919015,-0.082960639797614,0.0366060347546397,0.447355957470522
Physical measures,X4270.Volume level set by participant (left),TNNI3,"Troponin I, cardiac muscle",36109,0.0175017800529924,0.0230529713320948,-0.0276820437579133,0.0626856038638982,0.447757695028703
Physical measures,X4270.Volume level set by participant (left),PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",35165,-0.0170646221326758,0.0224808117393472,-0.0611270131417963,0.0269977688764446,0.447834959191577
Physical measures,X4270.Volume level set by participant (left),F11,Coagulation factor XI,35224,-0.0529594810190873,0.0697742869766021,-0.189717083493227,0.0837981214550529,0.447872741577209
Physical measures,X4270.Volume level set by participant (left),HAVCR2,Hepatitis A virus cellular receptor 2,36256,0.0415987675747631,0.0548403312027509,-0.0658882815826286,0.149085816732155,0.448149141636675
Physical measures,X4270.Volume level set by participant (left),HCG22,Protein PBMUCL2,35079,-0.0304485134821921,0.0401947062102643,-0.10923013765431,0.048333110689926,0.448762677971314
Physical measures,X4270.Volume level set by participant (left),SPESP1,Sperm equatorial segment protein 1,35313,0.0493078937424913,0.0650931578630604,-0.0782746956691071,0.17689048315409,0.448778560335005
Physical measures,X4270.Volume level set by participant (left),PTP4A3,Protein tyrosine phosphatase type IVA 3,35093,0.0338813645233387,0.0447344918482141,-0.0537982394991608,0.121560968545838,0.448844977333852
Physical measures,X4270.Volume level set by participant (left),PKD1,Polycystin-1,35313,-0.0623664554162318,0.0824190085013486,-0.223907712078875,0.0991748012464115,0.449256242605732
Physical measures,X4270.Volume level set by participant (left),WASF1,Wiskott-Aldrich syndrome protein family member 1,36109,-0.0148500869327826,0.0196482656425374,-0.053360687592156,0.0236605137265907,0.449795038657386
Physical measures,X4270.Volume level set by participant (left),CCL24,C-C motif chemokine 24,36268,0.0171608138647943,0.022725419979897,-0.0273810092958039,0.0617026370253924,0.450189764808428
Physical measures,X4270.Volume level set by participant (left),CTSV,Cathepsin L2,36326,0.0355198577130591,0.047042326330051,-0.0566831018938409,0.127722817319959,0.450235002204868
Physical measures,X4270.Volume level set by participant (left),NFYA,Nuclear transcription factor Y subunit alpha,35079,-0.0459547565329149,0.0608778195310194,-0.165275282813713,0.0733657697478832,0.450355257092943
Physical measures,X4270.Volume level set by participant (left),EP300,Histone acetyltransferase p300,35093,-0.0543000164112259,0.0719505158972365,-0.195323027569809,0.0867229947473576,0.450465047510988
Physical measures,X4270.Volume level set by participant (left),S100A12,Protein S100-A12,36143,0.0199879043691731,0.0265029797718692,-0.0319579359836905,0.0719337447220366,0.450767254864469
Physical measures,X4270.Volume level set by participant (left),MAPKAPK2,MAP kinase-activated protein kinase 2,35195,-0.0229388702728451,0.0304282376835548,-0.0825782161326125,0.0367004755869222,0.450955500191981
Physical measures,X4270.Volume level set by participant (left),CDKL5,Cyclin-dependent kinase-like 5,35083,-0.0337536275869165,0.0447991923645338,-0.121560044621403,0.0540527894475698,0.45121126310361
Physical measures,X4270.Volume level set by participant (left),PPIB,Peptidyl-prolyl cis-trans isomerase B,36266,-0.0150785424218399,0.0200233866530493,-0.0543243802618165,0.0241672954181368,0.451445069832917
Physical measures,X4270.Volume level set by participant (left),IL13RA2,Interleukin-13 receptor subunit alpha-2,35083,-0.0592217931747788,0.0786667965788785,-0.213408714469381,0.0949651281198231,0.451586538773802
Physical measures,X4270.Volume level set by participant (left),MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,35279,-0.0152564120687597,0.020292561605276,-0.0550298328151008,0.0245170086775813,0.452184085596749
Physical measures,X4270.Volume level set by participant (left),ADGRF5,Adhesion G protein-coupled receptor F5,35313,-0.0608590318155951,0.0809576900519287,-0.219536104317375,0.097818040686185,0.452234555120743
Physical measures,X4270.Volume level set by participant (left),MRPL24,"39S ribosomal protein L24, mitochondrial",35079,-0.0429808616139513,0.0571941794485272,-0.155081453333065,0.069119730105162,0.452385043992084
Physical measures,X4270.Volume level set by participant (left),JAM2,Junctional adhesion molecule B,36325,0.0540550856292148,0.0719939558166885,-0.0870530677714945,0.195163239029924,0.452778989673252
Physical measures,X4270.Volume level set by participant (left),ZNF830,Zinc finger protein 830,35279,-0.0211475969306031,0.0281837361946745,-0.0763877198721652,0.034092526010959,0.453071865049968
Physical measures,X4270.Volume level set by participant (left),B2M,Beta-2-microglobulin,35325,-0.0533765427286424,0.0711532956426933,-0.192837002188321,0.0860839167310366,0.453183023479977
Physical measures,X4270.Volume level set by participant (left),MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,35079,-0.026142030046886,0.0348718262271036,-0.094490809452009,0.0422067493582371,0.45348644541701
Physical measures,X4270.Volume level set by participant (left),PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,35285,-0.0138670091798516,0.0185025028962286,-0.0501319148564596,0.0223978964967565,0.453602365848464
Physical measures,X4270.Volume level set by participant (left),CERT,Ceramide transfer protein,36064,-0.0242221852312096,0.0323243509501416,-0.0875779130934871,0.0391335426310679,0.453671155558667
Physical measures,X4270.Volume level set by participant (left),ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,36109,-0.0459826039011502,0.061370456059644,-0.166268697778052,0.0743034899757521,0.453722263882215
Physical measures,X4270.Volume level set by participant (left),PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",35305,-0.021475221697956,0.0286822362014956,-0.0776924046528875,0.0347419612569754,0.454046843017767
Physical measures,X4270.Volume level set by participant (left),IL17RA,Interleukin-17 receptor A,36256,0.0311238208189638,0.0415744302646697,-0.0503620624997888,0.112609704137716,0.454103903005232
Physical measures,X4270.Volume level set by participant (left),PTGR1,Prostaglandin reductase 1,35313,-0.0196937853581865,0.0263531921254201,-0.0713460419240099,0.0319584712076368,0.454907650606859
Physical measures,X4270.Volume level set by participant (left),RCOR1,REST corepressor 1,36109,0.0305202393334858,0.0409101954805836,-0.0496637438084581,0.11070422247543,0.455672564224156
Physical measures,X4270.Volume level set by participant (left),COLEC12,Collectin-12,36232,0.0534531723881416,0.0717985048703527,-0.0872718971577497,0.194178241934033,0.456603832849583
Physical measures,X4270.Volume level set by participant (left),PNMA1,Paraneoplastic antigen Ma1,35151,-0.0287171769235137,0.0385823825870912,-0.104338646794212,0.0469042929471851,0.4567168576022
Physical measures,X4270.Volume level set by participant (left),IL18,Interleukin-18,36222,0.0311741872621481,0.0419348138426079,-0.0510180478693634,0.11336642239366,0.457264679874507
Physical measures,X4270.Volume level set by participant (left),M6PR,Cation-dependent mannose-6-phosphate receptor,35151,-0.042421973930514,0.0571194116288285,-0.154376020723018,0.0695320728619898,0.457696471513141
Physical measures,X4270.Volume level set by participant (left),PLA2G4A,Cytosolic phospholipase A2,36278,-0.0162154309366046,0.0218548587558419,-0.0590509540980547,0.0266200922248455,0.458134277034789
Physical measures,X4270.Volume level set by participant (left),CA12,Carbonic anhydrase 12,36216,-0.0428257854157459,0.0577520436453366,-0.156019790960606,0.0703682201291137,0.458385446690992
Physical measures,X4270.Volume level set by participant (left),GDF2,Growth/differentiation factor 2,36258,0.0392856787309454,0.0530012569097018,-0.0645967848120702,0.143168142273961,0.458581799750686
Physical measures,X4270.Volume level set by participant (left),PLSCR3,Phospholipid scramblase 3,35280,-0.027416724144964,0.0369921093035396,-0.0999212583799016,0.0450878100899736,0.458628194398467
Physical measures,X4270.Volume level set by participant (left),CD33,Myeloid cell surface antigen CD33,36289,0.0175662753601858,0.0237456642181954,-0.0289752265074771,0.0641077772278487,0.459463556103246
Physical measures,X4270.Volume level set by participant (left),SERPINA11,Serpin A11,36364,0.0329260043021759,0.0445422724411323,-0.0543768496824433,0.120228858286795,0.459803057277894
Physical measures,X4270.Volume level set by participant (left),DPT,Dermatopontin,36364,0.0536439803915338,0.0727534506594282,-0.0889527829009456,0.196240743684013,0.460938312112872
Physical measures,X4270.Volume level set by participant (left),CCL22,C-C motif chemokine 22,36162,0.026583050287737,0.0360609118393177,-0.0440963369173255,0.0972624374927996,0.461041384057858
Physical measures,X4270.Volume level set by participant (left),MTDH,Protein LYRIC,35093,-0.0179575641149398,0.0243638550450556,-0.0657107200032487,0.0297955917733691,0.461113976133444
Physical measures,X4270.Volume level set by participant (left),GRK5,G protein-coupled receptor kinase 5,36109,-0.0271019932109171,0.0367935956848964,-0.0992174407533141,0.0450134543314799,0.461391455751548
Physical measures,X4270.Volume level set by participant (left),ARHGAP30,Rho GTPase-activating protein 30,35195,-0.0394949755089126,0.0536894812961204,-0.144726358849309,0.0657364078314833,0.461989074910757
Physical measures,X4270.Volume level set by participant (left),CCL28,C-C motif chemokine 28,36227,-0.0241893208967346,0.032888776170364,-0.0886513221906482,0.0402726803971789,0.46206458737917
Physical measures,X4270.Volume level set by participant (left),BSND,Barttin,35095,0.046721973683336,0.0635294265486756,-0.0777957023520682,0.17123964971874,0.462099169030327
Physical measures,X4270.Volume level set by participant (left),F12,Coagulation factor XII,35325,0.0380360120163667,0.0517251012567398,-0.0633451864468434,0.139417210479577,0.462152504330221
Physical measures,X4270.Volume level set by participant (left),DKK4,Dickkopf-related protein 4,36165,-0.0307256722066828,0.0418231724023078,-0.112699090115206,0.0512477457018404,0.462571400945398
Physical measures,X4270.Volume level set by participant (left),SNX9,Sorting nexin-9,36258,-0.0210315052375855,0.0286380876594675,-0.0771621570501419,0.0350991465749708,0.462733998391749
Physical measures,X4270.Volume level set by participant (left),CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,35195,0.0230871677463092,0.0314655730192393,-0.0385853553713998,0.0847596908640181,0.463140705397596
Physical measures,X4270.Volume level set by participant (left),NMI,N-myc-interactor,35248,-0.0224926401585391,0.0306823711243932,-0.0826300875623498,0.0376448072452715,0.463535347129777
Physical measures,X4270.Volume level set by participant (left),TIMP2,Metalloproteinase inhibitor 2,35313,-0.0591024422076778,0.0806319944214841,-0.217141151273787,0.0989362668584311,0.463590159265837
Physical measures,X4270.Volume level set by participant (left),CD276,CD276 antigen,36232,0.038211639913203,0.052220279633544,-0.0641401081685432,0.140563387994949,0.464350074629832
Physical measures,X4270.Volume level set by participant (left),DCTD,Deoxycytidylate deaminase,35165,-0.0174942667245265,0.0239590658633291,-0.0644540358166515,0.0294655023675986,0.465310414859296
Physical measures,X4270.Volume level set by participant (left),LMOD2,Leiomodin-2,35083,0.0266186659721824,0.0364676892980196,-0.044858005051936,0.0980953369963009,0.465462618544059
Physical measures,X4270.Volume level set by participant (left),PON2,Serum paraoxonase/arylesterase 2,36109,0.0394071717344443,0.0540617535065847,-0.0665538651384617,0.14536820860735,0.466067929490437
Physical measures,X4270.Volume level set by participant (left),RNASE3,Eosinophil cationic protein,36223,-0.0116194816380024,0.0159438678150948,-0.0428694625555883,0.0196304992795835,0.466162111049637
Physical measures,X4270.Volume level set by participant (left),CHAD,Chondroadherin,35165,-0.0345366347219264,0.0474652470798622,-0.127568518998456,0.0584952495546035,0.466872559786467
Physical measures,X4270.Volume level set by participant (left),CA13,Carbonic anhydrase 13,36182,-0.0134975820759137,0.0185558746768271,-0.0498670964424948,0.0228719322906674,0.467002141357681
Physical measures,X4270.Volume level set by participant (left),XIAP,E3 ubiquitin-protein ligase XIAP,35093,-0.0273353621946255,0.0375936597067483,-0.101018935219852,0.0463482108306011,0.467174432947957
Physical measures,X4270.Volume level set by participant (left),SERPINF1,Pigment epithelium-derived factor,35204,0.0614413627139508,0.0845903322144577,-0.104355688426386,0.227238413854288,0.467655966393965
Physical measures,X4270.Volume level set by participant (left),TPPP3,Tubulin polymerization-promoting protein family member 3,36064,-0.0362083970275276,0.0498681309533088,-0.133949933696013,0.0615331396409576,0.467810728462075
Physical measures,X4270.Volume level set by participant (left),ART5,Ecto-ADP-ribosyltransferase 5,35083,0.0264658652093874,0.0365423187369194,-0.0451570795149746,0.0980888099337495,0.468936887748928
Physical measures,X4270.Volume level set by participant (left),CDA,Cytidine deaminase,35297,-0.0330842134975438,0.0457228967266097,-0.122701091081699,0.0565326640866111,0.469348371523713
Physical measures,X4270.Volume level set by participant (left),TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,36289,0.0319167948157611,0.0441614411006163,-0.0546396297414469,0.118473219372969,0.46986781981274
Physical measures,X4270.Volume level set by participant (left),SNU13,NHP2-like protein 1,35079,0.0256408789047801,0.0354867840889064,-0.0439132179094765,0.0951949757190367,0.469984166338964
Physical measures,X4270.Volume level set by participant (left),PPP1R2,Protein phosphatase inhibitor 2,36258,-0.0172566021802951,0.023932844570885,-0.0641649775392297,0.0296517731786396,0.47090528064764
Physical measures,X4270.Volume level set by participant (left),ACTN4,Alpha-actinin-4,36103,0.0420867447226662,0.0583697927274266,-0.07231804902309,0.156491538468422,0.470909599026017
Physical measures,X4270.Volume level set by participant (left),IL1R2,Interleukin-1 receptor type 2,36227,0.0683933784836215,0.095000408854918,-0.117807422872018,0.254594179839261,0.471591888081234
Physical measures,X4270.Volume level set by participant (left),TARBP2,RISC-loading complex subunit TARBP2,36064,-0.0176470024774538,0.0245201654577354,-0.0657065267746151,0.0304125218197075,0.471736302580271
Physical measures,X4270.Volume level set by participant (left),TPSG1,Tryptase gamma,35093,0.0584289618526788,0.0812115622559441,-0.100745700168972,0.217603623874329,0.471879719332938
Physical measures,X4270.Volume level set by participant (left),HMOX1,Heme oxygenase 1,36169,-0.0274557857864076,0.0382216490738438,-0.102370217971141,0.0474586463983262,0.472575556179932
Physical measures,X4270.Volume level set by participant (left),LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,36325,0.0383393393804866,0.0533795960684592,-0.0662846689136934,0.142963347674667,0.472631298482899
Physical measures,X4270.Volume level set by participant (left),LGMN,Legumain,36278,0.0370199914427634,0.0515743406600651,-0.0640657162509642,0.138105699136491,0.472903300740671
Physical measures,X4270.Volume level set by participant (left),SERPINA1,Alpha-1-antitrypsin,35180,-0.182188665341623,0.25434866482229,-0.680712048393311,0.316334717710065,0.473834673416556
Physical measures,X4270.Volume level set by participant (left),GZMA,Granzyme A,36342,-0.0395870104637959,0.0552999933188772,-0.147974997368795,0.0688009764412034,0.474099875080987
Physical measures,X4270.Volume level set by participant (left),OSM,Oncostatin-M,36208,0.0195708244200217,0.0273449791513975,-0.0340253347167175,0.0731669835567608,0.47419806794607
Physical measures,X4270.Volume level set by participant (left),COL6A3,Collagen alpha-3(VI) chain,36364,0.0380926050007383,0.0532722546470444,-0.0663210141074688,0.142506224108945,0.474596417084893
Physical measures,X4270.Volume level set by participant (left),PDGFRB,Platelet-derived growth factor receptor beta,36364,-0.0381772371502127,0.0534286867320386,-0.142897463145008,0.0665429888445829,0.474911312674737
Physical measures,X4270.Volume level set by participant (left),AKT1S1,Proline-rich AKT1 substrate 1,36064,-0.0219361169520637,0.0307063615582411,-0.0821205856062163,0.0382483517020889,0.475012443031701
Physical measures,X4270.Volume level set by participant (left),CRKL,Crk-like protein,36261,-0.0135281983547863,0.0189419405308197,-0.0506544017951928,0.0235980050856202,0.475129709388912
Physical measures,X4270.Volume level set by participant (left),RAD51,DNA repair protein RAD51 homolog 1,35195,-0.0301709965441835,0.0422627999132357,-0.113006084374125,0.0526640912857586,0.475320383818584
Physical measures,X4270.Volume level set by participant (left),GFRA1,GDNF family receptor alpha-1,36321,0.0482164676733987,0.0675461261775305,-0.0841739396345612,0.180606874981359,0.475353741531385
Physical measures,X4270.Volume level set by participant (left),ERC2,ERC protein 2,35133,0.0223379282301689,0.0313707020649198,-0.039148647817074,0.0838245042774118,0.476450966533473
Physical measures,X4270.Volume level set by participant (left),PILRA,Paired immunoglobulin-like type 2 receptor alpha,36256,0.0313959710408741,0.0441394475178335,-0.0551173460940794,0.117909288175828,0.476925896875663
Physical measures,X4270.Volume level set by participant (left),TRIAP1,TP53-regulated inhibitor of apoptosis 1,36327,-0.021347130202352,0.0300136751930598,-0.0801739335807492,0.0374796731760451,0.476952794663709
Physical measures,X4270.Volume level set by participant (left),SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,36289,0.0306744498714412,0.0431341695678739,-0.0538685224815916,0.115217422224474,0.477018827590069
Physical measures,X4270.Volume level set by participant (left),CSDE1,Cold shock domain-containing protein E1,35079,-0.0131054680158298,0.0184296776628413,-0.0492276362349986,0.0230167002033391,0.477043703827768
Physical measures,X4270.Volume level set by participant (left),ITGB2,Integrin beta-2,36239,-0.0471154771647343,0.0663119816261608,-0.177086961152009,0.0828560068225408,0.477408218449275
Physical measures,X4270.Volume level set by participant (left),CD28,T-cell-specific surface glycoprotein CD28,36060,0.0388215676022684,0.0546637956282683,-0.0683194718291375,0.145962607033674,0.477609815681161
Physical measures,X4270.Volume level set by participant (left),GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,36242,-0.0137105216730758,0.0193237373622934,-0.0515850469031708,0.0241640035570193,0.478025312310157
Physical measures,X4270.Volume level set by participant (left),SERPINB1,Leukocyte elastase inhibitor,36217,-0.0154793314006795,0.0218183935633265,-0.0582433827847994,0.0272847199834405,0.478059257054598
Physical measures,X4270.Volume level set by participant (left),CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,35305,-0.0184373168209219,0.0260293601178704,-0.069454862651948,0.0325802290101042,0.478766412637188
Physical measures,X4270.Volume level set by participant (left),PAMR1,Inactive serine protease PAMR1,36256,-0.0501253196547183,0.0707682781910463,-0.188831144909169,0.0885805055997325,0.478779249077581
Physical measures,X4270.Volume level set by participant (left),PAIP2B,Polyadenylate-binding protein-interacting protein 2B,35084,0.0287347749184858,0.0405975718114862,-0.0508364658320272,0.108306015668999,0.479097770150189
Physical measures,X4270.Volume level set by participant (left),EGLN1,Egl nine homolog 1,36242,-0.0238561884016316,0.0337445060310306,-0.0899954202224517,0.0422830434191884,0.479609724623916
Physical measures,X4270.Volume level set by participant (left),PXN,Paxillin,36064,0.0260327772252748,0.0368353876634932,-0.0461645825951719,0.0982301370457214,0.479754602964339
Physical measures,X4270.Volume level set by participant (left),TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",35133,0.0206685076633861,0.0292577673756621,-0.0366767163929117,0.0780137317196838,0.47994718400122
Physical measures,X4270.Volume level set by participant (left),PDIA4,Protein disulfide-isomerase A4,35320,-0.0249955472205761,0.0353964743406397,-0.0943726369282298,0.0443815424870776,0.480113609965074
Physical measures,X4270.Volume level set by participant (left),FOLR3,Folate receptor gamma,36274,0.00682295977194369,0.00967154266658315,-0.0121332638545593,0.0257791833984467,0.4805407236168
Physical measures,X4270.Volume level set by participant (left),CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,35079,0.0269280181812191,0.038174599660536,-0.0478941971534314,0.10175023351587,0.480592327806462
Physical measures,X4270.Volume level set by participant (left),IL13,Interleukin-13,36103,0.0279272347154757,0.0395939988722427,-0.0496770030741199,0.105531472505071,0.480620522535854
Physical measures,X4270.Volume level set by participant (left),FMNL1,Formin-like protein 1,36064,0.0211823613455322,0.0300589475122246,-0.0377331757784281,0.0800978984694924,0.481022653260311
Physical measures,X4270.Volume level set by participant (left),CA1,Carbonic anhydrase 1,36117,-0.0234575667534479,0.0333069320800997,-0.0887391536304434,0.0418240201235475,0.481277242163112
Physical measures,X4270.Volume level set by participant (left),TINAGL1,Tubulointerstitial nephritis antigen-like,36237,0.0597292141167501,0.0850012010948305,-0.106873140029118,0.226331568262618,0.482272439416866
Physical measures,X4270.Volume level set by participant (left),BTNL10,Butyrophilin-like protein 10,35095,-0.03861593960257,0.0549584685276359,-0.146334537916736,0.0691026587115964,0.482306213886489
Physical measures,X4270.Volume level set by participant (left),SOD1,Superoxide dismutase [Cu-Zn],36129,-0.0285051603140933,0.0405980917568178,-0.108077420157456,0.0510670995292696,0.48261946807701
Physical measures,X4270.Volume level set by participant (left),QDPR,Dihydropteridine reductase,36227,-0.0321040952520312,0.0457854932453898,-0.121843662012995,0.0576354715089327,0.483209049698923
Physical measures,X4270.Volume level set by participant (left),CENPJ,Centromere protein J,35195,0.0230744787773192,0.0329277938719695,-0.0414639972117409,0.0876129547663794,0.483477577062114
Physical measures,X4270.Volume level set by participant (left),CCL7,C-C motif chemokine 7,36242,0.0227368134115102,0.0324518131738538,-0.0408687404092433,0.0863423672322636,0.483553375360934
Physical measures,X4270.Volume level set by participant (left),ATF4,Cyclic AMP-dependent transcription factor ATF-4,35095,-0.0484316102707815,0.0691977526616926,-0.184059205487699,0.087195984946136,0.484013904522166
Physical measures,X4270.Volume level set by participant (left),NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,35084,-0.0437476513073574,0.0625449011392688,-0.166335657540324,0.0788403549256095,0.484289757246944
Physical measures,X4270.Volume level set by participant (left),SAMD9L,Sterile alpha motif domain-containing protein 9-like,36242,-0.0184151539457044,0.0263464236528513,-0.070054144305293,0.0332238364138841,0.484596940563556
Physical measures,X4270.Volume level set by participant (left),GUCY2C,Heat-stable enterotoxin receptor,35195,-0.0191198346754553,0.0273822300004177,-0.072789005476274,0.0345493361253635,0.485041095038532
Physical measures,X4270.Volume level set by participant (left),MPRIP,Myosin phosphatase Rho-interacting protein,35265,0.0335612779119889,0.0480868802916635,-0.0606890074596715,0.127811563283649,0.485245309772644
Physical measures,X4270.Volume level set by participant (left),NAMPT,Nicotinamide phosphoribosyltransferase,36060,0.0255687899151399,0.0366808782419254,-0.0463257314390339,0.0974633112693138,0.485786686368378
Physical measures,X4270.Volume level set by participant (left),SCARA5,Scavenger receptor class A member 5,36325,0.0437151365665118,0.0627752101184193,-0.07932427526559,0.166754548398614,0.486214480165054
Physical measures,X4270.Volume level set by participant (left),LRP11,Low-density lipoprotein receptor-related protein 11,36258,0.0357154009666528,0.0512951155567835,-0.0648230255246429,0.136253827457949,0.486279055300846
Physical measures,X4270.Volume level set by participant (left),BCL2,Apoptosis regulator Bcl-2,35285,-0.0295740048362245,0.0424754511211859,-0.112825889033749,0.0536778793613,0.486289539470969
Physical measures,X4270.Volume level set by participant (left),PALM3,Paralemmin-3,35079,-0.0196448016050021,0.0282574708395535,-0.0750294444505269,0.0357398412405227,0.486950306242007
Physical measures,X4270.Volume level set by participant (left),MPI,Mannose-6-phosphate isomerase,36216,-0.0156861342440532,0.0225667463493926,-0.0599169570888627,0.0285446886007564,0.487014158663951
Physical measures,X4270.Volume level set by participant (left),ATP6V1G2,V-type proton ATPase subunit G 2,35079,-0.0161026812015734,0.023199491526536,-0.061573684593584,0.0293683221904372,0.487646716524741
Physical measures,X4270.Volume level set by participant (left),LRP2,Low-density lipoprotein receptor-related protein 2,35133,-0.0420115693170999,0.0605458895675088,-0.160681512869417,0.0766583742352173,0.487782278980705
Physical measures,X4270.Volume level set by participant (left),CNTN1,Contactin-1,36364,-0.0481492224378461,0.0694132324074987,-0.184199157956543,0.0879007130808514,0.487915857894539
Physical measures,X4270.Volume level set by participant (left),CA6,Carbonic anhydrase 6,36242,-0.0206450971081306,0.0298074098487889,-0.0790676204117569,0.0377774261954957,0.488571449483581
Physical measures,X4270.Volume level set by participant (left),SCGB3A1,Secretoglobin family 3A member 1,35165,0.0586901105899303,0.0847810796882772,-0.107480805599093,0.224861026778954,0.488801815434612
Physical measures,X4270.Volume level set by participant (left),USO1,General vesicular transport factor p115,36216,-0.0152792476693912,0.0220849009390809,-0.0585656535099898,0.0280071581712075,0.48905806444922
Physical measures,X4270.Volume level set by participant (left),C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",35305,-0.0231276453845436,0.0334747204932432,-0.0887380975513004,0.0424828067822131,0.489653046375353
Physical measures,X4270.Volume level set by participant (left),VASN,Vasorin,36125,0.0480092785603635,0.069496428571747,-0.0882037214402607,0.184222278560988,0.489702190628923
Physical measures,X4270.Volume level set by participant (left),EPPK1,Epiplakin,35151,0.0203839825795406,0.0295379956838731,-0.0375104889608506,0.0782784541199318,0.490159767907845
Physical measures,X4270.Volume level set by participant (left),CAPS,Calcyphosin,35301,-0.0156051367269626,0.0226144194499619,-0.0599293988488879,0.0287191253949627,0.49018507920393
Physical measures,X4270.Volume level set by participant (left),PACS2,Phosphofurin acidic cluster sorting protein 2,35079,-0.0250578461969682,0.0363570105034686,-0.0963175867837666,0.0462018943898302,0.490711819687168
Physical measures,X4270.Volume level set by participant (left),SELPLG,P-selectin glycoprotein ligand 1,36242,-0.0461504812615428,0.0669621702558717,-0.177396334963051,0.0850953724399658,0.490716907032502
Physical measures,X4270.Volume level set by participant (left),EHBP1,EH domain-binding protein 1,35313,-0.0195646373400053,0.0283927349086852,-0.0752143977610284,0.0360851230810178,0.490801813431799
Physical measures,X4270.Volume level set by participant (left),SMAD1,Mothers against decapentaplegic homolog 1,36060,-0.0157121992282446,0.0228282882195278,-0.0604556441385191,0.0290312456820298,0.491299400407141
Physical measures,X4270.Volume level set by participant (left),ATG16L1,Autophagy-related protein 16-1,35285,-0.0179527846701436,0.0260991877214124,-0.0691071926041118,0.0332016232638246,0.491560060914115
Physical measures,X4270.Volume level set by participant (left),BRME1,Break repair meiotic recombinase recruitment factor 1,35083,-0.0381918289027741,0.0555538265120456,-0.147077328866384,0.0706936710608353,0.491808484570356
Physical measures,X4270.Volume level set by participant (left),DCDC2C,Doublecortin domain-containing protein 2C,35095,0.0241599656374898,0.035173362448271,-0.0447798247611213,0.0930997560361008,0.492181336546382
Physical measures,X4270.Volume level set by participant (left),CTSH,Pro-cathepsin H,36080,0.0177701661182857,0.0259342374803011,-0.0330609393431044,0.0686012715796759,0.49323831799749
Physical measures,X4270.Volume level set by participant (left),SEMA6C,Semaphorin-6C,35093,-0.058580078677184,0.0855018091696899,-0.226163624649776,0.109003467295408,0.4932847052669
Physical measures,X4270.Volume level set by participant (left),LBP,Lipopolysaccharide-binding protein,36289,0.0219586188469432,0.0320509480349433,-0.0408612393015458,0.0847784769954321,0.493291354976044
Physical measures,X4270.Volume level set by participant (left),ATP6AP2,Renin receptor,36060,-0.0320050220058408,0.046716271561965,-0.123568914267292,0.0595588702556106,0.493306107679839
Physical measures,X4270.Volume level set by participant (left),VAV3,Guanine nucleotide exchange factor VAV3,35083,-0.0158446596288641,0.023129285324531,-0.0611780588649449,0.0294887396072167,0.493338435651388
Physical measures,X4270.Volume level set by participant (left),PGF,Placenta growth factor,36342,0.0496857702708875,0.072559908897097,-0.0925316511674227,0.191903191709198,0.493518956757727
Physical measures,X4270.Volume level set by participant (left),CLEC5A,C-type lectin domain family 5 member A,36233,0.041988565637344,0.0613758990969725,-0.0783081965927221,0.16228532786741,0.49391929044411
Physical measures,X4270.Volume level set by participant (left),ERI1,3'-5' exoribonuclease 1,35195,-0.0442376907906392,0.0647555376946379,-0.17115854467213,0.0826831630908512,0.494536606509991
Physical measures,X4270.Volume level set by participant (left),FARSA,Phenylalanine--tRNA ligase alpha subunit,35133,-0.0214807235121301,0.0314854150844276,-0.0831921370776083,0.0402306900533481,0.495109116763821
Physical measures,X4270.Volume level set by participant (left),BAG3,BAG family molecular chaperone regulator 3,36163,-0.0315265040092192,0.0462153078351434,-0.1221085073661,0.0590554993476619,0.495154995215048
Physical measures,X4270.Volume level set by participant (left),HMOX2,Heme oxygenase 2,36064,0.0280054065503153,0.0410705293356122,-0.0524928309474846,0.108503644048115,0.49533239609934
Physical measures,X4270.Volume level set by participant (left),TOMM20,Mitochondrial import receptor subunit TOM20 homolog,35313,0.0193634301195184,0.0283972487256322,-0.0362951773827207,0.0750220376217576,0.495340279339295
Physical measures,X4270.Volume level set by participant (left),NFKB1,Nuclear factor NF-kappa-B p105 subunit,35079,-0.0213568684370309,0.0313324788037879,-0.0827685268924551,0.0400547900183933,0.495503150451568
Physical measures,X4270.Volume level set by participant (left),CDH5,Cadherin-5,36364,0.0422790004977784,0.062039944273341,-0.07931929027797,0.163877291273527,0.495587955133666
Physical measures,X4270.Volume level set by participant (left),GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",35151,-0.0198547478228671,0.0291596494258503,-0.0770076606975337,0.0372981650517994,0.495960091925125
Physical measures,X4270.Volume level set by participant (left),GLA,Alpha-galactosidase A,35148,0.0389162692448042,0.0572195935131694,-0.0732341340410078,0.151066672530616,0.496451659739343
Physical measures,X4270.Volume level set by participant (left),CFH,Complement factor H,34896,0.066622642388431,0.09798346655673,-0.12542495206276,0.258670236839622,0.496568987963466
Physical measures,X4270.Volume level set by participant (left),SLITRK2,SLIT and NTRK-like protein 2,36327,0.0310609667924092,0.0457014104915239,-0.0585137977709777,0.120635731355796,0.496746425866601
Physical measures,X4270.Volume level set by participant (left),PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",36204,-0.0176109681803847,0.0259767270854155,-0.0685253532677992,0.0333034169070297,0.497822908270459
Physical measures,X4270.Volume level set by participant (left),HSPA1A,Heat shock 70 kDa protein 1A,36271,-0.0185274612499088,0.0273328874621683,-0.0720999206757586,0.035044998175941,0.497890424347303
Physical measures,X4270.Volume level set by participant (left),CCN5,CCN family member 5,36256,-0.033477951543744,0.0494483636642103,-0.130396744325596,0.0634408412381081,0.498408334581373
Physical measures,X4270.Volume level set by participant (left),LETM1,Mitochondrial proton/calcium exchanger protein,35305,0.027723399045582,0.0409589171707102,-0.05255607860901,0.108002876700174,0.498518976275825
Physical measures,X4270.Volume level set by participant (left),NFE2,Transcription factor NF-E2 45 kDa subunit,35151,-0.0203039176732148,0.0300184028266011,-0.079139987213353,0.0385321518669234,0.498821813962153
Physical measures,X4270.Volume level set by participant (left),AP3S2,AP-3 complex subunit sigma-2,35301,-0.0295957604521043,0.0437782854121276,-0.115401199859874,0.0562096789556657,0.499040208892156
Physical measures,X4270.Volume level set by participant (left),NPHS2,Podocin,35093,0.0150125933225226,0.0222109135820663,-0.0285207972983275,0.0585459839433726,0.499121451117721
Physical measures,X4270.Volume level set by participant (left),HMBS,Porphobilinogen deaminase,36327,-0.0320623209012236,0.0475711502351532,-0.125301775362124,0.0611771335596767,0.500339960331604
Physical measures,X4270.Volume level set by participant (left),BCHE,Cholinesterase,35182,-0.0559223700110956,0.0829757074893638,-0.218554756690249,0.106710016668057,0.500359945764759
Physical measures,X4270.Volume level set by participant (left),SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,36325,0.0240980763509827,0.0358529693473594,-0.0461737435698417,0.0943698962718071,0.501517141402604
Physical measures,X4270.Volume level set by participant (left),MFAP3,Microfibril-associated glycoprotein 3,36109,-0.027078196492203,0.0403210875734635,-0.106107528136191,0.0519511351517855,0.501881881219544
Physical measures,X4270.Volume level set by participant (left),SIAE,Sialate O-acetylesterase,36275,0.0272370624261278,0.0406305100638488,-0.0523987372990158,0.106872862151271,0.502648603573007
Physical measures,X4270.Volume level set by participant (left),FSHB,Follitropin subunit beta,35151,-0.0361784591238491,0.0540056541369691,-0.142029541232309,0.0696726229846102,0.502944318886474
Physical measures,X4270.Volume level set by participant (left),POMC,Pro-opiomelanocortin,35151,0.0201483197616006,0.0301447894556377,-0.0389354675714493,0.0792321070946506,0.503911540512095
Physical measures,X4270.Volume level set by participant (left),PMM2,Phosphomannomutase 2,35079,-0.0247496392940598,0.0370316888812222,-0.0973317495012554,0.0478324709131358,0.50394246723796
Physical measures,X4270.Volume level set by participant (left),RRP15,RRP15-like protein,35083,-0.0164940386931611,0.0247096782062262,-0.0649250079773644,0.0319369305910423,0.504468091427136
Physical measures,X4270.Volume level set by participant (left),VPS53,Vacuolar protein sorting-associated protein 53 homolog,36216,-0.0158727730104397,0.023794494405609,-0.0625099820454335,0.030764436024554,0.504742817367281
Physical measures,X4270.Volume level set by participant (left),CD2,T-cell surface antigen CD2,35079,0.0370460049296702,0.0555827329647258,-0.0718961516811923,0.145988161540533,0.505114002928578
Physical measures,X4270.Volume level set by participant (left),FABP5,Fatty acid-binding protein 5,36296,-0.0190355129359071,0.0285646283558963,-0.0750221845134638,0.0369511586416496,0.505174448281062
Physical measures,X4270.Volume level set by participant (left),KIT,Mast/stem cell growth factor receptor Kit,36276,0.0423484471617595,0.0635927460210685,-0.0822933350395347,0.166990229363054,0.505474558351547
Physical measures,X4270.Volume level set by participant (left),LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,36179,-0.0118938120448311,0.0178735691322801,-0.0469260075441001,0.023138383454438,0.505788499951305
Physical measures,X4270.Volume level set by participant (left),CHRM1,Muscarinic acetylcholine receptor M1,35133,-0.0410589426073924,0.0617458251213581,-0.162080759845254,0.0799628746304695,0.506095015955675
Physical measures,X4270.Volume level set by participant (left),AGER,Advanced glycosylation end product-specific receptor,36224,-0.030679898241469,0.0461420837037448,-0.121118382300809,0.0597585858178707,0.506134203499957
Physical measures,X4270.Volume level set by participant (left),IGSF8,Immunoglobulin superfamily member 8,36258,0.040658346907513,0.0611518551357639,-0.0791992891585843,0.16051598297361,0.506150400344365
Physical measures,X4270.Volume level set by participant (left),SCT,Secretin,35133,-0.0320354903813505,0.0482034215542851,-0.126514196627749,0.0624432158650483,0.506336520585014
Physical measures,X4270.Volume level set by participant (left),OTUD7B,OTU domain-containing protein 7B,35305,-0.0226905971549444,0.0342137827894627,-0.0897496114222914,0.0443684171124026,0.50722497369997
Physical measures,X4270.Volume level set by participant (left),NOS1,"Nitric oxide synthase, brain",36064,-0.0213929663918687,0.0322637980323261,-0.0846300105352278,0.0418440777514905,0.507309982127119
Physical measures,X4270.Volume level set by participant (left),FAM3C,Protein FAM3C,36247,0.0419707050093121,0.0633746737095009,-0.0822436554613097,0.166185065479934,0.507822615255004
Physical measures,X4270.Volume level set by participant (left),LDLRAP1,Low density lipoprotein receptor adapter protein 1,35305,-0.0148178783331315,0.0223789842647495,-0.0586806874920405,0.0290449308257775,0.507908344020418
Physical measures,X4270.Volume level set by participant (left),SUSD1,Sushi domain-containing protein 1,36109,-0.0262967676307625,0.0397290280391632,-0.104165662587522,0.0515721273259974,0.5080536313695
Physical measures,X4270.Volume level set by participant (left),SH2B3,SH2B adapter protein 3,36060,-0.0134942061540841,0.0204269009364963,-0.0535309319896168,0.0265425196814486,0.508883139212543
Physical measures,X4270.Volume level set by participant (left),RNF149,E3 ubiquitin-protein ligase RNF149,35151,0.0472825553259347,0.0717164054779912,-0.093281599410928,0.187846710062797,0.509726961272875
Physical measures,X4270.Volume level set by participant (left),CNGB3,Cyclic nucleotide-gated cation channel beta-3,35083,0.028366211783346,0.0431557474694801,-0.056219053256835,0.112951476823527,0.511012290644879
Physical measures,X4270.Volume level set by participant (left),ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,35093,-0.0185586240203693,0.0282451403700223,-0.073919099145613,0.0368018511048745,0.511168548167307
Physical measures,X4270.Volume level set by participant (left),CDHR2,Cadherin-related family member 2,36216,0.018933064811258,0.0288198403571902,-0.0375538222888348,0.0754199519113507,0.511235810281829
Physical measures,X4270.Volume level set by participant (left),FAM3B,Protein FAM3B,36216,0.0347261760172867,0.0528703123535877,-0.0688996361957452,0.138351988230319,0.51131776373893
Physical measures,X4270.Volume level set by participant (left),LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,35133,-0.0316036155206811,0.0481763955296678,-0.12602935075883,0.0628221197174678,0.511848571662007
Physical measures,X4270.Volume level set by participant (left),SPTLC1,Serine palmitoyltransferase 1,35301,-0.0372370739522474,0.0569243921180184,-0.148808882503563,0.0743347345990687,0.513037823672228
Physical measures,X4270.Volume level set by participant (left),BRD2,Bromodomain-containing protein 2,35083,-0.0419298221895452,0.0642258165743272,-0.167812422675226,0.083952778296136,0.513876167530346
Physical measures,X4270.Volume level set by participant (left),RAB2B,Ras-related protein Rab-2B,35279,-0.0237788074883513,0.0364342771471084,-0.0951899906966837,0.0476323757199811,0.514004831313386
Physical measures,X4270.Volume level set by participant (left),CDK5RAP3,CDK5 regulatory subunit-associated protein 3,35305,-0.0238936903732504,0.036729109422435,-0.095882744841223,0.0480953640947223,0.515366906176264
Physical measures,X4270.Volume level set by participant (left),CR2,Complement receptor type 2,36289,-0.0259946262500603,0.040014222458269,-0.104422502268268,0.052433249768147,0.515947645361389
Physical measures,X4270.Volume level set by participant (left),DIABLO,"Diablo homolog, mitochondrial",36233,-0.0115313969803159,0.0177609554322719,-0.0463428696275689,0.0232800756669371,0.516192823514745
Physical measures,X4270.Volume level set by participant (left),CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,35285,0.0356475865752289,0.0549302445227111,-0.0720156926892848,0.143310865839743,0.516385886143718
Physical measures,X4270.Volume level set by participant (left),CD163,Scavenger receptor cysteine-rich type 1 protein M130,36289,0.0279720753497146,0.0431512499200161,-0.0566043744935169,0.112548525192946,0.516853458274023
Physical measures,X4270.Volume level set by participant (left),CA2,Carbonic anhydrase 2,36222,-0.0179868371624647,0.0277872612464175,-0.0724498692054429,0.0364761948805135,0.517453974501213
Physical measures,X4270.Volume level set by participant (left),ZNF75D,Zinc finger protein 75D,35195,-0.0239091323377414,0.0369382829877133,-0.0963081669936595,0.0484899023181767,0.517478177893767
Physical measures,X4270.Volume level set by participant (left),CCL2,C-C motif chemokine 2,36163,-0.0243923208860918,0.0377231636534335,-0.0983297216468214,0.0495450798746379,0.517901507823806
Physical measures,X4270.Volume level set by participant (left),HLA_E,,36242,0.0422413359722343,0.065488320250548,-0.0861157717188398,0.170598443663308,0.518933005349933
Physical measures,X4270.Volume level set by participant (left),RANGAP1,Ran GTPase-activating protein 1,36060,-0.0264428174131801,0.0410089148798162,-0.10682029057762,0.0539346557512597,0.51907238457245
Physical measures,X4270.Volume level set by participant (left),PRKD2,Serine/threonine-protein kinase D2,35079,-0.0327956175228463,0.0509205883927438,-0.132599970772624,0.0670087357269316,0.519563113773676
Physical measures,X4270.Volume level set by participant (left),REEP4,Receptor expression-enhancing protein 4,35305,-0.0207356929653045,0.0322069340894214,-0.0838612837805704,0.0423898978499614,0.519709669989248
Physical measures,X4270.Volume level set by participant (left),CANT1,Soluble calcium-activated nucleotidase 1,36233,0.0604658420762055,0.0944022116226698,-0.124562492704227,0.245494176856638,0.521858386643123
Physical measures,X4270.Volume level set by participant (left),CRLF1,Cytokine receptor-like factor 1,36278,0.0481502528660394,0.0752454766357821,-0.0993308813400935,0.195631387072172,0.52225090508314
Physical measures,X4270.Volume level set by participant (left),CRTAM,Cytotoxic and regulatory T-cell molecule,36179,0.0236071706883936,0.036927549590446,-0.0487708265088806,0.0959851678856678,0.522657891960145
Physical measures,X4270.Volume level set by participant (left),ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,35079,-0.036251872529756,0.0567148248424423,-0.147412929220943,0.0749091841614308,0.522718232482325
Physical measures,X4270.Volume level set by participant (left),ENO3,Beta-enolase,35151,-0.0223226349337631,0.0349383435498581,-0.090801788291485,0.0461565184239589,0.522900517888964
Physical measures,X4270.Volume level set by participant (left),PILRB,Paired immunoglobulin-like type 2 receptor beta,36258,0.0205932975918219,0.0322788292269571,-0.0426732076930141,0.0838598028766579,0.523504771638867
Physical measures,X4270.Volume level set by participant (left),TF,Serotransferrin,35325,0.0637574592271837,0.0999672838334496,-0.132178417086378,0.259693335540745,0.523636508077163
Physical measures,X4270.Volume level set by participant (left),CD7,T-cell antigen CD7,35082,0.0326603468517294,0.0512677913848917,-0.0678245242626583,0.133145217966117,0.524112238570221
Physical measures,X4270.Volume level set by participant (left),NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,35279,-0.0135705365447735,0.0213539463815277,-0.0554242714525678,0.0282831983630208,0.525120984984865
Physical measures,X4270.Volume level set by participant (left),MYL1,"Myosin light chain 1/3, skeletal muscle isoform",35079,0.0358951572968066,0.0564867848075202,-0.0748189409259329,0.146609255519546,0.525150149137532
Physical measures,X4270.Volume level set by participant (left),CNTN5,Contactin-5,36283,-0.0328469192361295,0.0516982866598122,-0.134175561089361,0.0684817226171024,0.525213893158942
Physical measures,X4270.Volume level set by participant (left),GIT1,ARF GTPase-activating protein GIT1,35093,-0.0153303680984425,0.0242114560500474,-0.0627848219565355,0.0321240857596505,0.526634144589672
Physical measures,X4270.Volume level set by participant (left),CPPED1,Serine/threonine-protein phosphatase CPPED1,36325,0.018046124336327,0.0285490556215595,-0.0379100246819297,0.0740022733545837,0.527334154704432
Physical measures,X4270.Volume level set by participant (left),RALY,RNA-binding protein Raly,35279,0.0283735305429167,0.0449344292920608,-0.0596979508695224,0.116445011955356,0.527772531085472
Physical measures,X4270.Volume level set by participant (left),S100A11,Protein S100-A11,36212,-0.0239172134595523,0.0378902597862723,-0.098182122640646,0.0503476957215414,0.5279135131798
Physical measures,X4270.Volume level set by participant (left),TNFAIP2,Tumor necrosis factor alpha-induced protein 2,35285,-0.0285185278426928,0.0452114720609609,-0.117133013082176,0.0600959573967906,0.528205441876759
Physical measures,X4270.Volume level set by participant (left),COMMD1,COMM domain-containing protein 1,35151,-0.0233067281773321,0.0370050924894604,-0.0958367094566744,0.0492232531020102,0.52883113683109
Physical measures,X4270.Volume level set by participant (left),ARHGEF12,Rho guanine nucleotide exchange factor 12,36242,-0.0121304164521311,0.019286199082132,-0.0499313666531098,0.0256705337488475,0.529388324741176
Physical measures,X4270.Volume level set by participant (left),SHD,SH2 domain-containing adapter protein D,35068,-0.0166142089968275,0.0264317641064369,-0.0684204666454438,0.0351920486517888,0.529652934528752
Physical measures,X4270.Volume level set by participant (left),FAS,Tumor necrosis factor receptor superfamily member 6,36339,0.0357314425383846,0.0568787922946708,-0.0757509903591701,0.147213875435939,0.529889342109772
Physical measures,X4270.Volume level set by participant (left),ASAH1,Acid ceramidase,35269,0.0302191256189723,0.0481352111746913,-0.0641258882834226,0.124564139521367,0.530158648393166
Physical measures,X4270.Volume level set by participant (left),ASGR2,Asialoglycoprotein receptor 2,35317,0.0520011076916142,0.0829650529441225,-0.110610396078866,0.214612611462094,0.530822618427678
Physical measures,X4270.Volume level set by participant (left),GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,35083,0.0218540684389946,0.0348813289030886,-0.0465133362110591,0.0902214730890483,0.530991890040221
Physical measures,X4270.Volume level set by participant (left),MINK1,Misshapen-like kinase 1,35301,-0.0150254082747613,0.024002988886856,-0.0620712664929991,0.0320204499434764,0.531348916985464
Physical measures,X4270.Volume level set by participant (left),GRAP2,GRB2-related adapter protein 2,36258,-0.0093981124509967,0.0150176432348877,-0.0388326931913765,0.0200364682893831,0.531461673914628
Physical measures,X4270.Volume level set by participant (left),GLI2,Zinc finger protein GLI2,35093,-0.0424815342135258,0.0679974499469942,-0.175756536109634,0.090793467682583,0.532155884763146
Physical measures,X4270.Volume level set by participant (left),CTHRC1,Collagen triple helix repeat-containing protein 1,35320,-0.0474319598876155,0.0759520106566601,-0.196297900774669,0.101433980999438,0.532321092622356
Physical measures,X4270.Volume level set by participant (left),SPRING1,SREBP regulating gene protein,35095,0.0217185118698518,0.0348798813283451,-0.0466460555337046,0.0900830792734081,0.53352598155417
Physical measures,X4270.Volume level set by participant (left),MTR,Methionine synthase,35079,-0.0207427397053792,0.0333351521052706,-0.0860796378317095,0.0445941584209512,0.533800557722215
Physical measures,X4270.Volume level set by participant (left),HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,35301,-0.0220402429183887,0.0354726555060437,-0.0915666477102344,0.0474861618734569,0.534403331753577
Physical measures,X4270.Volume level set by participant (left),CLEC12A,C-type lectin domain family 12 member A,35093,-0.0677979513475123,0.109326748295608,-0.282078378006905,0.14648247531188,0.535187021277629
Physical measures,X4270.Volume level set by participant (left),IFNGR1,Interferon gamma receptor 1,36278,0.0539395618720916,0.0871174006384244,-0.11681054337922,0.224689667123403,0.535829699586301
Physical measures,X4270.Volume level set by participant (left),CEND1,Cell cycle exit and neuronal differentiation protein 1,35083,0.0235185073191595,0.0380462116214173,-0.0510520674588184,0.0980890820971374,0.536494005108251
Physical measures,X4270.Volume level set by participant (left),HSDL2,Hydroxysteroid dehydrogenase-like protein 2,35151,-0.0287964243344849,0.0465844506530043,-0.120101947614373,0.0625090989454034,0.536494482131122
Physical measures,X4270.Volume level set by participant (left),TYMP,Thymidine phosphorylase,36213,-0.0178735848539686,0.0289659379818527,-0.0746468232983998,0.0388996535904627,0.537216727486271
Physical measures,X4270.Volume level set by participant (left),CCT5,T-complex protein 1 subunit epsilon,36060,-0.0239057984031463,0.0387502988478071,-0.0998563841448483,0.0520447873385557,0.537306940958302
Physical measures,X4270.Volume level set by participant (left),MVK,Mevalonate kinase,36103,-0.0147326072365765,0.023930777296524,-0.0616369307377635,0.0321717162646105,0.538154591485069
Physical measures,X4270.Volume level set by participant (left),NINJ1,Ninjurin-1,36060,-0.0220937071299731,0.0359228571448084,-0.0925025071337975,0.0483150928738513,0.53855234645155
Physical measures,X4270.Volume level set by participant (left),IL2RB,Interleukin-2 receptor subunit beta,36103,0.0335905620043583,0.0546902828242498,-0.0736023923311713,0.140783516339888,0.539104336717152
Physical measures,X4270.Volume level set by participant (left),MAP2,Microtubule-associated protein 2,35301,-0.0267612642414709,0.0435824109129443,-0.112182789630842,0.0586602611478999,0.539210952485552
Physical measures,X4270.Volume level set by participant (left),MSRA,Mitochondrial peptide methionine sulfoxide reductase,36289,-0.0164231922138547,0.0267690523468391,-0.0688905348136594,0.03604415038595,0.539554589365939
Physical measures,X4270.Volume level set by participant (left),FLT3,Receptor-type tyrosine-protein kinase FLT3,36060,-0.038920283646354,0.0635993804073573,-0.163575069244774,0.0857345019520664,0.540582809252961
Physical measures,X4270.Volume level set by participant (left),SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",36064,0.022034884702719,0.0360932865040079,-0.0487079568451364,0.0927777262505744,0.541550462632287
Physical measures,X4270.Volume level set by participant (left),PCDH17,Protocadherin-17,36258,-0.0312388899008345,0.0511791036201818,-0.131549932996391,0.0690721531947219,0.541625792677045
Physical measures,X4270.Volume level set by participant (left),NCK2,Cytoplasmic protein NCK2,36278,-0.0110055681105072,0.0180425049955022,-0.0463688779016916,0.0243577416806771,0.541893081563812
Physical measures,X4270.Volume level set by participant (left),DDT,D-dopachrome decarboxylase,35320,-0.0311405292244149,0.0511298105323355,-0.131354957867792,0.0690738994189627,0.542512956718056
Physical measures,X4270.Volume level set by participant (left),IL5RA,Interleukin-5 receptor subunit alpha,36242,-0.0205267189430081,0.0337091291285149,-0.0865966120348972,0.0455431741488811,0.542584640545167
Physical measures,X4270.Volume level set by participant (left),RET,Proto-oncogene tyrosine-protein kinase receptor Ret,36216,0.0310977152450235,0.0511157915643091,-0.0690892362210223,0.131284666711069,0.542955050344731
Physical measures,X4270.Volume level set by participant (left),ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,36364,-0.0482648995113721,0.0795294942504988,-0.20414270824235,0.107612909219605,0.543947970277704
Physical measures,X4270.Volume level set by participant (left),AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,35279,-0.0194652055993745,0.0320750534271203,-0.0823323103165303,0.0434018991177813,0.543961593258302
Physical measures,X4270.Volume level set by participant (left),TPSAB1,Tryptase alpha/beta-1,36330,-0.0215407537159121,0.035521400458172,-0.0911626986139292,0.048081191182105,0.544256209140781
Physical measures,X4270.Volume level set by participant (left),FGA,Fibrinogen alpha chain,35175,0.0439422557363354,0.0724703983123416,-0.0980997249558542,0.185984236428525,0.544304865766562
Physical measures,X4270.Volume level set by participant (left),ASPN,Asporin,35313,0.0472981093369406,0.0780735062597487,-0.105725962932167,0.200322181606048,0.544658029678303
Physical measures,X4270.Volume level set by participant (left),TDP1,Tyrosyl-DNA phosphodiesterase 1,35279,-0.0184688616886488,0.0305433056279983,-0.0783337407195254,0.0413960173422278,0.545413590009042
Physical measures,X4270.Volume level set by participant (left),DCXR,L-xylulose reductase,36289,0.0218278631921015,0.0361038328121239,-0.0489356491196614,0.0925913755038645,0.545472117400258
Physical measures,X4270.Volume level set by participant (left),UXS1,UDP-glucuronic acid decarboxylase 1,36060,-0.0212449938189743,0.035155163723238,-0.0901491147165209,0.0476591270785722,0.545648819135576
Physical measures,X4270.Volume level set by participant (left),IL17RB,Interleukin-17 receptor B,36151,0.0213036935919024,0.0352633161299296,-0.0478124060227597,0.0904197932065645,0.545774120297239
Physical measures,X4270.Volume level set by participant (left),PDCD1LG2,Programmed cell death 1 ligand 2,36216,0.0360882644005048,0.0598793746102103,-0.0812753098355074,0.153451838636517,0.546737730127099
Physical measures,X4270.Volume level set by participant (left),BLVRB,Flavin reductase,36256,-0.0166350212044697,0.0276109345344117,-0.0707524528919166,0.0374824104829773,0.546872875425773
Physical measures,X4270.Volume level set by participant (left),ANKRD54,Ankyrin repeat domain-containing protein 54,36060,-0.0199568186639221,0.0331432286978813,-0.0849175469117695,0.0450039095839253,0.547100163064139
Physical measures,X4270.Volume level set by participant (left),PTS,6-pyruvoyl tetrahydrobiopterin synthase,36041,-0.0211402603084263,0.0351111796212266,-0.0899581723660303,0.0476776517491777,0.547129357438674
Physical measures,X4270.Volume level set by participant (left),KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,35095,0.0174324564129117,0.0289637212978369,-0.0393364373308486,0.0742013501566721,0.547280280068209
Physical measures,X4270.Volume level set by participant (left),CASP1,Caspase-1,36064,-0.0159684174912814,0.0265480728769429,-0.0680026403300894,0.0360658053475267,0.547531515202435
Physical measures,X4270.Volume level set by participant (left),TNFSF10,Tumor necrosis factor ligand superfamily member 10,36342,-0.044276277220803,0.0736290009462429,-0.188589119075439,0.100036564633833,0.54762923237174
Physical measures,X4270.Volume level set by participant (left),IFNW1,Interferon omega-1,35079,-0.0391426137086003,0.0652317536814214,-0.166996850924186,0.0887116235069857,0.548490844991282
Physical measures,X4270.Volume level set by participant (left),ITM2A,Integral membrane protein 2A,36242,0.0178811700168679,0.0299215216307705,-0.0407650123794422,0.0765273524131781,0.550123046119928
Physical measures,X4270.Volume level set by participant (left),AGBL2,Cytosolic carboxypeptidase 2,35083,0.0155382824784374,0.0260099785567641,-0.0354412754928202,0.066517840449695,0.550263247562622
Physical measures,X4270.Volume level set by participant (left),FASLG,Tumor necrosis factor ligand superfamily member 6,36342,-0.0295109883910002,0.0494565574167502,-0.126445840927831,0.0674238641458302,0.550721628708722
Physical measures,X4270.Volume level set by participant (left),TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,35285,-0.012560758423028,0.021057968752818,-0.0538343771785512,0.0287128603324953,0.550871607362549
Physical measures,X4270.Volume level set by participant (left),DCUN1D1,DCN1-like protein 1,35083,-0.0176959221791071,0.0296699550085417,-0.0758490339958487,0.0404571896376346,0.550911744025878
Physical measures,X4270.Volume level set by participant (left),NME1,Nucleoside diphosphate kinase A,35093,-0.0608631326039679,0.102142958184558,-0.261063330645702,0.139337065437767,0.551288034697114
Physical measures,X4270.Volume level set by participant (left),AKR1B1,Aldo-keto reductase family 1 member B1,36060,-0.0159915528629741,0.0268724041798271,-0.0686614650554353,0.0366783593294871,0.551800030330596
Physical measures,X4270.Volume level set by participant (left),FBP1,"Fructose-1,6-bisphosphatase 1",36258,0.0148996324675355,0.0250716867181065,-0.0342408734999532,0.0640401384350242,0.552341602276233
Physical measures,X4270.Volume level set by participant (left),MAP3K5,Mitogen-activated protein kinase kinase kinase 5,36060,0.0110762881251865,0.0187347947867873,-0.0256439096569166,0.0477964859072896,0.55439442122778
Physical measures,X4270.Volume level set by participant (left),CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,36285,0.0463818575308967,0.0784571949208214,-0.107394244513913,0.200157959575707,0.554421202962569
Physical measures,X4270.Volume level set by participant (left),ECI2,Enoyl-CoA delta isomerase 2,35079,-0.02142431748601,0.0362421862284306,-0.092459002493734,0.0496103675217139,0.554445190429915
Physical measures,X4270.Volume level set by participant (left),PRSS27,Serine protease 27,36233,0.0279177379498334,0.0472289373220558,-0.064650979201396,0.120486455101063,0.554460814003228
Physical measures,X4270.Volume level set by participant (left),CD40,Tumor necrosis factor receptor superfamily member 5,36244,0.021878515239395,0.037070477615611,-0.0507796208872025,0.0945366513659926,0.555082716624031
Physical measures,X4270.Volume level set by participant (left),GP5,Platelet glycoprotein V,35165,-0.0354233086074596,0.0600392558357472,-0.153100250045524,0.082253632830605,0.555209315764872
Physical measures,X4270.Volume level set by participant (left),IDI2,Isopentenyl-diphosphate delta-isomerase 2,36064,-0.0232291365478589,0.0393789878457404,-0.10041195272551,0.0539536796297923,0.555284553652744
Physical measures,X4270.Volume level set by participant (left),DPEP2,Dipeptidase 2,36216,-0.0368803579955601,0.0626116548301463,-0.159599201462647,0.0858384854715266,0.555856323232174
Physical measures,X4270.Volume level set by participant (left),IL10,Interleukin-10,36103,0.0144145511687328,0.0244824124337069,-0.0335709772013327,0.0624000795387983,0.55603217516137
Physical measures,X4270.Volume level set by participant (left),GPNMB,Transmembrane glycoprotein NMB,36034,0.0394653189803019,0.0670497350059393,-0.0919521616313392,0.170882799591943,0.556149075070832
Physical measures,X4270.Volume level set by participant (left),LCAT,Phosphatidylcholine-sterol acyltransferase,35317,-0.058428222361299,0.0993072029274534,-0.253070340099108,0.13621389537651,0.55631157625491
Physical measures,X4270.Volume level set by participant (left),DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",36216,-0.025397765624142,0.0433074760297641,-0.11028041864248,0.0594848873941957,0.557589046045064
Physical measures,X4270.Volume level set by participant (left),FOXO3,Forkhead box protein O3,36060,-0.0119358542707337,0.0203546117170647,-0.0518308932361806,0.0279591846947132,0.557627465638205
Physical measures,X4270.Volume level set by participant (left),EGFR,Epidermal growth factor receptor,36364,-0.0662643824577927,0.11345142828478,-0.288629181895962,0.156100416980377,0.559185409051275
Physical measures,X4270.Volume level set by participant (left),DDC,Aromatic-L-amino-acid decarboxylase,36247,-0.0232715279246907,0.0398483569728094,-0.101374307591397,0.0548312517420157,0.559236068161141
Physical measures,X4270.Volume level set by participant (left),FGF19,Fibroblast growth factor 19,36278,-0.0144078815559913,0.0246907438353067,-0.0628017394731925,0.0339859763612099,0.559551212277087
Physical measures,X4270.Volume level set by participant (left),STK4,Serine/threonine-protein kinase 4,36258,-0.0127774454813551,0.0219311404750501,-0.0557624808124533,0.0302075898497431,0.56016861943756
Physical measures,X4270.Volume level set by participant (left),HMMR,Hyaluronan mediated motility receptor,35071,-0.0271433376709235,0.0467383947645406,-0.118750591409423,0.0644639160675761,0.561428976327525
Physical measures,X4270.Volume level set by participant (left),NUDT16,U8 snoRNA-decapping enzyme,35276,-0.0148826744542903,0.0256291993805952,-0.0651159052402569,0.0353505563316762,0.561467574401259
Physical measures,X4270.Volume level set by participant (left),MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",35133,-0.0224705747632364,0.0386972285759032,-0.0983171427720068,0.0533759932455339,0.561478480032153
Physical measures,X4270.Volume level set by participant (left),GIPC3,PDZ domain-containing protein GIPC3,35285,-0.0132291100598536,0.0228435886816243,-0.0580025438758372,0.03154432375613,0.562529765588502
Physical measures,X4270.Volume level set by participant (left),VAMP5,Vesicle-associated membrane protein 5,36109,-0.0210098851493659,0.0362815938286193,-0.0921218090534596,0.0501020387547279,0.562553690864286
Physical measures,X4270.Volume level set by participant (left),KLRC1,NKG2-A/NKG2-B type II integral membrane protein,35083,0.0218076589738654,0.037705528894235,-0.0520951776588351,0.0957104956065659,0.563036014311867
Physical measures,X4270.Volume level set by participant (left),AMFR,E3 ubiquitin-protein ligase AMFR,36064,-0.016903053748161,0.0292916339809182,-0.0743146563507608,0.0405085488544387,0.563915794363498
Physical measures,X4270.Volume level set by participant (left),C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,35160,-0.0259579067541554,0.0450022960014274,-0.114162406916953,0.0622465934086422,0.564085626884673
Physical measures,X4270.Volume level set by participant (left),FDX2,"Ferredoxin-2, mitochondrial",35079,-0.0234842200981014,0.0407240848316522,-0.10330342636814,0.056334986171937,0.564184732766714
Physical measures,X4270.Volume level set by participant (left),SMS,Spermine synthase,35083,-0.0203541426376374,0.0353107121730612,-0.0895631384968373,0.0488548532215625,0.564344806389739
Physical measures,X4270.Volume level set by participant (left),SNRPB2,U2 small nuclear ribonucleoprotein B'',35301,-0.0291900024102738,0.0507317577143945,-0.128624247530487,0.0702442427099394,0.565054139719839
Physical measures,X4270.Volume level set by participant (left),TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,35195,-0.0119597421098438,0.0207916905831895,-0.0527114556528951,0.0287919714332076,0.565163911668879
Physical measures,X4270.Volume level set by participant (left),LSM8,U6 snRNA-associated Sm-like protein LSm8,35195,0.015693289543567,0.0273052581834118,-0.0378250164959202,0.0692115955830541,0.565490096854478
Physical measures,X4270.Volume level set by participant (left),UBQLN3,Ubiquilin-3,35079,-0.0236863246791475,0.0412336694741392,-0.10450431684846,0.0571316674901653,0.565689132069939
Physical measures,X4270.Volume level set by participant (left),PRR5,Proline-rich protein 5,35093,-0.0281300790929897,0.0489834839177605,-0.1241377075718,0.0678775493858209,0.565800399265643
Physical measures,X4270.Volume level set by participant (left),SKAP2,Src kinase-associated phosphoprotein 2,36278,0.0103959364018925,0.0181290503847607,-0.0251370023522385,0.0459288751560235,0.566363101412425
Physical measures,X4270.Volume level set by participant (left),PLA2G10,Group 10 secretory phospholipase A2,36179,0.0182827625927508,0.0318887580901875,-0.0442192032640167,0.0807847284495183,0.566438698707751
Physical measures,X4270.Volume level set by participant (left),SCN3A,Sodium channel protein type 3 subunit alpha,35133,-0.037260245949019,0.0650180173931439,-0.164695560039581,0.0901750681415431,0.566613171119467
Physical measures,X4270.Volume level set by participant (left),SV2A,Synaptic vesicle glycoprotein 2A,35133,-0.0199860691895945,0.0349664659289372,-0.0885203424103115,0.0485482040311225,0.567627449536517
Physical measures,X4270.Volume level set by participant (left),TMPRSS15,Enteropeptidase,36216,-0.0123276832870182,0.021573223802545,-0.0546112019400063,0.02995583536597,0.567722051228866
Physical measures,X4270.Volume level set by participant (left),DDI2,Protein DDI1 homolog 2,35165,-0.0166385975786169,0.0291204763197564,-0.0737147311653395,0.0404375360081056,0.567767706890431
Physical measures,X4270.Volume level set by participant (left),PDGFB,Platelet-derived growth factor subunit B,36278,-0.0124379070080039,0.0217978768719301,-0.0551617456769868,0.0302859316609791,0.568286326575487
Physical measures,X4270.Volume level set by participant (left),IGLON5,IgLON family member 5,35095,-0.0144585492860573,0.0253711158629701,-0.0641859363774787,0.0352688378053641,0.568777265376819
Physical measures,X4270.Volume level set by participant (left),DCLRE1C,Protein artemis,35095,-0.0409606338585125,0.0719053625928317,-0.181895144540463,0.0999738768234376,0.568937233300562
Physical measures,X4270.Volume level set by participant (left),ATP6V1F,V-type proton ATPase subunit F,36053,-0.0166116354890487,0.0291693293596606,-0.0737835210339836,0.0405602500558861,0.569040962004779
Physical measures,X4270.Volume level set by participant (left),PLB1,"Phospholipase B1, membrane-associated",35301,0.0210193680476422,0.0369694594902776,-0.0514407725533019,0.0934795086485864,0.569673614680195
Physical measures,X4270.Volume level set by participant (left),HSPB6,Heat shock protein beta-6,36327,-0.0263949799653989,0.0465448873629575,-0.117622959196796,0.0648329992659978,0.570671854448416
Physical measures,X4270.Volume level set by participant (left),MCAM,Cell surface glycoprotein MUC18,36289,-0.0328963416810442,0.0580111669561376,-0.146598228915074,0.0808055455529854,0.570683778929991
Physical measures,X4270.Volume level set by participant (left),IGSF9,Protein turtle homolog A,35313,-0.0145294101960855,0.0257189607075029,-0.0649385731827912,0.0358797527906202,0.572140323319364
Physical measures,X4270.Volume level set by participant (left),CIT,Citron Rho-interacting kinase,35133,0.0264032776706942,0.0467971877216666,-0.0653192102637723,0.118125765605161,0.572632979444333
Physical measures,X4270.Volume level set by participant (left),GP2,Pancreatic secretory granule membrane major glycoprotein GP2,36025,0.013023175453131,0.0230984659301787,-0.0322498177700193,0.0582961686762813,0.572899614451518
Physical measures,X4270.Volume level set by participant (left),MGLL,Monoglyceride lipase,36268,-0.012587392471269,0.0223564055480651,-0.0564059473454765,0.0312311624029386,0.573428930248956
Physical measures,X4270.Volume level set by participant (left),SERPINE1,Plasminogen activator inhibitor 1,36364,-0.0155718070000008,0.0276634532246254,-0.0697921753202665,0.0386485613202649,0.573518029548394
Physical measures,X4270.Volume level set by participant (left),LAMP2,Lysosome-associated membrane glycoprotein 2,36029,0.053326244066892,0.0947637276588116,-0.132410662144379,0.239063150278163,0.573636806569721
Physical measures,X4270.Volume level set by participant (left),ARHGEF1,Rho guanine nucleotide exchange factor 1,35301,-0.0142784229125581,0.0253933972512863,-0.0640494815250793,0.0354926356999631,0.573938083297835
Physical measures,X4270.Volume level set by participant (left),PSG1,Pregnancy-specific beta-1-glycoprotein 1,36179,0.00945563340845691,0.0168206341008681,-0.0235128094292445,0.0424240762461583,0.574033940620305
Physical measures,X4270.Volume level set by participant (left),HSPB1,Heat shock protein beta-1,36140,-0.0159795740522038,0.0284432727907065,-0.0717283887219886,0.039769240617581,0.574265562019216
Physical measures,X4270.Volume level set by participant (left),FOLR1,Folate receptor alpha,36252,0.0364798778850682,0.0650078497958684,-0.0909355077148339,0.16389526348497,0.574704142925017
Physical measures,X4270.Volume level set by participant (left),TAX1BP1,Tax1-binding protein 1,35301,0.0188675681170232,0.0336459164716861,-0.0470784281674815,0.084813564401528,0.574974160895996
Physical measures,X4270.Volume level set by participant (left),BMP10,Bone morphogenetic protein 10,35165,0.043575717090003,0.0777471081134696,-0.108808614812397,0.195960048992403,0.575171055081797
Physical measures,X4270.Volume level set by participant (left),SMC3,Structural maintenance of chromosomes protein 3,35095,-0.0233636098875146,0.041704424880646,-0.105104282653581,0.0583770628785515,0.575349420754501
Physical measures,X4270.Volume level set by participant (left),COPB2,Coatomer subunit beta',35079,-0.0281913475446146,0.050349369846076,-0.126876112442924,0.0704934173536944,0.575557052050947
Physical measures,X4270.Volume level set by participant (left),EGFLAM,Pikachurin,35285,-0.0410212410710697,0.0733300308828546,-0.184748101601465,0.102705619459325,0.575903585758793
Physical measures,X4270.Volume level set by participant (left),ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,36258,-0.0330696714928447,0.059336624649722,-0.1493694558063,0.0832301128206104,0.577322991995706
Physical measures,X4270.Volume level set by participant (left),CLEC4M,C-type lectin domain family 4 member M,35310,0.0248666488699807,0.0446572130076983,-0.0626614886251078,0.112394786365069,0.577659517703888
Physical measures,X4270.Volume level set by participant (left),PLA2G2A,"Phospholipase A2, membrane associated",36256,-0.0197717410062423,0.035524200028368,-0.0893991730618435,0.0498556910493589,0.577836817666935
Physical measures,X4270.Volume level set by participant (left),RAB37,Ras-related protein Rab-37,36103,-0.0134079921746033,0.0241130675473663,-0.0606696045674412,0.0338536202182346,0.578195502672483
Physical measures,X4270.Volume level set by participant (left),METAP1,Methionine aminopeptidase 1,36064,-0.0371815435173574,0.0668754839616484,-0.168257492082188,0.0938944050474735,0.578240054858039
Physical measures,X4270.Volume level set by participant (left),VNN2,Vascular non-inflammatory molecule 2,36216,-0.0220684445148916,0.0397367255871843,-0.0999524266657727,0.0558155376359896,0.578660348894674
Physical measures,X4270.Volume level set by participant (left),SERPINB6,Serpin B6,36292,-0.017897078022484,0.0322504538331479,-0.0811079675354539,0.0453138114904858,0.578951606333535
Physical measures,X4270.Volume level set by participant (left),EPHA4,Ephrin type-A receptor 4,35165,0.0421115789585527,0.0759221908963376,-0.106695915198269,0.190919073115375,0.579140949574114
Physical measures,X4270.Volume level set by participant (left),ANK2,Ankyrin-2,35079,-0.0177693397104697,0.0320539374084408,-0.0805950570310137,0.0450563776100742,0.579353367599542
Physical measures,X4270.Volume level set by participant (left),DEFB103A_DEFB103B,Beta-defensin 103,35048,-0.029474043024556,0.053183967686272,-0.133714619689649,0.0747665336405371,0.5794677922285
Physical measures,X4270.Volume level set by participant (left),ACE2,Angiotensin-converting enzyme 2,36109,0.0198207660852632,0.0357684056382152,-0.0502853089656387,0.0899268411361651,0.57949836320387
Physical measures,X4270.Volume level set by participant (left),CBS,Cystathionine beta-synthase,35151,0.0241286348486604,0.0435516762330544,-0.0612326505681263,0.109489920265447,0.579581952854894
Physical measures,X4270.Volume level set by participant (left),CLEC10A,C-type lectin domain family 10 member A,36179,0.028425344888985,0.0514164552780479,-0.072350907455989,0.129201597233959,0.580385667468619
Physical measures,X4270.Volume level set by participant (left),CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,36060,-0.0184927839083264,0.0334575329005118,-0.0840695483933295,0.0470839805766767,0.580468932986002
Physical measures,X4270.Volume level set by participant (left),FCRLB,Fc receptor-like B,36060,0.0172739798207863,0.0312564179694785,-0.0439885993993915,0.0785365590409641,0.58051702329008
Physical measures,X4270.Volume level set by participant (left),CPXM1,Probable carboxypeptidase X1,36289,-0.0149972558259077,0.0271372034338949,-0.0681861745563418,0.0381916629045263,0.580522188086626
Physical measures,X4270.Volume level set by participant (left),ITGA2,Integrin alpha-2,35165,0.0344647491922569,0.0624375255016653,-0.0879128007910071,0.156842299175521,0.580975544256045
Physical measures,X4270.Volume level set by participant (left),MARS1,"Methionine--tRNA ligase, cytoplasmic",35148,-0.0147401360315952,0.0267641848119824,-0.0671979382630808,0.0377176661998903,0.581829977146869
Physical measures,X4270.Volume level set by participant (left),RGMB,RGM domain family member B,36325,-0.0371424933868702,0.0674472582786401,-0.169339119613005,0.0950541328392644,0.581862510198076
Physical measures,X4270.Volume level set by participant (left),PXDNL,Peroxidasin-like protein,35279,0.0199680240720943,0.0363291116833761,-0.051237034827323,0.0911730829715115,0.5825829824297
Physical measures,X4270.Volume level set by participant (left),SERPINB8,Serpin B8,36342,0.0171611507455998,0.0313013339697471,-0.0441894638351045,0.078511765326304,0.583531804334847
Physical measures,X4270.Volume level set by participant (left),WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,36179,-0.0203133743971562,0.0370517983945261,-0.0929348992504273,0.0523081504561149,0.58354148629835
Physical measures,X4270.Volume level set by participant (left),F2R,Proteinase-activated receptor 1,36268,-0.0178381250133303,0.0325481660473104,-0.0816325304660587,0.0459562804393981,0.583671366239295
Physical measures,X4270.Volume level set by participant (left),P4HB,Protein disulfide-isomerase,36232,-0.0267128225922595,0.0488133560160502,-0.122387000383718,0.0689613551991989,0.584227028590922
Physical measures,X4270.Volume level set by participant (left),ATXN3,Ataxin-3,35301,-0.0197639327660961,0.0361612702339071,-0.0906400224245541,0.0511121568923619,0.584706313610055
Physical measures,X4270.Volume level set by participant (left),PRKCQ,Protein kinase C theta type,36103,-0.023484557816817,0.0429998592352731,-0.107764281917952,0.0607951662843183,0.584976125347423
Physical measures,X4270.Volume level set by participant (left),FURIN,Furin,36289,-0.0309766871662788,0.0567400897329198,-0.142187263042802,0.080233888710244,0.585122995009028
Physical measures,X4270.Volume level set by participant (left),GJA8,Gap junction alpha-8 protein,35095,0.021022578248873,0.0385271430957529,-0.0544906222188026,0.0965357787165487,0.585320965653667
Physical measures,X4270.Volume level set by participant (left),APOA2,Apolipoprotein A-II,35317,0.0240946517469278,0.0441800905036846,-0.0624983256402941,0.11068762913415,0.585514761173519
Physical measures,X4270.Volume level set by participant (left),GAD1,Glutamate decarboxylase 1,35095,0.0468395484745009,0.085901678090136,-0.121527740582166,0.215206837531167,0.585587042662028
Physical measures,X4270.Volume level set by participant (left),ABRAXAS2,BRISC complex subunit Abraxas 2,35079,-0.0187722587967704,0.0344717845855396,-0.086336956584428,0.0487924389908872,0.586068859744843
Physical measures,X4270.Volume level set by participant (left),SLAMF8,SLAM family member 8,36060,0.0199328783157713,0.0366313703822139,-0.0518646076333679,0.0917303642649105,0.586356062809322
Physical measures,X4270.Volume level set by participant (left),MTSS1,Protein MTSS 1,35285,-0.0106752398287047,0.0196298949447145,-0.0491498339203452,0.0277993542629358,0.586579618979353
Physical measures,X4270.Volume level set by participant (left),FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,36053,0.0224666216586892,0.0413787934151411,-0.0586358134349873,0.103569056752366,0.587180375473262
Physical measures,X4270.Volume level set by participant (left),KIAA1549L,UPF0606 protein KIAA1549L,35195,-0.04406987310616,0.081211616593854,-0.203244641630114,0.115104895417794,0.587385849796819
Physical measures,X4270.Volume level set by participant (left),GGCT,Gamma-glutamylcyclotransferase,35302,-0.0255791586516403,0.0471992143991123,-0.1180896188739,0.0669313015706197,0.587877625312758
Physical measures,X4270.Volume level set by participant (left),CHRDL1,Chordin-like protein 1,36268,0.0312044399383867,0.057590660988283,-0.081673255598648,0.144082135475421,0.587950270378062
Physical measures,X4270.Volume level set by participant (left),CD1C,T-cell surface glycoprotein CD1c,36289,-0.0419874217738476,0.0775009163732326,-0.193889217865383,0.109914374317688,0.587994884508809
Physical measures,X4270.Volume level set by participant (left),GLRX5,"Glutaredoxin-related protein 5, mitochondrial",35165,-0.0136319324018368,0.0252062403464425,-0.0630361634808641,0.0357722986771906,0.588652925475366
Physical measures,X4270.Volume level set by participant (left),BGN,Biglycan,36048,-0.0091689569632729,0.0169687066949757,-0.0424276220854252,0.0240897081588794,0.588975246962802
Physical measures,X4270.Volume level set by participant (left),PRSS22,Brain-specific serine protease 4,35093,-0.0355202274912225,0.0657595367446664,-0.164408919510769,0.0933684645283236,0.589109884089243
Physical measures,X4270.Volume level set by participant (left),LRRC59,Leucine-rich repeat-containing protein 59,35313,0.0238359508300997,0.0441315209319521,-0.0626618301965265,0.110333731856726,0.589137926597157
Physical measures,X4270.Volume level set by participant (left),CA8,Carbonic anhydrase-related protein,35093,-0.0477700196609152,0.0886325523758376,-0.221489822317557,0.125949782995726,0.589928121135156
Physical measures,X4270.Volume level set by participant (left),DTX2,Probable E3 ubiquitin-protein ligase DTX2,35133,-0.0204014547740708,0.0378640828277442,-0.0946150571164495,0.0538121475683078,0.590038001223383
Physical measures,X4270.Volume level set by participant (left),PECR,Peroxisomal trans-2-enoyl-CoA reductase,35151,0.0436841701456105,0.081084210567396,-0.115240882566486,0.202609222857707,0.590077242707908
Physical measures,X4270.Volume level set by participant (left),CTSB,Cathepsin B,36267,0.0197511836544846,0.0366680043927411,-0.0521181049552879,0.0916204722642571,0.590144719185562
Physical measures,X4270.Volume level set by participant (left),SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",35093,-0.0254383696636502,0.0472386383192378,-0.118026100769356,0.0671493614420559,0.590245070982041
Physical measures,X4270.Volume level set by participant (left),SDK2,Protein sidekick-2,35165,-0.032067378091268,0.059588393878669,-0.148860630093459,0.0847258739109232,0.590493092258944
Physical measures,X4270.Volume level set by participant (left),GSTP1,Glutathione S-transferase P,36028,0.014876764971295,0.0276489592232763,-0.0393151951063265,0.0690687250489165,0.590552603427869
Physical measures,X4270.Volume level set by participant (left),ARHGAP45,Rho GTPase-activating protein 45,35165,-0.0147586092150739,0.0274539388424428,-0.0685683293462617,0.039051110916114,0.590887262959832
Physical measures,X4270.Volume level set by participant (left),PTPN1,Tyrosine-protein phosphatase non-receptor type 1,36179,-0.0128385963213388,0.0238867855681499,-0.0596566960349127,0.0339795033922351,0.590953998197673
Physical measures,X4270.Volume level set by participant (left),CASP3,Caspase-3,36364,-0.0119425779521631,0.0222227243589343,-0.0554991176956743,0.0316139617913481,0.591004081788208
Physical measures,X4270.Volume level set by participant (left),SNAP25,Synaptosomal-associated protein 25,35083,0.0245574920077012,0.0457638516101352,-0.0651396571481638,0.114254641163566,0.59155316814054
Physical measures,X4270.Volume level set by participant (left),RBP2,Retinol-binding protein 2,36216,0.0130597498489225,0.0243417446101788,-0.0346500695870279,0.060769569284873,0.591617249119647
Physical measures,X4270.Volume level set by participant (left),HEXIM1,Protein HEXIM1,36242,-0.013038984835117,0.0243291585167636,-0.0607241355279737,0.0346461658577396,0.59201517870992
Physical measures,X4270.Volume level set by participant (left),KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,36060,0.0131098703690277,0.0244952798845235,-0.0349008782046383,0.0611206189426937,0.592527622232024
Physical measures,X4270.Volume level set by participant (left),CSTB,Cystatin-B,36173,-0.0223730318044058,0.0418091213180468,-0.104318909587777,0.0595728459789659,0.59258036990926
Physical measures,X4270.Volume level set by participant (left),CR1,Complement receptor type 1,35287,0.0338675218847341,0.0633084271526538,-0.0902169953344673,0.157952039103936,0.592694813794455
Physical measures,X4270.Volume level set by participant (left),SLC13A1,Solute carrier family 13 member 1,35279,-0.0190537825934039,0.0356776574972571,-0.0889819912880279,0.05087442610122,0.593322210161516
Physical measures,X4270.Volume level set by participant (left),FOXO1,Forkhead box protein O1,36242,-0.012125378298392,0.0227102551697014,-0.0566374784310068,0.0323867218342228,0.593414891990997
Physical measures,X4270.Volume level set by participant (left),KLK6,Kallikrein-6,36277,0.0329331293273405,0.06173855487922,-0.0880744382359308,0.153940696890612,0.593752165990461
Physical measures,X4270.Volume level set by participant (left),STX3,Syntaxin-3,35301,0.0309839819847495,0.0580847969759728,-0.0828622200881573,0.144830184057656,0.593755933565449
Physical measures,X4270.Volume level set by participant (left),SEL1L,Protein sel-1 homolog 1,35151,-0.0390463583837767,0.0732528977924534,-0.182622038056985,0.104529321289432,0.594027441890153
Physical measures,X4270.Volume level set by participant (left),CEP85,Centrosomal protein of 85 kDa,36060,0.0150851351275484,0.0283090540278668,-0.0404006107670704,0.0705708810221673,0.5941372634681
Physical measures,X4270.Volume level set by participant (left),FLT3LG,Fms-related tyrosine kinase 3 ligand,36342,-0.0287279156852969,0.0539543208990316,-0.134478384647399,0.077022553276805,0.59443045103617
Physical measures,X4270.Volume level set by participant (left),ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,36060,0.0232332634496209,0.0436487970297003,-0.0623183787285917,0.108784905627833,0.594549816205692
Physical measures,X4270.Volume level set by participant (left),DNER,Delta and Notch-like epidermal growth factor-related receptor,36223,0.0380820404404297,0.071570615321071,-0.10219636558887,0.178360446469729,0.594678868752994
Physical measures,X4270.Volume level set by participant (left),SMPD3,Sphingomyelin phosphodiesterase 3,35093,0.0203206232048927,0.0382312418475247,-0.0546126108162558,0.0952538572260412,0.595077518692671
Physical measures,X4270.Volume level set by participant (left),ODAM,Odontogenic ameloblast-associated protein,36053,-0.0193947092431802,0.0365361885211276,-0.0910056387445903,0.0522162202582299,0.595548537397322
Physical measures,X4270.Volume level set by participant (left),SERPINI1,Neuroserpin,35148,-0.0391547710870566,0.0738552764445138,-0.183911112918304,0.10560157074419,0.596022199364566
Physical measures,X4270.Volume level set by participant (left),C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,35305,-0.03697471988769,0.0698049500736282,-0.173792422032001,0.0998429822566213,0.59634705154633
Physical measures,X4270.Volume level set by participant (left),HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,36242,0.025247864927982,0.0477493431707369,-0.0683408476866623,0.118836577542626,0.596988441106561
Physical measures,X4270.Volume level set by participant (left),NCR1,Natural cytotoxicity triggering receptor 1,36228,-0.0262106919240436,0.0496016565876642,-0.123429938835865,0.0710085549877782,0.59722065633319
Physical measures,X4270.Volume level set by participant (left),KLK12,Kallikrein-12,36060,-0.00763243616919072,0.0144451158664636,-0.0359448632674593,0.0206799909290779,0.59725490205229
Physical measures,X4270.Volume level set by participant (left),CETN2,Centrin-2,36064,-0.0147809040288819,0.0279765814441162,-0.0696150036593497,0.0400531956015858,0.597285115190089
Physical measures,X4270.Volume level set by participant (left),ITGA11,Integrin alpha-11,36242,0.0294563421231727,0.0558082382236183,-0.0799278047951192,0.138840489041465,0.597644109383969
Physical measures,X4270.Volume level set by participant (left),APOH,Beta-2-glycoprotein 1,36256,-0.0286806487262966,0.054341611414319,-0.135190207098362,0.0778289096457686,0.597664364374929
Physical measures,X4270.Volume level set by participant (left),ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,36060,0.0297271615069045,0.0563340272811948,-0.0806875319642372,0.140141854978046,0.597727028174188
Physical measures,X4270.Volume level set by participant (left),TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,36344,0.0351289896028255,0.06673138705271,-0.0956645290204862,0.165922508226137,0.59860887303284
Physical measures,X4270.Volume level set by participant (left),KIFBP,KIF-binding protein,36216,-0.0123598956730974,0.0235067013196762,-0.0584330302596627,0.033713238913468,0.599040357550647
Physical measures,X4270.Volume level set by participant (left),NTproBNP,N-terminal prohormone of brain natriuretic peptide,36258,0.00901408108942634,0.0171564432375761,-0.0246125476562229,0.0426407098350756,0.599316894743473
Physical measures,X4270.Volume level set by participant (left),HPSE,Heparanase,35215,-0.0123507624104122,0.0235134895333915,-0.0584372018958597,0.0337356770750352,0.599418094866844
Physical measures,X4270.Volume level set by participant (left),SGSH,N-sulphoglucosamine sulphohydrolase,35210,0.0208014488577746,0.0396271061205971,-0.0568676791385957,0.0984705768541449,0.599649605937085
Physical measures,X4270.Volume level set by participant (left),ITGB1BP2,Integrin beta-1-binding protein 2,36109,-0.00924682150710346,0.0176227406509501,-0.0437873931829656,0.0252937501687587,0.599800566340447
Physical measures,X4270.Volume level set by participant (left),ELAVL4,ELAV-like protein 4,35083,-0.0145387247220529,0.0277190816915727,-0.0688681248375354,0.0397906753934296,0.599947095872474
Physical measures,X4270.Volume level set by participant (left),SORCS2,VPS10 domain-containing receptor SorCS2,36060,-0.0282123956021422,0.0539031303831834,-0.133862531153182,0.0774377399488972,0.600717966926645
Physical measures,X4270.Volume level set by participant (left),FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,36218,0.0171877360838918,0.0328504093564092,-0.0471990662546703,0.0815745384224539,0.600841792085238
Physical measures,X4270.Volume level set by participant (left),STX6,Syntaxin-6,36060,0.0145210283750846,0.0277536598074039,-0.039876144847427,0.0689182015975962,0.600842766172188
Physical measures,X4270.Volume level set by participant (left),CXCL14,C-X-C motif chemokine 14,36103,0.0167207851607918,0.0319622089688771,-0.0459251444182073,0.079366714739791,0.6008906498442
Physical measures,X4270.Volume level set by participant (left),SLC16A1,Monocarboxylate transporter 1,36064,0.0184026627105703,0.035201303827662,-0.0505918927916472,0.0873972182127878,0.601140408925077
Physical measures,X4270.Volume level set by participant (left),CA4,Carbonic anhydrase 4,36364,-0.0400039523191401,0.0765327916916675,-0.190008224034808,0.110000319396528,0.6011955751462
Physical measures,X4270.Volume level set by participant (left),TPK1,Thiamin pyrophosphokinase 1,35313,-0.0414367590015327,0.0793483469250527,-0.196959518974636,0.114086000971571,0.601539092699808
Physical measures,X4270.Volume level set by participant (left),ZP4,Zona pellucida sperm-binding protein 4,35095,-0.0393584233216504,0.0754755054790298,-0.187290414060549,0.108573567417248,0.602055235960981
Physical measures,X4270.Volume level set by participant (left),CD4,T-cell surface glycoprotein CD4,36235,-0.0328441299486923,0.063092805792678,-0.156506029302341,0.0908177694049566,0.602682469221389
Physical measures,X4270.Volume level set by participant (left),CALCB,Calcitonin gene-related peptide 2,35301,0.0294482163265326,0.0566219134375081,-0.0815307340109832,0.140427166664048,0.603021416686532
Physical measures,X4270.Volume level set by participant (left),CDH2,Cadherin-2,36258,0.0267044334417895,0.0514550432499068,-0.0741474513280278,0.127556318211607,0.603785691774592
Physical measures,X4270.Volume level set by participant (left),PZP,Pregnancy zone protein,35325,-0.0341632092537351,0.0659248975197422,-0.16337600839243,0.0950495898849597,0.604325977062931
Physical measures,X4270.Volume level set by participant (left),ANG,Angiogenin,36236,0.0297094243383489,0.0573747504505272,-0.0827450865446844,0.142163935221382,0.60460335657067
Physical measures,X4270.Volume level set by participant (left),CLEC1B,C-type lectin domain family 1 member B,36325,-0.0100828942696258,0.0194756509287487,-0.0482551700899733,0.0280893815507217,0.604669896200644
Physical measures,X4270.Volume level set by participant (left),BGLAP,Osteocalcin,35320,0.0127917213779439,0.024732537182644,-0.0356840515000384,0.0612674942559261,0.605032082170711
Physical measures,X4270.Volume level set by participant (left),CD164L2,CD164 sialomucin-like 2 protein,35133,-0.0319918813991019,0.0622114298335588,-0.153926283872877,0.0899425210746733,0.60709850880632
Physical measures,X4270.Volume level set by participant (left),UGDH,UDP-glucose 6-dehydrogenase,35079,-0.0110982332739024,0.0215854180646408,-0.0534056526805984,0.0312091861327935,0.607161732321466
Physical measures,X4270.Volume level set by participant (left),RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,35083,-0.0206620439972429,0.0402285672920921,-0.0995100358897434,0.0581859478952576,0.607537860451877
Physical measures,X4270.Volume level set by participant (left),SEC31A,Protein transport protein Sec31A,35151,-0.0152613878656185,0.0297205487665995,-0.0735136634481535,0.0429908877169166,0.607621616673768
Physical measures,X4270.Volume level set by participant (left),KLK1,Kallikrein-1,36191,0.00761191625980549,0.0148281211047713,-0.0214512011055462,0.0366750336251572,0.607726162771075
Physical measures,X4270.Volume level set by participant (left),CD5,T-cell surface glycoprotein CD5,36315,0.028309640454348,0.0551480373855181,-0.0797805128212674,0.136399793729963,0.607728886153665
Physical measures,X4270.Volume level set by participant (left),CXCL3,C-X-C motif chemokine 3,36244,-0.00992978237945458,0.0193609427739977,-0.04787723021649,0.0280176654575809,0.60805218461359
Physical measures,X4270.Volume level set by participant (left),PDCL2,Phosducin-like protein 2,35095,0.0209770953144918,0.0409561640986364,-0.0592969863188356,0.101251176947819,0.608539605585336
Physical measures,X4270.Volume level set by participant (left),VASP,Vasodilator-stimulated phosphoprotein,35317,-0.0153688391332233,0.0300342939253817,-0.0742360552269715,0.0434983769605248,0.608871034776395
Physical measures,X4270.Volume level set by participant (left),SULT2A1,Bile salt sulfotransferase,36242,0.0165230795431716,0.0323024831160435,-0.0467897873642736,0.0798359464506169,0.609007983673567
Physical measures,X4270.Volume level set by participant (left),C1R,Complement C1r subcomponent,35325,0.0581673131975136,0.113727868637464,-0.164739309331916,0.281073935726943,0.609045436196796
Physical measures,X4270.Volume level set by participant (left),PHLDB1,Pleckstrin homology-like domain family B member 1,35285,0.0200507132976662,0.0392727260667071,-0.0569238297930796,0.0970252563884121,0.609682650012199
Physical measures,X4270.Volume level set by participant (left),SULT1A1,Sulfotransferase 1A1,36325,-0.00777962472167533,0.0152507767077207,-0.0376711470688078,0.0221118976254571,0.609986636035588
Physical measures,X4270.Volume level set by participant (left),EREG,Proepiregulin,36168,-0.0121100889301598,0.0237921144244101,-0.0587426332020036,0.034522455341684,0.610769935709527
Physical measures,X4270.Volume level set by participant (left),LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,35325,-0.0567205991333252,0.111438836948803,-0.27514071955298,0.161699521286329,0.610780056075024
Physical measures,X4270.Volume level set by participant (left),MBL2,Mannose-binding protein C,35230,0.0100319433219603,0.0197438217059026,-0.0286659472216088,0.0487298338655293,0.611396308234874
Physical measures,X4270.Volume level set by participant (left),FAM13A,Protein FAM13A,35285,-0.0160365658465153,0.0315625326524967,-0.0778991298454089,0.0458259981523782,0.611407918832423
Physical measures,X4270.Volume level set by participant (left),TCOF1,Treacle protein,35313,-0.0350724550772612,0.0690780311804157,-0.170465396190876,0.100320486036354,0.611664813346342
Physical measures,X4270.Volume level set by participant (left),DNAJC21,DnaJ homolog subfamily C member 21,35301,-0.0266928706031749,0.0526524502616862,-0.12989167311608,0.0765059319097301,0.612197116400717
Physical measures,X4270.Volume level set by participant (left),CCND2,G1/S-specific cyclin-D2,35195,-0.0307594796154139,0.0607769439187485,-0.149882289696161,0.0883633304653332,0.612800276032639
Physical measures,X4270.Volume level set by participant (left),APPL2,DCC-interacting protein 13-beta,35165,-0.0101915575732366,0.0201585222285217,-0.0497022611411392,0.029319145994666,0.613175057422866
Physical measures,X4270.Volume level set by participant (left),ABCA2,ATP-binding cassette sub-family A member 2,35079,0.0322627550902538,0.063843151040548,-0.0928698209492203,0.157395331129728,0.613334422012044
Physical measures,X4270.Volume level set by participant (left),CCNE1,G1/S-specific cyclin-E1,35093,-0.0119759139601789,0.0237003508197561,-0.0584286015669008,0.0344767736465431,0.613361547925605
Physical measures,X4270.Volume level set by participant (left),PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",35093,0.0272425578203931,0.0540026830207928,-0.0786027009003609,0.133087816541147,0.613950550388875
Physical measures,X4270.Volume level set by participant (left),PLAT,Tissue-type plasminogen activator,36339,0.018633320082646,0.0369651500885976,-0.0538183740910054,0.0910850142562973,0.614220899188863
Physical measures,X4270.Volume level set by participant (left),ADIPOQ,Adiponectin,35325,-0.0155541964732166,0.0309555488853276,-0.0762270722884587,0.0451186793420254,0.615354277131101
Physical measures,X4270.Volume level set by participant (left),DOK2,Docking protein 2,36258,-0.0077616307766894,0.0154757500820846,-0.0380941009375752,0.0225708393841964,0.616009053940873
Physical measures,X4270.Volume level set by participant (left),ITGA5,Integrin alpha-5,36256,0.0378492430095306,0.0755731446607759,-0.11027412052559,0.185972606544651,0.616505686101044
Physical measures,X4270.Volume level set by participant (left),AKT3,RAC-gamma serine/threonine-protein kinase,36033,-0.0165685105104919,0.0331012723831634,-0.0814470043814922,0.0483099833605085,0.616709731751105
Physical measures,X4270.Volume level set by participant (left),VNN1,Pantetheinase,35317,-0.014989565086647,0.0299488759052341,-0.0736893618609059,0.0437102316876119,0.616735872373711
Physical measures,X4270.Volume level set by participant (left),TNFRSF19,Tumor necrosis factor receptor superfamily member 19,36327,-0.0285758603538972,0.0572341163239543,-0.140754728348848,0.0836030076410532,0.617596230481092
Physical measures,X4270.Volume level set by participant (left),FRZB,Secreted frizzled-related protein 3,36150,-0.0382790214399151,0.0767117544864711,-0.188634060233398,0.112076017353568,0.617795251075088
Physical measures,X4270.Volume level set by participant (left),EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,35079,0.0153116213869932,0.0306848392586904,-0.04483066356004,0.0754539063340264,0.617798936967546
Physical measures,X4270.Volume level set by participant (left),DSC2,Desmocollin-2,36180,0.0272337384009797,0.054586290766866,-0.0797553915020776,0.134222868304037,0.617856084225032
Physical measures,X4270.Volume level set by participant (left),NPTX2,Neuronal pentraxin-2,35320,0.0316067174043708,0.0634588731774648,-0.0927726740234602,0.155986108832202,0.618453715996718
Physical measures,X4270.Volume level set by participant (left),VEGFD,Vascular endothelial growth factor D,36330,0.0241202280480036,0.0484337233620564,-0.0708098697416271,0.119050325837634,0.61849481245768
Physical measures,X4270.Volume level set by participant (left),ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,35079,-0.0237639421261895,0.0477792088365129,-0.117411191445755,0.0698833071933757,0.618945086785207
Physical measures,X4270.Volume level set by participant (left),FCN2,Ficolin-2,36203,-0.0227114681787178,0.046023537692803,-0.112917602056612,0.067494665699176,0.621691214604966
Physical measures,X4270.Volume level set by participant (left),TGFBR3,Transforming growth factor beta receptor type 3,36364,-0.0294058479344322,0.0595991635784069,-0.14622020854811,0.0874085126792452,0.621748439969485
Physical measures,X4270.Volume level set by participant (left),SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,35165,-0.0128299686253682,0.0260099267532893,-0.0638094250618153,0.0381494878110789,0.621836915851474
Physical measures,X4270.Volume level set by participant (left),ADRA2A,Alpha-2A adrenergic receptor,35079,-0.0155811823377122,0.0316017504415835,-0.0775206132032158,0.0463582485277914,0.621995333639047
Physical measures,X4270.Volume level set by participant (left),HPCAL1,Hippocalcin-like protein 1,36342,-0.0129703974948893,0.0263088329150184,-0.0645357100083254,0.0385949150185468,0.622022738128053
Physical measures,X4270.Volume level set by participant (left),SFRP4,Secreted frizzled-related protein 4,35165,0.0272743434730825,0.0553292387742432,-0.0811709645244342,0.135719651470599,0.622067026523182
Physical measures,X4270.Volume level set by participant (left),AXIN1,Axin-1,36242,-0.0100334754702214,0.0204592883052645,-0.0501336805485399,0.0300667296080971,0.623856646075717
Physical measures,X4270.Volume level set by participant (left),MDK,Midkine,36255,0.0182476499562065,0.0372153900200078,-0.0546945144830088,0.0911898143954218,0.623917734529936
Physical measures,X4270.Volume level set by participant (left),IFNLR1,Interferon lambda receptor 1,36242,0.0262598103856628,0.0535883547486679,-0.0787733649217264,0.131292985693052,0.624127945845121
Physical measures,X4270.Volume level set by participant (left),SCN3B,Sodium channel subunit beta-3,35083,0.0238743779893288,0.0488386405607352,-0.0718493575097121,0.11959811348837,0.624970115022263
Physical measures,X4270.Volume level set by participant (left),CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",35079,-0.0131871220920309,0.0270073750333293,-0.0661215771573564,0.0397473329732945,0.625369080263687
Physical measures,X4270.Volume level set by participant (left),PLTP,Phospholipid transfer protein,36339,-0.0242541395356944,0.0496883575245246,-0.121643320283763,0.0731350412123738,0.62547499575016
Physical measures,X4270.Volume level set by participant (left),MENT,Protein MENT,35165,0.0468058865106506,0.0959675532879213,-0.141290517933675,0.234902290954976,0.625760111863048
Physical measures,X4270.Volume level set by participant (left),MIA,Melanoma-derived growth regulatory protein,36289,0.0249683089883659,0.0513303743490101,-0.075639224735694,0.125575842712426,0.626680681697717
Physical measures,X4270.Volume level set by participant (left),EVPL,Envoplakin,35195,-0.0325195694131947,0.0668638657589852,-0.163572746300806,0.0985336074744164,0.626731721624416
Physical measures,X4270.Volume level set by participant (left),ARG1,Arginase-1,36264,0.0182864372168493,0.0376121429623133,-0.0554333629892847,0.0920062374229833,0.626850335966029
Physical measures,X4270.Volume level set by participant (left),LRRC37A2,Leucine-rich repeat-containing protein 37A2,35285,-0.0243941364521254,0.0502591752894331,-0.122902120019414,0.0741138471151634,0.627432072011133
Physical measures,X4270.Volume level set by participant (left),SLC44A4,Choline transporter-like protein 4,35133,-0.0163330161340138,0.033707341500623,-0.0823994054752349,0.0497333732072073,0.628009234566863
Physical measures,X4270.Volume level set by participant (left),PI16,Peptidase inhibitor 16,35317,0.0436594779826721,0.0901554858670296,-0.133045274316706,0.22036423028205,0.628210997766025
Physical measures,X4270.Volume level set by participant (left),DCUN1D2,DCN1-like protein 2,35095,0.0135740191441371,0.0280359777012986,-0.0413764971504081,0.0685245354386824,0.628285612400299
Physical measures,X4270.Volume level set by participant (left),INSL4,Early placenta insulin-like peptide,35279,-0.0219955466354734,0.0455789208232236,-0.111330231448992,0.0673391381780449,0.62940869860197
Physical measures,X4270.Volume level set by participant (left),CHMP6,Charged multivesicular body protein 6,35313,-0.0185211648785262,0.0383947024671083,-0.0937747817140584,0.056732451957006,0.629545688119542
Physical measures,X4270.Volume level set by participant (left),CCL26,C-C motif chemokine 26,36242,-0.00948049891885002,0.0196787240182798,-0.0480507979946785,0.0290898001569785,0.629987474775394
Physical measures,X4270.Volume level set by participant (left),ESM1,Endothelial cell-specific molecule 1,36232,-0.0257912334719953,0.0535630989437738,-0.130774907401792,0.0791924404578013,0.63016701360312
Physical measures,X4270.Volume level set by participant (left),PCDH12,Protocadherin-12,35305,0.0414394803178,0.0862061964097909,-0.12752466464539,0.21040362528099,0.630744088726014
Physical measures,X4270.Volume level set by participant (left),TSPAN7,Tetraspanin-7,35083,-0.0109698894710364,0.0228370179279897,-0.0557304446098962,0.0337906656678233,0.630990774298787
Physical measures,X4270.Volume level set by participant (left),SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,35279,0.0138419475018854,0.0288463420774967,-0.042696882970008,0.0703807779737788,0.631349030906355
Physical measures,X4270.Volume level set by participant (left),INHBC,Inhibin beta C chain,36256,0.0231244266182485,0.048219597581473,-0.0713859846414386,0.117634837877936,0.631550511836458
Physical measures,X4270.Volume level set by participant (left),ANXA3,Annexin A3,36318,-0.0134913615782149,0.0282267261581081,-0.0688157448481067,0.0418330216916769,0.632689303592014
Physical measures,X4270.Volume level set by participant (left),GFRA2,GDNF family receptor alpha-2,36216,-0.0446611004607596,0.0934719608023272,-0.227866143633321,0.138543942711802,0.632804774521948
Physical measures,X4270.Volume level set by participant (left),IL20,Interleukin-20,36103,0.018165920667988,0.0380302960559578,-0.0563734596016893,0.0927053009376653,0.632899223336864
Physical measures,X4270.Volume level set by participant (left),TRIM24,Transcription intermediary factor 1-alpha,35184,0.0160284687199824,0.0335594230887485,-0.0497480005339646,0.0818049379739294,0.632940435894146
Physical measures,X4270.Volume level set by participant (left),SIRPB1,Signal-regulatory protein beta-1,36225,0.0191622091596495,0.0402397756712303,-0.0597077511559619,0.0980321694752608,0.633945053465204
Physical measures,X4270.Volume level set by participant (left),MORF4L1,Mortality factor 4-like protein 1,35195,-0.025759443037888,0.0540948952521013,-0.131785437732007,0.0802665516562306,0.633954872318844
Physical measures,X4270.Volume level set by participant (left),ARMCX2,Armadillo repeat-containing X-linked protein 2,35083,-0.0180233578915551,0.0378558117258451,-0.0922207488742115,0.0561740330911014,0.634015312867676
Physical measures,X4270.Volume level set by participant (left),TEF,Thyrotroph embryonic factor,35079,0.0246565313834132,0.0518499110879239,-0.0769692943489177,0.126282357115744,0.634420578485141
Physical measures,X4270.Volume level set by participant (left),PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,36216,0.00465392681962083,0.0097871343228665,-0.0145288564531975,0.0238367100924392,0.634433759040727
Physical measures,X4270.Volume level set by participant (left),DIPK1C,Divergent protein kinase domain 1C,35133,-0.0257645048617451,0.0543860592236759,-0.13236118094015,0.0808321712166597,0.635705711274852
Physical measures,X4270.Volume level set by participant (left),NLGN2,Neuroligin-2,35083,0.0229910683103822,0.0485689741298954,-0.0722041209842129,0.118186257604977,0.635965571149987
Physical measures,X4270.Volume level set by participant (left),ANGPTL7,Angiopoietin-related protein 7,36327,0.0245244398390224,0.0518112102505777,-0.0770255322521099,0.126074411930155,0.63598233175525
Physical measures,X4270.Volume level set by participant (left),CREB3,Cyclic AMP-responsive element-binding protein 3,35095,0.0195576948194528,0.041372795696951,-0.0615329847465712,0.100648374385477,0.636429764033842
Physical measures,X4270.Volume level set by participant (left),LUZP2,Leucine zipper protein 2,35279,-0.0225323368710334,0.0476817648711054,-0.1159885960184,0.0709239222763333,0.636544936724358
Physical measures,X4270.Volume level set by participant (left),SEPTIN7,Septin-7,35195,-0.0196906799300812,0.0416820041966861,-0.101387408155586,0.0620060482954236,0.636655210932857
Physical measures,X4270.Volume level set by participant (left),MYOM1,Myomesin-1,35083,0.0220567737375656,0.0467537863924869,-0.0695806475917087,0.11369419506684,0.637110821356148
Physical measures,X4270.Volume level set by participant (left),MTIF3,"Translation initiation factor IF-3, mitochondrial",35285,-0.0118772519543829,0.0252015369659099,-0.0612722644075662,0.0375177604988005,0.6374484868357
Physical measures,X4270.Volume level set by participant (left),DUOX2,Dual oxidase 2,36109,0.01223796449127,0.0260340914588756,-0.0387888547681262,0.0632647837506662,0.638315394860026
Physical measures,X4270.Volume level set by participant (left),SNCA,Alpha-synuclein,35165,-0.00928645678897207,0.0197760095035184,-0.0480474354158681,0.0294745218379239,0.638669337265512
Physical measures,X4270.Volume level set by participant (left),KLRB1,Killer cell lectin-like receptor subfamily B member 1,36342,-0.0231116634935511,0.0492368101941302,-0.119615811474046,0.0733924844869442,0.638798354307754
Physical measures,X4270.Volume level set by participant (left),CMC1,COX assembly mitochondrial protein homolog,35313,-0.0112805153393558,0.0240410084528976,-0.058400891907035,0.0358398612283235,0.638927834037013
Physical measures,X4270.Volume level set by participant (left),POLR2A,DNA-directed RNA polymerase II subunit RPB1,35093,0.0351915946600321,0.0750688204126887,-0.111943293348838,0.182326482668902,0.639234710027795
Physical measures,X4270.Volume level set by participant (left),RPS10,40S ribosomal protein S10,35079,-0.0256181231031347,0.054649288387996,-0.132730728343607,0.0814944821373375,0.639247519996405
Physical measures,X4270.Volume level set by participant (left),ALPI,Intestinal-type alkaline phosphatase,35093,-0.00840499148983424,0.0179481381003149,-0.0435833421664515,0.026773359186783,0.639590638604981
Physical measures,X4270.Volume level set by participant (left),TNC,Tenascin,36289,0.0181325381947166,0.0387453913268889,-0.0578084288059856,0.0940735051954188,0.639803487772247
Physical measures,X4270.Volume level set by participant (left),MYCBP2,E3 ubiquitin-protein ligase MYCBP2,35305,0.0159427627431955,0.0341266225814312,-0.0509454175164096,0.0828309430028006,0.640397038477163
Physical measures,X4270.Volume level set by participant (left),SCARB2,Lysosome membrane protein 2,36025,0.0288593008485721,0.0619496723052196,-0.0925620568696584,0.150280658566803,0.641336011130534
Physical measures,X4270.Volume level set by participant (left),SNX2,Sorting nexin-2,35279,-0.0117188267544336,0.0251775905985823,-0.0610669043276549,0.0376292508187876,0.64162677192016
Physical measures,X4270.Volume level set by participant (left),IGF2R,Cation-independent mannose-6-phosphate receptor,36256,-0.0361355604917562,0.0776428228193201,-0.188315493217624,0.116044372234111,0.641652829572303
Physical measures,X4270.Volume level set by participant (left),DCTN6,Dynactin subunit 6,36064,-0.0122937202263704,0.0264168967255957,-0.064070837808538,0.0394833973557972,0.641677684541706
Physical measures,X4270.Volume level set by participant (left),IGFBP6,Insulin-like growth factor-binding protein 6,36227,-0.0285840077481271,0.061728015040013,-0.149570917226553,0.0924029017302985,0.643331870901257
Physical measures,X4270.Volume level set by participant (left),S100G,Protein S100-G,35305,-0.0204942085617556,0.0443123125482341,-0.107346341156294,0.0663579240327832,0.6437416349738
Physical measures,X4270.Volume level set by participant (left),ANPEP,Aminopeptidase N,36278,0.0316894553268105,0.0686873333107652,-0.102937717962289,0.16631662861591,0.644554805375523
Physical measures,X4270.Volume level set by participant (left),BTN1A1,Butyrophilin subfamily 1 member A1,35275,0.0264698727945443,0.0575269606587634,-0.0862829700966319,0.139222715685721,0.645438000977059
Physical measures,X4270.Volume level set by participant (left),TSPAN15,Tetraspanin-15,35079,0.021020093804948,0.0457146788849721,-0.0685806768095973,0.110620864419493,0.645667611755891
Physical measures,X4270.Volume level set by participant (left),MFAP5,Microfibrillar-associated protein 5,36364,-0.0210225835804728,0.0457649251623534,-0.110721836898686,0.0686766697377399,0.645988414845545
Physical measures,X4270.Volume level set by participant (left),WARS,"Tryptophan--tRNA ligase, cytoplasmic",36256,-0.0226055911042694,0.0493002794920319,-0.119234138908652,0.0740229567001132,0.646585697163505
Physical measures,X4270.Volume level set by participant (left),SPINK8,Serine protease inhibitor Kazal-type 8,35079,-0.0284940651075479,0.0622033186295505,-0.150412569621467,0.0934244394063712,0.646910695911814
Physical measures,X4270.Volume level set by participant (left),PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",36103,-0.00767064287334376,0.0167735240838972,-0.0405467500777822,0.0252054643310947,0.647463949256152
Physical measures,X4270.Volume level set by participant (left),CTRC,Chymotrypsin-C,36238,0.0132435485955561,0.0290354613465575,-0.0436659556436965,0.0701530528348087,0.648319287996192
Physical measures,X4270.Volume level set by participant (left),PYY,Peptide YY,35079,0.0106097090623843,0.0232897304484252,-0.0350381626165291,0.0562575807412977,0.648726643791058
Physical measures,X4270.Volume level set by participant (left),RIPK4,Receptor-interacting serine/threonine-protein kinase 4,35079,0.0152322061778429,0.0334664572410663,-0.0503620500146471,0.0808264623703328,0.649017701062227
Physical measures,X4270.Volume level set by participant (left),REG3G,Regenerating islet-derived protein 3-gamma,35279,0.0251797173695719,0.0554618221565278,-0.0835254540572225,0.133884888796366,0.649842934997666
Physical measures,X4270.Volume level set by participant (left),CLEC6A,C-type lectin domain family 6 member A,36060,0.0183129357739844,0.0403517799022651,-0.0607765528344552,0.097402424382424,0.649962835640924
Physical measures,X4270.Volume level set by participant (left),PYDC1,Pyrin domain-containing protein 1,35151,-0.024816397563973,0.0547184292993082,-0.132064518990617,0.0824317238626711,0.650182855173462
Physical measures,X4270.Volume level set by participant (left),SNCG,Gamma-synuclein,36179,0.0129982010144836,0.0288840889659968,-0.0436146133588702,0.0696110153878373,0.652714304899599
Physical measures,X4270.Volume level set by participant (left),STAT2,Signal transducer and activator of transcription 2,35093,-0.0128147284286488,0.0284996530657872,-0.0686740484375916,0.0430445915802941,0.652981402697248
Physical measures,X4270.Volume level set by participant (left),GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",36216,-0.0245990091538902,0.0547658954166309,-0.131940164170487,0.0827421458627064,0.653324290191454
Physical measures,X4270.Volume level set by participant (left),CCN3,CCN family member 3,36340,-0.0247994457199301,0.0552459817588727,-0.133081569967321,0.0834826785274604,0.6535225772771
Physical measures,X4270.Volume level set by participant (left),CHEK2,Serine/threonine-protein kinase Chk2,36109,0.0254808824941511,0.0567961362621505,-0.0858395445796639,0.136801309567966,0.653706053132376
Physical measures,X4270.Volume level set by participant (left),MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",35301,-0.0392907937345055,0.0875866969531406,-0.210960719762661,0.13237913229365,0.653739675552387
Physical measures,X4270.Volume level set by participant (left),C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,35165,-0.0268096735451333,0.059766804066939,-0.143952609516334,0.0903332624260671,0.653755745879383
Physical measures,X4270.Volume level set by participant (left),YES1,Tyrosine-protein kinase Yes,36216,-0.00761885403252851,0.0170232615808292,-0.0409844467309537,0.0257467386658967,0.654486772172147
Physical measures,X4270.Volume level set by participant (left),PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",36060,-0.0172853334230461,0.0386286630546023,-0.0929975130100665,0.0584268461639744,0.65454564743863
Physical measures,X4270.Volume level set by participant (left),STX16,Syntaxin-16,36060,0.0145967105991952,0.0326620880546051,-0.0494209819878308,0.0786144031862211,0.654959724284373
Physical measures,X4270.Volume level set by participant (left),GPR37,Prosaposin receptor GPR37,36109,0.0131292924323936,0.029426767545984,-0.0445471719577351,0.0708057568225223,0.655488510615109
Physical measures,X4270.Volume level set by participant (left),PGR,Progesterone receptor,35093,0.00961316812696695,0.0215535075286129,-0.0326317066291143,0.0518580428830482,0.655601944287445
Physical measures,X4270.Volume level set by participant (left),IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",36109,0.00893595702850464,0.0200560297555902,-0.0303738612924521,0.0482457753494614,0.655935437770364
Physical measures,X4270.Volume level set by participant (left),TREML2,Trem-like transcript 2 protein,36256,0.0243144766188214,0.0545835794854061,-0.0826693391725745,0.131298292410217,0.65600425830549
Physical measures,X4270.Volume level set by participant (left),PNLIPRP2,Pancreatic lipase-related protein 2,36232,0.00282081230077011,0.00633903653971127,-0.00960369931706399,0.0152453239186042,0.656339100329263
Physical measures,X4270.Volume level set by participant (left),DPEP1,Dipeptidase 1,36168,-0.0183071732083858,0.0412162733922828,-0.0990910690572601,0.0624767226404884,0.656929911030538
Physical measures,X4270.Volume level set by participant (left),SIRT1,NAD-dependent protein deacetylase sirtuin-1,35093,-0.0113479306480765,0.025564669292801,-0.0614546824619664,0.0387588211658134,0.657136076475214
Physical measures,X4270.Volume level set by participant (left),ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,35991,-0.010128874501246,0.0228519271572299,-0.0549186517294167,0.0346609027269247,0.657605560982613
Physical measures,X4270.Volume level set by participant (left),CD3D,T-cell surface glycoprotein CD3 delta chain,35083,-0.0300207700880244,0.0677556156888564,-0.162821776838183,0.102780236662134,0.65772680457934
Physical measures,X4270.Volume level set by participant (left),AOC1,Amiloride-sensitive amine oxidase [copper-containing],36103,0.0157403841304469,0.0356168533835866,-0.0540686485013829,0.0855494167622767,0.658547968181126
Physical measures,X4270.Volume level set by participant (left),SCG2,Secretogranin-2,36299,0.0249228745941998,0.0564118760467674,-0.0856444024574644,0.135490151645864,0.658644969452744
Physical measures,X4270.Volume level set by participant (left),SCRIB,Protein scribble homolog,35151,-0.0112927778028734,0.0256085267058479,-0.0614854901463353,0.0388999345405884,0.659244022293648
Physical measures,X4270.Volume level set by participant (left),KRT5,"Keratin, type II cytoskeletal 5",36064,0.0164986121609335,0.0374335504197715,-0.0568711466618186,0.0898683709836856,0.659411119739623
Physical measures,X4270.Volume level set by participant (left),KLRK1,NKG2-D type II integral membrane protein,35301,0.0201285681708035,0.0457586236365717,-0.0695583341568769,0.109815470498484,0.660034023268508
Physical measures,X4270.Volume level set by participant (left),CD2AP,CD2-associated protein,36258,-0.0133922749786246,0.0304562845957127,-0.0730865927862215,0.0463020428289723,0.66015143637229
Physical measures,X4270.Volume level set by participant (left),EPHB6,Ephrin type-B receptor 6,36168,0.0261085981427299,0.0593810029639771,-0.0902781676666652,0.142495363952125,0.660181952657905
Physical measures,X4270.Volume level set by participant (left),NEFL,Neurofilament light polypeptide,36047,-0.0182566260341042,0.0416005185725904,-0.0997936424363814,0.0632803903681731,0.660778811187062
Physical measures,X4270.Volume level set by participant (left),SLC39A5,Zinc transporter ZIP5,36242,0.0156696640895559,0.0357137214144514,-0.0543292298827689,0.0856685580618807,0.660849647182796
Physical measures,X4270.Volume level set by participant (left),MMP1,Interstitial collagenase,35995,0.00928371023426511,0.021230282584469,-0.0323276436312942,0.0508950640998244,0.661916554869719
Physical measures,X4270.Volume level set by participant (left),UHRF2,E3 ubiquitin-protein ligase UHRF2,35079,-0.0289353860817461,0.0661746192182148,-0.158637639749447,0.100766867585955,0.66193878275235
Physical measures,X4270.Volume level set by participant (left),GRP,Gastrin-releasing peptide,35151,-0.0183114954868893,0.0419653580491936,-0.100563597263309,0.0639406062895301,0.662598725912961
Physical measures,X4270.Volume level set by participant (left),SORD,Sorbitol dehydrogenase,36295,-0.0124617462026814,0.0285643613466072,-0.0684478944420314,0.0435244020366687,0.66265379345892
Physical measures,X4270.Volume level set by participant (left),COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",35151,-0.0221084843946493,0.0508579589370886,-0.121790083911343,0.0775731151220444,0.663786963359592
Physical measures,X4270.Volume level set by participant (left),ACE,Angiotensin-converting enzyme,35317,0.0349006705235095,0.0803194782892453,-0.122525506923411,0.19232684797043,0.663922571638524
Physical measures,X4270.Volume level set by participant (left),HSD17B3,Testosterone 17-beta-dehydrogenase 3,35079,-0.0190810072946239,0.0439627077291147,-0.105247914443689,0.0670858998544409,0.664283208228346
Physical measures,X4270.Volume level set by participant (left),RAB33A,Ras-related protein Rab-33A,35079,-0.0148303411245793,0.0342664691152537,-0.0819926205904764,0.0523319383413179,0.665178444495018
Physical measures,X4270.Volume level set by participant (left),NCF2,Neutrophil cytosol factor 2,36222,0.009693823329781,0.0224165013015348,-0.0342425192212271,0.0536301658807891,0.66543286904164
Physical measures,X4270.Volume level set by participant (left),LY75,Lymphocyte antigen 75,36242,0.0207226885083311,0.0479278397840309,-0.0732158774683695,0.114661254485032,0.665482776154164
Physical measures,X4270.Volume level set by participant (left),PON1,Serum paraoxonase/arylesterase 1,35317,0.0363358814469181,0.084169828242931,-0.128636981909227,0.201308744803063,0.665975344867766
Physical measures,X4270.Volume level set by participant (left),PLEKHO1,Pleckstrin homology domain-containing family O member 1,35301,-0.013186869394618,0.0305564999786189,-0.073077609352711,0.046703870563475,0.666077355485592
Physical measures,X4270.Volume level set by participant (left),SERPINA5,Plasma serine protease inhibitor,35234,-0.0298985247208102,0.0692948185341276,-0.1657163690477,0.10591931960608,0.666141848968038
Physical measures,X4270.Volume level set by participant (left),LHB,Lutropin subunit beta,36060,0.00936093978781615,0.0217026729212661,-0.0331762991378654,0.0518981787134977,0.666243391462441
Physical measures,X4270.Volume level set by participant (left),UPK3BL1,Uroplakin-3b-like protein 1,35171,-0.0172479382762956,0.0400613353909833,-0.0957681556426229,0.0612722790900317,0.666818256847861
Physical measures,X4270.Volume level set by participant (left),ID4,DNA-binding protein inhibitor ID-4,35195,-0.0211854796331602,0.0493219633284487,-0.11785652775692,0.0754855684905992,0.667548408057205
Physical measures,X4270.Volume level set by participant (left),GATA3,Trans-acting T-cell-specific transcription factor GATA-3,35095,-0.0360564879680532,0.0840650808233124,-0.200824046381746,0.128711070445639,0.668001792656619
Physical measures,X4270.Volume level set by participant (left),SERPINC1,Antithrombin-III,35317,-0.0633681113617016,0.147757656583743,-0.352973118265837,0.226236895542434,0.668035113598433
Physical measures,X4270.Volume level set by participant (left),COL15A1,Collagen alpha-1(XV) chain,35320,-0.0353136442656831,0.0823539357915141,-0.196727358417051,0.126100069885685,0.668080085335061
Physical measures,X4270.Volume level set by participant (left),TBC1D5,TBC1 domain family member 5,36242,0.00994919552892525,0.0232271536330621,-0.0355760255918764,0.0554744166497269,0.66841327864909
Physical measures,X4270.Volume level set by participant (left),ENTR1,Endosome-associated-trafficking regulator 1,35151,-0.0157128694998411,0.0367102115476401,-0.0876648841332157,0.0562391451335336,0.668647368926392
Physical measures,X4270.Volume level set by participant (left),CD72,B-cell differentiation antigen CD72,35165,-0.0222269292805882,0.0519305916823401,-0.124010888977975,0.0795570304167983,0.668656249754092
Physical measures,X4270.Volume level set by participant (left),TADA3,Transcriptional adapter 3,35279,-0.0231467867944071,0.0541024554232477,-0.129187599423973,0.0828940258351585,0.66878689991118
Physical measures,X4270.Volume level set by participant (left),DSCAM,Down syndrome cell adhesion molecule,35305,0.0262411370320804,0.0613859834138796,-0.0940753904591236,0.146557664523284,0.669045181280479
Physical measures,X4270.Volume level set by participant (left),EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,35305,-0.013287290829479,0.031084950842357,-0.0742137944804986,0.0476392128215406,0.669064658779726
Physical measures,X4270.Volume level set by participant (left),TIMP3,Metalloproteinase inhibitor 3,36278,-0.00623901240797319,0.0146336322651787,-0.0349209316477235,0.0224429068317771,0.669866613783739
Physical measures,X4270.Volume level set by participant (left),MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,36179,0.0117007560808259,0.0275227669071775,-0.042243867057242,0.0656453792188937,0.670753925833482
Physical measures,X4270.Volume level set by participant (left),COMP,Cartilage oligomeric matrix protein,36184,-0.0244185316105106,0.0574812484077611,-0.137081778489722,0.0882447152687012,0.670988226527434
Physical measures,X4270.Volume level set by participant (left),CDHR1,Cadherin-related family member 1,36064,0.0184266457889405,0.0433970922775405,-0.0666316550750388,0.10348494665292,0.671136497292737
Physical measures,X4270.Volume level set by participant (left),RNF4,E3 ubiquitin-protein ligase RNF4,35195,-0.0141306586443211,0.0332968123590056,-0.079392410867972,0.0511310935793299,0.671299106082234
Physical measures,X4270.Volume level set by participant (left),GFAP,Glial fibrillary acidic protein,36046,0.0177381218490825,0.0419840215414421,-0.0645505603721439,0.100026804070309,0.672674516985656
Physical measures,X4270.Volume level set by participant (left),FUCA1,Tissue alpha-L-fucosidase,36306,0.0095845926057677,0.022714685990733,-0.0349361919360691,0.0541053771476045,0.673069083988935
Physical measures,X4270.Volume level set by participant (left),GAL,Galanin peptides,36278,0.0118625043759601,0.0281400503100249,-0.0432919942316886,0.0670170029836089,0.673363597485821
Physical measures,X4270.Volume level set by participant (left),CYTH3,Cytohesin-3,35095,0.0127990312494163,0.0303965663744594,-0.0467782388445242,0.0723763013433567,0.673719130356589
Physical measures,X4270.Volume level set by participant (left),PFDN2,Prefoldin subunit 2,36064,-0.0146730542244884,0.034955753574824,-0.0831863312311434,0.0538402227821665,0.674672308501853
Physical measures,X4270.Volume level set by participant (left),RNASET2,Ribonuclease T2,36315,-0.0294461933696502,0.0702411744908154,-0.167118895371648,0.108226508632348,0.675070276572273
Physical measures,X4270.Volume level set by participant (left),IZUMO1,Izumo sperm-egg fusion protein 1,35095,0.0209282790183344,0.0500830481240793,-0.0772344953048609,0.11909105334153,0.676054882737991
Physical measures,X4270.Volume level set by participant (left),SSH3,Protein phosphatase Slingshot homolog 3,35095,0.0315772749806648,0.0757337692174301,-0.116860912685498,0.180015462646828,0.676727994500825
Physical measures,X4270.Volume level set by participant (left),FCRL1,Fc receptor-like protein 1,36258,-0.0175325149612367,0.0420645491290136,-0.0999790312541034,0.06491400133163,0.676836199985685
Physical measures,X4270.Volume level set by participant (left),CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,36216,-0.024064745201384,0.0578437247505405,-0.137438445712443,0.0893089553096754,0.677399519884582
Physical measures,X4270.Volume level set by participant (left),RNASE10,Inactive ribonuclease-like protein 10,35151,-0.019583884740201,0.0471234788023724,-0.111945903192851,0.0727781337124488,0.677726176462444
Physical measures,X4270.Volume level set by participant (left),LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,35133,0.0228580417685919,0.0550468821424368,-0.0850338472305843,0.130749930767768,0.677974883452172
Physical measures,X4270.Volume level set by participant (left),LGALS8,Galectin-8,36325,0.0126049451087993,0.0303831942662421,-0.0469461156530351,0.0721560058706338,0.67825174672667
Physical measures,X4270.Volume level set by participant (left),SART1,U4/U6.U5 tri-snRNP-associated protein 1,35079,-0.0246072245980933,0.0594450061264488,-0.141119436605933,0.0919049874097464,0.678924873163815
Physical measures,X4270.Volume level set by participant (left),MED21,Mediator of RNA polymerase II transcription subunit 21,35079,-0.0187786979705664,0.0454728353945892,-0.107905455343961,0.0703480594028284,0.679645791947702
Physical measures,X4270.Volume level set by participant (left),CD63,CD63 antigen,36163,-0.0156868623395284,0.0380319890816293,-0.0902295609395219,0.0588558362604651,0.680010364201517
Physical measures,X4270.Volume level set by participant (left),SAG,S-arrestin,35083,0.0169610481417994,0.0411558281558692,-0.0637043750437042,0.0976264713273031,0.680266736316468
Physical measures,X4270.Volume level set by participant (left),GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,35151,-0.0175458371315847,0.0425905612681982,-0.101023337217253,0.0659316629540838,0.68037827702193
Physical measures,X4270.Volume level set by participant (left),IMMT,MICOS complex subunit MIC60,35279,0.0205277366363696,0.04985858445756,-0.077195088900448,0.118250562173187,0.680558466106629
Physical measures,X4270.Volume level set by participant (left),UNG,Uracil-DNA glycosylase,35279,-0.0271834069671818,0.0661453946637727,-0.156828380508176,0.102461566573813,0.681111779158647
Physical measures,X4270.Volume level set by participant (left),FOLH1,Glutamate carboxypeptidase 2,35093,0.00847497946939878,0.0206725893387175,-0.0320432956344874,0.048993254573285,0.681847233943297
Physical measures,X4270.Volume level set by participant (left),NEDD9,Enhancer of filamentation 1,35093,-0.0260289323467702,0.0635126632716575,-0.150513752359219,0.0984558876656786,0.681949525415009
Physical measures,X4270.Volume level set by participant (left),DBNL,Drebrin-like protein,36278,-0.00861861298563471,0.0210429903685153,-0.0498628741079247,0.0326256481366553,0.682131602605132
Physical measures,X4270.Volume level set by participant (left),MCTS1,Malignant T-cell-amplified sequence 1,35285,-0.0333268442120985,0.0814751160954115,-0.193018071759105,0.126364383334908,0.682521050072115
Physical measures,X4270.Volume level set by participant (left),CCL15,C-C motif chemokine 15,36364,0.0172758436068799,0.0422431921867519,-0.0655208130791538,0.100072500292914,0.682579123801253
Physical measures,X4270.Volume level set by participant (left),ICA1,Islet cell autoantigen 1,36103,-0.00989728976110129,0.0242087229452712,-0.0573463867338328,0.0375518072116302,0.682674956723431
Physical measures,X4270.Volume level set by participant (left),IGF1R,Insulin-like growth factor 1 receptor,36216,0.0356469103527325,0.0873605983407988,-0.135579862395233,0.206873683100698,0.683253331333733
Physical measures,X4270.Volume level set by participant (left),WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",36155,-0.0188693986446105,0.0462590394164711,-0.109537115900894,0.071798318611673,0.683353315939873
Physical measures,X4270.Volume level set by participant (left),MTPN,Myotrophin,36109,-0.023572839761024,0.0578798527302451,-0.137017351112304,0.0898716715902564,0.683819885232484
Physical measures,X4270.Volume level set by participant (left),CES2,Cocaine esterase,36216,0.0134608016906885,0.0330886232193134,-0.0513928998191658,0.0783145032005428,0.68415855865392
Physical measures,X4270.Volume level set by participant (left),LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,36256,-0.0203224483611401,0.0499587995015818,-0.11824169538424,0.0775967986619602,0.684177896177533
Physical measures,X4270.Volume level set by participant (left),FGFBP3,Fibroblast growth factor-binding protein 3,35301,-0.0237358789413882,0.0583703411996314,-0.138141747692666,0.0906699898098894,0.684283350360593
Physical measures,X4270.Volume level set by participant (left),ESPL1,Separin,35095,-0.017174498329397,0.0422500260943033,-0.0999845494742314,0.0656355528154374,0.684391043192055
Physical measures,X4270.Volume level set by participant (left),NT5C1A,Cytosolic 5'-nucleotidase 1A,35301,-0.0284121385380019,0.0699642807107022,-0.165542128730978,0.108717851654974,0.684685835696214
Physical measures,X4270.Volume level set by participant (left),FSTL1,Follistatin-related protein 1,35151,0.0395578202523175,0.0975622101928836,-0.151664111725734,0.230779752230369,0.685150805130734
Physical measures,X4270.Volume level set by participant (left),PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,36289,0.00807096739386523,0.0199574948741118,-0.0310457225593939,0.0471876573471243,0.685924088755736
Physical measures,X4270.Volume level set by participant (left),RNASEH2A,Ribonuclease H2 subunit A,35305,-0.0178028111294546,0.0440556511152972,-0.104151887315437,0.0685462650565278,0.686153372184787
Physical measures,X4270.Volume level set by participant (left),CFC1,Cryptic protein,36060,0.0163586010738274,0.0405484631831953,-0.0631163867652353,0.0958335889128901,0.68664104693151
Physical measures,X4270.Volume level set by participant (left),SFRP1,Secreted frizzled-related protein 1,36149,0.0182410775142222,0.0453186094564898,-0.0705833970204978,0.107065552048942,0.687322014821985
Physical measures,X4270.Volume level set by participant (left),VSIG10,V-set and immunoglobulin domain-containing protein 10,35279,0.0257317397825964,0.0639647804482212,-0.0996392298959171,0.15110270946111,0.687490990144499
Physical measures,X4270.Volume level set by participant (left),FN1,Fibronectin,35325,-0.0316377938801969,0.0786870581766601,-0.185864427906451,0.122588840146057,0.687644467269911
Physical measures,X4270.Volume level set by participant (left),FGFR4,Fibroblast growth factor receptor 4,35165,0.0171735316398521,0.0427931969325526,-0.066701134347951,0.101048197627655,0.688201636244295
Physical measures,X4270.Volume level set by participant (left),CLMP,CXADR-like membrane protein,36327,0.0346819573383106,0.0865174626996464,-0.134892269552996,0.204256184229617,0.6885294617876
Physical measures,X4270.Volume level set by participant (left),VSTM1,V-set and transmembrane domain-containing protein 1,36064,-0.0154412535230313,0.0385481445469048,-0.0909956168349647,0.0601131097889022,0.688747761717537
Physical measures,X4270.Volume level set by participant (left),RNF31,E3 ubiquitin-protein ligase RNF31,35093,-0.0241188375055865,0.0603149282631884,-0.142336096901436,0.0940984218902627,0.689256793803111
Physical measures,X4270.Volume level set by participant (left),TXK,Tyrosine-protein kinase TXK,35195,0.0118448310376027,0.0296301975861511,-0.0462303562312534,0.0699200183064588,0.689349646383961
Physical measures,X4270.Volume level set by participant (left),MRI1,Methylthioribose-1-phosphate isomerase,35133,-0.013001703992816,0.032531852269353,-0.076764134440748,0.0507607264551159,0.689419487336147
Physical measures,X4270.Volume level set by participant (left),GCG,Pro-glucagon,36060,-0.00624479137197867,0.0156297848739059,-0.0368791697248343,0.0243895869808769,0.689503635484803
Physical measures,X4270.Volume level set by participant (left),PSMD5,26S proteasome non-ATPase regulatory subunit 5,35133,-0.0165744953029707,0.0414867958164666,-0.0978886151032452,0.0647396244973038,0.689528649338306
Physical measures,X4270.Volume level set by participant (left),MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,36242,-0.00487146020771237,0.0122108749068437,-0.0288047750251261,0.0190618546097014,0.689945321439246
Physical measures,X4270.Volume level set by participant (left),GCC1,GRIP and coiled-coil domain-containing protein 1,35301,-0.00822920211172979,0.0206467759118781,-0.0486968828990109,0.0322384786755514,0.690222181233484
Physical measures,X4270.Volume level set by participant (left),CCL19,C-C motif chemokine 19,36325,0.00639105386416806,0.0160379445829998,-0.0250433175185115,0.0378254252468476,0.690275757213916
Physical measures,X4270.Volume level set by participant (left),SLAMF6,SLAM family member 6,36060,0.0194618564405091,0.0488938905031526,-0.07637016894567,0.115293881826688,0.690610101625782
Physical measures,X4270.Volume level set by participant (left),ACHE,Acetylcholinesterase,35165,-0.0260518995675375,0.0656538424015073,-0.154733430674492,0.102629631539417,0.691522744961007
Physical measures,X4270.Volume level set by participant (left),CD46,Membrane cofactor protein,36205,0.0258532076481126,0.0651992992737295,-0.101937418928397,0.153643834224622,0.691728270841754
Physical measures,X4270.Volume level set by participant (left),SCGB2A2,Mammaglobin-A,35079,0.0290529963340978,0.0732833690217173,-0.114582406948468,0.172688399616664,0.691788114641561
Physical measures,X4270.Volume level set by participant (left),NPPB,Natriuretic peptides B,36109,-0.00549511704334211,0.0138884728745878,-0.0327165238775342,0.02172628979085,0.692366907316769
Physical measures,X4270.Volume level set by participant (left),CRYM,Ketimine reductase mu-crystallin,35083,-0.0113992638086721,0.0288321620222275,-0.0679103013722379,0.0451117737548938,0.692585626703353
Physical measures,X4270.Volume level set by participant (left),PPM1B,Protein phosphatase 1B,35093,-0.0140779509989102,0.0356889149464596,-0.0840282242939711,0.0558723222961506,0.693252313270965
Physical measures,X4270.Volume level set by participant (left),PGLYRP2,N-acetylmuramoyl-L-alanine amidase,35237,-0.0295203776745644,0.0748981439300298,-0.176320739777423,0.117279984428294,0.69349012010363
Physical measures,X4270.Volume level set by participant (left),NEK7,Serine/threonine-protein kinase Nek7,35195,-0.012546572597191,0.031899619401151,-0.075069826623447,0.0499766814290648,0.694100166953908
Physical measures,X4270.Volume level set by participant (left),L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,35313,0.00967089255794471,0.0245913904838728,-0.038528232790446,0.0578700179063355,0.694137479808894
Physical measures,X4270.Volume level set by participant (left),TRIM5,Tripartite motif-containing protein 5,36242,-0.00878603240182489,0.0223611662076832,-0.052613918168884,0.0350418533652342,0.694393398506939
Physical measures,X4270.Volume level set by participant (left),NRP2,Neuropilin-2,36256,-0.025961350293648,0.0661282421957849,-0.155572704997386,0.10365000441009,0.694632548808228
Physical measures,X4270.Volume level set by participant (left),IL17D,Interleukin-17D,36103,-0.0224837875690189,0.0572792173633732,-0.13475105360123,0.0897834784631926,0.694678108939931
Physical measures,X4270.Volume level set by participant (left),IL6ST,Interleukin-6 receptor subunit beta,36258,0.0415735195755834,0.10622798645523,-0.166633333876668,0.249780373027835,0.69554110949389
Physical measures,X4270.Volume level set by participant (left),C8B,Complement component C8 beta chain,35325,0.0279118217793586,0.0714084723624905,-0.112048784051123,0.16787242760984,0.695901657596071
Physical measures,X4270.Volume level set by participant (left),HDAC9,Histone deacetylase 9,35083,-0.0136760458526273,0.0350080445980317,-0.0822918132647694,0.0549397215595149,0.696065568091612
Physical measures,X4270.Volume level set by participant (left),PRL,Prolactin,36325,0.00965438733451192,0.0247161658804395,-0.0387892977911496,0.0580980724601734,0.696096135118091
Physical measures,X4270.Volume level set by participant (left),SRC,Proto-oncogene tyrosine-protein kinase Src,36269,-0.00618643216857955,0.015908805855466,-0.0373676916452929,0.0249948273081338,0.697384285726017
Physical measures,X4270.Volume level set by participant (left),ROBO2,Roundabout homolog 2,36325,-0.0311908450430944,0.0803751033675264,-0.188726047643446,0.126344357557257,0.697977887711935
Physical measures,X4270.Volume level set by participant (left),CABP2,Calcium-binding protein 2,35133,-0.0133454878488019,0.0344460294158795,-0.0808597055039256,0.0541687298063219,0.698449177954906
Physical measures,X4270.Volume level set by participant (left),GFER,FAD-linked sulfhydryl oxidase ALR,36060,-0.0115530251791637,0.0298327031978285,-0.0700251234469074,0.0469190730885801,0.698574475678867
Physical measures,X4270.Volume level set by participant (left),IL16,Pro-interleukin-16,36342,0.0173140852105118,0.0447145562300143,-0.0703264450003163,0.10495461542134,0.698608715026893
Physical measures,X4270.Volume level set by participant (left),HLA_DRA,,36211,0.0203220801423859,0.052508355099417,-0.0825942958524714,0.123238456137243,0.698748045724962
Physical measures,X4270.Volume level set by participant (left),GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,35195,-0.0179960739444796,0.0465137370228725,-0.10916299850931,0.0731708506203504,0.698844177095523
Physical measures,X4270.Volume level set by participant (left),PTPRR,Receptor-type tyrosine-protein phosphatase R,35301,-0.0221552568399435,0.0572774544983997,-0.134419067656807,0.0901085539769198,0.698912203502279
Physical measures,X4270.Volume level set by participant (left),TGM2,Protein-glutamine gamma-glutamyltransferase 2,36250,-0.00966032839077231,0.0250645751457708,-0.0587868956764831,0.0394662388949385,0.69993876542359
Physical measures,X4270.Volume level set by participant (left),GUSB,Beta-glucuronidase,36288,0.0119149061519624,0.0309509884166221,-0.0487490311446169,0.0725788434485417,0.700277377751057
Physical measures,X4270.Volume level set by participant (left),TMED10,Transmembrane emp24 domain-containing protein 10,35079,0.0183171247893963,0.0476158235305672,-0.0750098893305154,0.111644138909308,0.700482948298449
Physical measures,X4270.Volume level set by participant (left),AOC3,Membrane primary amine oxidase,36289,-0.0243523502344301,0.0633723524040682,-0.148562160946404,0.0998574604775436,0.700785973377176
Physical measures,X4270.Volume level set by participant (left),PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",35320,0.0132771051730825,0.0347397350734827,-0.0548127755709436,0.0813669859171086,0.702334113390212
Physical measures,X4270.Volume level set by participant (left),COCH,Cochlin,35313,-0.0179291973696492,0.0469709082632702,-0.109992177565659,0.0741337828263604,0.702689642988157
Physical measures,X4270.Volume level set by participant (left),CD300E,CMRF35-like molecule 2,36305,0.0174175994332808,0.0456923910702314,-0.0721394870643728,0.106974685930934,0.70307088519898
Physical measures,X4270.Volume level set by participant (left),EDF1,Endothelial differentiation-related factor 1,35305,-0.0125605879263796,0.0330201037532219,-0.0772799912826946,0.0521588154299355,0.703666403385296
Physical measures,X4270.Volume level set by participant (left),DOC2B,Double C2-like domain-containing protein beta,35133,-0.0230030732582169,0.0605396997445323,-0.1416608847575,0.0956547382410664,0.703982450579689
Physical measures,X4270.Volume level set by participant (left),ACRV1,Acrosomal protein SP-10,35093,0.00813984672801321,0.0214327293930145,-0.0338683028822951,0.0501479963383215,0.704116835203167
Physical measures,X4270.Volume level set by participant (left),CPLX2,Complexin-2,35095,-0.0259431321878004,0.0683488054107876,-0.159906790792944,0.108020526417343,0.704277308132623
Physical measures,X4270.Volume level set by participant (left),CCAR2,Cell cycle and apoptosis regulator protein 2,35301,0.0149721582065226,0.039529727791559,-0.062506108264933,0.0924504246779782,0.704880380736105
Physical measures,X4270.Volume level set by participant (left),SEZ6,Seizure protein 6 homolog,35133,0.0264136245859684,0.0698099864779908,-0.110413948910894,0.16324119808283,0.705172093702171
Physical measures,X4270.Volume level set by participant (left),FGF3,Fibroblast growth factor 3,35093,0.0268832293488824,0.071186259117978,-0.112641838522355,0.166408297220119,0.705705693512958
Physical measures,X4270.Volume level set by participant (left),IRAK1,Interleukin-1 receptor-associated kinase 1,36103,-0.0103160267617168,0.0273315950597279,-0.0638859530787835,0.0432538995553498,0.705857610221234
Physical measures,X4270.Volume level set by participant (left),SHH,Sonic hedgehog protein,35093,-0.0193154055099235,0.0512493718765799,-0.11976417438802,0.0811333633681731,0.706267243882718
Physical measures,X4270.Volume level set by participant (left),FOS,Proto-oncogene c-Fos,35084,-0.0237074097066892,0.0632193638990698,-0.147617362948866,0.100202543535488,0.707670993416521
Physical measures,X4270.Volume level set by participant (left),BCL7B,B-cell CLL/lymphoma 7 protein family member B,35279,-0.0175094371109279,0.0467242075261725,-0.109088883862226,0.0740700096403702,0.707865623109772
Physical measures,X4270.Volume level set by participant (left),STX4,Syntaxin-4,36216,-0.0101384287083608,0.0270751001722732,-0.0632056250460163,0.0429287676292947,0.7080756530001
Physical measures,X4270.Volume level set by participant (left),ELOA,Elongin-A,36216,-0.0131013000503381,0.0349881788172931,-0.0816781305322326,0.0554755304315565,0.708080478343848
Physical measures,X4270.Volume level set by participant (left),CRACR2A,EF-hand calcium-binding domain-containing protein 4B,36060,0.00821559464317675,0.0219591047720341,-0.0348242507100101,0.0512554399963635,0.708317059177771
Physical measures,X4270.Volume level set by participant (left),DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,36271,-0.0141656481867926,0.0378637484689401,-0.0883785951859151,0.0600472988123299,0.708324153681563
Physical measures,X4270.Volume level set by participant (left),CD82,CD82 antigen,35195,-0.0187898852068744,0.0502710234465308,-0.117321091162075,0.079741320748326,0.708586206559512
Physical measures,X4270.Volume level set by participant (left),DTX3,Probable E3 ubiquitin-protein ligase DTX3,36216,-0.0284069530978779,0.0760525282610005,-0.177469908489439,0.120656002293683,0.708773695471752
Physical measures,X4270.Volume level set by participant (left),PMS1,PMS1 protein homolog 1,35133,0.0164323250715037,0.0440004739332854,-0.0698086038377356,0.102673253980743,0.708819788468228
Physical measures,X4270.Volume level set by participant (left),PRKG1,cGMP-dependent protein kinase 1,35165,-0.00655556455480226,0.017586587607927,-0.0410252762663392,0.0279141471567347,0.709339616285724
Physical measures,X4270.Volume level set by participant (left),TJP3,Tight junction protein ZO-3,35083,-0.0202703828787051,0.0543996581777958,-0.126893712907185,0.0863529471497745,0.709443714667135
Physical measures,X4270.Volume level set by participant (left),CLIP2,CAP-Gly domain-containing linker protein 2,36242,-0.00629701854155195,0.0169048269661955,-0.0394304793952952,0.0268364423121913,0.709532244972502
Physical measures,X4270.Volume level set by participant (left),PRC1,Protein regulator of cytokinesis 1,35279,0.0175020715241303,0.0470307210378482,-0.0746781417100521,0.109682284758313,0.709799493846341
Physical measures,X4270.Volume level set by participant (left),SERPINA6,Corticosteroid-binding globulin,35325,-0.0525167713050509,0.141130880136662,-0.329133296372908,0.224099753762806,0.709819729745002
Physical measures,X4270.Volume level set by participant (left),CST7,Cystatin-F,36254,0.00744914059388506,0.0200314970607116,-0.0318125936451097,0.0467108748328799,0.709998908148374
Physical measures,X4270.Volume level set by participant (left),LY9,T-lymphocyte surface antigen Ly-9,36148,0.0236447820507647,0.0635990338055255,-0.101009324208065,0.148298888309595,0.710067877296177
Physical measures,X4270.Volume level set by participant (left),SCAMP3,Secretory carrier-associated membrane protein 3,36216,-0.00838992465099958,0.0225691658545099,-0.052625489725839,0.0358456404238398,0.710094709570911
Physical measures,X4270.Volume level set by participant (left),IL12A_IL12B,Interleukin-12,36216,-0.00924373758919036,0.0248684406621204,-0.0579858812869463,0.0394984061085656,0.710122431794537
Physical measures,X4270.Volume level set by participant (left),BID,BH3-interacting domain death agonist,36242,-0.0103803062656697,0.0279910409027587,-0.0652427464350767,0.0444821339037372,0.710764098200721
Physical measures,X4270.Volume level set by participant (left),ESR1,Estrogen receptor,35093,-0.0145513318457106,0.0392650273510026,-0.0915107854536758,0.0624081217622545,0.710953027068009
Physical measures,X4270.Volume level set by participant (left),PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",35095,0.0150573589332044,0.0409106360873683,-0.0651274877980375,0.0952422056644463,0.712844318876501
Physical measures,X4270.Volume level set by participant (left),ITGB1,Integrin beta-1,36260,0.0320197597557286,0.0870608587926666,-0.138619523477898,0.202659042989355,0.713043019508035
Physical measures,X4270.Volume level set by participant (left),MMUT,"Methylmalonyl-CoA mutase, mitochondrial",35079,-0.0162104822026672,0.044201731413681,-0.102845875773482,0.0704249113681475,0.713825974074017
Physical measures,X4270.Volume level set by participant (left),BRAP,BRCA1-associated protein,35217,-0.00789727071891535,0.0215386245074907,-0.0501129747535972,0.0343184333157665,0.713887193098665
Physical measures,X4270.Volume level set by participant (left),CASP2,Caspase-2,36242,0.0101238579967923,0.0276221692826937,-0.0440155937972874,0.064263309790872,0.713993170386462
Physical measures,X4270.Volume level set by participant (left),DEFB4A_DEFB4B,Beta-defensin 4A,36130,0.00481442987981082,0.0131523072596646,-0.0209640923491317,0.0305929521087534,0.71433647602365
Physical measures,X4270.Volume level set by participant (left),PEPD,Xaa-Pro dipeptidase,35317,-0.0297009022374578,0.081144746147481,-0.188744604686521,0.129342800211605,0.714358904436439
Physical measures,X4270.Volume level set by participant (left),HHEX,Hematopoietically-expressed homeobox protein HHEX,35301,-0.0102994870868733,0.0282306022746839,-0.0656314675452538,0.0450324933715071,0.71524674829283
Physical measures,X4270.Volume level set by participant (left),CCL3,C-C motif chemokine 3,36242,0.0108762455569331,0.0298285365076496,-0.0475876859980601,0.0693401771119263,0.715401057351054
Physical measures,X4270.Volume level set by participant (left),FGL1,Fibrinogen-like protein 1,35317,0.0123727342889141,0.033971668009449,-0.054211735009606,0.0789572035874342,0.715714579644026
Physical measures,X4270.Volume level set by participant (left),IQGAP2,Ras GTPase-activating-like protein IQGAP2,36216,0.0123481446216497,0.0339223016481706,-0.0541395666087647,0.0788358558520641,0.715858722484988
Physical measures,X4270.Volume level set by participant (left),SMAD5,Mothers against decapentaplegic homolog 5,36216,-0.0348853617062182,0.0960283187202169,-0.223100866397843,0.153330142985407,0.716404308824727
Physical measures,X4270.Volume level set by participant (left),ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,35325,-0.0318572943986485,0.0880237778267462,-0.204383898939071,0.140669310141774,0.717425493015747
Physical measures,X4270.Volume level set by participant (left),EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,36318,-0.0224497775312414,0.0621753010044407,-0.144313367499945,0.0994138124374623,0.718055303179243
Physical measures,X4270.Volume level set by participant (left),ADGRV1,Adhesion G-protein coupled receptor V1,35083,-0.0119125675171765,0.0330398794817577,-0.0766707313014215,0.0528455962670686,0.718446742759081
Physical measures,X4270.Volume level set by participant (left),YAP1,Transcriptional coactivator YAP1,35301,0.0282339422775541,0.0783110089279095,-0.125255635221149,0.181723519776257,0.718457667414381
Physical measures,X4270.Volume level set by participant (left),ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,36289,0.0146850495531395,0.0407614557864173,-0.0652074037882384,0.0945775028945175,0.718656600947271
Physical measures,X4270.Volume level set by participant (left),STAM,Signal transducing adapter molecule 1,35279,-0.0209635586758999,0.0586465553981437,-0.135910807256262,0.0939836899044618,0.720761816011457
Physical measures,X4270.Volume level set by participant (left),PDCD1,Programmed cell death protein 1,36309,0.0166581142913565,0.0466473367214124,-0.0747706656826118,0.108086894265325,0.721021100682827
Physical measures,X4270.Volume level set by participant (left),FIS1,Mitochondrial fission 1 protein,36247,-0.00887054269734219,0.0248996894880607,-0.0576739340939411,0.0399328486992567,0.72166233064628
Physical measures,X4270.Volume level set by participant (left),CD70,CD70 antigen,36242,0.0151756058263296,0.0426433357394352,-0.0684053322229634,0.0987565438756226,0.721945608894307
Physical measures,X4270.Volume level set by participant (left),MZT1,Mitotic-spindle organizing protein 1,36060,0.0120576449065263,0.0339052028977121,-0.0543965527729893,0.0785118425860419,0.722129111394689
Physical measures,X4270.Volume level set by participant (left),SCRG1,Scrapie-responsive protein 1,35313,0.028442159668866,0.0800414602182939,-0.12843910235899,0.185323421696722,0.722343935425854
Physical measures,X4270.Volume level set by participant (left),MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",35151,-0.00875222995861762,0.0246389019060873,-0.0570444776945488,0.0395400177773136,0.722436247371889
Physical measures,X4270.Volume level set by participant (left),PDGFC,Platelet-derived growth factor C,36060,-0.0242187753165054,0.0681902961159943,-0.157871755703854,0.109434205070843,0.722476371139239
Physical measures,X4270.Volume level set by participant (left),CRYBB1,Beta-crystallin B1,35313,-0.0119528199363592,0.0336847427128436,-0.0779749156535327,0.0540692757808143,0.722717813301427
Physical measures,X4270.Volume level set by participant (left),PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",35195,-0.0159041790305453,0.0449056032794878,-0.103919161458341,0.0721108033972509,0.723223454901586
Physical measures,X4270.Volume level set by participant (left),NUDC,Nuclear migration protein nudC,36342,-0.0107462137134515,0.0303948453436775,-0.0703201105870593,0.0488276831601563,0.723682917711387
Physical measures,X4270.Volume level set by participant (left),LGALS1,Galectin-1,36258,0.0189102303538153,0.05350296780611,-0.0859555865461602,0.123776047253791,0.723766354394151
Physical measures,X4270.Volume level set by participant (left),FLRT2,Leucine-rich repeat transmembrane protein FLRT2,36179,-0.0231268365255264,0.0654796374016114,-0.151466925832685,0.105213252781632,0.723954876268137
Physical measures,X4270.Volume level set by participant (left),RTKN2,Rhotekin-2,35079,0.0153087721145051,0.0434786429971288,-0.0699093681598674,0.100526912388878,0.724775727063753
Physical measures,X4270.Volume level set by participant (left),SLC39A14,Zinc transporter ZIP14,36064,-0.0203978821997624,0.0581236614295909,-0.13432025860176,0.0935244942022357,0.725643729123835
Physical measures,X4270.Volume level set by participant (left),ELOB,Elongin-B,35079,-0.02037312999962,0.0581809978199435,-0.134407885726709,0.0936616257274691,0.726223926602091
Physical measures,X4270.Volume level set by participant (left),FOXJ3,Forkhead box protein J3,35093,-0.0172864121576625,0.049410749974463,-0.11413148210761,0.079558657792285,0.726461694053632
Physical measures,X4270.Volume level set by participant (left),FOSB,Protein fosB,36064,0.0173641441909381,0.04981670390839,-0.0802765954695064,0.115004883851382,0.727428986116006
Physical measures,X4270.Volume level set by participant (left),CDAN1,Codanin-1,35301,-0.0366138025048554,0.105191526801613,-0.242789195036016,0.169561590026305,0.727800067176243
Physical measures,X4270.Volume level set by participant (left),PTPN6,Tyrosine-protein phosphatase non-receptor type 6,36268,-0.00766727009060137,0.0220987371655634,-0.0509807949351057,0.0356462547539029,0.728634557785738
Physical measures,X4270.Volume level set by participant (left),GAD2,Glutamate decarboxylase 2,35093,-0.0170058334593272,0.0490642291820983,-0.11317172265624,0.0791600557375855,0.728900454441618
Physical measures,X4270.Volume level set by participant (left),HEBP1,Heme-binding protein 1,36109,0.0126560917587161,0.0365693945681341,-0.0590199215948267,0.084332105112259,0.729289094007231
Physical measures,X4270.Volume level set by participant (left),TFPI2,Tissue factor pathway inhibitor 2,36264,-0.015998730434441,0.0463199568749804,-0.106785845909403,0.0747883850405206,0.729806124531852
Physical measures,X4270.Volume level set by participant (left),VEGFA,Vascular endothelial growth factor A,36326,-0.0115521101095128,0.0334634796498101,-0.0771405302231405,0.0540363100041149,0.729941807690396
Physical measures,X4270.Volume level set by participant (left),INSR,Insulin receptor,35093,0.0454390428052957,0.131637909084185,-0.212571258999706,0.303449344610298,0.72996870172383
Physical measures,X4270.Volume level set by participant (left),PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,35313,-0.0239377916137679,0.0695308138745441,-0.160218186807874,0.112342603580339,0.730649507858412
Physical measures,X4270.Volume level set by participant (left),GH1,Somatotropin,36247,-0.00367958498416625,0.0106948924153137,-0.0246415741181812,0.0172824041498486,0.730817638060066
Physical measures,X4270.Volume level set by participant (left),CTSO,Cathepsin O,36342,0.0211030434388834,0.0614052827991366,-0.0992513108474243,0.141457397725191,0.731105159610957
Physical measures,X4270.Volume level set by participant (left),EPCAM,Epithelial cell adhesion molecule,36233,-0.00690837850286184,0.0201577076302606,-0.0464174854581727,0.032600728452449,0.731821208072061
Physical measures,X4270.Volume level set by participant (left),IL21R,Interleukin-21 receptor,35093,0.0137439439816883,0.0401550507511439,-0.0649599554905538,0.0924478434539304,0.732157392528227
Physical measures,X4270.Volume level set by participant (left),XPNPEP2,Xaa-Pro aminopeptidase 2,36289,0.00585836101610518,0.0171275195392163,-0.0277115772807588,0.0394282993129692,0.732327319650901
Physical measures,X4270.Volume level set by participant (left),SIGLEC10,Sialic acid-binding Ig-like lectin 10,36242,-0.0187076618219588,0.0547263289783863,-0.125971266619596,0.0885559429756784,0.732480522628358
Physical measures,X4270.Volume level set by participant (left),CRTAP,Cartilage-associated protein,35133,-0.0148525605526289,0.0434998431458805,-0.100112253118555,0.0704071320132969,0.732783800882474
Physical measures,X4270.Volume level set by participant (left),AP2B1,AP-2 complex subunit beta,35133,-0.0151665138253809,0.0445223078376323,-0.10243023718714,0.0720972095363783,0.733378217014896
Physical measures,X4270.Volume level set by participant (left),TFRC,Transferrin receptor protein 1,36295,0.016931604557913,0.0498342822757224,-0.0807435887025028,0.114606797818329,0.734047927678053
Physical measures,X4270.Volume level set by participant (left),GAGE2A,G antigen 2A,35095,0.011620434532623,0.034202494070465,-0.0554164538454883,0.0786573229107343,0.734052774912627
Physical measures,X4270.Volume level set by participant (left),BMP4,Bone morphogenetic protein 4,36163,-0.0115737944977082,0.0340677457900422,-0.0783465762461909,0.0551989872507746,0.734070206356597
Physical measures,X4270.Volume level set by participant (left),PRG2,Bone marrow proteoglycan,35320,0.0145012665065683,0.0426887715579581,-0.0691687257470296,0.0981712587601661,0.734095009039682
Physical measures,X4270.Volume level set by participant (left),TNF,Tumor necrosis factor,36098,-0.0173071750496368,0.0511235563794913,-0.11750934555344,0.0828949954541661,0.734968626986826
Physical measures,X4270.Volume level set by participant (left),NEXN,Nexilin,35317,-0.0101211171154081,0.0299146032224435,-0.0687537394313974,0.0485115052005811,0.735122341831434
Physical measures,X4270.Volume level set by participant (left),SERPINB5,Serpin B5,36109,0.0134548091393638,0.0398812377911858,-0.0647124169313603,0.091622035210088,0.735845995019786
Physical measures,X4270.Volume level set by participant (left),AIFM1,"Apoptosis-inducing factor 1, mitochondrial",36204,-0.00614566769594773,0.0182469795307125,-0.0419097475761442,0.0296184121842487,0.736273460137643
Physical measures,X4270.Volume level set by participant (left),BAG4,BAG family molecular chaperone regulator 4,35093,-0.0149717463099558,0.0445633339525673,-0.102315880856988,0.072372388237076,0.736907683654023
Physical measures,X4270.Volume level set by participant (left),UMOD,Uromodulin,36334,-0.0118059068995919,0.0351844118559956,-0.0807673541373432,0.0571555403381594,0.737224108330671
Physical measures,X4270.Volume level set by participant (left),PON3,Serum paraoxonase/lactonase 3,36278,-0.0221455999737519,0.0662134763873601,-0.151924013692978,0.107632813745474,0.738043424545738
Physical measures,X4270.Volume level set by participant (left),GIPC2,PDZ domain-containing protein GIPC2,35301,0.022276568442033,0.0668093590185763,-0.108669775234377,0.153222912118442,0.738816499179227
Physical measures,X4270.Volume level set by participant (left),PMCH,Pro-MCH,35079,-0.00855611719072347,0.0256828546752615,-0.0588945123542361,0.0417822779727891,0.739035541619275
Physical measures,X4270.Volume level set by participant (left),F10,Coagulation factor X,35317,0.0255810256430115,0.07680570348651,-0.124958153190548,0.176120204476571,0.739098232024624
Physical measures,X4270.Volume level set by participant (left),SFTPA1,Pulmonary surfactant-associated protein A1,36060,-0.0114916436025331,0.0345430389604921,-0.0791959999650975,0.0562127127600314,0.739388141290443
Physical measures,X4270.Volume level set by participant (left),CNPY2,Protein canopy homolog 2,36109,-0.0107128517906769,0.0322708931048143,-0.0739638022761129,0.0525380986947592,0.739923909266201
Physical measures,X4270.Volume level set by participant (left),PSPN,Persephin,36242,-0.00714184563779313,0.02154460490222,-0.0493692712461443,0.035085579970558,0.74028262574264
Physical measures,X4270.Volume level set by participant (left),RASA1,Ras GTPase-activating protein 1,36064,-0.0193075709742751,0.0582865660767202,-0.133549240484647,0.0949340985360966,0.740463067068743
Physical measures,X4270.Volume level set by participant (left),IL18R1,Interleukin-18 receptor 1,36342,0.0187065063441845,0.0566204217445104,-0.0922695202750559,0.129682532963425,0.741118440259399
Physical measures,X4270.Volume level set by participant (left),DDX4,Probable ATP-dependent RNA helicase DDX4,35093,-0.0139107201210456,0.0422194902772583,-0.0966609210644719,0.0688394808223807,0.741799201223096
Physical measures,X4270.Volume level set by participant (left),GRSF1,G-rich sequence factor 1,35054,0.00885899178633775,0.0269190009767791,-0.0439022501281493,0.0616202337008248,0.742092231849069
Physical measures,X4270.Volume level set by participant (left),MNDA,Myeloid cell nuclear differentiation antigen,36248,0.00621953908974387,0.0189633185344861,-0.0309485652378488,0.0433876434173366,0.742937764703931
Physical measures,X4270.Volume level set by participant (left),NPY,Pro-neuropeptide Y,36327,0.00946765583450473,0.0289062372745951,-0.0471885692237016,0.0661238808927111,0.743276039117757
Physical measures,X4270.Volume level set by participant (left),CNDP1,Beta-Ala-His dipeptidase,36289,-0.0126294308024048,0.0385669237283911,-0.0882206013100514,0.0629617397052418,0.743322911305661
Physical measures,X4270.Volume level set by participant (left),H2AP,Huntingtin-interacting protein M,35095,-0.0143415357222742,0.0437987448545063,-0.100187075637107,0.0715040041925581,0.743344384755825
Physical measures,X4270.Volume level set by participant (left),SH2D1A,SH2 domain-containing protein 1A,36242,-0.0101873870388989,0.0311140836998779,-0.0711709910906595,0.0507962170128617,0.74335887928807
Physical measures,X4270.Volume level set by participant (left),THY1,Thy-1 membrane glycoprotein,36325,0.0210887847624198,0.0644465809465641,-0.105226513892846,0.147404083417685,0.743503622567769
Physical measures,X4270.Volume level set by participant (left),NXPH1,Neurexophilin-1,36064,-0.0159671999552579,0.0488205954487055,-0.111655567034721,0.0797211671242049,0.743632671287788
Physical measures,X4270.Volume level set by participant (left),TIE1,Tyrosine-protein kinase receptor Tie-1,36364,0.0144790620935393,0.0442761151867478,-0.0723021236724863,0.101260247859565,0.743663509443777
Physical measures,X4270.Volume level set by participant (left),CFI,Complement factor I,35325,-0.0358200628867501,0.109573976210663,-0.25058505625965,0.17894493048615,0.743751421149122
Physical measures,X4270.Volume level set by participant (left),THAP12,52 kDa repressor of the inhibitor of the protein kinase,35084,-0.00878095775980365,0.0268621973399649,-0.0614308645461349,0.0438689490265276,0.743762371325793
Physical measures,X4270.Volume level set by participant (left),TOR1AIP1,Torsin-1A-interacting protein 1,35151,-0.013836682374028,0.0424186151656789,-0.0969771680987586,0.0693038033507026,0.744288279267804
Physical measures,X4270.Volume level set by participant (left),RARRES1,Retinoic acid receptor responder protein 1,36060,0.0194757947776348,0.0598642781604169,-0.0978581904167823,0.136809779972052,0.744938569747202
Physical measures,X4270.Volume level set by participant (left),IDS,Iduronate 2-sulfatase,36342,0.0623504318283398,0.191736783801672,-0.313453664422937,0.438154528079617,0.745047854721393
Physical measures,X4270.Volume level set by participant (left),APOE,Apolipoprotein E,35325,0.0103653442903096,0.0322233392248472,-0.052792400590391,0.0735230891710102,0.74771123350874
Physical measures,X4270.Volume level set by participant (left),HPGDS,Hematopoietic prostaglandin D synthase,36060,0.0166997871350943,0.0520144788590677,-0.0852485914286784,0.118648165698867,0.748173649382863
Physical measures,X4270.Volume level set by participant (left),FNDC1,Fibronectin type III domain-containing protein 1,35301,0.0147325463176001,0.0460547457551423,-0.0755347553624789,0.104999847997679,0.749060153889876
Physical measures,X4270.Volume level set by participant (left),TXNDC5,Thioredoxin domain-containing protein 5,36325,-0.00875024767443809,0.0273612295358067,-0.0623782575646192,0.044877762215743,0.749125095331066
Physical measures,X4270.Volume level set by participant (left),APOM,Apolipoprotein M,36276,-0.0209217060076157,0.0656206328063045,-0.149538146307972,0.107694734292741,0.749865496963097
Physical measures,X4270.Volume level set by participant (left),CD69,Early activation antigen CD69,36225,0.00698323261684575,0.0219886478633387,-0.0361145171952981,0.0500809824289896,0.750809561253087
Physical measures,X4270.Volume level set by participant (left),ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,35079,0.0141752564991667,0.0446565022209672,-0.073351487853929,0.101702000852262,0.750928548524484
Physical measures,X4270.Volume level set by participant (left),NFIC,Nuclear factor 1 C-type,35305,-0.0153676099016416,0.0487981342614996,-0.111011953054181,0.0802767332508976,0.752830621135295
Physical measures,X4270.Volume level set by participant (left),SERPING1,Plasma protease C1 inhibitor,35317,0.03752022683493,0.119484605310478,-0.196669599573607,0.271710053243468,0.7535176955669
Physical measures,X4270.Volume level set by participant (left),PCDHB15,Protocadherin beta-15,35279,-0.0177833559067851,0.056686959464019,-0.128889796456262,0.0933230846426922,0.753749902290407
Physical measures,X4270.Volume level set by participant (left),OMP,Olfactory marker protein,35083,-0.0150286678683888,0.0479509263856807,-0.109012483584323,0.0789551478475455,0.753973444868212
Physical measures,X4270.Volume level set by participant (left),SLITRK6,SLIT and NTRK-like protein 6,36109,-0.0172510789270359,0.0551701077819572,-0.125384490179672,0.0908823323256002,0.754525735391652
Physical measures,X4270.Volume level set by participant (left),LIF,Leukemia inhibitory factor,36064,-0.0113177094468556,0.0362487566911641,-0.0823652725615372,0.059729853667826,0.754879487702151
Physical measures,X4270.Volume level set by participant (left),CCL4,C-C motif chemokine 4,36254,-0.00955113002844318,0.0306262447622979,-0.069578569762547,0.0504763097056606,0.755154692582121
Physical measures,X4270.Volume level set by participant (left),HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",35079,0.0161522827515664,0.0518061452154779,-0.0853877618707704,0.117692327373903,0.755215373156455
Physical measures,X4270.Volume level set by participant (left),PLXDC1,Plexin domain-containing protein 1,36060,0.0188262804849339,0.0604147385195783,-0.0995866070134396,0.137239167983307,0.755340061394075
Physical measures,X4270.Volume level set by participant (left),CILP,Cartilage intermediate layer protein 1,35320,-0.0123767455365913,0.0397230903178943,-0.0902340025596642,0.0654805114864815,0.755372753037739
Physical measures,X4270.Volume level set by participant (left),ISM1,Isthmin-1,36242,0.0144912882244519,0.0466793022459878,-0.0770001441776842,0.105982720626588,0.756232151350159
Physical measures,X4270.Volume level set by participant (left),DDX1,ATP-dependent RNA helicase DDX1,35285,-0.0139378619785631,0.0451070902335301,-0.102347758836282,0.0744720348791558,0.757335020630542
Physical measures,X4270.Volume level set by participant (left),ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,36216,0.0131034824254161,0.0424160180411378,-0.070031912935214,0.0962388777860463,0.757384987140644
Physical measures,X4270.Volume level set by participant (left),SDC4,Syndecan-4,36258,0.0122118394651438,0.0395349836449772,-0.0652767284790115,0.0897004074092991,0.757415950268683
Physical measures,X4270.Volume level set by participant (left),PLXNB2,Plexin-B2,36329,0.0235244149736106,0.0761807697653099,-0.125789893766397,0.172838723713618,0.757484059605095
Physical measures,X4270.Volume level set by participant (left),CDC123,Cell division cycle protein 123 homolog,35095,-0.0106937491208641,0.0346577802218627,-0.078622998355715,0.0572355001139867,0.757671762122192
Physical measures,X4270.Volume level set by participant (left),NCS1,Neuronal calcium sensor 1,36327,0.0201423577003328,0.0657844054387915,-0.108795076959698,0.149079792360364,0.759470198751135
Physical measures,X4270.Volume level set by participant (left),GGA1,ADP-ribosylation factor-binding protein GGA1,36064,-0.00875350428137413,0.0287327087085845,-0.0650696133501998,0.0475626047874516,0.760638989620638
Physical measures,X4270.Volume level set by participant (left),CA9,Carbonic anhydrase 9,36327,0.0122790171676813,0.040377186761748,-0.0668602688853449,0.0914183032207074,0.761053961625851
Physical measures,X4270.Volume level set by participant (left),PCBD1,Pterin-4-alpha-carbinolamine dehydratase,35151,0.0142357200411872,0.0470770580627738,-0.0780353137618494,0.106506753844224,0.762362949387636
Physical measures,X4270.Volume level set by participant (left),ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,35093,0.0180898115639488,0.0598497158857535,-0.099215631572128,0.135395254700026,0.762468184407385
Physical measures,X4270.Volume level set by participant (left),CTF1,Cardiotrophin-1,36109,0.00698415546857804,0.0231647473965818,-0.0384187494287223,0.0523870603658784,0.763042124507238
Physical measures,X4270.Volume level set by participant (left),CGN,Cingulin,35133,0.0185347352223032,0.0616882610675745,-0.102374256470143,0.139443726914749,0.763837347695487
Physical measures,X4270.Volume level set by participant (left),BAMBI,BMP and activin membrane-bound inhibitor homolog,36060,-0.0193071084202449,0.0642609059036542,-0.145258483991407,0.106644267150917,0.763843263737675
Physical measures,X4270.Volume level set by participant (left),JUN,Transcription factor AP-1,36103,-0.0114506093516988,0.0381700301045238,-0.0862638683565655,0.0633626496531679,0.764193456477566
Physical measures,X4270.Volume level set by participant (left),SPAG1,Sperm-associated antigen 1,35305,-0.011024619890879,0.0367557008718735,-0.0830657935997511,0.0610165538179931,0.764229838718929
Physical measures,X4270.Volume level set by participant (left),PTTG1,Securin,35195,-0.0157932218588915,0.0527725850722896,-0.119227488600579,0.0876410448827961,0.764743906316575
Physical measures,X4270.Volume level set by participant (left),TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",35093,0.010745654218018,0.0359415252066268,-0.0596997351869706,0.0811910436230067,0.764967913911987
Physical measures,X4270.Volume level set by participant (left),CTNNA1,Catenin alpha-1,35083,0.0197195585813429,0.0660227835034718,-0.109685097085462,0.149124214248148,0.765195256612006
Physical measures,X4270.Volume level set by participant (left),CNST,Consortin,36258,0.00549085376904132,0.01839607631192,-0.030565455802322,0.0415471633404046,0.765345233975766
Physical measures,X4270.Volume level set by participant (left),DENR,Density-regulated protein,35093,-0.0115754401418479,0.0389176982274846,-0.0878541286677176,0.0647032483840219,0.766144836704032
Physical measures,X4270.Volume level set by participant (left),NGRN,Neugrin,35301,-0.0289022508463048,0.0971768455518917,-0.219368868128012,0.161564366435403,0.766155779865617
Physical measures,X4270.Volume level set by participant (left),TMPRSS11B,Transmembrane protease serine 11B,35083,0.00890213000513995,0.0299447545339002,-0.0497895888813045,0.0675938488915844,0.766258368626617
Physical measures,X4270.Volume level set by participant (left),SPRR3,Small proline-rich protein 3,35301,-0.0102183766640064,0.0344238142283783,-0.0776890525516279,0.057252299223615,0.766597611405627
Physical measures,X4270.Volume level set by participant (left),CBX2,Chromobox protein homolog 2,35079,-0.0172106571348793,0.0579980574961081,-0.130886849827251,0.0964655355574925,0.766670404886089
Physical measures,X4270.Volume level set by participant (left),GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,35006,0.0267586614930459,0.0902675991645719,-0.150165832869515,0.203683155855607,0.766905942775181
Physical measures,X4270.Volume level set by participant (left),ARID4B,AT-rich interactive domain-containing protein 4B,36064,-0.0134794073857549,0.0455385459626802,-0.102734957472608,0.0757761427010983,0.767238356519569
Physical measures,X4270.Volume level set by participant (left),C1S,Complement C1s subcomponent,35325,0.0298951833911559,0.101003827416375,-0.168072318344939,0.227862685127251,0.767253964608224
Physical measures,X4270.Volume level set by participant (left),NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,35165,-0.0304592425612413,0.103093522694311,-0.232522547042091,0.171604061919608,0.767657554625183
Physical measures,X4270.Volume level set by participant (left),DDX39A,ATP-dependent RNA helicase DDX39A,35093,0.0264771592326998,0.0897538925774177,-0.149440470219039,0.202394788684438,0.768005350509097
Physical measures,X4270.Volume level set by participant (left),CD8A,T-cell surface glycoprotein CD8 alpha chain,36325,0.0106734499909696,0.0363115413984458,-0.0604971711499841,0.0818440711319233,0.768810904690085
Physical measures,X4270.Volume level set by participant (left),TEX101,Testis-expressed protein 101,35133,-0.0108159426327605,0.0367982040063863,-0.0829404224852776,0.0613085372197566,0.768823922057112
Physical measures,X4270.Volume level set by participant (left),ICAM3,Intercellular adhesion molecule 3,36364,0.0202322525320481,0.0688827287187197,-0.114777895756643,0.155242400820739,0.76897953071008
Physical measures,X4270.Volume level set by participant (left),GID8,Glucose-induced degradation protein 8 homolog,35305,-0.0182404588187573,0.062115876845871,-0.139987577436664,0.10350665979915,0.76903283869299
Physical measures,X4270.Volume level set by participant (left),ANGPTL1,Angiopoietin-related protein 1,36120,0.0194273975463897,0.0664728177624432,-0.110859325267999,0.149714120360778,0.770095309378885
Physical measures,X4270.Volume level set by participant (left),LYAR,Cell growth-regulating nucleolar protein,36060,0.0105396209588579,0.0361251415561633,-0.0602656564912221,0.081344898408938,0.770483544934542
Physical measures,X4270.Volume level set by participant (left),SPARCL1,SPARC-like protein 1,36255,-0.0196096447544949,0.0673202243955041,-0.151557284569683,0.112337995060693,0.770838150435474
Physical measures,X4270.Volume level set by participant (left),NPTN,Neuroplastin,36060,0.00716243953253406,0.0246025743182209,-0.0410586061311788,0.055383485196247,0.770963348327595
Physical measures,X4270.Volume level set by participant (left),PDZD2,PDZ domain-containing protein 2,35079,-0.0103504414560865,0.0355753705966062,-0.0800781678254347,0.0593772849132618,0.77110344824776
Physical measures,X4270.Volume level set by participant (left),TMEM25,Transmembrane protein 25,35305,0.0139640394190879,0.0481113082973882,-0.0803341248437929,0.108262203681969,0.771638225271645
Physical measures,X4270.Volume level set by participant (left),JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,35095,-0.0112366386437528,0.0388442422764843,-0.0873713535056621,0.0648980762181564,0.772380760947186
Physical measures,X4270.Volume level set by participant (left),EIF5A,Eukaryotic translation initiation factor 5A-1,36103,0.0172505532880577,0.0597032123078126,-0.0997677428352549,0.13426884941137,0.772636469122372
Physical measures,X4270.Volume level set by participant (left),ITGA6,Integrin alpha-6,36242,-0.0101952146124158,0.0353724089251554,-0.0795251361057204,0.0591347068808888,0.773182288447505
Physical measures,X4270.Volume level set by participant (left),RYR1,Ryanodine receptor 1,35079,0.0182750535698903,0.0635552225576413,-0.106293182643087,0.142843289782867,0.773703443374592
Physical measures,X4270.Volume level set by participant (left),IL6R,Interleukin-6 receptor subunit alpha,36204,-0.0157457171128415,0.0547719259173719,-0.12309869191089,0.0916072576852074,0.77375427405065
Physical measures,X4270.Volume level set by participant (left),S100A14,Protein S100-A14,35305,0.01278168196315,0.0444740041873301,-0.0743873662440169,0.099950730170317,0.773817474459339
Physical measures,X4270.Volume level set by participant (left),PTPRS,Receptor-type tyrosine-protein phosphatase S,36364,0.0211557313212258,0.0736963411506156,-0.123289097333981,0.165600559976432,0.77406926735144
Physical measures,X4270.Volume level set by participant (left),C2CD2L,Phospholipid transfer protein C2CD2L,36053,-0.0130085966634603,0.045353625016835,-0.101901701696457,0.0758845083695363,0.77425356716151
Physical measures,X4270.Volume level set by participant (left),KIRREL1,Kin of IRRE-like protein 1,35083,-0.0115130400356401,0.0401944612266672,-0.0902941840399078,0.0672681039686276,0.774555279978102
Physical measures,X4270.Volume level set by participant (left),CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,36109,0.0107241048735386,0.0375463497436916,-0.0628667406240969,0.084314950371174,0.775174688957949
Physical measures,X4270.Volume level set by participant (left),APOC1,Apolipoprotein C-I,35317,-0.016375953638062,0.0573717924723671,-0.128824666883902,0.0960727596077774,0.775319219656891
Physical measures,X4270.Volume level set by participant (left),TCP11,T-complex protein 11 homolog,35195,0.0117687536418359,0.0412829864952845,-0.0691458998889218,0.0926834071725936,0.775595522222532
Physical measures,X4270.Volume level set by participant (left),POSTN,Periostin,35320,-0.0164121789673453,0.0576603099593012,-0.129426386487576,0.0966020285528851,0.775932081439049
Physical measures,X4270.Volume level set by participant (left),F7,Coagulation factor VII,36284,0.0172733421194893,0.0607479637654118,-0.101792666860718,0.136339351099696,0.776154143356316
Physical measures,X4270.Volume level set by participant (left),CEP290,Centrosomal protein of 290 kDa,35195,0.0115348755905888,0.0406768150572622,-0.0681916819216451,0.0912614331028226,0.776745987647173
Physical measures,X4270.Volume level set by participant (left),CHGB,Secretogranin-1,36302,0.0126160474371802,0.0444972467173458,-0.0745985561288176,0.099830651003178,0.776782636963335
Physical measures,X4270.Volume level set by participant (left),CDHR5,Cadherin-related family member 5,36258,-0.0137371724493151,0.04849273512145,-0.108782933287357,0.081308588388727,0.776967489624465
Physical measures,X4270.Volume level set by participant (left),HLA_A,,35305,-0.0186459965103188,0.0660836476332271,-0.148169945871444,0.110877952850806,0.777831460758707
Physical measures,X4270.Volume level set by participant (left),OTOA,Otoancorin,35083,-0.0117726643354066,0.041789517815951,-0.0936801192546705,0.0701347905838573,0.778172326135978
Physical measures,X4270.Volume level set by participant (left),EFCAB14,EF-hand calcium-binding domain-containing protein 14,35285,-0.0213756195516316,0.0762157957858716,-0.17075857929194,0.128007340188677,0.779131908694918
Physical measures,X4270.Volume level set by participant (left),PROC,Vitamin K-dependent protein C,36276,0.0205064233822744,0.0731627253505291,-0.122892518304763,0.163905365069311,0.77926632064098
Physical measures,X4270.Volume level set by participant (left),CTSS,Cathepsin S,34556,0.0267788559300033,0.0962434745709754,-0.161858354229108,0.215416066089115,0.780837223701311
Physical measures,X4270.Volume level set by participant (left),ATP5PO,"ATP synthase subunit O, mitochondrial",36064,-0.01207358155423,0.0436108449578778,-0.0975508376716704,0.0734036745632105,0.781904379723021
Physical measures,X4270.Volume level set by participant (left),GRIK2,"Glutamate receptor ionotropic, kainate 2",35305,0.0147711109208228,0.0535568131952814,-0.0902002429419288,0.119742464783574,0.782708152721294
Physical measures,X4270.Volume level set by participant (left),XCL1,Lymphotactin,36327,-0.00948292190997172,0.0347390838496721,-0.0775715262553291,0.0586056824353857,0.784879277278019
Physical measures,X4270.Volume level set by participant (left),RNF5,E3 ubiquitin-protein ligase RNF5,35151,-0.00887934148932444,0.0325436605570363,-0.0726649161811155,0.0549062332024667,0.784981763436931
Physical measures,X4270.Volume level set by participant (left),EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",35240,-0.00552377070706194,0.0203258136080931,-0.0453623653789243,0.0343148239648005,0.785813971908423
Physical measures,X4270.Volume level set by participant (left),IL22RA1,Interleukin-22 receptor subunit alpha-1,36103,-0.0118434008956963,0.0436472821538439,-0.0973920739172304,0.0737052721258378,0.786134415953404
Physical measures,X4270.Volume level set by participant (left),DMD,Dystrophin,35151,-0.0106396419902373,0.0394188289019509,-0.087900546638061,0.0666212626575865,0.787235932847612
Physical measures,X4270.Volume level set by participant (left),CD22,B-cell receptor CD22,36342,-0.0119712018751785,0.0443684722487402,-0.0989334074827092,0.0749910037323523,0.787311119454489
Physical measures,X4270.Volume level set by participant (left),NPL,N-acetylneuraminate lyase,35313,-0.0128698027867766,0.0478139567756233,-0.106585158066998,0.0808455524934451,0.787811646454898
Physical measures,X4270.Volume level set by participant (left),EPN1,Epsin-1,35195,-0.0139346727111118,0.052032591599485,-0.115918552246102,0.0880492068238789,0.788856550277314
Physical measures,X4270.Volume level set by participant (left),SEMA3F,Semaphorin-3F,36258,-0.019094456060134,0.07144114053672,-0.159119091512105,0.120930179391837,0.789264362231342
Physical measures,X4270.Volume level set by participant (left),PDCD6,Programmed cell death protein 6,36258,-0.00700234045883029,0.0262719638587249,-0.058495389621931,0.0444907087042704,0.789836069989385
Physical measures,X4270.Volume level set by participant (left),PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,35195,0.00850154274779489,0.0319614502102515,-0.0541428996642981,0.0711459851598878,0.790252419369425
Physical measures,X4270.Volume level set by participant (left),PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",35301,-0.00607126013135648,0.0228471637499887,-0.0508517010813342,0.0387091808186213,0.79045252717607
Physical measures,X4270.Volume level set by participant (left),PPP3R1,Calcineurin subunit B type 1,36179,-0.0123810338446081,0.0466815262038673,-0.103876825204188,0.0791147575149718,0.790844573206326
Physical measures,X4270.Volume level set by participant (left),ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,36318,-0.0171339815736918,0.064632619148363,-0.143813915104483,0.1095459519571,0.790941008635599
Physical measures,X4270.Volume level set by participant (left),BANK1,B-cell scaffold protein with ankyrin repeats,36242,-0.00514309596461232,0.0194081154968846,-0.0431830023385062,0.0328968104092815,0.791018780640601
Physical measures,X4270.Volume level set by participant (left),COL9A2,Collagen alpha-2(IX) chain,35195,0.012501020866077,0.0474106593258094,-0.0804238714125094,0.105425913144663,0.792038354626428
Physical measures,X4270.Volume level set by participant (left),ERVV_1,,35079,-0.0137372831314335,0.0521152684160531,-0.115883209226898,0.0884086429640306,0.792101005295504
Physical measures,X4270.Volume level set by participant (left),ADGRE1,Adhesion G protein-coupled receptor E1,35285,-0.0106407708838283,0.040436155806483,-0.089895636264535,0.0686140944968783,0.792443147675868
Physical measures,X4270.Volume level set by participant (left),NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,35151,-0.0227927554456073,0.0869514809262082,-0.193217658060975,0.147632147169761,0.793228012301452
Physical measures,X4270.Volume level set by participant (left),GPKOW,G-patch domain and KOW motifs-containing protein,36064,-0.017087185150067,0.0652560593222464,-0.14498906142167,0.110814691121536,0.793445664111381
Physical measures,X4270.Volume level set by participant (left),KYNU,Kynureninase,36342,-0.010844518032331,0.0414369600470019,-0.0920609597244547,0.0703719236597927,0.793551042069401
Physical measures,X4270.Volume level set by participant (left),KDM3A,Lysine-specific demethylase 3A,35093,0.00637540055775841,0.0243637273962619,-0.0413775051389149,0.0541283062544317,0.793579617895908
Physical measures,X4270.Volume level set by participant (left),ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",36234,0.00724376222633389,0.027705860611511,-0.0470597245722276,0.0615472490248954,0.793750750844096
Physical measures,X4270.Volume level set by participant (left),DAPK2,Death-associated protein kinase 2,35093,-0.0105021034198541,0.0402608081814758,-0.0894132874555467,0.0684090806158384,0.794215089040882
Physical measures,X4270.Volume level set by participant (left),MSLNL,Mesothelin-like protein,35133,-0.0160545359033907,0.0616139077285381,-0.136817795051325,0.104708723244544,0.794434847117236
Physical measures,X4270.Volume level set by participant (left),CRISP2,Cysteine-rich secretory protein 2,36327,0.00908443424232792,0.034920793453244,-0.0593603209260302,0.0775291894106861,0.794759647281557
Physical measures,X4270.Volume level set by participant (left),NOTCH1,Neurogenic locus notch homolog protein 1,36364,0.0296933311937348,0.114265315620324,-0.1942666874221,0.253653349809569,0.794976322337197
Physical measures,X4270.Volume level set by participant (left),LRPAP1,Alpha-2-macroglobulin receptor-associated protein,36325,0.0085844493376201,0.033126195461782,-0.0563428937674725,0.0735117924427127,0.795531171700699
Physical measures,X4270.Volume level set by participant (left),DEFB116,Beta-defensin 116,35083,0.00799800208686735,0.0308740865155818,-0.0525152074836729,0.0685112116574076,0.795603142172225
Physical measures,X4270.Volume level set by participant (left),CD80,T-lymphocyte activation antigen CD80,35313,0.0169587907303431,0.0657493038836938,-0.111909844881697,0.145827426342383,0.796467987098548
Physical measures,X4270.Volume level set by participant (left),MLN,Promotilin,36242,-0.00544546455331607,0.0211289507862583,-0.0468582080943824,0.0359672789877502,0.796625884090791
Physical measures,X4270.Volume level set by participant (left),EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,36342,-0.00515997134338984,0.0200363269924502,-0.0444311722485923,0.0341112295618126,0.796775888060575
Physical measures,X4270.Volume level set by participant (left),ZPR1,Zinc finger protein ZPR1,35083,0.00633062248463648,0.0246576347329192,-0.0419983415918851,0.054659586561158,0.797386973281446
Physical measures,X4270.Volume level set by participant (left),VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,35165,0.00952539289646699,0.0371885699566403,-0.063364204218548,0.082414990011482,0.797852580277343
Physical measures,X4270.Volume level set by participant (left),SMOC2,SPARC-related modular calcium-binding protein 2,36278,0.0124312330594167,0.048659773230603,-0.0829419224725651,0.107804388591399,0.7983650402913
Physical measures,X4270.Volume level set by participant (left),GBA,Lysosomal acid glucosylceramidase,35133,-0.0108354033343106,0.0424675993136723,-0.0940718979891083,0.072401091320487,0.79861900410866
Physical measures,X4270.Volume level set by participant (left),NFASC,Neurofascin,36342,0.0163694626050292,0.0642232113617113,-0.109508031663925,0.142246956873983,0.798819543994078
Physical measures,X4270.Volume level set by participant (left),UROS,Uroporphyrinogen-III synthase,35133,-0.00869781602013631,0.0341739582673024,-0.075678774224049,0.0582831421837763,0.799105030105003
Physical measures,X4270.Volume level set by participant (left),GP6,Platelet glycoprotein VI,36237,-0.00548413012805004,0.0215791243143064,-0.0477792137840905,0.0368109535279904,0.799393835873676
Physical measures,X4270.Volume level set by participant (left),TRPV3,Transient receptor potential cation channel subfamily V member 3,35079,0.0116510045711579,0.0458580409837171,-0.0782307557569276,0.101532764899243,0.799452037255671
Physical measures,X4270.Volume level set by participant (left),DGKZ,Diacylglycerol kinase zeta,36103,-0.0133373444188876,0.052545426755661,-0.116326380859983,0.0896516920222079,0.799637694735778
Physical measures,X4270.Volume level set by participant (left),CNTNAP4,Contactin-associated protein-like 4,35133,-0.0052462502981606,0.0206725271579328,-0.0457644035277088,0.0352719029313876,0.799674398844339
Physical measures,X4270.Volume level set by participant (left),MMP13,Collagenase 3,36064,-0.015648630877784,0.0618049796752671,-0.136786391041308,0.105489129285739,0.800125517956843
Physical measures,X4270.Volume level set by participant (left),SIL1,Nucleotide exchange factor SIL1,35151,-0.0168301966131043,0.0667005639674432,-0.147563301989293,0.113902908763084,0.800798054263134
Physical measures,X4270.Volume level set by participant (left),DEFB118,Beta-defensin 118,35083,-0.0102147022497789,0.0405325493812577,-0.0896584990370439,0.0692290945374861,0.801039524857932
Physical measures,X4270.Volume level set by participant (left),CD6,T-cell differentiation antigen CD6,36328,0.00923805193519196,0.0366612623892127,-0.0626180223476649,0.0810941262180489,0.801060126102714
Physical measures,X4270.Volume level set by participant (left),TNN,Tenascin-N,35320,0.0125442165828123,0.0499834455261568,-0.0854233366484551,0.11051176981408,0.80184697143497
Physical measures,X4270.Volume level set by participant (left),TNFRSF9,Tumor necrosis factor receptor superfamily member 9,36179,-0.0119915040538509,0.0478530867534298,-0.105783554090573,0.0818005459828715,0.802137924696191
Physical measures,X4270.Volume level set by participant (left),KAZN,Kazrin,35285,-0.00544263437296613,0.0217407954521961,-0.0480545934592705,0.0371693247133383,0.802330569759795
Physical measures,X4270.Volume level set by participant (left),RSPO3,R-spondin-3,36327,0.0171548570874797,0.0688964237690291,-0.117882133499817,0.152191847674777,0.803371358673412
Physical measures,X4270.Volume level set by participant (left),CLEC4A,C-type lectin domain family 4 member A,36242,-0.0130138285627435,0.0524589329023405,-0.115833337051331,0.0898056799258439,0.804081884272485
Physical measures,X4270.Volume level set by participant (left),NPR1,Atrial natriuretic peptide receptor 1,35079,-0.0125380619341043,0.0506180174836309,-0.111749376202021,0.0866732523338123,0.804374705687254
Physical measures,X4270.Volume level set by participant (left),IL3RA,Interleukin-3 receptor subunit alpha,36103,0.0148205830550563,0.0598664539536999,-0.102517666694196,0.132158832804308,0.804481074461035
Physical measures,X4270.Volume level set by participant (left),SPP1,Osteopontin,36350,-0.0102101990317433,0.0413117077393163,-0.0911811462008033,0.0707607481373168,0.804798492420152
Physical measures,X4270.Volume level set by participant (left),APOD,Apolipoprotein D,35052,-0.013987917810704,0.0567915070248235,-0.125299271579358,0.0973234359579501,0.805455536819439
Physical measures,X4270.Volume level set by participant (left),ZBTB17,Zinc finger and BTB domain-containing protein 17,36109,-0.0107868930226705,0.0438778510363495,-0.0967874810539155,0.0752136950085745,0.805813481439724
Physical measures,X4270.Volume level set by participant (left),SHC1,SHC-transforming protein 1,35095,-0.00487920376177467,0.019850082720695,-0.0437853658943369,0.0340269583707876,0.805842743649369
Physical measures,X4270.Volume level set by participant (left),TAP1,Antigen peptide transporter 1,35195,-0.00924400995921355,0.0376960030093207,-0.0831281758574821,0.0646401559390549,0.806289696993035
Physical measures,X4270.Volume level set by participant (left),DLK1,Protein delta homolog 1,36364,-0.00788495706775352,0.0321644120774064,-0.0709272047394701,0.0551572906039631,0.80635034688876
Physical measures,X4270.Volume level set by participant (left),GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,36103,-0.0107978067783723,0.0441983778523909,-0.0974266273690584,0.0758310138123139,0.807002659449064
Physical measures,X4270.Volume level set by participant (left),GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,36216,0.0162509585047675,0.0667011339175079,-0.114483263973548,0.146985180983083,0.807517438965119
Physical measures,X4270.Volume level set by participant (left),ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",36060,0.00575061153688978,0.0236220771820097,-0.0405486597398493,0.0520498828136288,0.807669516336008
Physical measures,X4270.Volume level set by participant (left),TSLP,Thymic stromal lymphopoietin,36109,-0.00778242758482398,0.0320605676621209,-0.0706211402025809,0.0550562850329329,0.808212354145652
Physical measures,X4270.Volume level set by participant (left),PTPRC,Receptor-type tyrosine-protein phosphatase C,35320,-0.0232912677457984,0.096072349461154,-0.21159307268966,0.165010537198063,0.808450779185086
Physical measures,X4270.Volume level set by participant (left),CXCL10,C-X-C motif chemokine 10,36278,0.00707549221471777,0.0291913232793655,-0.0501395014128387,0.0642904858422742,0.808489571480862
Physical measures,X4270.Volume level set by participant (left),EPB41L5,Band 4.1-like protein 5,35133,0.00851345728129268,0.0351329540933271,-0.0603471327416284,0.0773740473042138,0.808538948931258
Physical measures,X4270.Volume level set by participant (left),ANGPTL3,Angiopoietin-related protein 3,36260,-0.0131110277388765,0.0541107183264155,-0.119168035658651,0.0929459801808978,0.808554193183482
Physical measures,X4270.Volume level set by participant (left),CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,36060,-0.010332481664402,0.042685059194757,-0.0939951976861258,0.0733302343573218,0.808737855401086
Physical measures,X4270.Volume level set by participant (left),GH2,Growth hormone variant,36060,0.00293325718615878,0.0121221408550903,-0.0208261388898183,0.0266926532621359,0.808806051083059
Physical measures,X4270.Volume level set by participant (left),OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,35195,-0.00825295169556075,0.0341867698343255,-0.0752590205708388,0.0587531171797173,0.809246603610557
Physical measures,X4270.Volume level set by participant (left),BATF,Basic leucine zipper transcriptional factor ATF-like,35133,0.00649791347557935,0.0269247076181969,-0.0462745134560866,0.0592703404072453,0.809301936482057
Physical measures,X4270.Volume level set by participant (left),SKAP1,Src kinase-associated phosphoprotein 1,36168,-0.00651729731928337,0.0271701123879293,-0.0597707175996248,0.0467361229610581,0.810437467205183
Physical measures,X4270.Volume level set by participant (left),ORM1,Alpha-1-acid glycoprotein 1,35302,0.0259462853664762,0.10829166128781,-0.186305370757632,0.238197941490585,0.810650535005654
Physical measures,X4270.Volume level set by participant (left),RELB,Transcription factor RelB,35093,-0.0107548782271359,0.0449254902609868,-0.09880883913867,0.0772990826843983,0.810807893417037
Physical measures,X4270.Volume level set by participant (left),DNMBP,Dynamin-binding protein,36179,-0.00719884768783601,0.0304809652370299,-0.0669415395524146,0.0525438441767426,0.813303116772144
Physical measures,X4270.Volume level set by participant (left),HJV,Hemojuvelin,35305,0.0123309277449543,0.0522291640538949,-0.0900382338006797,0.114700089290588,0.813367902554593
Physical measures,X4270.Volume level set by participant (left),IGFBP2,Insulin-like growth factor-binding protein 2,36350,0.00734390703979687,0.0311475987607825,-0.0537053865313368,0.0683932006109306,0.813611459468143
Physical measures,X4270.Volume level set by participant (left),RBPMS2,RNA-binding protein with multiple splicing 2,35151,0.00499160735894149,0.0212242014731248,-0.0366078275283832,0.0465910422462662,0.814072738485585
Physical measures,X4270.Volume level set by participant (left),TCL1B,T-cell leukemia/lymphoma protein 1B,36109,0.00565078906566375,0.0240516202971607,-0.0414903867167712,0.0527919648480987,0.814258439577144
Physical measures,X4270.Volume level set by participant (left),PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,36242,-0.0072761379288251,0.0310139174472082,-0.0680634161253532,0.053511140267703,0.81451866721555
Physical measures,X4270.Volume level set by participant (left),PAM,Peptidyl-glycine alpha-amidating monooxygenase,36335,-0.0154858039361997,0.0660147131054041,-0.144874641622792,0.113903033750392,0.814540092612623
Physical measures,X4270.Volume level set by participant (left),FEN1,Flap endonuclease 1,36060,0.00691092501352239,0.0294769458027744,-0.0508638887599155,0.0646857387869603,0.814640632185924
Physical measures,X4270.Volume level set by participant (left),HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,36198,0.0166764193472541,0.0712740393522654,-0.123020697783186,0.156373536477694,0.815009865743117
Physical measures,X4270.Volume level set by participant (left),CLEC2L,C-type lectin domain family 2 member L,35133,-0.00977673874466084,0.0420091765099078,-0.0921147247040802,0.0725612472147585,0.815979417863255
Physical measures,X4270.Volume level set by participant (left),CXCL1,Growth-regulated alpha protein,36225,0.00481464551869272,0.0207208677665941,-0.0357982553038317,0.0454275463412171,0.816266725775121
Physical measures,X4270.Volume level set by participant (left),NOTCH2,Neurogenic locus notch homolog protein 2,35320,-0.0228055879768073,0.0984986409745554,-0.215862924286936,0.170251748333321,0.816908575837378
Physical measures,X4270.Volume level set by participant (left),RAB44,Ras-related protein Rab-44,35279,-0.0114031602461166,0.0492976550873684,-0.108026564217359,0.0852202437251255,0.817079181861394
Physical measures,X4270.Volume level set by participant (left),PARD3,Partitioning defective 3 homolog,35195,0.00672253590017054,0.0290973517435308,-0.0503082735171498,0.0637533453174909,0.817294000857434
Physical measures,X4270.Volume level set by participant (left),ACP6,Lysophosphatidic acid phosphatase type 6,36321,-0.00641422691117846,0.0277905622690142,-0.0608837289584462,0.0480552751360893,0.817471682282056
Physical measures,X4270.Volume level set by participant (left),WFDC1,WAP four-disulfide core domain protein 1,35127,0.00906648668525027,0.0393437586140727,-0.0680472801983321,0.0861802535688327,0.817754916153735
Physical measures,X4270.Volume level set by participant (left),ITGBL1,Integrin beta-like protein 1,35320,-0.0129190473070223,0.056254461679902,-0.12317779219963,0.0973396975855856,0.81836783973585
Physical measures,X4270.Volume level set by participant (left),LDLR,Low-density lipoprotein receptor,36303,-0.00844301414668271,0.036770097455737,-0.0805124051599272,0.0636263768665618,0.818396029745489
Physical measures,X4270.Volume level set by participant (left),ESYT2,Extended synaptotagmin-2,35301,-0.00585539410017539,0.025547946906179,-0.0559293700362862,0.0442185818359354,0.818726412468583
Physical measures,X4270.Volume level set by participant (left),FGF2,Fibroblast growth factor 2,36242,-0.00622931710899671,0.0271980529295165,-0.0595375008508491,0.0470788666328557,0.818847528335919
Physical measures,X4270.Volume level set by participant (left),APOA4,Apolipoprotein A-IV,35325,-0.0144890037917061,0.0633892130741388,-0.138731861417018,0.109753853833606,0.81920848598786
Physical measures,X4270.Volume level set by participant (left),MUC2,Mucin-2,35320,0.00533799365024651,0.0233666654044711,-0.0404606705425169,0.0511366578430099,0.819307403946196
Physical measures,X4270.Volume level set by participant (left),POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",36216,-0.0125911131216299,0.0552129728549648,-0.120808539917361,0.0956263136741011,0.819616385685878
Physical measures,X4270.Volume level set by participant (left),IL12B,Interleukin-12 subunit beta,36342,-0.00777661208005231,0.0341130370328255,-0.0746381646643903,0.0590849405042857,0.819678707013201
Physical measures,X4270.Volume level set by participant (left),PROS1,Vitamin K-dependent protein S,35325,0.0194882664131198,0.0858035510147599,-0.14868669357581,0.187663226402049,0.820332229323389
Physical measures,X4270.Volume level set by participant (left),LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,35079,-0.010067638258139,0.0444552227761453,-0.0971998748993838,0.0770645983831058,0.820845417054651
Physical measures,X4270.Volume level set by participant (left),MFGE8,Lactadherin,36256,0.00935528023572292,0.0417287316736089,-0.0724330338445506,0.0911435943159964,0.822613288288449
Physical measures,X4270.Volume level set by participant (left),MERTK,Tyrosine-protein kinase Mer,36342,0.0166058838646288,0.0746918813081926,-0.129790203499429,0.163001971228686,0.824066640286859
Physical measures,X4270.Volume level set by participant (left),VWA5A,von Willebrand factor A domain-containing protein 5A,35095,0.00674487986735472,0.0304318512032986,-0.0529015484911106,0.06639130822582,0.82460202398028
Physical measures,X4270.Volume level set by participant (left),PVALB,Parvalbumin alpha,36303,-0.00368445808224778,0.0166478482337822,-0.0363142406204608,0.0289453244559653,0.824851190086803
Physical measures,X4270.Volume level set by participant (left),SOX9,Transcription factor SOX-9,35133,0.0181193946235178,0.0819124736566113,-0.14242905374344,0.178667842990476,0.824940246898279
Physical measures,X4270.Volume level set by participant (left),SHBG,Sex hormone-binding globulin,35317,0.0102352561240396,0.0462785196074803,-0.0804706423066219,0.100941154554701,0.824969553096397
Physical measures,X4270.Volume level set by participant (left),KLK7,Kallikrein-7,35016,-0.0127976344690861,0.0579846712941215,-0.126447590205564,0.100852321267392,0.825327450532891
Physical measures,X4270.Volume level set by participant (left),SCN2B,Sodium channel subunit beta-2,35133,-0.0174167184155271,0.0789727954898008,-0.172203397575537,0.137369960744482,0.825456945396968
Physical measures,X4270.Volume level set by participant (left),DSG2,Desmoglein-2,36256,0.0152921035321603,0.0693671461805635,-0.120667502981744,0.151251710046065,0.825525285132568
Physical measures,X4270.Volume level set by participant (left),HTRA2,"Serine protease HTRA2, mitochondrial",36289,0.00671611435061187,0.0305540009741402,-0.0531697275587029,0.0666019562599266,0.826023964432397
Physical measures,X4270.Volume level set by participant (left),DUSP29,Dual specificity phosphatase 29,35133,0.00745402390026793,0.0340191368603336,-0.0592234843459859,0.0741315321465217,0.826569129569482
Physical measures,X4270.Volume level set by participant (left),STAU1,Double-stranded RNA-binding protein Staufen homolog 1,35095,-0.00749500083465821,0.0342218099203644,-0.0745697482785723,0.0595797466092559,0.826647270734571
Physical measures,X4270.Volume level set by participant (left),CFP,Properdin,35325,-0.0221275427929842,0.101045543162685,-0.220176807391846,0.175921721805878,0.826667729274978
Physical measures,X4270.Volume level set by participant (left),CXCL9,C-X-C motif chemokine 9,36278,0.00642318638768272,0.0293332914630619,-0.0510700648799186,0.063916437655284,0.826677233247158
Physical measures,X4270.Volume level set by participant (left),ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,36109,-0.0188030927650088,0.085954234143719,-0.187273391686698,0.14966720615668,0.826845270641213
Physical measures,X4270.Volume level set by participant (left),IGFBP1,Insulin-like growth factor-binding protein 1,36363,0.00315980145708157,0.0144451189400852,-0.0251526316654855,0.0314722345796486,0.826854234236884
Physical measures,X4270.Volume level set by participant (left),CDNF,Cerebral dopamine neurotrophic factor,36216,-0.0124185800980468,0.0568469205962738,-0.123838544466743,0.09900138427065,0.82707929245908
Physical measures,X4270.Volume level set by participant (left),APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,36216,0.00889066963760118,0.0407671273274603,-0.0710128999242209,0.0887942391994233,0.827369289975896
Physical measures,X4270.Volume level set by participant (left),ZBTB16,Zinc finger and BTB domain-containing protein 16,36060,0.00555908431696465,0.0255013045839381,-0.044423472667554,0.0555416413014833,0.827441189362525
Physical measures,X4270.Volume level set by participant (left),CHCHD6,MICOS complex subunit MIC25,35279,0.0162781581768839,0.0747283461130718,-0.130189400204737,0.162745716558505,0.827567365904858
Physical measures,X4270.Volume level set by participant (left),BRDT,Bromodomain testis-specific protein,35079,0.0132754803736158,0.0610048684086772,-0.106294061707391,0.132845022454623,0.827737153603161
Physical measures,X4270.Volume level set by participant (left),HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,36327,0.0121618956349562,0.0559415415355573,-0.0974835257747361,0.121807317044649,0.827899524858466
Physical measures,X4270.Volume level set by participant (left),CD93,Complement component C1q receptor,35977,0.0136276412966257,0.0627933362390379,-0.109447297731889,0.13670258032514,0.828195889881284
Physical measures,X4270.Volume level set by participant (left),LRG1,Leucine-rich alpha-2-glycoprotein,35325,0.0176602316968585,0.0814437430192929,-0.141969504620956,0.177289968014673,0.828339901144367
Physical measures,X4270.Volume level set by participant (left),CST3,Cystatin-C,36275,0.0145306942006643,0.0670827867199282,-0.116951567770395,0.146012956171724,0.828519308566717
Physical measures,X4270.Volume level set by participant (left),CRHR1,Corticotropin-releasing factor receptor 1,36109,0.00674727281744822,0.031159629903214,-0.0543256017928513,0.0678201474277477,0.828573570293756
Physical measures,X4270.Volume level set by participant (left),SCN4B,Sodium channel subunit beta-4,35151,-0.0110550257007529,0.0511104875010951,-0.111231581202899,0.0891215298013934,0.828763281127272
Physical measures,X4270.Volume level set by participant (left),NDRG1,Protein NDRG1,36064,0.00636510880381982,0.0294712175670436,-0.0513984776275857,0.0641286952352253,0.829011483444177
Physical measures,X4270.Volume level set by participant (left),MICALL2,MICAL-like protein 2,35133,-0.00633594083294697,0.0293591093685908,-0.063879795195385,0.051207913529491,0.829143882800002
Physical measures,X4270.Volume level set by participant (left),NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,35279,0.00784898513957008,0.0363743841045536,-0.0634448077053551,0.0791427779844952,0.829163247732072
Physical measures,X4270.Volume level set by participant (left),CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,36302,0.00410691041140117,0.0190727490250986,-0.033275677677792,0.0414894985005943,0.829516752258037
Physical measures,X4270.Volume level set by participant (left),LTO1,Protein LTO1 homolog,36103,-0.00998017990942683,0.0464754099663817,-0.101071983443535,0.0811116236246813,0.829975027788404
Physical measures,X4270.Volume level set by participant (left),NFAT5,Nuclear factor of activated T-cells 5,35093,-0.00535527791264943,0.0249440714174677,-0.0542456578908861,0.0435351020655872,0.830014664045044
Physical measures,X4270.Volume level set by participant (left),ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,35279,0.012760147830965,0.0594736012386475,-0.103808110596784,0.129328406258714,0.830123596689779
Physical measures,X4270.Volume level set by participant (left),S100A3,Protein S100-A3,35279,0.0109407610885612,0.0513118190792652,-0.0896304043067985,0.111511926483921,0.831161043420884
Physical measures,X4270.Volume level set by participant (left),CCL13,C-C motif chemokine 13,36330,0.00573674654512521,0.0269209667817068,-0.0470283483470201,0.0585018414372705,0.831257816041254
Physical measures,X4270.Volume level set by participant (left),KIAA2013,Uncharacterized protein KIAA2013,35279,-0.0080521689699501,0.0378135761670007,-0.0821667782572714,0.0660624403173712,0.831377251235359
Physical measures,X4270.Volume level set by participant (left),CRIM1,Cysteine-rich motor neuron 1 protein,36278,-0.019197173679599,0.0901871148098468,-0.195963918706899,0.157569571347701,0.831442296603381
Physical measures,X4270.Volume level set by participant (left),TREH,Trehalase,35320,-0.00607401158739187,0.0287478117720767,-0.0624197226606622,0.0502716994858785,0.8326704776708
Physical measures,X4270.Volume level set by participant (left),AMIGO2,Amphoterin-induced protein 2,36216,-0.0166741597417876,0.0793206660649968,-0.172142665229181,0.138794345745606,0.833507801379975
Physical measures,X4270.Volume level set by participant (left),RNF168,E3 ubiquitin-protein ligase RNF168,35093,0.0114494462792477,0.0545359701675463,-0.095441055249143,0.118339947807638,0.833718735272678
Physical measures,X4270.Volume level set by participant (left),UNC79,Protein unc-79 homolog,35095,0.00839166910188954,0.0399975768105299,-0.0700035814467491,0.0867869196505282,0.833826893070857
Physical measures,X4270.Volume level set by participant (left),LGALS3BP,Galectin-3-binding protein,35325,-0.0148680398055658,0.0710243787374031,-0.154075822130876,0.124339742519744,0.834191409586597
Physical measures,X4270.Volume level set by participant (left),TFPI,Tissue factor pathway inhibitor,36236,-0.0123866209472809,0.0592472881395617,-0.128511305700822,0.10373806380626,0.834401934081933
Physical measures,X4270.Volume level set by participant (left),TG,Thyroglobulin,35279,-0.00440252349201497,0.021080417360303,-0.0457201415182088,0.0369150945341788,0.834576215076772
Physical measures,X4270.Volume level set by participant (left),IL12RB1,Interleukin-12 receptor subunit beta-1,36103,0.0107454516335387,0.0515977858847009,-0.090386208700475,0.111877111967552,0.835036205932896
Physical measures,X4270.Volume level set by participant (left),FGF23,Fibroblast growth factor 23,36325,0.00787330970643566,0.0378978613358751,-0.0664064985118795,0.0821531179247508,0.835429055675057
Physical measures,X4270.Volume level set by participant (left),MTSS2,Protein MTSS 2,35279,-0.00465756341940822,0.0224427195776522,-0.0486452937916066,0.0393301669527901,0.835601397359286
Physical measures,X4270.Volume level set by participant (left),FBN2,Fibrillin-2,35133,0.0077071048549799,0.0371745141549128,-0.0651549428886492,0.080569152598609,0.835764643629763
Physical measures,X4270.Volume level set by participant (left),PNMA2,Paraneoplastic antigen Ma2,35083,0.0104878034950076,0.0507189285664854,-0.0889212964953037,0.109896903485319,0.836185964339267
Physical measures,X4270.Volume level set by participant (left),NRXN3,Neurexin-3,35133,0.0127247815405403,0.061585975807925,-0.107983731042993,0.133433294124073,0.836314511723855
Physical measures,X4270.Volume level set by participant (left),LTA,Lymphotoxin-alpha,36242,-0.00963715781132169,0.0469099579600754,-0.10158067541307,0.0823063597904261,0.837234244149728
Physical measures,X4270.Volume level set by participant (left),MKI67,Proliferation marker protein Ki-67,35093,-0.0116180209582921,0.0565793242436303,-0.122513496475807,0.0992774545592233,0.837312623361497
Physical measures,X4270.Volume level set by participant (left),GOLGA3,Golgin subfamily A member 3,35305,-0.00591149077601026,0.0288288531870602,-0.0624160430226482,0.0505930614706277,0.837535644581937
Physical measures,X4270.Volume level set by participant (left),AZI2,5-azacytidine-induced protein 2,35305,-0.00775416615485402,0.0378986041879358,-0.0820354303632082,0.0665270980535001,0.837888564662163
Physical measures,X4270.Volume level set by participant (left),ALDH2,"Aldehyde dehydrogenase, mitochondrial",35279,0.00838406460218518,0.0409806717129962,-0.0719380519552874,0.0887061811596577,0.837901966441415
Physical measures,X4270.Volume level set by participant (left),CLASP1,CLIP-associating protein 1,35095,0.00605383370545991,0.0296234208231834,-0.0520080711079795,0.0641157385188993,0.838078818090468
Physical measures,X4270.Volume level set by participant (left),FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,36325,0.00812369022785696,0.0401094727612526,-0.0704908763841981,0.086738256839912,0.839501532269322
Physical measures,X4270.Volume level set by participant (left),SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,35083,0.00785296660588961,0.038829899787684,-0.068253636977971,0.0839595701897502,0.839735298009184
Physical measures,X4270.Volume level set by participant (left),MUC16,Mucin-16,36216,-0.00200981659516524,0.00994013259890375,-0.0214924764890166,0.0174728432986861,0.839771927069321
Physical measures,X4270.Volume level set by participant (left),PADI4,Protein-arginine deiminase type-4,36053,-0.00528362618850913,0.0261799756960232,-0.0565963785527145,0.0460291261756963,0.840063448723807
Physical measures,X4270.Volume level set by participant (left),NUDT15,Nucleotide triphosphate diphosphatase NUDT15,35079,0.00874709291441728,0.0434075079095714,-0.0763316225883427,0.0938258084171773,0.840305311437963
Physical measures,X4270.Volume level set by participant (left),RAB10,Ras-related protein Rab-10,35313,0.0081019545105498,0.0402229001354725,-0.0707349297549763,0.0869388387760759,0.840371269132742
Physical measures,X4270.Volume level set by participant (left),GPR158,Probable G-protein coupled receptor 158,35305,0.0122168776937944,0.0607131321753018,-0.106780861369797,0.131214616757386,0.840530325991229
Physical measures,X4270.Volume level set by participant (left),ADGRG2,Adhesion G-protein coupled receptor G2,36258,-0.0141735149379629,0.0706193416596818,-0.152587424590939,0.124240394715013,0.840936132344767
Physical measures,X4270.Volume level set by participant (left),USP28,Ubiquitin carboxyl-terminal hydrolase 28,35301,-0.0121655324626519,0.060687470256748,-0.131112974165878,0.106781909240574,0.841125350226424
Physical measures,X4270.Volume level set by participant (left),IL5,Interleukin-5,36103,-0.00278738227885474,0.0139067612037771,-0.0300446342382579,0.0244698696805484,0.841146914432381
Physical measures,X4270.Volume level set by participant (left),CPVL,Probable serine carboxypeptidase CPVL,36327,-0.0092248275518305,0.0460488626054132,-0.0994805982584403,0.0810309431547793,0.841230171662784
Physical measures,X4270.Volume level set by participant (left),SEMA7A,Semaphorin-7A,36339,-0.0133109497810765,0.0664937530675221,-0.14363870579342,0.117016806231267,0.841342361689748
Physical measures,X4270.Volume level set by participant (left),CYB5A,Cytochrome b5,35095,-0.00640145944183135,0.0320052191814052,-0.0691316890373856,0.0563287701537229,0.841476690012474
Physical measures,X4270.Volume level set by participant (left),HYAL1,Hyaluronidase-1,36230,0.0161326496520567,0.0807393100066111,-0.142116397960901,0.174381697265014,0.841633265952725
Physical measures,X4270.Volume level set by participant (left),CRTAC1,Cartilage acidic protein 1,36364,-0.0120930199808566,0.0608897255828494,-0.131436882123241,0.107250842161528,0.842576738262103
Physical measures,X4270.Volume level set by participant (left),COL4A4,Collagen alpha-4(IV) chain,35189,0.00842718502350013,0.0425246691245984,-0.0749211664607127,0.091775536507713,0.842916862312603
Physical measures,X4270.Volume level set by participant (left),ARSB,Arylsulfatase B,36216,-0.00664610480433454,0.0339879885349911,-0.0732625623329172,0.0599703527242481,0.844973291116325
Physical measures,X4270.Volume level set by participant (left),NENF,Neudesin,35279,0.00373818475471275,0.0191309780020827,-0.0337585321293693,0.0412349016387948,0.845086104642989
Physical measures,X4270.Volume level set by participant (left),SYTL4,Synaptotagmin-like protein 4,35313,0.00561559147513225,0.0287478351000657,-0.0507301653209964,0.0619613482712609,0.845132988735884
Physical measures,X4270.Volume level set by participant (left),RAB27B,Ras-related protein Rab-27B,35313,0.00531726183561175,0.0272949104050377,-0.0481807625582621,0.0588152862294856,0.845549302439611
Physical measures,X4270.Volume level set by participant (left),ADA,Adenosine deaminase,36342,-0.0100124900698627,0.0515440278099617,-0.111038784577388,0.0910138044376622,0.845984280633345
Physical measures,X4270.Volume level set by participant (left),MOCS2,Molybdopterin synthase catalytic subunit,35165,-0.00633918802369115,0.0326719389919388,-0.0703761884478913,0.057697812400509,0.846161951516978
Physical measures,X4270.Volume level set by participant (left),PROK1,Prokineticin-1,36242,-0.00718745362936659,0.0370570624119247,-0.079819295956739,0.0654443886980059,0.846215195150769
Physical measures,X4270.Volume level set by participant (left),AHNAK2,Protein AHNAK2,35151,0.0138453256380449,0.0715551805703566,-0.126402828279854,0.154093479555944,0.846579993541856
Physical measures,X4270.Volume level set by participant (left),LYPD1,Ly6/PLAUR domain-containing protein 1,36064,-0.00611942106240929,0.0316411874383734,-0.0681361484416211,0.0558973063168025,0.846650598520847
Physical measures,X4270.Volume level set by participant (left),TP53I3,Quinone oxidoreductase PIG3,35006,-0.00845644736680956,0.0437249532072176,-0.094157355652956,0.0772444609193369,0.846651108077543
Physical measures,X4270.Volume level set by participant (left),GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",35083,-0.00798636780636579,0.0414255120910393,-0.0891803715048028,0.0732076358920712,0.847130548473068
Physical measures,X4270.Volume level set by participant (left),IL36G,Interleukin-36 gamma,35061,0.00652967631974518,0.0339301192685127,-0.0599733574465398,0.0730327100860301,0.847399823814987
Physical measures,X4270.Volume level set by participant (left),C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,36289,-0.00821163357247207,0.0429666002538724,-0.092426170070062,0.0760029029251179,0.848439235392341
Physical measures,X4270.Volume level set by participant (left),GBP1,Guanylate-binding protein 1,35281,-0.00663316808516103,0.0347588962944963,-0.0747606048223738,0.0614942686520517,0.848661701963655
Physical measures,X4270.Volume level set by participant (left),SPARC,SPARC,36289,-0.00498111456371036,0.026135408866068,-0.0562065159412037,0.046244286813783,0.84885284869338
Physical measures,X4270.Volume level set by participant (left),GHR,Growth hormone receptor,35165,0.0148086128686099,0.0781109340210593,-0.138288817812666,0.167906043549886,0.849640693129061
Physical measures,X4270.Volume level set by participant (left),VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,36109,0.00637010631314946,0.0336276249914424,-0.0595400386700776,0.0722802512963765,0.849760345553263
Physical measures,X4270.Volume level set by participant (left),FGF6,Fibroblast growth factor 6,35093,0.0110724618310699,0.0587784480077939,-0.104133296264206,0.126278219926346,0.850587629642254
Physical measures,X4270.Volume level set by participant (left),SOD3,Extracellular superoxide dismutase,35317,0.00656986916361862,0.0351422916379058,-0.0623090224466768,0.0754487607739141,0.85170508873101
Physical measures,X4270.Volume level set by participant (left),FOLR2,Folate receptor beta,36325,-0.0119278732480522,0.0638597626337999,-0.1370930080103,0.113237261514196,0.851836233167228
Physical measures,X4270.Volume level set by participant (left),OSTN,Osteocrin,35133,-0.0100849868078022,0.0543921544528359,-0.11669360953536,0.0965236359197561,0.852911242150296
Physical measures,X4270.Volume level set by participant (left),HDAC8,Histone deacetylase 8,35093,-0.00676831056433301,0.0365051752280277,-0.0783184540112673,0.0647818328826013,0.852915708042584
Physical measures,X4270.Volume level set by participant (left),TOP2B,DNA topoisomerase 2-beta,35093,-0.00539152146487536,0.0290905641118446,-0.0624090271240909,0.0516259841943401,0.852971492242711
Physical measures,X4270.Volume level set by participant (left),THBS2,Thrombospondin-2,36256,-0.00895425175185418,0.0483204611518552,-0.10366235560949,0.0857538521057821,0.85299101518089
Physical measures,X4270.Volume level set by participant (left),GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,35133,-0.0080570514385564,0.0435438680668641,-0.0934030328496101,0.0772889299724973,0.853208918408166
Physical measures,X4270.Volume level set by participant (left),PRTG,Protogenin,36327,-0.0136271160812856,0.0740613105089182,-0.158787284678765,0.131533052516194,0.85402003327988
Physical measures,X4270.Volume level set by participant (left),CD300LG,CMRF35-like molecule 9,36256,-0.00937938836985514,0.0513844982282898,-0.110093004897303,0.0913342281575929,0.855168961719847
Physical measures,X4270.Volume level set by participant (left),TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,35313,0.00980900931832838,0.0538730429812718,-0.0957821549249643,0.115400173561621,0.855528275181636
Physical measures,X4270.Volume level set by participant (left),KLK4,Kallikrein-4,36327,-0.00538902346122895,0.0297008444096957,-0.0636026785042326,0.0528246315817747,0.856024283287752
Physical measures,X4270.Volume level set by participant (left),PGLYRP4,Peptidoglycan recognition protein 4,35079,0.00655924179477259,0.0362572447896388,-0.0645049579929195,0.0776234415824647,0.856445100769586
Physical measures,X4270.Volume level set by participant (left),BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",36242,-0.00802754594291715,0.0443754151294258,-0.0950033595965917,0.0789482677107574,0.856450278059884
Physical measures,X4270.Volume level set by participant (left),SCPEP1,Retinoid-inducible serine carboxypeptidase,35135,0.00786913867834418,0.0436615562871252,-0.0777075116444213,0.0934457890011097,0.856977303700129
Physical measures,X4270.Volume level set by participant (left),PRG3,Proteoglycan 3,35320,0.00771279030147731,0.0429202891866865,-0.0764109765044283,0.0918365571073829,0.857393251688123
Physical measures,X4270.Volume level set by participant (left),KLK11,Kallikrein-11,36216,0.010478941758046,0.0583759963755177,-0.103938011137969,0.124895894654061,0.85754383675311
Physical measures,X4270.Volume level set by participant (left),STC1,Stanniocalcin-1,36325,0.00736696228113602,0.0410518960842306,-0.0730947540439559,0.087828678606228,0.857585266455588
Physical measures,X4270.Volume level set by participant (left),TMOD4,Tropomodulin-4,35095,0.0101464595838727,0.0565687251080463,-0.100728241627898,0.121021160795643,0.857656567538741
Physical measures,X4270.Volume level set by participant (left),EEF1D,Elongation factor 1-delta,35313,-0.00428358518244412,0.0239039008016763,-0.0511352307537297,0.0425680603888414,0.857785871982675
Physical measures,X4270.Volume level set by participant (left),LAMB1,Laminin subunit beta-1,35151,0.0126383484722679,0.071291519933808,-0.127093030597996,0.152369727542532,0.859296280482255
Physical measures,X4270.Volume level set by participant (left),SDHB,Succinate dehydrogenase,35285,0.00620224425336327,0.0351660399082071,-0.0627231939667226,0.0751276824734491,0.860008397824681
Physical measures,X4270.Volume level set by participant (left),CCL11,Eotaxin,36342,0.00876681946108431,0.049796764218363,-0.0888348384069072,0.106368477329076,0.860257704075254
Physical measures,X4270.Volume level set by participant (left),CA7,Carbonic anhydrase 7,35195,-0.0118684791400292,0.067556237078174,-0.14427870381325,0.120541745533192,0.860548425645589
Physical measures,X4270.Volume level set by participant (left),FCRL5,Fc receptor-like protein 5,36256,0.00560012502446902,0.0319014606948075,-0.0569267379373537,0.0681269879862918,0.860656475144041
Physical measures,X4270.Volume level set by participant (left),KIAA0319,Dyslexia-associated protein KIAA0319,35301,-0.0122865043210551,0.0701076970630757,-0.149697590564683,0.125124581922573,0.860887033652496
Physical measures,X4270.Volume level set by participant (left),ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,36258,0.00671826176079387,0.0384195832405955,-0.0685841213907733,0.0820206449123611,0.861189900620766
Physical measures,X4270.Volume level set by participant (left),ERMAP,Erythroid membrane-associated protein,35093,0.00863420056253641,0.0496098275033322,-0.0886010613439948,0.105869462469068,0.86183777264344
Physical measures,X4270.Volume level set by participant (left),CEP170,Centrosomal protein of 170 kDa,35151,-0.00483589221094444,0.0280160008768323,-0.0597472539295357,0.0500754695076468,0.862961914447888
Physical measures,X4270.Volume level set by participant (left),ABO,Histo-blood group ABO system transferase,35317,0.00260436944833048,0.0151449630026455,-0.0270797580368547,0.0322884969335157,0.863471998623371
Physical measures,X4270.Volume level set by participant (left),CD5L,CD5 antigen-like,35293,-0.00771965512472905,0.0451644506539387,-0.0962419784064489,0.0808026681569908,0.864289276283577
Physical measures,X4270.Volume level set by participant (left),FABP2,"Fatty acid-binding protein, intestinal",36258,-0.00401852636343528,0.0235845893147225,-0.0502443214202915,0.0422072686934209,0.864709666386489
Physical measures,X4270.Volume level set by participant (left),ANGPT2,Angiopoietin-2,36327,0.00819203347939244,0.0483494606918916,-0.086572909476715,0.1029569764355,0.865459866073914
Physical measures,X4270.Volume level set by participant (left),IL18RAP,Interleukin-18 receptor accessory protein,36135,-0.00188790791924291,0.0112152079945823,-0.0238697155886241,0.0200938997501383,0.866324549365859
Physical measures,X4270.Volume level set by participant (left),DAG1,Dystroglycan,36278,-0.00658264207446109,0.0392515885940667,-0.0835157557188319,0.0703504715699097,0.866820694787715
Physical measures,X4270.Volume level set by participant (left),LEO1,RNA polymerase-associated protein LEO1,35305,-0.0122715257406738,0.073185518925543,-0.155715142834738,0.131172091353391,0.866842477524161
Physical measures,X4270.Volume level set by participant (left),IKZF2,Zinc finger protein Helios,36060,0.00362847998320602,0.0216879076383324,-0.0388798189879255,0.0461367789543376,0.867135165555321
Physical measures,X4270.Volume level set by participant (left),SIGLEC9,Sialic acid-binding Ig-like lectin 9,36315,0.0100773653585741,0.0602411975933708,-0.107995381924433,0.128150112641581,0.867151281120768
Physical measures,X4270.Volume level set by participant (left),CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,35305,-0.00336373963186328,0.0201787245931183,-0.0429140398343752,0.0361865605706487,0.867613230651225
Physical measures,X4270.Volume level set by participant (left),PODXL2,Podocalyxin-like protein 2,36289,0.0109500700453891,0.0658538190486485,-0.118123415289962,0.14002355538074,0.867942208971226
Physical measures,X4270.Volume level set by participant (left),NACC1,Nucleus accumbens-associated protein 1,35279,-0.00652810805819408,0.0395678913527894,-0.0840811751096612,0.0710249589932731,0.86896079360126
Physical measures,X4270.Volume level set by participant (left),ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",35083,-0.00808658929809208,0.0491789122860674,-0.104477257378784,0.0883040787826,0.86939616433754
Physical measures,X4270.Volume level set by participant (left),BACH1,Transcription regulator protein BACH1,36242,0.00432059242295049,0.0263046814256996,-0.0472365831714207,0.0558777680173217,0.869537235463067
Physical measures,X4270.Volume level set by participant (left),GPR101,Probable G-protein coupled receptor 101,35083,-0.00643263070535434,0.0391887691929113,-0.0832426183234604,0.0703773569127518,0.86962231387491
Physical measures,X4270.Volume level set by participant (left),PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,35165,-0.00517762392359588,0.0315671394467197,-0.0670492172391664,0.0566939693919746,0.869720906860443
Physical measures,X4270.Volume level set by participant (left),DAND5,DAN domain family member 5,35093,-0.00624658493576357,0.0381365213829642,-0.0809941668463733,0.0685009969748462,0.869897351356773
Physical measures,X4270.Volume level set by participant (left),LONP1,"Lon protease homolog, mitochondrial",35151,-0.00417350691430573,0.0256680816666691,-0.0544829469809772,0.0461359331523657,0.87084218246388
Physical measures,X4270.Volume level set by participant (left),SELP,P-selectin,36289,-0.00536754250602307,0.033052895081683,-0.0701512168661217,0.0594161318540755,0.871001039735155
Physical measures,X4270.Volume level set by participant (left),TMED4,Transmembrane emp24 domain-containing protein 4,35079,0.00630234365900271,0.0390844290066733,-0.070303137194077,0.0829078245120825,0.871901945452054
Physical measures,X4270.Volume level set by participant (left),CD160,CD160 antigen,36342,0.00624565167890524,0.0387755139382058,-0.069754355639978,0.0822456589977885,0.872040854761321
Physical measures,X4270.Volume level set by participant (left),VAMP8,Vesicle-associated membrane protein 8,35093,-0.004171558660123,0.0259091213909477,-0.0549534365863805,0.0466103192661345,0.872092632701036
Physical measures,X4270.Volume level set by participant (left),GPHA2,Glycoprotein hormone alpha-2,35285,-0.00806218796525887,0.0502533839179215,-0.106558820444385,0.0904344445138672,0.872546619538579
Physical measures,X4270.Volume level set by participant (left),CFHR2,Complement factor H-related protein 2,35275,-0.00612909903026534,0.0383827210631406,-0.0813592323140209,0.0691010342534902,0.873134990835175
Physical measures,X4270.Volume level set by participant (left),B4GALT1,"Beta-1,4-galactosyltransferase 1",36278,-0.0107748944882797,0.0679081962783872,-0.143874959193919,0.122325170217359,0.873934198672951
Physical measures,X4270.Volume level set by participant (left),CRNN,Cornulin,36054,-0.0044558777802373,0.0282847978348995,-0.0598940815366402,0.0509823259761657,0.874826599115685
Physical measures,X4270.Volume level set by participant (left),SERPINA12,Serpin A12,36018,0.00260890712447775,0.016650685257377,-0.0300264359799812,0.0352442502289367,0.875497635126262
Physical measures,X4270.Volume level set by participant (left),APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,36312,-0.00533606361291742,0.0341112329810091,-0.0721940802556952,0.0615219530298603,0.875697184213712
Physical measures,X4270.Volume level set by participant (left),VWC2L,von Willebrand factor C domain-containing protein 2-like,35305,-0.00765105263642521,0.0489996610585516,-0.103690388311186,0.0883882830383359,0.87592342233154
Physical measures,X4270.Volume level set by participant (left),IL17F,Interleukin-17F,36103,-0.00404562207422642,0.0259933768564638,-0.0549926407128954,0.0469013965644426,0.876320591069601
Physical measures,X4270.Volume level set by participant (left),SPINT3,Kunitz-type protease inhibitor 3,35285,0.00205679891557846,0.0132924922151906,-0.0239964858261951,0.028110083657352,0.87703579141529
Physical measures,X4270.Volume level set by participant (left),ANGPTL2,Angiopoietin-related protein 2,36253,-0.00724415323618101,0.0470885883570043,-0.0995377864159095,0.0850494799435475,0.877739201480369
Physical measures,X4270.Volume level set by participant (left),NIT2,Omega-amidase NIT2,35290,-0.00483314411851725,0.0314672098183419,-0.0665088753624673,0.0568425871254328,0.87793526719371
Physical measures,X4270.Volume level set by participant (left),BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",35083,-0.00666330562256441,0.0434336788206758,-0.091793316111089,0.0784667048659602,0.878077104645471
Physical measures,X4270.Volume level set by participant (left),ERBB4,Receptor tyrosine-protein kinase erbB-4,36289,0.0121783679386386,0.0794604626719494,-0.143564138898382,0.167920874775659,0.878194711988913
Physical measures,X4270.Volume level set by participant (left),SAA4,Serum amyloid A-4 protein,35325,-0.0104665265769697,0.0683616311523529,-0.144455323635581,0.123522270481642,0.87831984884586
Physical measures,X4270.Volume level set by participant (left),DBN1,Drebrin,35093,-0.00647432955573102,0.0424164103679705,-0.0896104938769532,0.0766618347654911,0.87868899391554
Physical measures,X4270.Volume level set by participant (left),RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",35305,-0.00364877991875254,0.0239744172977953,-0.0506386378224314,0.0433410779849263,0.879037933231072
Physical measures,X4270.Volume level set by participant (left),TSC1,Hamartin,35093,0.00439183758379456,0.0289587665240577,-0.0523673448033585,0.0611510199709476,0.879461154553103
Physical measures,X4270.Volume level set by participant (left),FGR,Tyrosine-protein kinase Fgr,36064,-0.00480980704220645,0.0318221586078155,-0.0671812379135249,0.057561623829112,0.879864259521255
Physical measures,X4270.Volume level set by participant (left),SATB1,DNA-binding protein SATB1,35305,0.011480494166552,0.0762750961559631,-0.138018694299136,0.16097968263224,0.880363383923023
Physical measures,X4270.Volume level set by participant (left),PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,36256,0.0101077802117081,0.0675349135149018,-0.1222606502775,0.142476210700916,0.881030911466585
Physical measures,X4270.Volume level set by participant (left),RICTOR,Rapamycin-insensitive companion of mTOR,35093,-0.00707059004799945,0.0473592282276381,-0.09989467737417,0.0857534972781711,0.881323932070268
Physical measures,X4270.Volume level set by participant (left),GPC1,Glypican-1,36327,-0.00951287797680525,0.0637528962698585,-0.134468554665728,0.115442798712117,0.881388008997637
Physical measures,X4270.Volume level set by participant (left),CDC27,Cell division cycle protein 27 homolog,36060,-0.00453258222957319,0.0303969323092639,-0.0641105695557305,0.0550454050965841,0.881468384471061
Physical measures,X4270.Volume level set by participant (left),MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",35305,-0.00767638399467264,0.0517253232674783,-0.10905801759893,0.0937052496095849,0.882026285771523
Physical measures,X4270.Volume level set by participant (left),SHPK,Sedoheptulokinase,35195,0.00797358675709955,0.0543539706859652,-0.0985601957873923,0.114507369301591,0.883375348424159
Physical measures,X4270.Volume level set by participant (left),SLMAP,Sarcolemmal membrane-associated protein,35285,-0.00362534828872833,0.0250597222632378,-0.0527424039246744,0.0454917073472177,0.884977104364176
Physical measures,X4270.Volume level set by participant (left),SCARF1,Scavenger receptor class F member 1,36364,-0.00625202612838329,0.0432276874765005,-0.0909782935823243,0.0784742413255577,0.885006661239697
Physical measures,X4270.Volume level set by participant (left),LAMA1,Laminin subunit alpha-1,35079,0.00628027312959309,0.0434537826661628,-0.0788891408960859,0.0914496871552721,0.885088320800809
Physical measures,X4270.Volume level set by participant (left),PRRT3,Proline-rich transmembrane protein 3,35151,0.00836750779540309,0.0580506636755849,-0.105411793008743,0.12214680859955,0.885393196834733
Physical measures,X4270.Volume level set by participant (left),OSBPL2,Oxysterol-binding protein-related protein 2,35301,-0.00821850624615905,0.0574989965437466,-0.120916539471902,0.104479526979584,0.886347365446885
Physical measures,X4270.Volume level set by participant (left),VWA1,von Willebrand factor A domain-containing protein 1,36321,0.00634506133086945,0.0444357497058781,-0.0807490080926517,0.0934391307543906,0.886458329320816
Physical measures,X4270.Volume level set by participant (left),CALCA,Calcitonin,36168,-0.00394521667010766,0.0277442572565639,-0.0583239608929729,0.0504335275527576,0.886926294296345
Physical measures,X4270.Volume level set by participant (left),MYH9,Myosin-9,35320,0.00270576943875777,0.0190718019578899,-0.0346749623987064,0.0400865012762219,0.887184755181559
Physical measures,X4270.Volume level set by participant (left),C1QA,Complement C1q subcomponent subunit A,36321,-0.0118412087370909,0.0839708556898538,-0.176424085889204,0.152741668415023,0.887861222077237
Physical measures,X4270.Volume level set by participant (left),FGFBP2,Fibroblast growth factor-binding protein 2,35320,0.0059934810299265,0.0426113570170994,-0.0775247787235883,0.0895117407834413,0.888147073465396
Physical measures,X4270.Volume level set by participant (left),PCSK7,Proprotein convertase subtilisin/kexin type 7,35279,0.00707102022916328,0.0503822969275492,-0.0916782817488331,0.10582032220716,0.888389814234455
Physical measures,X4270.Volume level set by participant (left),CFHR4,Complement factor H-related protein 4,35311,-0.00417819166023173,0.029808592245331,-0.0626030324610805,0.054246649140617,0.888531969076938
Physical measures,X4270.Volume level set by participant (left),FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,35305,-0.00312242282976803,0.0222822688405357,-0.0467956697572181,0.040550824097682,0.888561187537038
Physical measures,X4270.Volume level set by participant (left),LYPD8,Ly6/PLAUR domain-containing protein 8,36060,0.00500139748108644,0.0356967772469654,-0.0649642859229658,0.0749670808851386,0.888578589614
Physical measures,X4270.Volume level set by participant (left),MANF,Mesencephalic astrocyte-derived neurotrophic factor,36278,-0.00224820811178434,0.0162251746325504,-0.0340495503915832,0.0295531341680145,0.889799155201608
Physical measures,X4270.Volume level set by participant (left),PFDN4,Prefoldin subunit 4,35095,-0.0058909196458143,0.0426375701347703,-0.0894605571099641,0.0776787178183355,0.890116158549545
Physical measures,X4270.Volume level set by participant (left),LAMTOR5,Ragulator complex protein LAMTOR5,35279,-0.00730203876486559,0.0529776734353614,-0.111138278698174,0.0965342011684428,0.890377050574284
Physical measures,X4270.Volume level set by participant (left),VWC2,Brorin,36152,-0.00654220063903172,0.0475912547289021,-0.0998210599076798,0.0867366586296164,0.890665779411262
Physical measures,X4270.Volume level set by participant (left),TBR1,T-box brain protein 1,35133,0.00671912597363888,0.0488970961066295,-0.089119182395355,0.102557434342633,0.890708118837405
Physical measures,X4270.Volume level set by participant (left),TPR,Nucleoprotein TPR,35079,-0.00639619880854096,0.0466208624480589,-0.0977730892067363,0.0849806915896544,0.890880087285622
Physical measures,X4270.Volume level set by participant (left),SEMA4D,Semaphorin-4D,36325,0.00844303602462277,0.0616385139977298,-0.112368451410928,0.129254523460173,0.891052837251392
Physical measures,X4270.Volume level set by participant (left),ATP5IF1,"ATPase inhibitor, mitochondrial",36278,-0.00242794006452096,0.0177892862090756,-0.0372949410343092,0.0324390609052672,0.891442824111373
Physical measures,X4270.Volume level set by participant (left),CLEC4C,C-type lectin domain family 4 member C,36242,0.00527242213525253,0.038692109793726,-0.0705641130604504,0.0811089573309555,0.891614528547576
Physical measures,X4270.Volume level set by participant (left),ARHGEF10,Rho guanine nucleotide exchange factor 10,35305,-0.00320349264973769,0.0235312489149959,-0.0493247405231296,0.0429177552236542,0.8917164279973
Physical measures,X4270.Volume level set by participant (left),BTD,Biotinidase,35325,0.0140611825051832,0.103325619865434,-0.188457032431067,0.216579397441433,0.891757276672943
Physical measures,X4270.Volume level set by participant (left),PDLIM7,PDZ and LIM domain protein 7,36278,0.00200624474650499,0.0147529989792114,-0.0269096332527494,0.0309221227457593,0.891833587959426
Physical measures,X4270.Volume level set by participant (left),DPP10,Inactive dipeptidyl peptidase 10,36242,-0.00695850543898445,0.0516206400556417,-0.108134959948042,0.0942179490700733,0.892772896203995
Physical measures,X4270.Volume level set by participant (left),MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,36268,-0.00348040721089578,0.0258327102769982,-0.0541125193538122,0.0471517049320207,0.892829926238185
Physical measures,X4270.Volume level set by participant (left),PTX3,Pentraxin-related protein PTX3,36242,-0.00505781718631515,0.0375822858922375,-0.0787190975351007,0.0686034631624704,0.892947645026965
Physical measures,X4270.Volume level set by participant (left),CWC15,Spliceosome-associated protein CWC15 homolog,35252,-0.00470522552739513,0.0351882705153027,-0.0736742357373885,0.0642637846825982,0.893631407358165
Physical measures,X4270.Volume level set by participant (left),FAP,Prolyl endopeptidase FAP,36364,0.0090048003025883,0.0681446572770522,-0.124558727960434,0.142568328565611,0.89487506486413
Physical measures,X4270.Volume level set by participant (left),TP53INP1,Tumor protein p53-inducible nuclear protein 1,36109,0.00806529719951539,0.061286433945938,-0.112056113334523,0.128186707733554,0.895304180449175
Physical measures,X4270.Volume level set by participant (left),TNXB,Tenascin-X,36256,0.0095681887542551,0.0727164226745821,-0.132955999687926,0.152092377196436,0.895318203823354
Physical measures,X4270.Volume level set by participant (left),GASK1A,Golgi-associated kinase 1A,35079,-0.00685559375382394,0.0521098170664448,-0.108990835204056,0.0952796476964078,0.895336014610592
Physical measures,X4270.Volume level set by participant (left),FAM3D,Protein FAM3D,35285,0.00328446650584457,0.0249721012105162,-0.0456608518667672,0.0522297848784564,0.895363625879486
Physical measures,X4270.Volume level set by participant (left),DCC,Netrin receptor DCC,35133,0.0126956216734762,0.096598622087736,-0.176637677618486,0.202028920965439,0.895441951843761
Physical measures,X4270.Volume level set by participant (left),NADK,NAD kinase,36258,-0.00437004039497162,0.0334855940793652,-0.0700018047905275,0.0612617240005843,0.896170258283875
Physical measures,X4270.Volume level set by participant (left),ECE1,Endothelin-converting enzyme 1,36064,0.00688046026924699,0.0528324030043138,-0.096671049619208,0.110431970157702,0.89638652703646
Physical measures,X4270.Volume level set by participant (left),NUCB2,Nucleobindin-2,36317,-0.00647161388440141,0.0497052696900374,-0.103893942476875,0.0909507147080719,0.896411784099014
Physical measures,X4270.Volume level set by participant (left),C19orf12,Protein C19orf12,36064,0.00375960478896798,0.0291261557395536,-0.053327660460557,0.060846870038493,0.897297810135182
Physical measures,X4270.Volume level set by participant (left),PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,35095,0.00497761985985229,0.0385817216860219,-0.0706425546447506,0.0805977943644552,0.897349796076981
Physical measures,X4270.Volume level set by participant (left),GBP4,Guanylate-binding protein 4,36064,0.00494244946140672,0.0383821966641695,-0.0702866560003655,0.0801715549231789,0.897543651273054
Physical measures,X4270.Volume level set by participant (left),IGSF3,Immunoglobulin superfamily member 3,36216,-0.00699409478074406,0.0544886407906353,-0.113791830730389,0.0998036411689011,0.897868450337141
Physical measures,X4270.Volume level set by participant (left),EDN1,Endothelin-1,35151,0.00942655104546349,0.0734885356693772,-0.134610978866516,0.153464080957443,0.897937343299336
Physical measures,X4270.Volume level set by participant (left),SYT1,Synaptotagmin-1,35301,-0.00709232086317241,0.0557957003961263,-0.11645189363958,0.102267251913235,0.898855317100453
Physical measures,X4270.Volume level set by participant (left),ESAM,Endothelial cell-selective adhesion molecule,36364,-0.00726200765692157,0.0573162297735166,-0.119601818013014,0.105077802699171,0.899180557090891
Physical measures,X4270.Volume level set by participant (left),SOST,Sclerostin,36247,0.00614357564188846,0.048660109640745,-0.0892302392539716,0.101517390537749,0.899533502210028
Physical measures,X4270.Volume level set by participant (left),XG,Glycoprotein Xg,36314,0.00691151130734332,0.0550253725324624,-0.100938218856283,0.11476124147097,0.900047168827273
Physical measures,X4270.Volume level set by participant (left),TRAF3,"TNF receptor-associated factor 3, Isoform 2",35093,-0.00747940810492615,0.0596206205809478,-0.124335824443584,0.109377008233732,0.900171175448757
Physical measures,X4270.Volume level set by participant (left),TBC1D23,TBC1 domain family member 23,36216,-0.00254104787913395,0.0202594069855195,-0.0422494855707522,0.0371673898124843,0.900189949626784
Physical measures,X4270.Volume level set by participant (left),MLLT1,Protein ENL,35095,-0.00418534452950633,0.0333778609614008,-0.0696059520138519,0.0612352629548393,0.900216444787422
Physical measures,X4270.Volume level set by participant (left),MARCO,Macrophage receptor MARCO,36258,0.00908040186086267,0.0724887732220774,-0.132997593654409,0.151158397376134,0.900316004286345
Physical measures,X4270.Volume level set by participant (left),ANXA1,Annexin A1,35126,0.00607269607306943,0.0488860442796116,-0.0897439507149694,0.101889342861108,0.901143754242852
Physical measures,X4270.Volume level set by participant (left),PGA4,Pepsin A-4,35317,-0.00375285237143977,0.0302475078941578,-0.0630379678439891,0.0555322631011096,0.901262411723224
Physical measures,X4270.Volume level set by participant (left),ZCCHC8,Zinc finger CCHC domain-containing protein 8,35079,-0.00460437033016321,0.0371606827379695,-0.0774393084965834,0.068230567836257,0.901394852110055
Physical measures,X4270.Volume level set by participant (left),CD109,CD109 antigen,36256,-0.00684497099761137,0.0555394724348299,-0.115702336969878,0.102012394974655,0.901916204412446
Physical measures,X4270.Volume level set by participant (left),KLRF1,Killer cell lectin-like receptor subfamily F member 1,35093,0.00587198652907107,0.0481389245235653,-0.088480305537117,0.100224278595259,0.902918625763457
Physical measures,X4270.Volume level set by participant (left),EPHX2,Bifunctional epoxide hydrolase 2,36109,-0.00373582295430489,0.0309065232350808,-0.0643126084950632,0.0568409625864534,0.903793357412792
Physical measures,X4270.Volume level set by participant (left),IL7R,Interleukin-7 receptor subunit alpha,36256,0.00441604136566842,0.0366534450049995,-0.0674247108441306,0.0762567935754674,0.904105343178424
Physical measures,X4270.Volume level set by participant (left),PCDH7,Protocadherin-7,35285,-0.00711034179817919,0.059092002127536,-0.12293066596815,0.108709982371791,0.904228023001468
Physical measures,X4270.Volume level set by participant (left),VCAN,Versican core protein,36325,0.00742928325446898,0.0617600353304315,-0.113620385993177,0.128478952502115,0.904254392452598
Physical measures,X4270.Volume level set by participant (left),NTF3,Neurotrophin-3,36242,-0.00634696315511266,0.0533932653267963,-0.110997763195633,0.098303836885408,0.905379906900391
Physical measures,X4270.Volume level set by participant (left),ABL1,Tyrosine-protein kinase ABL1,36216,-0.00324186105568011,0.0273082519427797,-0.0567660348635282,0.050282312752168,0.905505389020272
Physical measures,X4270.Volume level set by participant (left),REG1B,Lithostathine-1-beta,36364,0.00383012036144462,0.03260111239976,-0.0600680599420849,0.0677283006649741,0.906479288529982
Physical measures,X4270.Volume level set by participant (left),PAK4,Serine/threonine-protein kinase PAK 4,36064,-0.00366887374782625,0.0312599338562247,-0.0649383441060267,0.0576005966103742,0.906572669174285
Physical measures,X4270.Volume level set by participant (left),ARHGAP1,Rho GTPase-activating protein 1,36060,-0.00498114765743976,0.0424743012580406,-0.0882307781231993,0.0782684828083198,0.90664577923417
Physical measures,X4270.Volume level set by participant (left),TPRKB,EKC/KEOPS complex subunit TPRKB,35095,-0.00393803799079716,0.0336408116173518,-0.0698740287608067,0.0619979527792124,0.90681507804873
Physical measures,X4270.Volume level set by participant (left),IL3,Interleukin-3,35095,0.00434615072712919,0.0373964051891699,-0.0689508034436438,0.0776431048979022,0.907483041743466
Physical measures,X4270.Volume level set by participant (left),B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",35151,0.00692907389113156,0.0597340269245647,-0.110149618881015,0.124007766663278,0.907657070546233
Physical measures,X4270.Volume level set by participant (left),TGFBI,Transforming growth factor-beta-induced protein ig-h3,36204,-0.00812308783750025,0.0705373856365557,-0.146376363685149,0.130130188010149,0.908321316788008
Physical measures,X4270.Volume level set by participant (left),CD207,C-type lectin domain family 4 member K,36089,0.00563100548936558,0.0489156668225209,-0.0902437014827754,0.101505712461507,0.908355786076489
Physical measures,X4270.Volume level set by participant (left),LAG3,Lymphocyte activation gene 3 protein,36216,-0.005436958365637,0.0473019072430838,-0.0981486965620813,0.0872747798308073,0.908494418299831
Physical measures,X4270.Volume level set by participant (left),IGFBPL1,Insulin-like growth factor-binding protein-like 1,36258,0.00653846654547263,0.0573447870929498,-0.105857316156709,0.118934249247654,0.909224736860477
Physical measures,X4270.Volume level set by participant (left),GLRX,Glutaredoxin-1,36220,0.0037196980653699,0.0326816234611022,-0.0603362839183904,0.0677756800491302,0.909386499022984
Physical measures,X4270.Volume level set by participant (left),TLR4,Toll-like receptor 4,35093,0.00881607692912963,0.0779270665543215,-0.143920973517341,0.1615531273756,0.909929078707755
Physical measures,X4270.Volume level set by participant (left),MPO,Myeloperoxidase,36256,0.00453795852482008,0.0402355659275505,-0.0743237506931789,0.0833996677428191,0.910204161542496
Physical measures,X4270.Volume level set by participant (left),IKBKG,NF-kappa-B essential modulator,36242,-0.00249990172153154,0.0222200150456433,-0.0460511312109923,0.0410513277679292,0.910424572603716
Physical measures,X4270.Volume level set by participant (left),HDGF,Hepatoma-derived growth factor,36308,0.00236040294208349,0.0210197182275054,-0.0388382447838271,0.043559050667994,0.91059266965711
Physical measures,X4270.Volume level set by participant (left),MORF4L2,Mortality factor 4-like protein 2,35095,0.00648407851310773,0.0581212127443858,-0.107433498465889,0.120401655492104,0.911174701096125
Physical measures,X4270.Volume level set by participant (left),LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,36309,-0.00588684777177067,0.0529608524446497,-0.109690118563284,0.0979164230197428,0.911496566341669
Physical measures,X4270.Volume level set by participant (left),CLINT1,Clathrin interactor 1,35095,-0.00484653097710613,0.0436672528058148,-0.090434346476503,0.0807412845222908,0.911629476470737
Physical measures,X4270.Volume level set by participant (left),OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",35151,-0.00326982114555455,0.0297640992254454,-0.0616074556274275,0.0550678133363184,0.912525445603113
Physical measures,X4270.Volume level set by participant (left),LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,36364,0.00286175111274766,0.0261800848026733,-0.048451215100492,0.0541747173259873,0.912959258250614
Physical measures,X4270.Volume level set by participant (left),ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,36364,0.00838424168571219,0.077082595769093,-0.14269764602171,0.159466129393134,0.913388062966223
Physical measures,X4270.Volume level set by participant (left),CXCL5,C-X-C motif chemokine 5,36235,-0.00182253575928928,0.016782502931375,-0.0347162415047843,0.0310711699862058,0.913524697983431
Physical measures,X4270.Volume level set by participant (left),CRYBB2,Beta-crystallin B2,35301,-0.00319837722407766,0.0295572705979126,-0.0611306275959863,0.054733873147831,0.913832757167087
Physical measures,X4270.Volume level set by participant (left),BRK1,Protein BRICK1,36064,-0.00461698769887817,0.0427537255027436,-0.0884142896842557,0.0791803142864994,0.914006289434301
Physical measures,X4270.Volume level set by participant (left),TUBB3,Tubulin beta-3 chain,35083,0.00848464633656545,0.0785907402518677,-0.145553204557095,0.162522497230226,0.9140308652323
Physical measures,X4270.Volume level set by participant (left),ADAMTSL2,ADAMTS-like protein 2,35320,0.0068280158999332,0.0636236018914337,-0.117874243807277,0.131530275607143,0.914539184621024
Physical measures,X4270.Volume level set by participant (left),SNAP23,Synaptosomal-associated protein 23,36258,-0.00244329849590965,0.0228425872334851,-0.0472147694735404,0.0423281724817211,0.914821593110943
Physical measures,X4270.Volume level set by participant (left),SERPINA3,Alpha-1-antichymotrypsin,35294,0.0152677200871279,0.143422465268468,-0.26584031183907,0.296375752013326,0.915226310181085
Physical measures,X4270.Volume level set by participant (left),OPHN1,Oligophrenin-1,35301,-0.00220298809068552,0.0207028906077391,-0.0427806536818541,0.038374677500483,0.915260495009401
Physical measures,X4270.Volume level set by participant (left),CPTP,Ceramide-1-phosphate transfer protein,35079,0.00590422019981357,0.05556984411623,-0.103012674267997,0.114821114667624,0.915388373379931
Physical measures,X4270.Volume level set by participant (left),TJAP1,Tight junction-associated protein 1,36289,-0.00242712820352872,0.0229819066201777,-0.047471665179077,0.0426174087720196,0.915894233953595
Physical measures,X4270.Volume level set by participant (left),SSBP1,"Single-stranded DNA-binding protein, mitochondrial",35093,-0.00699412931062732,0.0667024045051199,-0.137730842140662,0.123742583519408,0.916493527932762
Physical measures,X4270.Volume level set by participant (left),CBLN1,Cerebellin-1,35083,-0.00248743037767619,0.0241413181262543,-0.0498044139051347,0.0448295531497823,0.917937405908167
Physical measures,X4270.Volume level set by participant (left),EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,36109,-0.00555002150338592,0.0541502540112559,-0.111684519365448,0.100584476358676,0.918368113719573
Physical measures,X4270.Volume level set by participant (left),PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",36103,-0.00274386830762542,0.0267826451512726,-0.0552378528041197,0.0497501161888689,0.918402642713347
Physical measures,X4270.Volume level set by participant (left),GUCA2A,Guanylin,36208,0.00567496333472685,0.0554627545060461,-0.103032035497124,0.114381962166577,0.918505174009027
Physical measures,X4270.Volume level set by participant (left),NXPH3,Neurexophilin-3,35093,-0.00750877853099724,0.0734059145264028,-0.151384371002747,0.136366813940752,0.918528706224979
Physical measures,X4270.Volume level set by participant (left),PPM1A,Protein phosphatase 1A,36060,0.00596486320203975,0.0583341880211182,-0.108370145319352,0.120299871723431,0.91855837186143
Physical measures,X4270.Volume level set by participant (left),SAT1,Diamine acetyltransferase 1,35079,0.00467156118202307,0.0462655272343229,-0.0860088721972498,0.0953519945612959,0.919575154825875
Physical measures,X4270.Volume level set by participant (left),TIGIT,T-cell immunoreceptor with Ig and ITIM domains,35195,0.00586387892993709,0.0581457670570627,-0.108101824501906,0.11982958236178,0.919674263042555
Physical measures,X4270.Volume level set by participant (left),COL28A1,Collagen alpha-1(XXVIII) chain,35133,0.00277873100618238,0.0275539429373147,-0.0512269971509543,0.0567844591633191,0.919675054992674
Physical measures,X4270.Volume level set by participant (left),SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",35095,0.0038152792624426,0.0384063148475091,-0.0714610978386751,0.0790916563635603,0.920871471055515
Physical measures,X4270.Volume level set by participant (left),KRT14,"Keratin, type I cytoskeletal 14",35847,-0.00634841800635483,0.0639517569780025,-0.13169386168324,0.11899702567053,0.920927549226818
Physical measures,X4270.Volume level set by participant (left),BTC,Probetacellulin,36060,0.0025653878183186,0.0259845782171689,-0.0483643854873325,0.0534951611239697,0.921357428731299
Physical measures,X4270.Volume level set by participant (left),CBLIF,Cobalamin binding intrinsic factor,36247,0.00252641580396967,0.0256387208293215,-0.0477254770215004,0.0527783086294397,0.921506830252129
Physical measures,X4270.Volume level set by participant (left),SHMT1,"Serine hydroxymethyltransferase, cytosolic",36268,-0.00223554875432795,0.0226973420895121,-0.0467223392497717,0.0422512417411158,0.92154272552509
Physical measures,X4270.Volume level set by participant (left),KRT17,"Keratin, type I cytoskeletal 17",35079,0.00533499860133544,0.0546662074169041,-0.101810767935797,0.112480765138467,0.92225909277581
Physical measures,X4270.Volume level set by participant (left),VIT,Vitrin,35313,-0.00552849743337042,0.0568778997314596,-0.117009180907031,0.10595218604029,0.922570951610933
Physical measures,X4270.Volume level set by participant (left),LAYN,Layilin,36168,0.00536837823306133,0.0552393620625396,-0.102900771409516,0.113637527875639,0.922582905020703
Physical measures,X4270.Volume level set by participant (left),HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",35079,-0.00332560070352977,0.0343240274981419,-0.0706006945998879,0.0639494931928283,0.922818005264082
Physical measures,X4270.Volume level set by participant (left),DLG4,Disks large homolog 4,35301,0.00284952362750872,0.0296733473051162,-0.055310237090519,0.0610092843455365,0.923499830806643
Physical measures,X4270.Volume level set by participant (left),MAGED1,Melanoma-associated antigen D1,36060,-0.00379582937928916,0.0396272943613286,-0.0814653263274933,0.073873667568915,0.923691319495606
Physical measures,X4270.Volume level set by participant (left),BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,35313,-0.00608676649681492,0.0640156932025267,-0.131557525173767,0.119383992180137,0.924252207394423
Physical measures,X4270.Volume level set by participant (left),CFD,Complement factor D,35325,-0.010270331237261,0.10835183857102,-0.222639934836459,0.202099272361937,0.924486944302966
Physical measures,X4270.Volume level set by participant (left),SCGN,Secretagogin,36103,0.00397053048241642,0.0428849937485205,-0.0800840572646837,0.0880251182295165,0.926235301369258
Physical measures,X4270.Volume level set by participant (left),KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,35285,0.00117149416954272,0.0127491356654149,-0.0238168117346705,0.0261598000737559,0.926789681054176
Physical measures,X4270.Volume level set by participant (left),ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",35093,-0.00443928579040233,0.048399078696606,-0.0993014800357501,0.0904229084549454,0.926921329911894
Physical measures,X4270.Volume level set by participant (left),COX6B1,Cytochrome c oxidase subunit 6B1,35313,-0.00600895319877451,0.0660235274671482,-0.135415067034385,0.123397160636836,0.927485532959378
Physical measures,X4270.Volume level set by participant (left),ISM2,Isthmin-2,35320,-0.00464934013674017,0.0511222633096357,-0.104848976223626,0.0955502959501457,0.927538602738614
Physical measures,X4270.Volume level set by participant (left),C2orf69,UPF0565 protein C2orf69,35133,0.00355356504230655,0.0390984161123,-0.0730793305378014,0.0801864606224146,0.927584612854757
Physical measures,X4270.Volume level set by participant (left),CES1,Liver carboxylesterase 1,36301,0.00201995592931017,0.0222513455744243,-0.0415926813965614,0.0456325932551818,0.927670521821314
Physical measures,X4270.Volume level set by participant (left),NAGA,Alpha-N-acetylgalactosaminidase,35082,-0.00348581446552357,0.0384711763829393,-0.0788893201760847,0.0719176912450376,0.927806501743447
Physical measures,X4270.Volume level set by participant (left),A1BG,Alpha-1B-glycoprotein,35325,-0.0114949346007861,0.127707836734956,-0.2618022946013,0.238812425399727,0.928282247253008
Physical measures,X4270.Volume level set by participant (left),TNIP1,TNFAIP3-interacting protein 1,35301,-0.00229874990604217,0.0255677694218166,-0.0524115779728026,0.0478140781607183,0.928362922141353
Physical measures,X4270.Volume level set by participant (left),SDCCAG8,Serologically defined colon cancer antigen 8,35279,0.00180188572396595,0.0200656083068245,-0.03752670655741,0.0411304780053419,0.928449075746002
Physical measures,X4270.Volume level set by participant (left),IFNG,Interferon gamma,36103,-0.00150828206421198,0.0168514500970475,-0.034537124254425,0.0315205601260011,0.928683299038729
Physical measures,X4270.Volume level set by participant (left),CXCL12,Stromal cell-derived factor 1,36103,0.00426920412831101,0.0483403463467401,-0.0904778747112996,0.0990162829679216,0.929628240464189
Physical measures,X4270.Volume level set by participant (left),ENDOU,Poly(U)-specific endoribonuclease,34800,-0.00363179982892814,0.0411965434675291,-0.0843770250252851,0.0771134253674288,0.929754044429431
Physical measures,X4270.Volume level set by participant (left),PAPPA,Pappalysin-1,36103,-0.00353886016159147,0.0402470111628042,-0.0824230020406877,0.0753452817175048,0.929935835512047
Physical measures,X4270.Volume level set by participant (left),DEFB104A_DEFB104B,Beta-defensin 104,35083,-0.00354673871833356,0.0408162137494664,-0.0835465176672876,0.0764530402306205,0.930757389535345
Physical measures,X4270.Volume level set by participant (left),ATRN,"Attractin, Isoform 2",35325,-0.0113482639322718,0.132070956237599,-0.270207338157966,0.247510810293423,0.931528193592014
Physical measures,X4270.Volume level set by participant (left),PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",35079,-0.0031155469360085,0.0364813397982269,-0.0746189729405332,0.0683878790685162,0.931945150215332
Physical measures,X4270.Volume level set by participant (left),TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,35133,-0.00353220041386532,0.0415387143167462,-0.0849480804746879,0.0778836796469572,0.932237017441184
Physical measures,X4270.Volume level set by participant (left),SERPINH1,Serpin H1,35195,0.00145321075489723,0.017275314963002,-0.0324064065725867,0.0353128280823811,0.932963059434411
Physical measures,X4270.Volume level set by participant (left),FGF5,Fibroblast growth factor 5,36103,0.0046687454157619,0.0556196879572486,-0.104345842980445,0.113683333811969,0.933105964829052
Physical measures,X4270.Volume level set by participant (left),PCDH1,Protocadherin-1,36308,0.00743829163118705,0.0889469154428072,-0.166897662636715,0.181774245899089,0.933355815888408
Physical measures,X4270.Volume level set by participant (left),CSF1R,Macrophage colony-stimulating factor 1 receptor,35317,0.00461755456909419,0.0552656917536387,-0.103703201268038,0.112938310406226,0.933415187612021
Physical measures,X4270.Volume level set by participant (left),NCLN,Nicalin,36103,0.00297500993236543,0.0367033469273723,-0.0689635500452843,0.0749135699100152,0.935399938915839
Physical measures,X4270.Volume level set by participant (left),CD83,CD83 antigen,36242,0.00441201791423698,0.0556771722391854,-0.104715239674566,0.11353927550304,0.936841536481721
Physical measures,X4270.Volume level set by participant (left),CXCL11,C-X-C motif chemokine 11,36325,-0.00190622533831903,0.0242410375178824,-0.0494186588733684,0.0456062081967304,0.937323956473594
Physical measures,X4270.Volume level set by participant (left),TSPAN1,Tetraspanin-1,36109,-0.00202058910667805,0.0257372061387867,-0.0524655131387,0.0484243349253439,0.937425672344747
Physical measures,X4270.Volume level set by participant (left),WASHC3,WASH complex subunit 3,35301,0.00216129951967882,0.0276021227847815,-0.0519388611384929,0.0562614601778505,0.937590220252662
Physical measures,X4270.Volume level set by participant (left),TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,36179,0.00262455116765413,0.0336386871494191,-0.0633072756452074,0.0685563779805157,0.937812766578448
Physical measures,X4270.Volume level set by participant (left),SUOX,"Sulfite oxidase, mitochondrial",35305,-0.00271524954410323,0.0348450707271545,-0.0710115881693261,0.0655810890811196,0.937891239557812
Physical measures,X4270.Volume level set by participant (left),CASP9,Caspase-9,35093,0.00275821005839075,0.0354122632521025,-0.0666498259157301,0.0721662460325116,0.937919103640834
Physical measures,X4270.Volume level set by participant (left),PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,36242,-0.00373266795175126,0.0482498608964755,-0.0983023953088433,0.0908370594053408,0.938338218812419
Physical measures,X4270.Volume level set by participant (left),GBP6,Guanylate-binding protein 6,35079,-0.00378094710752303,0.0495203179999336,-0.100840770387393,0.0932788761723469,0.939141868293826
Physical measures,X4270.Volume level set by participant (left),TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,35165,0.0026676543365623,0.0350718842765855,-0.0660732388455453,0.0714085475186699,0.939371712635265
Physical measures,X4270.Volume level set by participant (left),REST,RE1-silencing transcription factor,35095,0.00500869885237763,0.0661251947825362,-0.124596682921393,0.134614080626149,0.939623754780075
Physical measures,X4270.Volume level set by participant (left),DDX58,Antiviral innate immune response receptor RIG-I,36060,-0.00260117756649613,0.0343815725291564,-0.0699890597236427,0.0647867045906504,0.939694689029833
Physical measures,X4270.Volume level set by participant (left),NBL1,Neuroblastoma suppressor of tumorigenicity 1,36289,0.00532076397324612,0.0704716449193041,-0.13280366006859,0.143445188015082,0.93981711507801
Physical measures,X4270.Volume level set by participant (left),CPE,Carboxypeptidase E,36285,-0.00348557097661043,0.0466411679496719,-0.0949022601579674,0.0879311182047465,0.940430178751087
Physical measures,X4270.Volume level set by participant (left),MET,Hepatocyte growth factor receptor,36295,-0.00724270863943328,0.0969336474018795,-0.197232657547117,0.182747240268251,0.940440861518781
Physical measures,X4270.Volume level set by participant (left),SERPINA7,Thyroxine-binding globulin,35325,0.00856858078264942,0.116299120292788,-0.219377694991214,0.236514856556513,0.941269520750024
Physical measures,X4270.Volume level set by participant (left),CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",35301,0.00377758323526022,0.0516149170437622,-0.0973876541705137,0.104942820641034,0.941658844333358
Physical measures,X4270.Volume level set by participant (left),DAAM1,Disheveled-associated activator of morphogenesis 1,35165,0.00195872900103674,0.0269095659874632,-0.050784020334391,0.0547014783364645,0.94197598851422
Physical measures,X4270.Volume level set by participant (left),THRAP3,Thyroid hormone receptor-associated protein 3,35079,-0.00154330609094547,0.0213128208452515,-0.0433164349476385,0.0402298227657475,0.942276192729897
Physical measures,X4270.Volume level set by participant (left),COL4A1,Collagen alpha-1(IV) chain,36258,0.00342384870270045,0.04738500998275,-0.0894507708634896,0.0962984682688905,0.942400111027041
Physical measures,X4270.Volume level set by participant (left),MYL6B,Myosin light chain 6B,35133,0.00176391814405032,0.0244989309876307,-0.0462539865917058,0.0497818228798064,0.942604271608792
Physical measures,X4270.Volume level set by participant (left),AP1G2,AP-1 complex subunit gamma-like 2,35279,0.00191774340014234,0.026759106267813,-0.0505301048847711,0.0543655916850558,0.942869109237161
Physical measures,X4270.Volume level set by participant (left),FYB1,FYN-binding protein 1,36237,-0.00146772607172319,0.0205062003049333,-0.0416598786693925,0.0387244265259461,0.942942213481696
Physical measures,X4270.Volume level set by participant (left),KRT8,"Keratin, type II cytoskeletal 8",35083,-0.00209920120791773,0.029462858086348,-0.0598464030571598,0.0556480006413243,0.943201727956866
Physical measures,X4270.Volume level set by participant (left),PGM2,Phosphoglucomutase-2,35133,0.00263885841804532,0.0370599408029019,-0.0699986255556425,0.0752763423917331,0.943236668111725
Physical measures,X4270.Volume level set by participant (left),IFT20,Intraflagellar transport protein 20 homolog,35133,-0.0034377706059708,0.0490678566317171,-0.0996107696041363,0.0927352283921947,0.944146807119222
Physical measures,X4270.Volume level set by participant (left),EHD3,EH domain-containing protein 3,35151,-0.00138329774745236,0.0197669532552381,-0.040126526127719,0.0373599306328143,0.944211459220526
Physical measures,X4270.Volume level set by participant (left),PDIA2,Protein disulfide-isomerase A2,35095,0.00394864623999935,0.0569420226435534,-0.107657718141365,0.115555010621364,0.944717119358472
Physical measures,X4270.Volume level set by participant (left),LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,35320,-0.00103337301367918,0.0150026245929403,-0.0304385172158421,0.0283717711884838,0.945087600826155
Physical measures,X4270.Volume level set by participant (left),CEP164,Centrosomal protein of 164 kDa,36103,-0.00201534485427319,0.0299209665766023,-0.0606604393444137,0.0566297496358673,0.946300405096814
Physical measures,X4270.Volume level set by participant (left),EPHA10,Ephrin type-A receptor 10,36064,0.00197451828780983,0.0294773033389772,-0.0558009962565856,0.0597500328322052,0.946595949251726
Physical measures,X4270.Volume level set by participant (left),CLSTN2,Calsyntenin-2,36342,0.00308232474202717,0.0460708651427444,-0.0872165709377518,0.0933812204218062,0.946659864140137
Physical measures,X4270.Volume level set by participant (left),BRD1,Bromodomain-containing protein 1,35195,0.00489203945656996,0.0745628352407394,-0.141251117615279,0.151035196528419,0.947690617688263
Physical measures,X4270.Volume level set by participant (left),FCRL6,Fc receptor-like protein 6,36242,0.00176308370914193,0.0271068668540223,-0.0513663753247419,0.0548925427430257,0.948142294847724
Physical measures,X4270.Volume level set by participant (left),IFNGR2,Interferon gamma receptor 2,36179,-0.00231475508854121,0.0357491357949181,-0.0723830612465808,0.0677535510694983,0.948374792820016
Physical measures,X4270.Volume level set by participant (left),GBP2,Guanylate-binding protein 2,36103,0.00209708625418309,0.0325020871137127,-0.0616070044886939,0.0658011769970601,0.948556638226472
Physical measures,X4270.Volume level set by participant (left),PODXL,Podocalyxin,36216,0.00784964250029633,0.123529238780182,-0.23426766550886,0.249966950509453,0.949334343210374
Physical measures,X4270.Volume level set by participant (left),CEBPB,CCAAT/enhancer-binding protein beta,36109,0.00293429624453784,0.0467041835424079,-0.0886059034985817,0.0944744959876573,0.949905725116587
Physical measures,X4270.Volume level set by participant (left),TPT1,Translationally-controlled tumor protein,36103,-0.00186069305557149,0.0298968765588381,-0.0604585711108941,0.0567371849997511,0.950375725673689
Physical measures,X4270.Volume level set by participant (left),IL20RB,Interleukin-20 receptor subunit beta,35093,0.00324105294567922,0.0526921914232531,-0.100035642243897,0.106517748135255,0.95095560587062
Physical measures,X4270.Volume level set by participant (left),PKLR,Pyruvate kinase PKLR,36261,0.00174154149859097,0.0285898514706825,-0.0542945673839467,0.0577776503811286,0.951428752105039
Physical measures,X4270.Volume level set by participant (left),PTGDS,Prostaglandin-H2 D-isomerase,36198,-0.00373222050088548,0.0615071737540876,-0.124286281058897,0.116821840057126,0.951616107200753
Physical measures,X4270.Volume level set by participant (left),CXCL6,C-X-C motif chemokine 6,36342,-0.00153558751507421,0.0253523956209449,-0.0512262829321261,0.0481551079019777,0.951703452828702
Physical measures,X4270.Volume level set by participant (left),LPA,Apolipoprotein(a),35180,0.00073262189065666,0.0123033352602319,-0.0233819152193979,0.0248471590007112,0.952518552047891
Physical measures,X4270.Volume level set by participant (left),NECTIN1,Nectin-1,35093,0.00409562245455252,0.0688185076448011,-0.130788652529258,0.138979897438363,0.952545035715259
Physical measures,X4270.Volume level set by participant (left),PEAR1,Platelet endothelial aggregation receptor 1,36364,-0.00481925754342753,0.0810456462835285,-0.163668724259143,0.154030209172288,0.952584470177815
Physical measures,X4270.Volume level set by participant (left),KCNH2,Potassium voltage-gated channel subfamily H member 2,35133,0.00174390999320462,0.0293737226875072,-0.0558285864743095,0.0593164064607188,0.952659438969557
Physical measures,X4270.Volume level set by participant (left),LSM1,U6 snRNA-associated Sm-like protein LSm1,36060,0.00209788399288621,0.0354913372865625,-0.0674651370887763,0.0716609050745487,0.952866278555091
Physical measures,X4270.Volume level set by participant (left),IFNAR1,Interferon alpha/beta receptor 1,35285,-0.00508148113808778,0.0867690471653769,-0.175148813582227,0.164985851306051,0.953301699558915
Physical measures,X4270.Volume level set by participant (left),MFAP4,Microfibril-associated glycoprotein 4,35165,-0.00392042465106059,0.068184550450456,-0.137562143533954,0.129721294231833,0.954150841383183
Physical measures,X4270.Volume level set by participant (left),CXCL13,C-X-C motif chemokine 13,36325,0.00183301565268351,0.0318892132925472,-0.060669842400709,0.064335873706076,0.954163733367394
Physical measures,X4270.Volume level set by participant (left),IL12RB2,Interleukin-12 receptor subunit beta-2,35093,0.00303904841438533,0.0534166588683644,-0.101657602967609,0.107735699796379,0.954631966524156
Physical measures,X4270.Volume level set by participant (left),SEZ6L2,Seizure 6-like protein 2,36216,-0.00438957789781448,0.0778873421847446,-0.157048768579914,0.148269612784285,0.955058062497083
Physical measures,X4270.Volume level set by participant (left),SIGLEC7,Sialic acid-binding Ig-like lectin 7,36258,-0.00374714815706751,0.068013311773415,-0.137053239232961,0.129558942918826,0.956064747392191
Physical measures,X4270.Volume level set by participant (left),MXRA8,Matrix remodeling-associated protein 8,35165,0.00398265225704895,0.0726911931411896,-0.138492086299683,0.146457390813781,0.956308511631501
Physical measures,X4270.Volume level set by participant (left),FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,36060,0.00172203034741736,0.0316028508267116,-0.0602195572729374,0.0636636179677721,0.956546462046334
Physical measures,X4270.Volume level set by participant (left),PLAU,Urokinase-type plasminogen activator,36256,-0.00356799536627086,0.0655037864958963,-0.131955416898228,0.124819426165686,0.956562081375365
Physical measures,X4270.Volume level set by participant (left),BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,35093,0.00262846812584678,0.048461452622564,-0.0923559790143786,0.0976129152660721,0.956746954327458
Physical measures,X4270.Volume level set by participant (left),PLXNA4,Plexin-A4,36242,0.0012901641278592,0.0238029998485786,-0.0453637155753549,0.0479440438310733,0.95677584780518
Physical measures,X4270.Volume level set by participant (left),TAFA5,Chemokine-like protein TAFA-5,36216,0.00282794440301985,0.0523478591908548,-0.0997738596110556,0.105429748417095,0.956918926717662
Physical measures,X4270.Volume level set by participant (left),ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,35971,0.00270993433258122,0.0506767079678078,-0.096616413284322,0.102036281949484,0.957354940286405
Physical measures,X4270.Volume level set by participant (left),C7orf50,Uncharacterized protein C7orf50,35301,0.00535237169708084,0.101563958119766,-0.193712986217661,0.204417729611823,0.957972894193093
Physical measures,X4270.Volume level set by participant (left),ENPEP,Glutamyl aminopeptidase,35079,-0.0029835199181089,0.056680805108556,-0.114077897930879,0.108110858094661,0.958022585580051
Physical measures,X4270.Volume level set by participant (left),MAVS,Mitochondrial antiviral-signaling protein,36060,-0.00107575800169707,0.0205477230319206,-0.0413492951442614,0.0391977791408673,0.958247931502986
Physical measures,X4270.Volume level set by participant (left),NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",36242,0.0010234508823477,0.0196440248742864,-0.0374788378712537,0.0395257396359491,0.958450489355804
Physical measures,X4270.Volume level set by participant (left),CHRDL2,Chordin-like protein 2,36258,-0.00213635393448874,0.0411493323175563,-0.0827890452768991,0.0785163374079217,0.958596104739776
Physical measures,X4270.Volume level set by participant (left),EVI5,Ecotropic viral integration site 5 protein homolog,35093,-0.00131770816150758,0.0254026558280921,-0.051106913584568,0.0484714972615529,0.95863160394028
Physical measures,X4270.Volume level set by participant (left),FGFBP1,Fibroblast growth factor-binding protein 1,36289,0.00284101310861225,0.0560162233664108,-0.106950784689553,0.112632810906777,0.95955180300879
Physical measures,X4270.Volume level set by participant (left),FCN1,Ficolin-1,35301,-0.00184878243261172,0.0388447402197002,-0.077984473263224,0.0742869083980006,0.962041112516609
Physical measures,X4270.Volume level set by participant (left),CLPS,Colipase,36237,-0.00122747216154849,0.0261675438092562,-0.0525158580276907,0.0500609137045937,0.962587626248267
Physical measures,X4270.Volume level set by participant (left),DIPK2B,Divergent protein kinase domain 2B,35165,0.00328938679208572,0.0737398742736044,-0.141240766784179,0.14781954036835,0.964421139667386
Physical measures,X4270.Volume level set by participant (left),DNM3,Dynamin-3,35305,0.00172895459820193,0.0389013214880053,-0.0745176355182884,0.0779755447146923,0.964551316217358
Physical measures,X4270.Volume level set by participant (left),PCSK9,Proprotein convertase subtilisin/kexin type 9,36364,0.00201018957223698,0.045236926158395,-0.0866541856982173,0.0906745648426912,0.964557277712026
Physical measures,X4270.Volume level set by participant (left),ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",36216,0.00194862192666226,0.0438818532227791,-0.0840598103899848,0.0879570542433093,0.964581864626876
Physical measures,X4270.Volume level set by participant (left),CLSTN1,Calsyntenin-1,36064,0.00166060086140989,0.0378047165997163,-0.072436643674034,0.0757578453968538,0.964964758065185
Physical measures,X4270.Volume level set by participant (left),SNAP29,Synaptosomal-associated protein 29,36289,0.000927705577292848,0.0211508508222457,-0.0405279620343087,0.0423833731888944,0.965016036624772
Physical measures,X4270.Volume level set by participant (left),ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",35313,0.00105685189434316,0.0244909358891627,-0.0469453824484157,0.049059086237102,0.965581032499109
Physical measures,X4270.Volume level set by participant (left),CKB,Creatine kinase B-type,35320,-0.00164621202481464,0.0383700241546915,-0.07685145936801,0.0735590353183807,0.965779657223508
Physical measures,X4270.Volume level set by participant (left),CHM,Rab proteins geranylgeranyltransferase component A 1,35133,0.00154321943930198,0.0363822963490602,-0.069766081404856,0.0728525202834599,0.966167757941774
Physical measures,X4270.Volume level set by participant (left),IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",36064,0.00164590240232664,0.0388674958443872,-0.0745343894526724,0.0778261942573256,0.966223610220077
Physical measures,X4270.Volume level set by participant (left),EGFL7,Epidermal growth factor-like protein 7,36060,0.00199151656352283,0.0485707318042732,-0.0932071177728526,0.0971901508998983,0.967295080413765
Physical measures,X4270.Volume level set by participant (left),CASC3,Protein CASC3,35133,0.00208452681933091,0.0511194964163096,-0.0981096861566359,0.102278739795298,0.967474499233683
Physical measures,X4270.Volume level set by participant (left),MEPE,Matrix extracellular phosphoglycoprotein,36232,-0.00306195403419961,0.0759663234455076,-0.151955947987395,0.145832039918995,0.967849643658567
Physical measures,X4270.Volume level set by participant (left),ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,36342,-0.00208561165271144,0.0528005379520687,-0.105574666038766,0.101403442733343,0.968492917295637
Physical measures,X4270.Volume level set by participant (left),MTUS1,Microtubule-associated tumor suppressor 1,35195,-0.0015066127860944,0.039130129704246,-0.0782016670064166,0.0751884414342278,0.969288102957539
Physical measures,X4270.Volume level set by participant (left),ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,35093,-0.00253240502025786,0.0671645657073628,-0.134174953806689,0.129110143766173,0.969924463717803
Physical measures,X4270.Volume level set by participant (left),CEP20,Centrosomal protein 20,36060,0.0009720056357314,0.0259391829135429,-0.0498687928748127,0.0518128041462755,0.97010928179172
Physical measures,X4270.Volume level set by participant (left),BIN2,Bridging integrator 2,36256,-0.000779587626499499,0.0208408554903702,-0.041627664387625,0.040068489134626,0.970161706332111
Physical measures,X4270.Volume level set by participant (left),MMP9,Matrix metalloproteinase-9,36241,-0.00116233153082964,0.031573481178471,-0.0630463546406328,0.0607216915789736,0.970634642109348
Physical measures,X4270.Volume level set by participant (left),SCN2A,Sodium channel protein type 2 subunit alpha,35083,-0.00174750962959999,0.0476961902790571,-0.0952320425765519,0.0917370233173519,0.970774495121371
Physical measures,X4270.Volume level set by participant (left),OLFM4,Olfactomedin-4,34860,-0.000661109549439654,0.0183971731423892,-0.0367195689085224,0.0353973498096431,0.971335025101678
Physical measures,X4270.Volume level set by participant (left),SIGLEC8,Sialic acid-binding Ig-like lectin 8,35151,0.00173170511599458,0.0483972065312544,-0.0931268196852641,0.0965902299172532,0.971457996914856
Physical measures,X4270.Volume level set by participant (left),DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,35301,0.00156806359848118,0.0441728549750615,-0.0850107321526394,0.0881468593496017,0.971683417484247
Physical measures,X4270.Volume level set by participant (left),PDIA5,Protein disulfide-isomerase A5,35095,0.00127982630602785,0.0362184177572801,-0.0697082724982412,0.0722679251102969,0.971812633073506
Physical measures,X4270.Volume level set by participant (left),TTR,Transthyretin,35255,0.00310922429945044,0.0884861337718476,-0.170323597893371,0.176542046492272,0.971970768029992
Physical measures,X4270.Volume level set by participant (left),CCL18,C-C motif chemokine 18,36171,0.000933519764665223,0.0265751329906546,-0.0511537408970178,0.0530207804263483,0.971978946104468
Physical measures,X4270.Volume level set by participant (left),STX8,Syntaxin-8,36242,0.0013066883259282,0.037430356019363,-0.0720568094720233,0.0746701861238797,0.972152533838044
Physical measures,X4270.Volume level set by participant (left),HNF1A,Hepatocyte nuclear factor 1-alpha,35133,0.00106791235142652,0.0308046049461299,-0.0593091133429882,0.0614449380458412,0.972346099014112
Physical measures,X4270.Volume level set by participant (left),AXL,Tyrosine-protein kinase receptor UFO,36289,0.00228001920289202,0.068762376868624,-0.132494239459611,0.137054277865395,0.973549494611773
Physical measures,X4270.Volume level set by participant (left),C3,Complement C3,34955,-0.00144022388031578,0.0434897961485481,-0.08668022433147,0.0837997765708385,0.97358283454021
Physical measures,X4270.Volume level set by participant (left),MUCL3,Mucin-like protein 3,35095,0.00179763367968505,0.0545107323687926,-0.105043401763149,0.108638669122519,0.973693456250757
Physical measures,X4270.Volume level set by participant (left),CCL5,C-C motif chemokine 5,36289,-0.000595091782139369,0.0180958488920617,-0.0360629556105804,0.0348727720463017,0.973766717016128
Physical measures,X4270.Volume level set by participant (left),IL15RA,Interleukin-15 receptor subunit alpha,36103,0.0017978901145627,0.0547316701107412,-0.10547618330249,0.109071963531615,0.973795738873906
Physical measures,X4270.Volume level set by participant (left),INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",36216,-0.000654429424618089,0.0201885864495996,-0.0402240588658334,0.0389152000165972,0.974141302665106
Physical measures,X4270.Volume level set by participant (left),PRSS53,Serine protease 53,35301,0.00178965934978097,0.0553209999613277,-0.106639500574421,0.110218819273983,0.974193539323667
Physical measures,X4270.Volume level set by participant (left),SLC1A4,Neutral amino acid transporter A,35133,-0.00140740290661437,0.045106811687878,-0.0898167538148552,0.0870019480016264,0.975109749106111
Physical measures,X4270.Volume level set by participant (left),DYNLT3,Dynein light chain Tctex-type 3,35279,-0.00145424016063111,0.0470505260253148,-0.0936732711702481,0.0907647908489859,0.975343791402688
Physical measures,X4270.Volume level set by participant (left),PPP1R9B,Neurabin-2,36342,-0.000575071058560443,0.0193725134568836,-0.0385451974340522,0.0373950553169314,0.976319122840076
Physical measures,X4270.Volume level set by participant (left),MYH4,Myosin-4,35079,0.00144292010807681,0.0486326793744967,-0.0938771314659367,0.0967629716820903,0.976331340585013
Physical measures,X4270.Volume level set by participant (left),BCR,Breakpoint cluster region protein,36242,0.000623729642711911,0.0213792420846444,-0.0412795848431912,0.042527044128615,0.976726145515116
Physical measures,X4270.Volume level set by participant (left),VWF,von Willebrand factor,36364,-0.000715697389718017,0.0247325250123286,-0.049191446413882,0.047760051634446,0.976915183207082
Physical measures,X4270.Volume level set by participant (left),ANXA5,Annexin A5,36051,-0.00180650223605775,0.0631623098659375,-0.125604629573295,0.12199162510118,0.977183618548722
Physical measures,X4270.Volume level set by participant (left),ZNRD2,Protein ZNRD2,35285,0.000875865526498202,0.0309007011089109,-0.0596895086469672,0.0614412396999637,0.977388219853073
Physical measures,X4270.Volume level set by participant (left),MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,35083,0.00196283579560181,0.0702923441793955,-0.135810158796013,0.139735830387217,0.977723713058406
Physical measures,X4270.Volume level set by participant (left),MILR1,Allergin-1,36103,-0.00103322155443812,0.0372985620499609,-0.0741384031723614,0.0720719600634852,0.977901061913327
Physical measures,X4270.Volume level set by participant (left),HRAS,GTPase Hras,35169,0.000582671355913049,0.0225406151899565,-0.0435969344164016,0.0447622771282277,0.979377891977579
Physical measures,X4270.Volume level set by participant (left),BAP18,Chromatin complexes subunit BAP18,35301,0.00083626888949793,0.0328422224263323,-0.0635344870661134,0.0652070248451093,0.979686239946928
Physical measures,X4270.Volume level set by participant (left),B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,35079,-0.00259887824364338,0.108045216974293,-0.214367503513258,0.209169747025971,0.980810582145826
Physical measures,X4270.Volume level set by participant (left),HSBP1,Heat shock factor-binding protein 1,35151,0.000565495946762684,0.0237886615828853,-0.0460602807556926,0.047191272649218,0.981035470994723
Physical measures,X4270.Volume level set by participant (left),TOP1MT,"DNA topoisomerase I, mitochondrial",35095,0.00108240970780099,0.0474210835841979,-0.091862914117227,0.0940277335328289,0.981790172723134
Physical measures,X4270.Volume level set by participant (left),LAMA4,Laminin subunit alpha-4,36278,-0.00125795012045226,0.0554053054143787,-0.109852348732635,0.10733644849173,0.981886571271616
Physical measures,X4270.Volume level set by participant (left),SPART,Spartin,35165,-0.000617765853247869,0.029214711042482,-0.0578785994965126,0.0566430677900169,0.983130063394025
Physical measures,X4270.Volume level set by participant (left),IL20RA,Interleukin-20 receptor subunit alpha,36103,0.000884990958333459,0.0418607435470629,-0.0811620663939099,0.0829320483105768,0.983133493987564
Physical measures,X4270.Volume level set by participant (left),CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,36242,0.000466413716564017,0.0221937869128844,-0.0430334086326894,0.0439662360658175,0.983233833321581
Physical measures,X4270.Volume level set by participant (left),FRMD4B,FERM domain-containing protein 4B,35079,-0.000575862072482505,0.0289191626829676,-0.0572574209310991,0.0561056967861341,0.984113531985101
Physical measures,X4270.Volume level set by participant (left),CRX,Cone-rod homeobox protein,36109,0.000348280738149884,0.0180081616635221,-0.0349477161223535,0.0356442775986533,0.984570260460318
Physical measures,X4270.Volume level set by participant (left),HGF,Hepatocyte growth factor,36342,0.00101227384872459,0.0529765023695727,-0.102821670795638,0.104846218493087,0.984755459550999
Physical measures,X4270.Volume level set by participant (left),CDC42BPB,Serine/threonine-protein kinase MRCK beta,35285,0.000364438674649113,0.0205652205543006,-0.0399433936117801,0.0406722709610783,0.98586186363756
Physical measures,X4270.Volume level set by participant (left),FMR1,Synaptic functional regulator FMR1,36060,-0.000942730039742557,0.0533217148729402,-0.105453291190705,0.10356783111122,0.985894577111782
Physical measures,X4270.Volume level set by participant (left),TDO2,"Tryptophan 2,3-dioxygenase",35133,-0.00096496677554743,0.0561882256842584,-0.111093889116694,0.109163955565599,0.986298468115742
Physical measures,X4270.Volume level set by participant (left),AMOTL2,Angiomotin-like protein 2,35234,0.000731701142833269,0.0429250259017063,-0.083401349624511,0.0848647519101776,0.986400409839588
Physical measures,X4270.Volume level set by participant (left),CACYBP,Calcyclin-binding protein,35148,0.000375313568416377,0.0222746216377877,-0.0432829448416474,0.0440335719784802,0.986557289367255
Physical measures,X4270.Volume level set by participant (left),ARL13B,ADP-ribosylation factor-like protein 13B,35079,-0.000541001475578455,0.0325204769878086,-0.0642811363716832,0.0631991334205263,0.986727742336836
Physical measures,X4270.Volume level set by participant (left),GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,35313,-0.00121778339038217,0.0778260001639411,-0.153756743711707,0.151321176930942,0.987516065208583
Physical measures,X4270.Volume level set by participant (left),BOC,Brother of CDO,36109,0.00126610778204235,0.081261474830131,-0.158006382885014,0.160538598449099,0.987569345345004
Physical measures,X4270.Volume level set by participant (left),LMOD1,Leiomodin-1,35305,-0.000834544541486421,0.0593458708494636,-0.117152451406435,0.115483362323462,0.988780627707635
Physical measures,X4270.Volume level set by participant (left),GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,35195,0.000409520666851628,0.0307053243002381,-0.0597729149616151,0.0605919562953183,0.98935923507293
Physical measures,X4270.Volume level set by participant (left),CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,35195,-0.000633791960057636,0.0482112213098359,-0.095127785727336,0.0938602018072208,0.989511589604781
Physical measures,X4270.Volume level set by participant (left),ATRAID,All-trans retinoic acid-induced differentiation factor,35285,-0.000854627096413829,0.0763120435794523,-0.15042623251214,0.148716978319313,0.991064922829563
Physical measures,X4270.Volume level set by participant (left),CTSC,Dipeptidyl peptidase 1,36220,-0.000440853521481342,0.0415281353788204,-0.0818359988639693,0.0809542918210067,0.991530270666719
Physical measures,X4270.Volume level set by participant (left),IL1RL2,Interleukin-1 receptor-like 2,36103,-0.000492891264411901,0.0503304715283909,-0.099140615460058,0.0981548329312342,0.992186623278653
Physical measures,X4270.Volume level set by participant (left),FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,35305,-0.000859410584513676,0.0910591436413797,-0.179335332121618,0.17761651095259,0.992470007400166
Physical measures,X4270.Volume level set by participant (left),NOS3,"Nitric oxide synthase, endothelial",36064,-0.000316956365217549,0.0381681140266747,-0.0751264598575,0.074492547127065,0.993374490301755
Physical measures,X4270.Volume level set by participant (left),REG1A,Lithostathine-1-alpha,36214,0.000293172929602661,0.0384583629450574,-0.0750852184427098,0.0756715643019151,0.99391788451058
Physical measures,X4270.Volume level set by participant (left),TCN2,Transcobalamin-2,36350,0.000432801901466706,0.0625944494670728,-0.122252319053996,0.123117922856929,0.994483343771164
Physical measures,X4270.Volume level set by participant (left),EPHA2,Ephrin type-A receptor 2,36004,0.00030459441807195,0.0613942043477575,-0.120028046103533,0.120637234939677,0.996041613704501
Physical measures,X4270.Volume level set by participant (left),HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,35093,-0.000279380712389881,0.0592968676222946,-0.116501241252087,0.115942479827308,0.996240878237437
Physical measures,X4270.Volume level set by participant (left),ECSCR,Endothelial cell-specific chemotaxis regulator,35083,0.000189195295301362,0.0419659319437848,-0.0820640313145168,0.0824424219051195,0.996403042589992
Physical measures,X4270.Volume level set by participant (left),GIGYF2,GRB10-interacting GYF protein 2,35305,9.41050479613117e-05,0.0269976812227995,-0.0528213501487258,0.0530095602446484,0.997218945901678
Physical measures,X4270.Volume level set by participant (left),CFB,Complement factor B,35203,-0.000211439715367067,0.0668565297593341,-0.131250238043662,0.130827358612928,0.997476718974529
Physical measures,X4270.Volume level set by participant (left),TNFSF8,Tumor necrosis factor ligand superfamily member 8,35320,-0.000186738704916752,0.0608863016037371,-0.119523889848241,0.119150412438408,0.997552977490136
Physical measures,X4270.Volume level set by participant (left),JAM3,Junctional adhesion molecule C,35165,-8.20832749016669e-05,0.0429305078923431,-0.0842258787438942,0.0840617121940909,0.998474501096369
Physical measures,X4270.Volume level set by participant (left),CES3,Carboxylesterase 3,36216,-3.27422153099791e-05,0.0220333092578287,-0.0432180283606542,0.0431525439300342,0.998814356922816
Physical measures,X4270.Volume level set by participant (left),PTPRB,Receptor-type tyrosine-protein phosphatase beta,35313,9.00281775283856e-05,0.074763805752622,-0.146447031097611,0.146627087452668,0.999039249025049
Physical measures,X4270.Volume level set by participant (left),PSAPL1,Proactivator polypeptide-like 1,35285,4.829522705858e-05,0.043107654607198,-0.0844427078030496,0.0845392982571667,0.999106131691994
Physical measures,X4270.Volume level set by participant (left),CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,35151,-2.43411922615705e-05,0.0298948646473701,-0.058618275901107,0.0585695935165838,0.999350366088273
Physical measures,X4270.Volume level set by participant (left),SKIV2L,Helicase SKI2W,35079,3.71546599216752e-05,0.058183573469947,-0.114002649341174,0.114076958661018,0.999490509411339
Physical measures,X4270.Volume level set by participant (left),SERPIND1,Heparin cofactor 2,35317,-3.57971539217005e-05,0.074490136711346,-0.14603646510816,0.145964870800317,0.999616581025459
